uric acid has been researched along with Obesity in 855 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the characteristics of female versus male gout patients and assess urate-lowering efficacy and safety of febuxostat or allopurinol treatment in women with gout." | 9.16 | Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol. ( Becker, MA; Chefo, S; Chohan, S; Jackson, RL; MacDonald, PA, 2012) |
| "The purpose of this study was to compare urate-lowering (UL) efficacy and safety of daily febuxostat and allopurinol in subjects with gout and serum urate (sUA) > or = 8." | 9.14 | The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial. ( Becker, MA; Espinoza, LR; Lademacher, C; Lloyd, E; MacDonald, P; Schumacher, HR; Wells, AF, 2010) |
| "An assessment of the effects of ezetimibe and orlistat administration, alone or in combination, on LDL-C and sdLDL-C levels (primary endpoint), as well as on anthropometric variables and metabolic parameters (secondary endpoints) in overweight and obese patients [body mass index (BMI)>28 kg/m(2)] with hypercholesterolaemia [total cholesterol>200 mg/dL (5." | 9.13 | The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemia. ( Elisaf, MS; Filippatos, TD; Georgoula, M; Kiortsis, DN; Mikhailidis, DP; Nakou, ES; Tselepis, AD, 2008) |
| "Serum uric acid levels were measured in 40 polycystic ovary syndrome (PCOS) patients and 40 non-hyperandrogenic women matched for BMI and grade of obesity, and were followed-up in 34 PCOS patients who were randomized to an oral contraceptive containing 35 mg ethinyl-estradiol plus 2 mg cyproterone acetate (Diane(35) Diario) or metformin (850 mg twice daily) for 24 weeks." | 9.13 | Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin. ( Alvarez-Blasco, F; Escobar-Morreale, HF; Luque-Ramírez, M; Uriol Rivera, MG, 2008) |
| "The aim of this study was to determine whether the severity of sleep-disordered breathing (SDB) was associated with increased levels of uric acid (UA), both in serum and in urine, as a marker of tissue hypoxia, in a sample of overweight and obese subjects, irrespective of indexes of adiposity." | 9.12 | Sleep-disordered breathing and uric acid in overweight and obese children and adolescents. ( De Backer, WA; Desager, KN; Haentjens, D; Rooman, R; Schrauwen, N; Van Gaal, L; Van Hoeck, K; Verhulst, SL, 2007) |
| "Gout is characterized by high serum uric acid (SUA) levels and arthritis." | 9.01 | Impact of bariatric surgery on serum uric acid levels and the incidence of gout-A meta-analysis. ( Kaushal, S; Koura, A; Lim, B; Oo, AM; Rao, J; Syn, N; Yeo, C; Yeo, D, 2019) |
| "After adjustment for age, body mass index, and other covariates, the relative risks (RRs) of developing hypertension comparing the highest and lowest uric acid quartiles were 1." | 8.85 | Plasma uric acid and hypertension in a Chinese community: prospective study and metaanalysis. ( Hu, FB; Hui, R; Sun, K; Yang, Y; Zhang, H; Zhang, W, 2009) |
| " Measurements of anthropometric parameters, blood pressure, fasting blood glucose, insulin concentration, insulin resistance (HOMA-IR), lipid profile, C reactive protein, uric acid, resistin and prevalence of Metabolic Syndrome were determined." | 8.31 | Resistin/uric acid index as a marker of metabolic syndrome in females with obesity. ( de Luis, D; Izaola, O; Primo, D, 2023) |
| "This cohort study intended to elucidate the association between serum uric acid (SUA) levels and cardiovascular disease events in Japanese patients with obesity." | 8.31 | Novel pathological implications of serum uric acid with cardiovascular disease risk in obesity. ( Kasahara, M; Kasama, S; Kato, H; Kato, S; Kusakabe, T; Ozu, N; Satoh-Asahara, N; Tanaka, M; Wakabayashi, D; Yamakage, H, 2023) |
| "To investigate the relationship between fibrinogen-like protein 1 (FGL-1) concentrations and various metabolic characteristics in patients with polycystic ovary syndrome (PCOS) and explore whether FGL-1 could be a predictive biomarker for PCOS." | 8.12 | Serum fibrinogen-like protein 1 as a novel biomarker in polycystic ovary syndrome: a case-control study. ( Cai, M; Chen, D; Dilimulati, D; Gao, X; Qu, S; Shao, X; Sun, H; You, H; Zhang, M; Zhang, Y, 2022) |
| " Ongoing research is examining the association of obesity, dietary patterns, and blood pressure (BP) with serum uric acid (sUA)." | 8.12 | Correlation of obesity, dietary patterns, and blood pressure with uric acid: data from the NHANES 2017-2018. ( Fan, GJ; Lin, YP; Lu, QY; Yao, J; Zhang, Y; Zhao, J, 2022) |
| "To investigate whether serum uric acid (SUA) levels and hyperuricemia can be predictive biomarkers of incident metabolic syndrome(MS) among different body mass index(BMI) categories, and to investigate SUA cutoffs that best discriminate individuals with incident MS." | 8.12 | Serum uric acid is a predictive biomarker of incident metabolic syndrome at the Brazilian longitudinal study of adult Health (ELSA - Brasil). ( B Duncan, B; Haueisen Sander Diniz, MF; Inês Schmidt, M; Isabel Rodrigues Galvão, A; Luiz P Ribeiro, A; M Benseñor, I; M R Beleigoli, A; Maria Barreto, S; Vidigal, PG; Weiss Telles, R, 2022) |
| "Undoubtedly, the relationship between serum uric acid (SUA) and obesity is less data for Chinese patients with obesity." | 8.12 | Prevalence of hyperuricemia in patients with severe obesity and the relationship between serum uric acid and severe obesity: A decade retrospective cross-section study in Chinese adults. ( Chan, W; Cheang, C; Dong, Z; Law, S; Ren, J; Wang, C, 2022) |
| " Additionally, anthropometric parameters (height, weight, BMI, waist circumference, hip circumference) such as lab data including lipid profile (triglycerides, HDL, LDL), liver function parameters (ALT, AST), uric acid, glucose metabolism (fasting insulin and glucagon, HbA1c, glucose 120 min) and indices evaluating insulin resistance (HIRI, SPISE, HOMA-IR, WBISI) were measured." | 8.12 | Determinants of hyperglucagonemia in pediatric non-alcoholic fatty liver disease. ( Ahlström, H; Bergsten, P; Forslund, A; Kullberg, J; Manell, H; Mangge, H; Maruszczak, K; Mörwald, K; Pixner, T; Radzikowski, K; Schütz, S; Weghuber, D, 2022) |
| " Anthropometric measurements, fasting glucose, fasting insulin, homeostasis model assessment of insulin resistance (HOMA-IR), HOMA- β (%), lipids profile, monocyte to lymphocyte ratio (MLR), neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), uric acid, gamma glutamyl transpeptidase (GGT), AST/ALT ratio and total bilirubin were assessed." | 8.12 | Association Between Total Bilirubin Levels and Cardio-Metabolic Risk Factors Related to Obesity. ( Asar, M; El-Eshmawy, MM; Elsehely, I; Mahsoub, N, 2022) |
| "Elevated serum uric acid (SUA) levels, body shape index (BSI) and body roundness index (BRI) were associated with incident metabolic syndrome (MetS)." | 8.02 | Serum uric acid is associated with incident metabolic syndrome independent of body shape index and body roundness index in healthy individuals. ( Chen, CC; Liu, CW; Tseng, GS; Tu, CM; Wei, TE, 2021) |
| "This study aims to investigate the correlation between serum uric acid levels and body fat distribution in patients with polycystic ovary syndrome (PCOS)." | 8.02 | Correlation Between Serum Uric Acid and Body Fat Distribution in Patients With Polycystic Ovary Syndrome. ( Cai, M; Cui, R; Dilimulati, D; Fei, H; Gao, X; Lin, Z; Qu, S; Shao, X; Sun, H; Zeng, Q; Zhang, M; Zhang, Y, 2021) |
| "This cross-sectional study investigates the association between insulin resistance (IR) and serum uric acid (sUA) and relative fat (RFM) and lean mass (RLM) profiles in children with chronic kidney disease (CKD)." | 8.02 | Association between relative fat mass, uric acid, and insulin resistance in children with chronic kidney disease. ( Christoforidis, A; Dotis, J; Karava, V; Kollios, K; Kondou, A; Liakopoulos, V; Papachristou, F; Printza, N; Tsioni, K, 2021) |
| " Thus, this study investigated whether the XOR inhibitor, topiroxostat, affected body weight." | 8.02 | Influence of xanthine oxidoreductase inhibitor, topiroxostat, on body weight of diabetic obese mice. ( Akari, S; Katoh, N; Mizukami, H; Murase, T; Nakamura, T; Nampei, M; Satoh, E, 2021) |
| "We aimed to investigate the association between serum uric acid (SUA) and all-cause or cardiovascular mortality among participants with obesity." | 7.96 | Relationship between serum uric acid level and all-cause and cardiovascular mortality in population with obesity. ( Chen, CL; Feng, YQ; Huang, JY; Huang, YQ; Li, J; Liu, L; Lo, K; Sun, S; Zhang, B, 2020) |
| "This study shows, for the first time, that 1) an unexpectedly high percentage (69%) of overweight/obese subjects is affected by hypertension; 2) early hypertensive subjects have an increased eGFR and higher FT4 serum levels; 3) lower potassium and uric acid levels are independent predictors of pathological nocturnal non-dipping." | 7.91 | Uric Acid and Potassium Serum Levels Are Independent Predictors of Blood Pressure Non-Dipping in Overweight or Obese Subjects. ( Boninfante, B; Castellana, F; De Pergola, G; Giannelli, G; Lampignano, L; Lattanzio, A; Sardone, R; Zupo, R, 2019) |
| "The aim of this study was to assess the association between serum uric acid concentration (SUAC) and the parameters of the metabolic syndrome (MetS) and insulin resistance (IR)." | 7.91 | Associations Between Serum Uric Acid Concentrations and Cardiometabolic Risk and Renal Injury in Obese and Overweight Children ( Ersoy, B; Özalp Kızılay, D; Şen, S, 2019) |
| " Elevated serum uric acid has been demonstrated to be associated with obesity in the adult population in many countries; however, there is still a lack of evidence for the Bangladeshi population." | 7.88 | Prevalence of hyperuricemia and the relationship between serum uric acid and obesity: A study on Bangladeshi adults. ( Ahmed, S; Ali, N; Haque, T; Islam, F; Islam, S; Kathak, RR; Mahmood, S; Mohanto, NC; Molla, NH; Nurunnabi, SM; Perveen, R; Rahman, M; Rahman, S; Sumon, AH, 2018) |
| "To disclose the link between the composition of urolithiasis, especially that of uric acid calculi, and obesity, prediabetes, type 2 diabetes mellitus, and hypertension." | 7.85 | The Association of Uric Acid Calculi with Obesity, Prediabetes, Type 2 Diabetes Mellitus, and Hypertension. ( Chang, CC; Chu, FY; Ho, JL; Huang, PH; Ku, PW; Lin, YN; Su, MJ; Sun, JT; Yen, TH, 2017) |
| "Obesity is a common chronic disease, and elevated serum uric acid has been suggested to be associated with obesity." | 7.85 | Serum Uric Acid Levels and the Risk of Obesity: a Longitudinal Population-Based Epidemiological Study. ( Chen, C; Chen, Q; Lu, R; Mao, Y; Yang, T; Zheng, R, 2017) |
| "We aim to explore the associations between serum uric acid (SUA) and obesity and cardio-cerebrovascular events (CCEs) in Chinese inpatients with type 2 diabetes mellitus (T2DM)." | 7.85 | Serum uric acid levels are associated with obesity but not cardio-cerebrovascular events in Chinese inpatients with type 2 diabetes. ( Bao, YQ; Chen, MY; Jia, WP; Li, LX; Li, TT; Yu, TP; Zhao, CC; Zhu, Y, 2017) |
| "To investigate the association between serum direct bilirubin (DBIL) with metabolic syndrome (MS) and its components." | 7.83 | [Association between serum direct bilirubin with metabolic syndrome and its components based on a longitudinal health check-up study]. ( Chen, L; Chen, Q; Chen, X; Wang, S; Xiao, J; Zhang, P, 2016) |
| "Elevated uric acid (UA) is associated with the presence of the metabolic syndrome (MetS)." | 7.83 | Overweight modifies the longitudinal association between uric acid and some components of the metabolic syndrome: The Tromsø Study. ( Eriksen, BO; Jenssen, TG; Norvik, JV; Solbu, MD; Storhaug, HM; Ytrehus, K; Zykova, SN, 2016) |
| " We evaluated the association between serum uric acid and uACR in persons with 0, and 1-2 metabolic syndrome (MetS) components and determined the modification effects of visceral adiposity index (VAI), mean arterial pressure (MAP), and fasting glucose on this association." | 7.83 | The Impact of Blood Pressure and Visceral Adiposity on the Association of Serum Uric Acid With Albuminuria in Adults Without Full Metabolic Syndrome. ( Bruthans, J; Cifkova, R; Hamet, P; Krajcoviechova, A; Tahir, MR; Tremblay, J; Wohlfahrt, P, 2016) |
| " Linear regression was used to evaluate associations between uric acid and clinical and laboratory findings associated with metabolic syndrome." | 7.81 | [Metabolic complications of obesity during adolescence, particularly regarding elevated uric acid levels]. ( Almási, A; Barkai, L; Fehér, V; Kiss-Tóth, E; Ságodi, L, 2015) |
| "High serum uric acid was positively associated with obesity in overweight and obesity group." | 7.81 | Association between serum uric acid levels and obesity among university students (China). ( Chen, Y; Duan, Y; He, L; Jin, Y; Liang, W; Nie, Z; Wang, L; Yao, Y; Zhang, T; Zhu, L, 2015) |
| "Uric acid (UA) is associated with high blood pressure in adolescents and with left ventricular hypertrophy (LVH) and cardiovascular disease (CVD) in adults." | 7.81 | Elevated uric acid and obesity-related cardiovascular disease risk factors among hypertensive youth. ( Appel, LJ; Brady, TM; Fadrowski, JJ; Holmes, KW; Loeffler, LF; Miller, ER; Reschke, LD, 2015) |
| "The purpose of the present study was to investigate multiple anthropometric parameters used to evaluate obesity, particularly visceral abdominal fat area, and various metabolic parameters including malondialdehyde (MDA) as an oxidative stress marker." | 7.81 | Urinary Malondialdehyde Is Associated with Visceral Abdominal Obesity in Middle-Aged Men. ( Cho, AR; Cho, YH; Han, J; Hwang, HR; Jeon, JS; Jeong, DW; Kim, YJ; Lee, JG; Lee, SH; Lee, SM; Lee, SY; Park, EJ; Tak, YJ; Yi, YH, 2015) |
| " We evaluated whether alterations in levels of circulating uric acid (UA), a systemic antioxidant, affects the following: 1) systemic (plasma and saliva) nonenzymatic antioxidant capacity (NEAC); 2) markers of systemic (urinary 8-iso-prostaglandin-F2α) and muscle (carbonylated protein content) oxidative stress; and 3) whole-body insulin sensitivity (percentage increase in glucose uptake during a hyperinsulinemic-euglycemic clamp procedure)." | 7.80 | Effect of plasma uric acid on antioxidant capacity, oxidative stress, and insulin sensitivity in obese subjects. ( Colic Baric, I; Fabbrini, E; Hazen, SL; Klein, S; Serafini, M, 2014) |
| "Serum uric acid (UA) is now beginning to be considered a risk predictor for cardiovascular diseases." | 7.80 | Serum uric acid as a risk predictor for erectile dysfunction. ( Heydari, R; Mehrsai, A; Pourmand, G; Salem, S, 2014) |
| "This study investigated the correlation between elevated serum uric acid (SUA) and angiotensinogen in obesity patients with hypertension." | 7.80 | Elevated serum uric acid is associated with angiotensinogen in obese patients with untreated hypertension. ( Chen, B; Deng, W; Zhang, J; Zhang, Y, 2014) |
| "To evaluate whether uric acid (UA) predicts 4-yr incidence of metabolic syndrome (MetS) in non-diabetic participants of the Strong Heart Study (SHS) cohort." | 7.80 | Serum uric acid does not predict incident metabolic syndrome in a population with high prevalence of obesity. ( de Simone, G; Devereux, RB; Ferrara, LA; Franceschini, N; Howard, BV; Jolly, S; Lee, ET; Umans, JG; Wang, H; Yeh, J, 2014) |
| "To elucidate links of blood serum uric acid level (SUAL) with cardiometabolic risk factors (CMR) in adolescent boys with arterial hypertension (AH)." | 7.80 | [Uric acid and factors of cardiometabolic risk in adolescents with arterial hypertension]. ( Dolgikh, VV; Pogodina, AV; Rychkova, LV, 2014) |
| "To study the relationship between serum uric acid (SUA) level and metabolic syndrome (MS) in Uygur children and adolescents with overweight or obesity." | 7.80 | [Relationship between serum uric acid level and metabolic syndrome in Uygur children and adolescents with overweight or obesity]. ( Li, M; Mao, JF; Yi, LD; Zhang, MC, 2014) |
| "The predictive value of serum uric acid (SUA) for adverse cardiovascular events among obese and overweight patients is not known, but potentially important because of the relation between hyperuricaemia and obesity." | 7.79 | Uric acid as a risk factor for cardiovascular disease and mortality in overweight/obese individuals. ( Andersson, C; Caterson, ID; Coutinho, W; Finer, N; James, WP; Maggioni, AP; Sharma, AM; Skak-Nielsen, H; Torp-Pedersen, C; Van Gaal, L, 2013) |
| "The objective of this study was to examine the association between uric acid, GGT, obesity and the individual components of metabolic syndrome in children and adolescents." | 7.79 | Associations of uric acid and gamma-glutamyltransferase (GGT) with obesity and components of metabolic syndrome in children and adolescents. ( Chan, CW; Chan, JC; Chan, MH; Choi, KC; Ho, CS; Kong, AP; Ozaki, R, 2013) |
| "Substance P (SP) is an important neurotransmitter and is an important pathogenic factor in obesity." | 7.77 | Substance P is associated with the development of obesity, chronic inflammation and type 2 diabetes mellitus. ( Fu, J; Li, G; Liu, B; Liu, L; Liu, P; Liu, X; Wu, B, 2011) |
| " Studies on the association between serum uric acid (sUA) and metabolic syndrome (MetS) in juvenile obesity are scant." | 7.77 | Gender-specific association of serum uric acid with metabolic syndrome and its components in juvenile obesity. ( Chrzanowska, J; Gamian, A; Krzystek-Korpacka, M; Kustrzeba-Wojcicka, I; Noczynska, A; Patryn, E, 2011) |
| "Hyperuricemia may underlie obesity and related disorders, but the impact of weight reduction and metformin on serum uric acid (sUA) in Caucasian children/adolescents is unknown." | 7.77 | The effect of a one-year weight reduction program on serum uric acid in overweight/obese children and adolescents. ( Chrzanowska, J; Gamian, A; Krzystek-Korpacka, M; Kustrzeba-Wojcicka, I; Noczynska, A; Patryn, E, 2011) |
| " The objective of this study was to analyze the relationships of leptin, C-reactive protein (CRP), adiponectin, insulin, and uric acid to the metabolic syndrome components in lean, overweight, and obese young females." | 7.75 | Analysis of the relationship of leptin, high-sensitivity C-reactive protein, adiponectin, insulin, and uric acid to metabolic syndrome in lean, overweight, and obese young females. ( Abdullah, AR; Hasan, HA; Raigangar, VL, 2009) |
| "The effects of exercise and serum uric acid on the metabolic syndrome (MetS) were evaluated." | 7.74 | Effects of exercise and serum uric acid on the metabolic syndrome for Japanese workers. ( Amezawa, M; Kawada, T, 2008) |
| "The aim of this study was to examine whether serum uric acid (SUA) concentration was related to the metabolic syndrome (MS)." | 7.74 | Serum uric acid is significantly related to the components of the metabolic syndrome in Japanese workingmen. ( Katsumata, M; Kawada, T; Otsuka, T; Suzuki, H, 2007) |
| "The link between uric acid levels and metabolic syndrome was investigated." | 7.74 | Comparison of serum uric acid levels between Japanese with and without metabolic syndrome. ( Makino, H; Miyatake, N; Numata, T; Wada, J, 2008) |
| "The purpose of this study was to assess whether increasing serum uric acid (UA) levels are related to cardiovascular disease (CVD) mortality, all-cause mortality, and incident (fatal and nonfatal) myocardial infarction (MI) in men from the general population taking into account C-reactive protein (CRP), a sensitive marker of systemic inflammation." | 7.74 | Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population: the MONICA/KORA cohort study. ( Baumert, J; Döring, A; Koenig, W; Meisinger, C, 2008) |
| "The levels of the liporegulatory hormone leptin are increased in obesity, which contributes to the metabolic syndrome; the latter is associated with elevated cardiovascular risk and morbidity." | 7.73 | Gender-specific leptinemia and its relationship with some components of the metabolic syndrome in Moroccans. ( Chraibi, A; Israili, ZH; Lyoussi, B; Mguil, M; Ragala, MA, 2005) |
| "In adults, serum uric acid levels are positively correlated with body mass index (BMI) and hyperuricemia is considered to be a common lifestyle disorder related with obesity." | 7.73 | Serum uric acid as an obesity-related indicator in early adolescence. ( Komatsu, K; Miyashita, M; Ohno, T; Oyama, C; Oyamada, M; Oyamada, T; Saito, S; Takada, G; Takahashi, T; Takashina, K, 2006) |
| "Abdominal obesity is the main determinant of uric acid variance." | 7.73 | Serum uric acid is a determinant of metabolic syndrome in a population-based study. ( Albayrak, S; Hergenç, G; Karabulut, A; Keleş, I; Onat, A; Sari, I; Uyarel, H; Yazici, M, 2006) |
| "The aim of the study was to assess the influence of overweight and obesity on the risk of calcium oxalate stone formation." | 7.72 | The role of overweight and obesity in calcium oxalate stone formation. ( Glatz, S; Hesse, A; Nicolay, C; Siener, R, 2004) |
| "Body weight and BP decreased significantly in the diet group but not in the troglitazone group at the end of the intervention periods." | 7.71 | Decreases in serum uric acid by amelioration of insulin resistance in overweight hypertensive patients: effect of a low-energy diet and an insulin-sensitizing agent. ( Kamide, K; Kawano, Y; Minami, J; Tsunoda, S, 2002) |
| " The aim of this study was to analyse the role of different variables of metabolic syndrome, including leptin, in 74 non-obese children and 68 children with non-syndromal obesity." | 7.71 | Leptin and metabolic syndrome in obese and non-obese children. ( Bueno, M; Fleta, J; Giner, A; Juste, MG; Moreno, LA; Pineda, I; Rodríguez, G; Sarría, A, 2002) |
| "To examine the relation between fitness and fibrinogen, white blood cell count, uric acid and metabolic syndrome across levels of adiposity in apparently healthy, nonsmoking men." | 7.71 | Relative associations of fitness and fatness to fibrinogen, white blood cell count, uric acid and metabolic syndrome. ( Blair, SN; Church, TS; Earnest, CP; Finley, CE; Gibbons, LW; Kampert, JB, 2002) |
| "Patients with LBS demonstrated similar metabolic features in terms of insulin sensitivity and hyperleptinemia as patients with "simple" truncal obesity." | 7.71 | Insulin resistance, hyperleptinemia, and obstructive sleep apnea in Launois-Bensaude syndrome. ( Ficker, JH; Fuchs, FS; Hahn, EG; Harsch, IA; Konturek, PC; Lohmann, T; Schahin, SP, 2002) |
| "The aim of this study was to elucidate the relationship between serum leptin levels and fatty liver in male adolescents." | 7.70 | Relationship between serum leptin and fatty liver in Japanese male adolescent university students. ( Higashi, T; Imai, A; Iwasaki, Y; Matsuura, K; Ogura, T; Shimomura, H; Tobe, K; Tsuji, T; Tsukamoto, C, 1999) |
| "Various epidemiologic studies have linked an increase in serum uric acid level to an increased risk of coronary heart disease." | 7.69 | Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome. The Normative Aging Study. ( Landsberg, L; Lee, J; Sparrow, D; Vokonas, PS; Weiss, ST, 1995) |
| "To examine the relationships of serum uric acid concentration with several risk factors of cardiovascular diseases (CVD)." | 7.69 | Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. ( Bonora, E; Branzi, P; Cacciatori, V; Muggeo, M; Saggiani, F; Santi, L; Targher, G; Tosi, F; Travia, D; Zenere, MB; Zenti, MG, 1996) |
| "The uric acid concentration was significantly higher in postmenopausal versus premenopausal women." | 6.69 | The effect of menopause on serum uric acid levels in non-obese healthy women. ( Stevenson, JC; Walton, C; Wingrove, CS, 1998) |
| "Hyperuricemia has long been known to be associated with cardiovascular disease, and it is particularly common in people with hypertension, metabolic syndrome, or kidney disease." | 6.43 | Role of uric acid in hypertension, renal disease, and metabolic syndrome. ( Heinig, M; Johnson, RJ, 2006) |
| "This study focused on the visceral obesity defined by increased visceral fat area." | 5.72 | The abundance of bifidobacterium in relation to visceral obesity and serum uric acid. ( Gao, H; Gong, H; He, J; Ren, Q, 2022) |
| "Phthalimide derivatives have been extensively researched with various biological actions." | 5.72 | Antihyperlipidemic Activity of Glycoconjugated Phthalimides in Mice Submitted to a Model of Dyslipidemia and Insulin Resistance. ( da Rocha, IG; da Silva Júnior, JG; da Silva Neto, JC; de Araújo, HDA; de Menezes Lima, VL; de Oliveira Assis, SP; Oliveira, RN, 2022) |
| "Obesity has been demonstrated to show a consistent link with the increased possibility of nonalcoholic fatty liver disease (NAFLD)." | 5.62 | Serum Uric Acid Is a Mediator of the Association Between Obesity and Incident Nonalcoholic Fatty Liver Disease: A Prospective Cohort Study. ( Chen, S; Jiao, Y; Ma, X; Shi, H; Sun, X; Wu, S; Xing, J; Yang, R; Zhang, Q; Zhang, S, 2021) |
| "Obesity is a risk factor for periodontal disease (PD)." | 5.62 | Obesity-Related Gut Microbiota Aggravates Alveolar Bone Destruction in Experimental Periodontitis through Elevation of Uric Acid. ( Kato, T; Miura, N; Nakanishi, Y; Ohno, H; Okuda, S; Sato, K; Tsuzuno, T; Yamada-Hara, M; Yamazaki, K; Yokoji-Takeuchi, M, 2021) |
| "As uric acid levels increase there is a relevant clustering of metabolic risk factors, whereas elevated blood pressure is the risk factor less frequently present." | 5.48 | Uric acid is linked to cardiometabolic risk factors in overweight and obese youths. ( Alvarez-Pitti, J; Borghi, C; Lurbe, E; Redon, J; Redon, P; Torro, MI, 2018) |
| "Hyperuricemia is associated with metabolic syndrome (MetS), but the association is often confounded by the shared background of obesity." | 5.46 | Combined effect of obesity and uric acid on nonalcoholic fatty liver disease and hypertriglyceridemia. ( Du, T; Li, M; Lin, X; Lu, H; Yu, X; Zhang, S, 2017) |
| "The prevalence rates of NAFLD were 71." | 5.43 | Serum uric acid is independently and linearly associated with risk of nonalcoholic fatty liver disease in obese Chinese adults. ( Chen, N; He, CM; Li, X; Li, Z; Liu, CQ; Liu, S; Liu, Y; Shi, X; Wang, D; Yan, B; Yang, S; Zeng, X, 2016) |
| "Obesity is often accompanied by hyperuricemia." | 5.39 | Uric acid secretion from adipose tissue and its increase in obesity. ( Funahashi, T; Imaizumi, K; Kato, K; Maeda, N; Nagao, H; Nakatsuji, H; Nishizawa, H; Sekimoto, R; Shimomura, I; Shirakura, T; Takahashi, H; Tamura, M; Tochino, Y; Tsushima, Y, 2013) |
| "In conclusion, weight loss is effective in treating obese children with SDB." | 5.38 | Weight loss and sleep-disordered breathing in childhood obesity: effects on inflammation and uric acid. ( Aerts, P; De Backer, WA; Debode, P; Desager, KN; Franckx, H; Ramet, J; Van Gaal, LF; Van Hoorenbeeck, K; Verhulst, SL; Wouters, K, 2012) |
| "Hyperuricemia was defined as SUA ≥70 mg/L in men and ≥60 mg/L in women." | 5.38 | Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome. ( Gonçalves, JP; Lopes, C; Oliveira, A; Santos, AC; Severo, M, 2012) |
| "Moreover, hyperuricemia is significantly correlated with hypertriglyceridemia, hypertension, and visceral obesity." | 5.35 | Serum uric acid levels and risk of metabolic syndrome in healthy adults. ( Bandarian, F; Ebrahimpour, P; Fakhrzadeh, H; Heshmat, R; Larijani, B, 2008) |
| "Hyperuricemia is part of the "metabolic syndrome"." | 5.32 | Serum uric acid levels in obese children and adolescents: linkage to testosterone levels and pre-metabolic syndrome. ( Debatin, KM; Denzer, C; Heinze, E; Mayer, H; Muche, R; Wabitsch, M, 2003) |
| "Addition of fructose to the diet of normal weight and overweight subjects can increase postprandial plasma triglyceride and uric acid concentration." | 5.24 | Metabolic Effects of Replacing Sugar-Sweetened Beverages with Artificially-Sweetened Beverages in Overweight Subjects with or without Hepatic Steatosis: A Randomized Control Clinical Trial. ( Boesch, C; Brandejsky, V; Campos, V; Despland, C; Kreis, R; Schneiter, P; Tappy, L, 2017) |
| "Fructose acutely raises serum uric acid in normal subjects, but the effect in subjects with metabolic syndrome or subjects with chronic kidney disease is unknown." | 5.20 | The fructose tolerance test in patients with chronic kidney disease and metabolic syndrome in comparison to healthy controls. ( Donderski, R; Grajewska, M; Johnson, RJ; Junik, R; Kamińska, A; Kretowicz, M; Lanaspa, M; Manitius, J; Miśkowiec-Wiśniewska, I; Odrowąż-Sypniewska, G; Pluta, A; Siódmiak, J; Stefańska, A, 2015) |
| "To compare the characteristics of female versus male gout patients and assess urate-lowering efficacy and safety of febuxostat or allopurinol treatment in women with gout." | 5.16 | Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol. ( Becker, MA; Chefo, S; Chohan, S; Jackson, RL; MacDonald, PA, 2012) |
| "The purpose of this study was to compare urate-lowering (UL) efficacy and safety of daily febuxostat and allopurinol in subjects with gout and serum urate (sUA) > or = 8." | 5.14 | The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial. ( Becker, MA; Espinoza, LR; Lademacher, C; Lloyd, E; MacDonald, P; Schumacher, HR; Wells, AF, 2010) |
| "An assessment of the effects of ezetimibe and orlistat administration, alone or in combination, on LDL-C and sdLDL-C levels (primary endpoint), as well as on anthropometric variables and metabolic parameters (secondary endpoints) in overweight and obese patients [body mass index (BMI)>28 kg/m(2)] with hypercholesterolaemia [total cholesterol>200 mg/dL (5." | 5.13 | The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemia. ( Elisaf, MS; Filippatos, TD; Georgoula, M; Kiortsis, DN; Mikhailidis, DP; Nakou, ES; Tselepis, AD, 2008) |
| "Serum uric acid levels were measured in 40 polycystic ovary syndrome (PCOS) patients and 40 non-hyperandrogenic women matched for BMI and grade of obesity, and were followed-up in 34 PCOS patients who were randomized to an oral contraceptive containing 35 mg ethinyl-estradiol plus 2 mg cyproterone acetate (Diane(35) Diario) or metformin (850 mg twice daily) for 24 weeks." | 5.13 | Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin. ( Alvarez-Blasco, F; Escobar-Morreale, HF; Luque-Ramírez, M; Uriol Rivera, MG, 2008) |
| "The aim of this study was to determine whether the severity of sleep-disordered breathing (SDB) was associated with increased levels of uric acid (UA), both in serum and in urine, as a marker of tissue hypoxia, in a sample of overweight and obese subjects, irrespective of indexes of adiposity." | 5.12 | Sleep-disordered breathing and uric acid in overweight and obese children and adolescents. ( De Backer, WA; Desager, KN; Haentjens, D; Rooman, R; Schrauwen, N; Van Gaal, L; Van Hoeck, K; Verhulst, SL, 2007) |
| " Patients treated with olanzapine, however, had significantly greater weight gain and increases in the levels of hepatic enzymes, prolactin, fasting glucose, fasting total cholesterol, and uric acid." | 5.12 | Olanzapine versus placebo in the treatment of adolescents with bipolar mania. ( Biederman, J; Carlson, G; Delbello, M; Dittmann, RW; Findling, R; Kowatch, R; Kryzhanovskaya, L; Lin, D; Robertson-Plouch, C; Tohen, M; Wagner, K; Wozniak, J; Xu, W, 2007) |
| "We performed the present study to determine the degree of visceral fat accumulation and incidence of visceral fat obesity in 138 gout patients who were classified as overexcretion type (n = 53) and underexcretion type (n = 85) by their levels of uric acid clearance and urinary uric acid excretion." | 5.09 | Increased visceral fat accumulation further aggravates the risks of insulin resistance in gout. ( Hada, T; Moriwaki, Y; Takahashi, S; Tsutsumi, Z; Yamakita , J; Yamamoto, T, 2001) |
| " In the present review, we summarize experimental data on the potential biological mechanisms linking fructose and uric acid in the development of insulin resistance, metabolic syndrome, obesity, diabetes, hypertension, non-alcoholic fatty liver disease and chronic renal disease, thereby contributing to an increase in cardiovascular risk at pediatric age." | 5.05 | Fructose and Uric Acid: Major Mediators of Cardiovascular Disease Risk Starting at Pediatric Age. ( Esposito, P; Garibotto, G; Leoncini, G; Pontremoli, R; Russo, E; Viazzi, F, 2020) |
| "Gout is characterized by high serum uric acid (SUA) levels and arthritis." | 5.01 | Impact of bariatric surgery on serum uric acid levels and the incidence of gout-A meta-analysis. ( Kaushal, S; Koura, A; Lim, B; Oo, AM; Rao, J; Syn, N; Yeo, C; Yeo, D, 2019) |
| "Gout is the most common form of inflammatory arthropathy and is caused by an excess of uric acid in the blood (hyperuricemia)." | 4.95 | Change gout: the need for a new approach. ( Punzi, L, 2017) |
| "Diabetes and obesity are already recognized as potential risk factors for nephrolithiasis, especially for uric acid stones." | 4.95 | Kidney stones diseases and glycaemic statuses: focus on the latest clinical evidences. ( Angelini, C; Badalamenti, S; Gambaro, G; Maringhini, S; Spatola, L, 2017) |
| " The link between increased fructose consumption and increases in uric acid also has been confirmed as a potential risk factor for metabolic syndrome, and insulin resistance/hyperinsulinemia may be causally related to the development of hypertension." | 4.91 | Health implications of high-fructose intake and current research. ( de Lima, WG; Dornas, WC; Pedrosa, ML; Silva, ME, 2015) |
| "There is an increased prevalence of nephrolithiasis and an increase in the incidence of renal colic in patients with diabetes, obesity, hypertension and insulin resistance because of an increased frequency of uric acid crystallization." | 4.88 | Beware the low urine pH--the major cause of the increased prevalence of nephrolithiasis in the patient with type 2 diabetes. ( Bell, DS, 2012) |
| "During the past few decades, the mean serum uric acid levels and the prevalence of hyperuricemia in the general population appear to have increased." | 4.87 | The epidemiology of uric acid and fructose. ( Choi, HK; Rho, YH; Zhu, Y, 2011) |
| "After adjustment for age, body mass index, and other covariates, the relative risks (RRs) of developing hypertension comparing the highest and lowest uric acid quartiles were 1." | 4.85 | Plasma uric acid and hypertension in a Chinese community: prospective study and metaanalysis. ( Hu, FB; Hui, R; Sun, K; Yang, Y; Zhang, H; Zhang, W, 2009) |
| "Hyperuricemia (serum urate level >7 mg/dL) is caused by accelerated generation of uric acid and/or impaired excretion in the kidney." | 4.84 | [Definition and classification of hyperuricemia]. ( Yamamoto, T, 2008) |
| "The association of elevated serum uric acid (hyperuricemia, gout) with the presence of classical coronary risk factors and coronary artery disease (CAD) or myocardial infarction (MI) has been analysed in many epidemiological studies." | 4.83 | [Is hyperuricemia a cardiovascular risk factor?]. ( Chizyński, K; Rózycka, M, 2006) |
| "The therapy of gout is discussed taking into consideration the concomitant diseases occurring significantly frequently in patients with gout: Hypertension, uric acid-nephrolithiasis, hyperlipoproteinaemia, obesity, premature arteriosclerosis as well as diabetes mellitus." | 4.75 | [Therapy of gout]. ( Heidelmann, G; Thiele, P, 1977) |
| " In the stratified analysis by uric acid levels, the prevalence of NAFLD was significantly higher in participants with MHO, MUNW, and MUO in the hyperuricemia group than those in the normal uric acid group, and the interaction effect of metabolic phenotypes and uric acid on NAFLD was statistical significant (P < 0." | 4.31 | Hyperuricemia as an effect modifier of the association between metabolic phenotypes and nonalcoholic fatty liver disease in Chinese population. ( Li, X; Miao, Y; Zhang, Q; Zhang, Y; Zheng, J, 2023) |
| " Measurements of anthropometric parameters, blood pressure, fasting blood glucose, insulin concentration, insulin resistance (HOMA-IR), lipid profile, C reactive protein, uric acid, resistin and prevalence of Metabolic Syndrome were determined." | 4.31 | Resistin/uric acid index as a marker of metabolic syndrome in females with obesity. ( de Luis, D; Izaola, O; Primo, D, 2023) |
| "The aim of this study was to examine trends in serum uric acid (SUA) levels over a recent 5-year period according to age, sex, obesity, and abdominal obesity among Korean children and adolescents." | 4.31 | Trends in serum uric acid levels among Korean children and adolescents between 2016 and 2020: a nationwide study. ( Kim, EY; Kwon, YJ; Lee, HW; Lee, JW; Son, NH, 2023) |
| " The metabolism-related index, including obesity, bone mineral density (BMD), and serum uric acid (SUA), was obtained from examination data." | 4.31 | Comprehensive evaluation of serum cotinine on human health: Novel evidence for the systemic toxicity of tobacco smoke in the US general population. ( Hu, Y; Hua, L; Lei, T; Li, M; Yang, J; Zhu, Z, 2023) |
| "This cohort study intended to elucidate the association between serum uric acid (SUA) levels and cardiovascular disease events in Japanese patients with obesity." | 4.31 | Novel pathological implications of serum uric acid with cardiovascular disease risk in obesity. ( Kasahara, M; Kasama, S; Kato, H; Kato, S; Kusakabe, T; Ozu, N; Satoh-Asahara, N; Tanaka, M; Wakabayashi, D; Yamakage, H, 2023) |
| " The asymptomatic hyperuricemia group was defined according to serum uric acid levels." | 4.31 | Association between Asymptomatic Hyperuricemia with Adiposity Indices: A Cross-Sectional Study in a Spanish Population. ( Calderón-García, JF; Juárez-Vela, R; López-Espuela, F; Rey-Sánchez, P; Rico-Martín, S; Sánchez Muñoz-Torrero, JF; Sánchez-Bacaicoa, C; Santano-Mogena, E, 2023) |
| " The clinical evaluation included lipid and glycid profile, platelets, leukocytes, lymphocytes, monocytes, uric acid and blood pressure, as well as the presence of metabolic syndrome (MS) and its components." | 4.12 | Cardiometabolic risk in adolescents with normal weight obesity. ( Cota, BC; de Faria, ER; de Faria, FR; Juvanhol, LL; Pereira, PF; Priore, SE; Ribeiro, SAV, 2022) |
| " We aim to investigate the effect of overweight and/or obesity on high blood pressure (HBP), dyslipidemia, elevated serum uric acid (SUA) and their clustering among children and adolescents in an island in South China." | 4.12 | Body mass index was linked with multi-cardiometabolic abnormalities in Chinese children and adolescents: a community-based survey. ( Du, J; He, H; Jia, P; Jin, Y; Pan, L; Shan, G, 2022) |
| " 113 patients fulfilled the criteria for central obesity with the mean uric acid level of 8." | 4.12 | A Clinical Profile of Patients with Hyperuricemia and the Relationship between Hyperuricemia and Metabolic Syndrome: A Cross-sectional Study at a Tertiary Hospital in the Indian Population. ( Ingawale, S; Raghorte, N; Rajadhyaksha, A; Sarate, N, 2022) |
| " In addition, this diet does not increase serum cholesterol and uric acid, which encourage the use of this diet in obesity management." | 4.12 | The effect of low-carbohydrate ketogenic diet in the management of obesity compared with low caloric, low-fat diet. ( Al Aamri, KS; Al Balushi, F; Al Balushi, S; Al Busaidi, N; Al Githi, MS; Al Jabri, K; Alrawahi, AH; Ronquillo-Talara, R; Waly, M, 2022) |
| "To investigate the relationship between fibrinogen-like protein 1 (FGL-1) concentrations and various metabolic characteristics in patients with polycystic ovary syndrome (PCOS) and explore whether FGL-1 could be a predictive biomarker for PCOS." | 4.12 | Serum fibrinogen-like protein 1 as a novel biomarker in polycystic ovary syndrome: a case-control study. ( Cai, M; Chen, D; Dilimulati, D; Gao, X; Qu, S; Shao, X; Sun, H; You, H; Zhang, M; Zhang, Y, 2022) |
| " Ongoing research is examining the association of obesity, dietary patterns, and blood pressure (BP) with serum uric acid (sUA)." | 4.12 | Correlation of obesity, dietary patterns, and blood pressure with uric acid: data from the NHANES 2017-2018. ( Fan, GJ; Lin, YP; Lu, QY; Yao, J; Zhang, Y; Zhao, J, 2022) |
| " Overweight/obesity, alcohol consumption, smoking and sedentary behavior are modifiable risk factors (MRFs) for elevated serum uric acid (SUA), but their population attributable fractions (PAFs) for hyperuricemia is still unclear." | 4.12 | Prevalence of hyperuricemia and the population attributable fraction of modifiable risk factors: Evidence from a general population cohort in China. ( Chen, S; Guo, F; Guo, P; He, H; He, J; Li, Q; Liu, F; Ma, S; Niu, Y; Pan, L; Shan, G; Zhang, B; Zhang, J; Zhang, M; Zhang, R, 2022) |
| "To investigate whether serum uric acid (SUA) levels and hyperuricemia can be predictive biomarkers of incident metabolic syndrome(MS) among different body mass index(BMI) categories, and to investigate SUA cutoffs that best discriminate individuals with incident MS." | 4.12 | Serum uric acid is a predictive biomarker of incident metabolic syndrome at the Brazilian longitudinal study of adult Health (ELSA - Brasil). ( B Duncan, B; Haueisen Sander Diniz, MF; Inês Schmidt, M; Isabel Rodrigues Galvão, A; Luiz P Ribeiro, A; M Benseñor, I; M R Beleigoli, A; Maria Barreto, S; Vidigal, PG; Weiss Telles, R, 2022) |
| "Undoubtedly, the relationship between serum uric acid (SUA) and obesity is less data for Chinese patients with obesity." | 4.12 | Prevalence of hyperuricemia in patients with severe obesity and the relationship between serum uric acid and severe obesity: A decade retrospective cross-section study in Chinese adults. ( Chan, W; Cheang, C; Dong, Z; Law, S; Ren, J; Wang, C, 2022) |
| " Additionally, anthropometric parameters (height, weight, BMI, waist circumference, hip circumference) such as lab data including lipid profile (triglycerides, HDL, LDL), liver function parameters (ALT, AST), uric acid, glucose metabolism (fasting insulin and glucagon, HbA1c, glucose 120 min) and indices evaluating insulin resistance (HIRI, SPISE, HOMA-IR, WBISI) were measured." | 4.12 | Determinants of hyperglucagonemia in pediatric non-alcoholic fatty liver disease. ( Ahlström, H; Bergsten, P; Forslund, A; Kullberg, J; Manell, H; Mangge, H; Maruszczak, K; Mörwald, K; Pixner, T; Radzikowski, K; Schütz, S; Weghuber, D, 2022) |
| "The uric acid serum level is higher in people with hypertension and overweight/obesity." | 4.12 | Hyperuricaemia and its association with other risk factors for cardiovascular diseases: A population-based study. ( Baniasad, A; Najafipour, H; Najafzadeh, MJ; Shakibi, MR; Sistani, S; Yazdi, F, 2022) |
| "Hypertensive children with obesity had higher serum copeptin and uric acid and lower blood potassium levels." | 4.12 | Serum copeptin as a biomarker of hypertension in children with obesity. ( Bezen, D; Dursun, H; Gor, Z; Irdem, A; Turkmenoglu, Y; Vurgun, E, 2022) |
| " Anthropometric measurements, fasting glucose, fasting insulin, homeostasis model assessment of insulin resistance (HOMA-IR), HOMA- β (%), lipids profile, monocyte to lymphocyte ratio (MLR), neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), uric acid, gamma glutamyl transpeptidase (GGT), AST/ALT ratio and total bilirubin were assessed." | 4.12 | Association Between Total Bilirubin Levels and Cardio-Metabolic Risk Factors Related to Obesity. ( Asar, M; El-Eshmawy, MM; Elsehely, I; Mahsoub, N, 2022) |
| " Hyperuricemia was defined as serum uric acid (SUA) level 420 umol/L in men and 360 umol/L in women." | 4.02 | Positive association between body fat percentage and hyperuricemia in patients with hypertension: The China H-type hypertension registry study. ( Bao, H; Cheng, X; Huang, X; Wang, S; Wangsheng, F; Xiong, Y; Zhou, W, 2021) |
| "Elevated serum uric acid (SUA) levels, body shape index (BSI) and body roundness index (BRI) were associated with incident metabolic syndrome (MetS)." | 4.02 | Serum uric acid is associated with incident metabolic syndrome independent of body shape index and body roundness index in healthy individuals. ( Chen, CC; Liu, CW; Tseng, GS; Tu, CM; Wei, TE, 2021) |
| " In addition, the present results suggest that melatonin supplementation attenuates adipose-hepatic metabolic dysfunction, accompanying obesity by suppression of oxidative stress/inflammation-dependent mechanism and increasing circulating obestatin." | 4.02 | Protective role of melatonin against adipose-hepatic metabolic comorbidities in experimentally induced obese rat model. ( Akintayo, CO; Atuma, CL; Aturamu, A; Badejogbin, OC; Mahmud, H; Obayemi, MJ; Olaniyi, KS; Oniyide, AA; Saidi, AO, 2021) |
| "This study aims to investigate the correlation between serum uric acid levels and body fat distribution in patients with polycystic ovary syndrome (PCOS)." | 4.02 | Correlation Between Serum Uric Acid and Body Fat Distribution in Patients With Polycystic Ovary Syndrome. ( Cai, M; Cui, R; Dilimulati, D; Fei, H; Gao, X; Lin, Z; Qu, S; Shao, X; Sun, H; Zeng, Q; Zhang, M; Zhang, Y, 2021) |
| "This cross-sectional study investigates the association between insulin resistance (IR) and serum uric acid (sUA) and relative fat (RFM) and lean mass (RLM) profiles in children with chronic kidney disease (CKD)." | 4.02 | Association between relative fat mass, uric acid, and insulin resistance in children with chronic kidney disease. ( Christoforidis, A; Dotis, J; Karava, V; Kollios, K; Kondou, A; Liakopoulos, V; Papachristou, F; Printza, N; Tsioni, K, 2021) |
| " Thus, this study investigated whether the XOR inhibitor, topiroxostat, affected body weight." | 4.02 | Influence of xanthine oxidoreductase inhibitor, topiroxostat, on body weight of diabetic obese mice. ( Akari, S; Katoh, N; Mizukami, H; Murase, T; Nakamura, T; Nampei, M; Satoh, E, 2021) |
| "In a multi-center study (n=2495), we used unsupervised machine learning to cluster patients with obesity from Shanghai Tenth People's hospital (n=882, main cohort) based on three clinical variables (AUCs of glucose and of insulin during OGTT, and uric acid)." | 4.02 | Machine Learning to Identify Metabolic Subtypes of Obesity: A Multi-Center Study. ( Arefan, D; Cheng, X; Du, L; Feng, W; Gao, L; Lin, Z; Liu, Y; Ma, C; Qu, S; Wu, S; You, H; Yu, J; Zhou, D; Zhu, D; Zhu, J, 2021) |
| "Both the presence of diabetes and obesity blunt the serum uric acid response to fructose ingestion." | 3.96 | Fructose tolerance test in obese people with and without type 2 diabetes. ( Al Salem, D; Al-Ozairi, E; Alhubail, A; Asad, RA; Bjornstad, P; Johnson, RJ; Kuwabara, M; Lanaspa, MA; Megahed, A; Rivard, CJ; Sanchez Lozada, LG, 2020) |
| "Uric acid was significantly and positively associated with blood pressure, BMI, waist circumference, insulin resistance, C-reactive protein and leptin (p < 0." | 3.96 | Circulating leptin is associated with serum uric acid level and its tubular reabsorption in a sample of adult middle-aged men. ( Cappuccio, FP; D'Elia, L; Galletti, F; Giaquinto, A; Iacone, R; Russo, O; Strazzullo, P, 2020) |
| "We aimed to investigate the association between serum uric acid (SUA) and all-cause or cardiovascular mortality among participants with obesity." | 3.96 | Relationship between serum uric acid level and all-cause and cardiovascular mortality in population with obesity. ( Chen, CL; Feng, YQ; Huang, JY; Huang, YQ; Li, J; Liu, L; Lo, K; Sun, S; Zhang, B, 2020) |
| "Background Elevated serum uric acid concentrations have been associated with metabolic syndrome." | 3.96 | Elevated serum uric acid, hyperuricaemia and dietary patterns among adolescents in mainland China. ( Du, Y; Lu, Y; Ma, ZF; Pan, B; Shao, J; Wang, L; Wei, H; Wu, Q; Zhao, Q; Zhou, H; Zhu, W, 2020) |
| " After adjustment for age, sex, body mass index (BMI), alanine aminotransferase (ALT), uric acid (UA), total bilirubin (TB), fasting plasma glucose (FPG) and Homeostasis Model Assessment of Insulin Resistance (HOMA-IR), the OR for tertile 3 (OR = 1." | 3.96 | Association between the non-HDL-cholesterol to HDL-cholesterol ratio and non-alcoholic fatty liver disease in Chinese children and adolescents: a large single-center cross-sectional study. ( Lu, G; Miao, L; Xu, C; Xue, Z; Yang, S; Ye, M; Zhong, J; Zhou, X, 2020) |
| " The definition of metabolic obesity phenotype includes elevated blood pressure, glucose, lipid, and uric acid levels and abnormal lipoprotein levels." | 3.91 | Metabolic Features of Individuals with Obesity Referred for Bariatric and Metabolic Surgery: a Cohort Study. ( Jin, L; Li, M; Liu, Y; Lv, H; Wang, L; Xu, W; Zeng, N; Zhang, M; Zhang, P; Zhang, Z; Zhao, K, 2019) |
| "This study shows, for the first time, that 1) an unexpectedly high percentage (69%) of overweight/obese subjects is affected by hypertension; 2) early hypertensive subjects have an increased eGFR and higher FT4 serum levels; 3) lower potassium and uric acid levels are independent predictors of pathological nocturnal non-dipping." | 3.91 | Uric Acid and Potassium Serum Levels Are Independent Predictors of Blood Pressure Non-Dipping in Overweight or Obese Subjects. ( Boninfante, B; Castellana, F; De Pergola, G; Giannelli, G; Lampignano, L; Lattanzio, A; Sardone, R; Zupo, R, 2019) |
| "The aim of this study was to assess the association between serum uric acid concentration (SUAC) and the parameters of the metabolic syndrome (MetS) and insulin resistance (IR)." | 3.91 | Associations Between Serum Uric Acid Concentrations and Cardiometabolic Risk and Renal Injury in Obese and Overweight Children ( Ersoy, B; Özalp Kızılay, D; Şen, S, 2019) |
| " The levels of leptin, fibrinogen, homocysteine, high-sensitivity C-reactive protein (hs-CRP), triglycerides, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol (LDL-C), fasting blood glucose and insulin, glycated hemoglobin, and uric acid of the obese patients who were put on calorie restricted diet were evaluated retrospectively and compared before and after weight loss." | 3.91 | Does weight loss affect the parameters that are metabolically related to cardiovascular diseases? ( Persil-Ozkan, O; Yigit, E; Yigit, Z, 2019) |
| "These findings indicated that increased uric acid levels probably associated with obesity and type 2 diabetes, and more definite research is needed to define any role for uric acid in relation to these diseases." | 3.88 | Temporal relationship between hyperuricemia and obesity, and its association with future risk of type 2 diabetes. ( Guo, X; Han, T; Li, Y; Liu, L; Ma, H; Meng, X; Na, L; Qu, R; Shan, R; Shi, D; Sun, C; Zhao, Y; Zi, T, 2018) |
| " Classical (fasting glucose, TGL, HDL, blood pressure) and non classical (insulin resistance [HOMA-IR], creatinine, AST, ALT, uric acid, fibrinogen, liver US and 24h BP profile) risk factors were compared between groups with and without MS." | 3.88 | Shall we diagnose metabolic syndrome in adolescents? ( Janus, D; Ruszała, A; Starzyk, JB; Szczudlik, E; Sztefko, K; Wójcik, M, 2018) |
| "Our study indicates LDJB-LSG is similar to LRYGB in the improvements of the body weight, blood glucose, insulin resistance, islet β cell function, blood lipid profile and serum uric acid, and thus LDJB-LSG is applicable in T2DM patients with 27." | 3.88 | Laparoscopic sleeve gastrectomy combined with single-anastomosis duodenal-jejunal bypass in the treatment of type 2 diabetes mellitus of patients with body mass index higher than 27.5 kg/m2 but lower than 32.5 kg/m2. ( Fang, DH; Li, YX; Liu, TX, 2018) |
| "High-dose exenatide treatment can effectively reduce body mass of obese mice, but it has little difference when compared with dietary intervention in improving blood fat and liver steatosis." | 3.85 | [The Preliminary Investigation of GLP-1 Receptor Agonist on Liver Steatosis in Obese Mice]. ( An, ZM; He, H; Huang, HJ; Li, SQ; Li, SY; Liang, LB; Wang, X; Zhang, M, 2017) |
| "This study aimed to a) examine IR and β-cell function as measured by the homeostasis model assessment of insulin resistance (HOMA-IR) and insulin sensitivity and β cell function (HOMA-B) and glucotoxicity (conceptualized as increased glucose levels versus lowered HOMA-B values) in 74 participants with major depressive disorder (MDD) and bipolar disorder, with and or without MetS and TUD, versus 46 healthy controls, and b) whether IR is associated with IO&NS biomarkers, including nitric oxide metabolites (NOx), lipid hydroperoxides (LOOH), plasma advanced oxidation protein products (AOPP), C-reactive protein (CRP), haptoglobin (Hp) and uric acid." | 3.85 | Indices of insulin resistance and glucotoxicity are not associated with bipolar disorder or major depressive disorder, but are differently associated with inflammatory, oxidative and nitrosative biomarkers. ( Berk, M; Camargo, AEI; de Farias, CC; Dodd, S; Favaro Soares, J; Gastaldello Moreira, E; Higachi, L; Landucci Bonifácio, K; Maes, M; Nunes, SOV; Odebrecht Vargas, H; Sabbatini Barbosa, D, 2017) |
| "To disclose the link between the composition of urolithiasis, especially that of uric acid calculi, and obesity, prediabetes, type 2 diabetes mellitus, and hypertension." | 3.85 | The Association of Uric Acid Calculi with Obesity, Prediabetes, Type 2 Diabetes Mellitus, and Hypertension. ( Chang, CC; Chu, FY; Ho, JL; Huang, PH; Ku, PW; Lin, YN; Su, MJ; Sun, JT; Yen, TH, 2017) |
| " Our study indicates that stone-forming children who are overweight or obese have low urinary volume and elevated uric acid compared to normal-weight stone-forming children." | 3.85 | Do Overweight and Obese Pediatric Stone Formers Have Differences in Metabolic Abnormalities Compared With Normal-weight Stone Formers? ( Bayne, AP; Cambareri, GM; Chiang, G; Corbett, S; Giel, DW; Kovacevic, L; Schurtz, E; Sukhu, T; Yap, M, 2017) |
| "We aim to explore the associations between serum uric acid (SUA) and obesity and cardio-cerebrovascular events (CCEs) in Chinese inpatients with type 2 diabetes mellitus (T2DM)." | 3.85 | Serum uric acid levels are associated with obesity but not cardio-cerebrovascular events in Chinese inpatients with type 2 diabetes. ( Bao, YQ; Chen, MY; Jia, WP; Li, LX; Li, TT; Yu, TP; Zhao, CC; Zhu, Y, 2017) |
| " Uric acid levels, insulin resistance (homeostasis model assessment insulin resistance; HOMA-IR), C-reactive protein (CRP), triacylglycerol (TG), systolic blood pressure (SBP), abdominal fat and cIMT (both by ultrasound) were assessed." | 3.83 | Uric acid, carotid intima-media thickness and body composition in prepubertal children. ( Bassols, J; Carreras-Badosa, G; de Zegher, F; Díaz-Roldán, F; Ibáñez, L; López-Bermejo, A; Martínez-Calcerrada, JM; Osiniri, I; Prats-Puig, A; Riera-Pérez, E, 2016) |
| "The mechanisms by which weight loss decreases serum uric acid (SUA) levels are poorly known." | 3.83 | Weight Loss, Xanthine Oxidase, and Serum Urate Levels: A Prospective Longitudinal Study of Obese Patients. ( Bardin, T; Bouillot, JL; Clément, K; Denis, J; Manivet, P; Oppert, JM; Poitou, C; Richette, P, 2016) |
| "Subject age and measurements of liver enzymes, γ- glutamyl transpeptidase (γGT), uric acid, high-density lipoprotein cholesterol, and insulin resistance were significantly different between the non-NAFLD group and NAFLD group." | 3.83 | Insulin resistance, body composition, and fat distribution in obese children with nonalcoholic fatty liver disease. ( Chang, EJ; Yang, HR, 2016) |
| "To assess gender differences in uric acid (UA) as predictor for hard events (HE, mortality and nonfatal myocardial infarction) in a large cohort of patients referred for coronary angiography." | 3.83 | Gender differences for uric acid as predictor of hard events in patients referred for coronary angiography. ( Arvia, C; Battaglia, D; Carpeggiani, C; Chatzianagnostou, K; Guiducci, L; Landi, P; Maffei, S; Vannucci, A; Vassalle, C, 2016) |
| "To investigate the association between serum direct bilirubin (DBIL) with metabolic syndrome (MS) and its components." | 3.83 | [Association between serum direct bilirubin with metabolic syndrome and its components based on a longitudinal health check-up study]. ( Chen, L; Chen, Q; Chen, X; Wang, S; Xiao, J; Zhang, P, 2016) |
| "Elevated uric acid (UA) is associated with the presence of the metabolic syndrome (MetS)." | 3.83 | Overweight modifies the longitudinal association between uric acid and some components of the metabolic syndrome: The Tromsø Study. ( Eriksen, BO; Jenssen, TG; Norvik, JV; Solbu, MD; Storhaug, HM; Ytrehus, K; Zykova, SN, 2016) |
| " We evaluated the association between serum uric acid and uACR in persons with 0, and 1-2 metabolic syndrome (MetS) components and determined the modification effects of visceral adiposity index (VAI), mean arterial pressure (MAP), and fasting glucose on this association." | 3.83 | The Impact of Blood Pressure and Visceral Adiposity on the Association of Serum Uric Acid With Albuminuria in Adults Without Full Metabolic Syndrome. ( Bruthans, J; Cifkova, R; Hamet, P; Krajcoviechova, A; Tahir, MR; Tremblay, J; Wohlfahrt, P, 2016) |
| "At high altitude, increased γGT levels were associated with hyperglycemia; increased uric acid levels were associated with overweight/obesity, hemoglobin, dyslipidemia, high blood pressure and kidney disease." | 3.81 | Increased levels of serum γ-glutamyltransferase and uric acid on metabolic, hepatic and kidney parameters in subjects at high altitudes. ( Gonzales, GF; Tapia, V, 2015) |
| " Hence, we aimed to compare the prevalence of elevated lipoprotein (a), apolipoprotein B, and uric acid (UA) levels, apolipoprotein B/apolipoprotein A1 ratio, and visceral adiposity index (VAI) scores, and low apolipoprotein A1 levels among 6 body size phenotypes (normal weight with and without metabolic abnormalities, overweight with and without metabolic abnormalities, and obese with or without metabolic abnormalities)." | 3.81 | Nontraditional risk factors for cardiovascular disease and visceral adiposity index among different body size phenotypes. ( Du, T; Liu, Z; Sun, X; Yu, X; Yuan, G; Zhang, J; Zhang, M; Zhou, X, 2015) |
| " Obesity and overweight had no direct influence on the lithogenic risk profile in the urinary stone formers in our study, but there was an indication that higher serum uric acid may be associated with impairment in renal function, which in turn could influence the excretion of lithogenic parameters." | 3.81 | Does obesity or hyperuricemia influence lithogenic risk profile in children with urolithiasis? ( Kirejczyk, JK; Kuroczycka-Saniutycz, E; Porowska, H; Porowski, T; Protas, PT; Pszczółkowska, M; Wasilewska, A, 2015) |
| "Pink urine syndrome (PUS) is attributed to the precipitation of uric acid caused by low urinary pH (U-pH)." | 3.81 | Elucidation of the etiology and characteristics of pink urine in young healthy subjects. ( Ito, S; Kabayama, S; Kinouchi, Y; Mori, T; Nako, K; Ogawa, S; Okamura, M; Sakamoto, T; Takiguchi, J, 2015) |
| "Our results show that variation in serum uric acid in Hispanic children is under considerable genetic influence and is associated with obesity-related phenotypes." | 3.81 | Serum uric acid concentrations and SLC2A9 genetic variation in Hispanic children: the Viva La Familia Study. ( Butte, NF; Cole, SA; Comuzzie, AG; Haack, K; Laston, S; Mehta, NR; Voruganti, VS, 2015) |
| " Linear regression was used to evaluate associations between uric acid and clinical and laboratory findings associated with metabolic syndrome." | 3.81 | [Metabolic complications of obesity during adolescence, particularly regarding elevated uric acid levels]. ( Almási, A; Barkai, L; Fehér, V; Kiss-Tóth, E; Ságodi, L, 2015) |
| "High serum uric acid was positively associated with obesity in overweight and obesity group." | 3.81 | Association between serum uric acid levels and obesity among university students (China). ( Chen, Y; Duan, Y; He, L; Jin, Y; Liang, W; Nie, Z; Wang, L; Yao, Y; Zhang, T; Zhu, L, 2015) |
| "Uric acid (UA) is associated with high blood pressure in adolescents and with left ventricular hypertrophy (LVH) and cardiovascular disease (CVD) in adults." | 3.81 | Elevated uric acid and obesity-related cardiovascular disease risk factors among hypertensive youth. ( Appel, LJ; Brady, TM; Fadrowski, JJ; Holmes, KW; Loeffler, LF; Miller, ER; Reschke, LD, 2015) |
| "Elevated serum uric acid concentration was strongly associated with obesity and hyperlipidemia in both men and women." | 3.81 | Relationship Between Hyperuricemia and Cardiovascular Disease Risk Factors in a Chinese Population: A Cross-Sectional Study. ( Hong, L; Li, L; Su, P; Sun, H; Zhao, Y, 2015) |
| "These data suggest that BMI influences serum urate and gout risk in response to chronic SSB intake, and renal tubular uric acid handling in response to an acute fructose load." | 3.81 | Body mass index modulates the relationship of sugar-sweetened beverage intake with serum urate concentrations and gout. ( Dalbeth, N; Gamble, GD; Horne, A; House, ME; Merriman, TR; Phipps-Green, A; Stamp, LK, 2015) |
| "The purpose of the present study was to investigate multiple anthropometric parameters used to evaluate obesity, particularly visceral abdominal fat area, and various metabolic parameters including malondialdehyde (MDA) as an oxidative stress marker." | 3.81 | Urinary Malondialdehyde Is Associated with Visceral Abdominal Obesity in Middle-Aged Men. ( Cho, AR; Cho, YH; Han, J; Hwang, HR; Jeon, JS; Jeong, DW; Kim, YJ; Lee, JG; Lee, SH; Lee, SM; Lee, SY; Park, EJ; Tak, YJ; Yi, YH, 2015) |
| " The changes of BMI-SDS in the time period of 1-year were related to baseline fasting insulin resistance index HOMA, blood pressure, waist circumference, waist-to-height ratio, lipids, uric acid, and HbA1c." | 3.80 | Components of the metabolic syndrome are negative predictors of weight loss in obese children with lifestyle intervention. ( Knop, C; Reinehr, T; Uysal, Y; Wolters, B, 2014) |
| " We evaluated whether alterations in levels of circulating uric acid (UA), a systemic antioxidant, affects the following: 1) systemic (plasma and saliva) nonenzymatic antioxidant capacity (NEAC); 2) markers of systemic (urinary 8-iso-prostaglandin-F2α) and muscle (carbonylated protein content) oxidative stress; and 3) whole-body insulin sensitivity (percentage increase in glucose uptake during a hyperinsulinemic-euglycemic clamp procedure)." | 3.80 | Effect of plasma uric acid on antioxidant capacity, oxidative stress, and insulin sensitivity in obese subjects. ( Colic Baric, I; Fabbrini, E; Hazen, SL; Klein, S; Serafini, M, 2014) |
| "4, and he was also mis-diagnosed with osteochondritis dissecans and underwent medical treatment for JIA, assorted imaging studies, and multiple surgical procedures before the key history of increased pain with red meat ingestion, noticed by the patient, and a subsequent elevated uric acid confirmed his ultimate diagnosis." | 3.80 | Gout in a 15-year-old boy with juvenile idiopathic arthritis: a case study. ( Grant, K; Khanna, G; Morris, H; White, AJ, 2014) |
| "The prevalence of MetS is related to obesity and elevated serum uric acid." | 3.80 | Clinical investigation of metabolic syndrome in the female elderly occupational population. ( Chang, HT; Chen, YF; Hu, YC; Shen, HC; Tung, TH, 2014) |
| "Serum uric acid (UA) is now beginning to be considered a risk predictor for cardiovascular diseases." | 3.80 | Serum uric acid as a risk predictor for erectile dysfunction. ( Heydari, R; Mehrsai, A; Pourmand, G; Salem, S, 2014) |
| "This study investigated the correlation between elevated serum uric acid (SUA) and angiotensinogen in obesity patients with hypertension." | 3.80 | Elevated serum uric acid is associated with angiotensinogen in obese patients with untreated hypertension. ( Chen, B; Deng, W; Zhang, J; Zhang, Y, 2014) |
| "To evaluate whether uric acid (UA) predicts 4-yr incidence of metabolic syndrome (MetS) in non-diabetic participants of the Strong Heart Study (SHS) cohort." | 3.80 | Serum uric acid does not predict incident metabolic syndrome in a population with high prevalence of obesity. ( de Simone, G; Devereux, RB; Ferrara, LA; Franceschini, N; Howard, BV; Jolly, S; Lee, ET; Umans, JG; Wang, H; Yeh, J, 2014) |
| "To elucidate links of blood serum uric acid level (SUAL) with cardiometabolic risk factors (CMR) in adolescent boys with arterial hypertension (AH)." | 3.80 | [Uric acid and factors of cardiometabolic risk in adolescents with arterial hypertension]. ( Dolgikh, VV; Pogodina, AV; Rychkova, LV, 2014) |
| "To study the relationship between serum uric acid (SUA) level and metabolic syndrome (MS) in Uygur children and adolescents with overweight or obesity." | 3.80 | [Relationship between serum uric acid level and metabolic syndrome in Uygur children and adolescents with overweight or obesity]. ( Li, M; Mao, JF; Yi, LD; Zhang, MC, 2014) |
| "The predictive value of serum uric acid (SUA) for adverse cardiovascular events among obese and overweight patients is not known, but potentially important because of the relation between hyperuricaemia and obesity." | 3.79 | Uric acid as a risk factor for cardiovascular disease and mortality in overweight/obese individuals. ( Andersson, C; Caterson, ID; Coutinho, W; Finer, N; James, WP; Maggioni, AP; Sharma, AM; Skak-Nielsen, H; Torp-Pedersen, C; Van Gaal, L, 2013) |
| "Parameters were correlated with homeostasis model assessment for insulin resistance, fasting insulin, blood pressure, transaminases, lipids and uric acid, applying adjusted regression models, with age group, pubertal stage and gender as covariates." | 3.79 | Body mass index, waist circumference, and waist-to-height ratio as predictors of cardiometabolic risk in childhood obesity depending on pubertal development. ( Blüher, S; Holl, RW; Kiess, W; L'Allemand-Jander, D; Molz, E; Otto, KP; Sergeyev, E; Tuschy, S; Wiegand, S, 2013) |
| " The higher CRP group was discriminated by the above variables in addition to lower VO(2max), serum metabolic syndrome components (triglycerides, glucose, and HDL cholesterol), higher insulin, homeostasis assessment of insulin resistance, uric acid, gamma-GT, and homocysteine." | 3.79 | Pathological and behavioral risk factors for higher serum C-reactive protein concentrations in free-living adults--a Brazilian community-based study. ( Burini, RC; de Oliveira, EP; Manda, RM; Michelin, E; Moreto, F; Teixeira, O; Torezan, GA, 2013) |
| " Blood pressure, lipids, glucose, insulin, homeostasis model assessment-insulin resistance (HOMA-IR) and uric acid levels were compared across BMI groups." | 3.79 | Association between WHO cut-offs for childhood overweight and obesity and cardiometabolic risk. ( Brines, J; de Onis, M; Martínez-Costa, C; Montal, A; Nguefack-Tsague, G; Núñez, F, 2013) |
| "Current evidence suggests a direct association of uric acid with diabetes risk, but it is still unclear whether this is independent of risk factors such as obesity and diet." | 3.79 | Plasma uric acid is associated with increased risk of type 2 diabetes independent of diet and metabolic risk factors. ( Beulens, JW; Schulze, MB; Sluijs, I; Spijkerman, AM; van der A, DL; van der Schouw, YT, 2013) |
| "The objective of this study was to examine the association between uric acid, GGT, obesity and the individual components of metabolic syndrome in children and adolescents." | 3.79 | Associations of uric acid and gamma-glutamyltransferase (GGT) with obesity and components of metabolic syndrome in children and adolescents. ( Chan, CW; Chan, JC; Chan, MH; Choi, KC; Ho, CS; Kong, AP; Ozaki, R, 2013) |
| "Previous reports suggested that gout incidence increased with serum uric acid (sUA) level." | 3.78 | Gender-specific risk factors for incident gout: a prospective cohort study. ( Chen, JH; Chuang, SY; Pan, WH; Wu, YY; Yeh, WT, 2012) |
| "Several genome-wide association studies (GWASs) have reported associations between single nucleotide polymorphisms (SNPs) and uric acid concentrations or gout in a number of different ethnic populations." | 3.78 | Association between gout and polymorphisms in GCKR in male Han Chinese. ( Chu, N; Han, L; Li, C; Liu, S; Ma, X; Meng, D; Miao, Z; Wang, B; Wang, J; Zhang, K, 2012) |
| " Obesity was not associated with differences in composition, although a secondary analysis of morbidly obese patients showed a higher proportion of uric acid stones and a lower proportion of calcium oxalate stones." | 3.78 | Metabolic syndrome and urinary stone composition: what factors matter most? ( Fridirici, ZC; Greco, K; Hart, ST; Kadlec, AO; Turk, TM; Vellos, T, 2012) |
| "Obesity and SLC2A9 genotype are strong determinants of uric acid levels." | 3.78 | Changes in uric acid levels following bariatric surgery are not associated with SLC2A9 variants in the Swedish Obese Subjects Study. ( Bouchard, C; Carlsson, B; Carlsson, LM; Jacobson, P; Rankinen, T; Sarzynski, MA; Sjöström, L, 2012) |
| "Substance P (SP) is an important neurotransmitter and is an important pathogenic factor in obesity." | 3.77 | Substance P is associated with the development of obesity, chronic inflammation and type 2 diabetes mellitus. ( Fu, J; Li, G; Liu, B; Liu, L; Liu, P; Liu, X; Wu, B, 2011) |
| " Blood pressure and uric acid was most strongly correlated with body weight and height (heavier and taller boys)." | 3.77 | Differential relationships between anthropometry measures and cardiovascular risk factors in boys and girls. ( Beilin, LJ; de Klerk, N; Hands, B; Huang, RC; Landau, LI; Mori, TA; Newnham, JP; Oddy, WH; Stanley, FJ, 2011) |
| " Studies on the association between serum uric acid (sUA) and metabolic syndrome (MetS) in juvenile obesity are scant." | 3.77 | Gender-specific association of serum uric acid with metabolic syndrome and its components in juvenile obesity. ( Chrzanowska, J; Gamian, A; Krzystek-Korpacka, M; Kustrzeba-Wojcicka, I; Noczynska, A; Patryn, E, 2011) |
| "The aim of this study was to examine the independent relationship between serum uric acid (SUA) and blood pressure, and to assess their joint effects on obesity, fasting glucose and lipids." | 3.77 | Interaction between serum uric acid and triglycerides in relation to blood pressure. ( Liang, J; Song, H; Teng, F; Xue, Y; Yang, M; Zhu, R; Zou, C, 2011) |
| "Hyperuricemia may underlie obesity and related disorders, but the impact of weight reduction and metformin on serum uric acid (sUA) in Caucasian children/adolescents is unknown." | 3.77 | The effect of a one-year weight reduction program on serum uric acid in overweight/obese children and adolescents. ( Chrzanowska, J; Gamian, A; Krzystek-Korpacka, M; Kustrzeba-Wojcicka, I; Noczynska, A; Patryn, E, 2011) |
| " MRFs (serum lipid profile, insulin resistance indexes, blood pressure) in addition to uric acid, homocysteine, leptin, and inflammatory markers were measured." | 3.77 | Nitric oxide production is increased in severely obese children and related to markers of oxidative stress and inflammation. ( Alonso-Iglesias, E; Codoñer-Franch, P; Megías-Vericat, J; Murria-Estal, R; Tavárez-Alonso, S; Tortajada-Girbés, M, 2011) |
| "Studies have shown that obesity is associated with an increase in serum uric acid; and few data are available on the relationship between changes in measures of obesity and changes in uric acid concentrations." | 3.76 | Changes in waist circumference and body mass index in relation to changes in serum uric acid in Japanese individuals. ( Ishizaka, N; Ishizaka, Y; Koike, K; Nagai, R; Tani, M; Toda, A; Yamakado, M, 2010) |
| " The objective of this study was to analyze the relationships of leptin, C-reactive protein (CRP), adiponectin, insulin, and uric acid to the metabolic syndrome components in lean, overweight, and obese young females." | 3.75 | Analysis of the relationship of leptin, high-sensitivity C-reactive protein, adiponectin, insulin, and uric acid to metabolic syndrome in lean, overweight, and obese young females. ( Abdullah, AR; Hasan, HA; Raigangar, VL, 2009) |
| "The cases comprised 3028 male office workers with hyperuricemia (serum uric acid level >or=7." | 3.75 | The effect of the interaction between obesity and drinking on hyperuricemia in Japanese male office workers. ( Shiraishi, H; Une, H, 2009) |
| " Each measurement was used as a main predictor in the logistic model where the presence of a metabolic risk factor (high blood pressure, high triglyceride, low high-density lipoprotein cholesterol, high glucose, and high uric acid) was predicted." | 3.75 | Use of waist circumference and ultrasonographic assessment of abdominal fat distribution in predicting metabolic risk factors in healthy Japanese adults. ( Abe, M; Hori, Y; Kimata, A; Kondo, T; Ueyama, J; Yamamoto, K, 2009) |
| " Rosiglitazone was also administered to demonstrate whether improved insulin sensitivity would prevent high-purine diet induced renal injury and gouty-like lesions." | 3.75 | Insulin resistance acts as an independent risk factor exacerbating high-purine diet induced renal injury and knee joint gouty lesions. ( Gu, J; Li, C; Li, Y; Meng, D; Miao, Z; Wang, B; Wang, CY; Wang, J; Wang, L; Xing, X; Yan, S; Yuan, Y; Zhang, S, 2009) |
| " In both sexes, those who developed diabetes were slightly older, were more obese, had a more adverse metabolic profile (higher glucose values, HbA(1c), fasting insulin, uric acid, and triglycerides) and were more likely to have hypertension at baseline than were participants remaining free of diabetes (P < 0." | 3.75 | Incidence of Type 2 diabetes in the elderly German population and the effect of clinical and lifestyle risk factors: KORA S4/F4 cohort study. ( Giani, G; Heier, M; Holle, R; Meisinger, C; Rathmann, W; Strassburger, K; Thorand, B, 2009) |
| "The effects of exercise and serum uric acid on the metabolic syndrome (MetS) were evaluated." | 3.74 | Effects of exercise and serum uric acid on the metabolic syndrome for Japanese workers. ( Amezawa, M; Kawada, T, 2008) |
| "The aim of this study was to examine whether serum uric acid (SUA) concentration was related to the metabolic syndrome (MS)." | 3.74 | Serum uric acid is significantly related to the components of the metabolic syndrome in Japanese workingmen. ( Katsumata, M; Kawada, T; Otsuka, T; Suzuki, H, 2007) |
| " The risk for metabolic syndrome increased with an increase of body mass index and plasma uric acid level, and decreased with the vigorous physical activity and current alcohol drinking." | 3.74 | Obesity and hepatitis B infection are associated with increased risk of metabolic syndrome in university freshmen. ( Chiu, TY; Huang, KC; Lee, LT; Lee, YC; Lin, YC; Yen, SL, 2008) |
| "The link between uric acid levels and metabolic syndrome was investigated." | 3.74 | Comparison of serum uric acid levels between Japanese with and without metabolic syndrome. ( Makino, H; Miyatake, N; Numata, T; Wada, J, 2008) |
| "The purpose of this study was to assess whether increasing serum uric acid (UA) levels are related to cardiovascular disease (CVD) mortality, all-cause mortality, and incident (fatal and nonfatal) myocardial infarction (MI) in men from the general population taking into account C-reactive protein (CRP), a sensitive marker of systemic inflammation." | 3.74 | Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population: the MONICA/KORA cohort study. ( Baumert, J; Döring, A; Koenig, W; Meisinger, C, 2008) |
| "High serum uric acid levels lead to gout and have been reported to be associated with an increased risk of hypertension, obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease." | 3.74 | Sex-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMI. ( Adams, TD; Brandstätter, A; Coassin, S; Heid, IM; Hopkins, PN; Hunt, SC; Illig, T; Kiechl, S; Kollerits, B; Kronenberg, F; Willeit, J, 2008) |
| "The levels of the liporegulatory hormone leptin are increased in obesity, which contributes to the metabolic syndrome; the latter is associated with elevated cardiovascular risk and morbidity." | 3.73 | Gender-specific leptinemia and its relationship with some components of the metabolic syndrome in Moroccans. ( Chraibi, A; Israili, ZH; Lyoussi, B; Mguil, M; Ragala, MA, 2005) |
| " After adjustment for the degree of obesity, subjects with MS had significantly higher uric acid (6." | 3.73 | Metabolic syndrome in obese Caucasian children: prevalence using WHO-derived criteria and association with nontraditional cardiovascular risk factors. ( Gilardini, L; Girola, A; Invitti, C; Maffeis, C; Mazzilli, G; Morabito, F; Pontiggia, B; Sartorio, A; Viberti, GC, 2006) |
| "In adults, serum uric acid levels are positively correlated with body mass index (BMI) and hyperuricemia is considered to be a common lifestyle disorder related with obesity." | 3.73 | Serum uric acid as an obesity-related indicator in early adolescence. ( Komatsu, K; Miyashita, M; Ohno, T; Oyama, C; Oyamada, M; Oyamada, T; Saito, S; Takada, G; Takahashi, T; Takashina, K, 2006) |
| "Abdominal obesity is the main determinant of uric acid variance." | 3.73 | Serum uric acid is a determinant of metabolic syndrome in a population-based study. ( Albayrak, S; Hergenç, G; Karabulut, A; Keleş, I; Onat, A; Sari, I; Uyarel, H; Yazici, M, 2006) |
| "2-5 months-lingth ambulatory tested hypocaloric diet in patients mith obesity makes for normalization of lipid, hydrocarbon metabolism, as creatinine and uric acid in blood against the background of patients body weight reduction." | 3.73 | [The influence of ambulatory tested hypocaloric diet on biochemical indexes of patients of different ages suffering from obesity]. ( Gapparov, MM; Gavrik, MV, 2006) |
| " The degree of obesity did not relate to insulin resistance but was independently correlated with inflammatory proteins, uric acid, and systolic BP, variables that were often abnormal in this population." | 3.72 | Prevalence and concomitants of glucose intolerance in European obese children and adolescents. ( Gilardini, L; Guzzaloni, G; Invitti, C; Morabito, F; Viberti, G, 2003) |
| "Experimental animal models suggest that uric acid might have a pathogenic role in the early development of primary hypertension." | 3.72 | Hyperuricemia in childhood primary hypertension. ( Feig, DI; Johnson, RJ, 2003) |
| "The aim of the study was to assess the influence of overweight and obesity on the risk of calcium oxalate stone formation." | 3.72 | The role of overweight and obesity in calcium oxalate stone formation. ( Glatz, S; Hesse, A; Nicolay, C; Siener, R, 2004) |
| " The objective of the present study was determination of incidence of selected risk factors of IHD, such as overweight and obesity, tobacco smoking, arterial hypertension, type 2 diabetes mellitus, dyslipidaemia, and elevated serum concentration of uric acid." | 3.72 | Selected risk factors of ischemic heart disease in Polish seafarers. Preliminary report. ( Filikowski, J; Renke, W; Rzepiak, M; Smolińska, D; Winnicka, A, 2003) |
| "The aim of the present study was to determine the change of serum uric acid (UA) levels in male adolescents and to characterize the relationship between UA levels and obesity or its related factors." | 3.72 | Recent trends of hyperuricemia and obesity in Japanese male adolescents, 1991 through 2002. ( Kishida, M; Matsumoto, Y; Matsuura, K; Mimura, Y; Ogura, T; Otsuka, F; Tobe, K, 2004) |
| "A 7-year followup study among men with hyperuricemia was conducted to study the longterm relationships between serum uric acid concentrations and cardiovascular diseases." | 3.72 | Hypertension was the major risk factor leading to development of cardiovascular diseases among men with hyperuricemia. ( Chen, CH; Chou, P; Lin, KC; Tsao, HM, 2004) |
| "Anthropometric parameters, blood lipid spectrum, levels of glucose, uric acid (UA), immunoreactive insulin, HOMA index were studied in 55 male patients with gout (mean age 50." | 3.72 | [Insulin resistance syndrome in patients with gout and its influence on formation of clinical characteristics of the disease]. ( Barskova, VG; Eliseev, MS; Iakunina, IA; Il'inykh, EV; Nasonov, EL; Zilov, AV, 2004) |
| " In addition, she received allopurinol 300 mg daily for prevention of tumor lysis syndrome (TLS)." | 3.72 | Use of single-dose rasburicase in an obese female. ( Arnold, TM; Delman, BS; Reuter, JP; Shanholtz, CB, 2004) |
| "Blood levels of uric acid, cholesterol, triglycerides (TG), high and low density lipoproteins were examined and glucose tolerance test was made in 108 adolescents with arterial hypertension (AH) and different physical constitution (normal, with overweight and obese)." | 3.72 | [Arterial hypertension in adolescents with different physical constitution including those with signs of metabolic syndrome]. ( Kazakova, LM; Rovda, EIu; Rovda, IuI; Rovda, TS, 2004) |
| "Body weight and BP decreased significantly in the diet group but not in the troglitazone group at the end of the intervention periods." | 3.71 | Decreases in serum uric acid by amelioration of insulin resistance in overweight hypertensive patients: effect of a low-energy diet and an insulin-sensitizing agent. ( Kamide, K; Kawano, Y; Minami, J; Tsunoda, S, 2002) |
| " The aim of this study was to analyse the role of different variables of metabolic syndrome, including leptin, in 74 non-obese children and 68 children with non-syndromal obesity." | 3.71 | Leptin and metabolic syndrome in obese and non-obese children. ( Bueno, M; Fleta, J; Giner, A; Juste, MG; Moreno, LA; Pineda, I; Rodríguez, G; Sarría, A, 2002) |
| "The plasma adiponectin levels negatively correlated with BMI, waist-to-hip ratio, fasting plasma glucose, insulin, triglyceride, uric acid levels, hyperinsulinemia, and glucose intolerance in OGTT, but positively with high-density lipoprotein-cholesterol." | 3.71 | Plasma adiponectin levels in overweight and obese Asians. ( Chao, CL; Chen, CL; Chuang, LM; Funahashi, T; Lee, WJ; Matsuzawa, Y; Tai, TY; Tanaka, S; Yang, WS, 2002) |
| "To study on effect of obesity on changes in serum hypoxanthine with exercise, exercise stress testing with treadmill was performed on 7 obese subjects (body mass index [BMI], 30." | 3.71 | Changes in serum hypoxanthine levels by exercise in obese subjects. ( Kamimoto, M; Kohzuki, M; Saiki, S; Sato, T; Yosida, T, 2001) |
| "To examine the relation between fitness and fibrinogen, white blood cell count, uric acid and metabolic syndrome across levels of adiposity in apparently healthy, nonsmoking men." | 3.71 | Relative associations of fitness and fatness to fibrinogen, white blood cell count, uric acid and metabolic syndrome. ( Blair, SN; Church, TS; Earnest, CP; Finley, CE; Gibbons, LW; Kampert, JB, 2002) |
| "Patients with LBS demonstrated similar metabolic features in terms of insulin sensitivity and hyperleptinemia as patients with "simple" truncal obesity." | 3.71 | Insulin resistance, hyperleptinemia, and obstructive sleep apnea in Launois-Bensaude syndrome. ( Ficker, JH; Fuchs, FS; Hahn, EG; Harsch, IA; Konturek, PC; Lohmann, T; Schahin, SP, 2002) |
| " The serum leptin concentration, body mass index (BMI), percent body fat, total fat mass (FM), waist and hip circumference, waist to hip ratio (WHR), prevalence of hypertension, and triglyceride (TG), lipoprotein, and uric acid concentration were determined in 86 type 2 diabetic (n = 59) and healthy (n = 27) subjects." | 3.70 | Serum leptin is associated with serum uric acid concentrations in humans. ( Beyer, J; Fruehwald-Schultes, B; Kern, W; Peters, A; Pfützner, A, 1999) |
| "The aim of this study was to elucidate the relationship between serum leptin levels and fatty liver in male adolescents." | 3.70 | Relationship between serum leptin and fatty liver in Japanese male adolescent university students. ( Higashi, T; Imai, A; Iwasaki, Y; Matsuura, K; Ogura, T; Shimomura, H; Tobe, K; Tsuji, T; Tsukamoto, C, 1999) |
| "Various epidemiologic studies have linked an increase in serum uric acid level to an increased risk of coronary heart disease." | 3.69 | Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome. The Normative Aging Study. ( Landsberg, L; Lee, J; Sparrow, D; Vokonas, PS; Weiss, ST, 1995) |
| "The major aim of this study was to compare various aspects of carbohydrate, insulin, and lipoprotein metabolism, serum uric acid concentration, and blood pressure in normal subjects stratified on the basis of both plasma insulin concentration and degree of obesity." | 3.69 | Hyperinsulinaemia, obesity, and syndrome X. ( Bonini, L; Dall'Aglio, E; Fantuzzi, M; Passeri, M; Reaven, GM; Zavaroni, I, 1994) |
| " Urinary excretion rates of calcium, sodium, chloride, potassium, urinary calcium/creatinine index, the fractional excretion of sodium, potassium and uric acid, the creatinine clearance and serum values of creatinine, urea, uric acid, electrolytes, total proteins, parathormone (intact molecule), plasma renin activity, aldosterone, glucose, and insulin (fasting and after an oral glucose load) were performed in every patient and control subject." | 3.69 | Urinary calcium excretion in treated and untreated essential hypertension. ( Navarro-Antolin, J; Orte, L; Ortuño, J; Quereda, C; Sabater, J; Villafruela, JJ, 1996) |
| "To examine the relationships of serum uric acid concentration with several risk factors of cardiovascular diseases (CVD)." | 3.69 | Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. ( Bonora, E; Branzi, P; Cacciatori, V; Muggeo, M; Saggiani, F; Santi, L; Targher, G; Tosi, F; Travia, D; Zenere, MB; Zenti, MG, 1996) |
| "In order to study the relationships between obesity, serum uric acid, insulin secretion and insulin resistance in female subjects, we evaluated serum C-peptide and glucose-induced insulin utilization (euglycemic hyperinsulinemic clamp) in 16 obese (8 nonhyperuricemic and 8 hyperuricemic) and 10 nonobese control subjects." | 3.69 | Serum uric acid, insulin secretion and resistance in nonhyperuricemic and hyperuricemic obese female subjects. ( Bonaventura, V; Greco, D; Scarpitta, AM; Sinagra, D, 1996) |
| "To assess the relationship between obesity and body fat distribution with cardiovascular risk factors in children, various measures of obesity and waist-to-hip circumference ratio (WHR) were related to serum lipids, lipoproteins, apolipoproteins, glucose, insulin, uric acid, systolic (SBP) and diastolic blood pressure (DBP)." | 3.68 | Cardiovascular risk factors in obese children in relation to weight and body fat distribution. ( Mueller, T; Pakosta, R; Widhalm, K; Zwiauer, KF, 1992) |
| "We carried out a study of 43 male asymptomatic subjects with high levels of uric acid but showing no signs of arterial hypertension, obesity or alcohol abuse." | 3.68 | Hyperuricemia-hyperlipemia association in the absence of obesity and alcohol abuse. ( Añon Barbudo, J; Collantes Estevez, E; Pineda Priego, M; Sanchez Guijo, P, 1990) |
| " This link between obesity and subsequent osteoarthritis persisted after controlling for serum uric acid level and physical activity level, and was strongest for persons with severest radiographic disease." | 3.67 | Obesity and knee osteoarthritis. The Framingham Study. ( Anderson, JJ; Felson, DT; Meenan, RF; Naimark, A; Walker, AM, 1988) |
| " A number of antecedent metabolic risk factors proved atherogenic, including blood lipids, glucose tolerance, uric acid, and menopause." | 3.67 | Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study. ( Kannel, WB, 1987) |
| " From more than 30 variables examined in multivariate analyses, blood pressure, obesity, cigarette smoking, alcohol consumption, serum glucose, uric acid and triglyceride, were inversely associated with staying healthy while forced vital capacity and years spent in Japan were directly associated with health." | 3.67 | Biological and social predictors of health in an aging cohort. ( Benfante, R; Brody, J; Reed, D, 1985) |
| " cholesterol, triglyceride, uric acid in serum; the number of erythrocytes and the components; obesity and blood pressure." | 3.66 | Serum high density lipoprotein cholesterol: as a cholesterol risk factor index for atherosclerotic diseases. ( Murata, K; Nakazawa, K, 1982) |
| "A total of 2,923 elderly subjects were studied to determine the relationship between obesity, hypertension, thyroid disease, renal function, alcohol consumption, selected drugs, and the serum uric acid level." | 3.66 | Selected physiologic and drug effects on serum uric acid levels in an elderly population. ( Hale, WE; Marks, RG; Stewart, RB; Yost, RL, 1981) |
| "Obesity, alcohol consumption, and hematocrit provide an index of plasma uric acid, which in path analysis has a cultural heritability of 0." | 3.66 | Determinants of plasma uric acid. ( Gulbrandsen, CL; Kagan, A; Morton, NE; Rao, DC; Rhoads, GG, 1979) |
| "Plasma uric acid levels in 35 obese gouty and non-gouty subjects showed a highly significant mean fall of 0." | 3.65 | The effect of weight loss on plasma and urinary uric acid and lipid levels. ( Scott, JT; Sturge, RA, 1977) |
| " Under these conditions ketoacidosis causes impaired renal uric acid excretion and hyperuricemia." | 3.65 | [Acute kidney failure as a complication of fasting therapy]. ( Binswanger, U; Huber, M; Lämmli, J; Meier, HR; Wick, A; Zürcher, HU, 1977) |
| " Data on blood pressure, obesity and serum lipids are presented here, and are discussed together with smoking and serum uric acid." | 3.65 | Coronary risk factors in New Zealand Maori and European adolescents: The Rotoua Lakes Study 2. ( Malcolm, JB; Stanhope, JM, 1975) |
| "In a group of healthy adult males, the correlation of serum triglycerides with cholesterol, uric acid, blood sugar and obesity was not significant." | 3.64 | Correlation of serum lipids with uric acid and blood sugar in normal males. ( Dunn, JP; Moses, C, 1965) |
| "Overweight and obesity are typical risk factors for the increased prevalence and incidence of gout." | 3.11 | The effects of aerobic exercise on body composition in overweight and obese patients with gout: a randomized, open-labeled, controlled trial. ( Geng, H; Jia, E; Liu, R; Ma, W; Wo, X; Yao, X; Zeng, Y; Zhan, Z; Zhang, J; Zhu, H, 2022) |
| "Psoriasis is a chronic inflammatory dermatosis leading to the development of systemic inflammatory reaction." | 2.78 | [Analysis of the chosen parameters of metabolic status in patients with psoriasis]. ( Kacalak-Rzepka, A; Kiedrowicz, M; Maleszka, R, 2013) |
| "Lercanidipine is a calcium channel blockers of high efficacy and low incidence of adverse effects in the clinical settings of general practice." | 2.71 | [Evaluation of lercanidipine in the general practice setting]. ( Aguilar, A; Angulo, E; Canelada, JA; Cidoncha, F; Díaz Olea, E; Fuentes, J; Garrido, J; Guerras, M; Hidalgo, P; Iglesias, M; Lapie, J; López Acedo, A; Peña, J; Robles, NR, 2003) |
| "The uric acid concentration was significantly higher in postmenopausal versus premenopausal women." | 2.69 | The effect of menopause on serum uric acid levels in non-obese healthy women. ( Stevenson, JC; Walton, C; Wingrove, CS, 1998) |
| "Obesity was prevalent in both groups." | 2.67 | [Forestier disease and metabolism disorders. A prospective controlled study of 25 cases]. ( Gerster, JC; Troillet, N, 1993) |
| "Gout is the most common inflammatory arthritis and occurs when hyperuricaemia, sustained elevation of serum urate levels resulting in supersaturation of body tissues with urate, leads to the formation and deposition of monosodium urate crystals in and around the joints." | 2.66 | Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. ( Dehlin, M; Jacobsson, L; Roddy, E, 2020) |
| "Gout is caused by monosodium urate crystal deposition in joints and tissues." | 2.66 | Gout: Rapid Evidence Review. ( Clebak, KT; Croad, JR; Morrison, A, 2020) |
| "Obesity is one of the actual problems of modern medicine." | 2.61 | [A role of fructose in urinary stone formation]. ( Golodnikov, II; Kamalov, AA; Nizov, AN; Pavlova, ZS, 2019) |
| "Gout is both an inflammatory and a metabolic disease." | 2.55 | Gout and Metabolic Syndrome: a Tangled Web. ( Krasnokutsky, S; Pillinger, MH; Thottam, GE, 2017) |
| " Two studies indicated dose-response relationship for sUA, achieving sUA target and gout attacks." | 2.55 | Weight loss for overweight and obese individuals with gout: a systematic review of longitudinal studies. ( Astrup, A; Bartels, EM; Bliddal, H; Carmona, L; Christensen, R; Gudbergsen, H; Henriksen, M; Knop, FK; Kristensen, LE; Nielsen, SM; Perez-Ruiz, F; Singh, JA; Taylor, WJ; Wæhrens, EE, 2017) |
| "Gout is the most common inflammatory arthritis in men, affecting approximately 1-2% of adult men in Western countries." | 2.43 | Recent developments in diet and gout. ( Kavanaugh, A; Lee, SJ; Terkeltaub, RA, 2006) |
| "Hyperuricemia has long been known to be associated with cardiovascular disease, and it is particularly common in people with hypertension, metabolic syndrome, or kidney disease." | 2.43 | Role of uric acid in hypertension, renal disease, and metabolic syndrome. ( Heinig, M; Johnson, RJ, 2006) |
| "Insulin resistance/hyperinsulinemia, in turn, is associated with a series of hypertensiogenic and atherogenic side effects, aggravating the individual components of the metabolic syndrome." | 2.39 | [The metabolic syndrome. Pathophysiologic causes, diagnosis, therapy]. ( Rett, K; Standl, E; Wicklmayr, M, 1994) |
| "One hundred sixty NIDDM patients who had undergone the clamp study were stratified into 5 groups according to the serum uric acid level." | 2.39 | [Hyperuricemia and insulin resistance]. ( Iwatani, M; Katsumori, K; Saeki, A; Wasada, T, 1996) |
| "In Japan, hyperuricemia is on the rise." | 1.91 | Effect of Dietary Counseling on Patients with Asymptomatic Hyperuricemia. ( Akiyama, M; Arai, H; Asai, T; Kawakami, Y; Koike, R; Kondo, R; Onishi, M, 2023) |
| "Uric acid stones were associated with medical conditions such as diabetes, hypertension, ischemic heart disease, and obesity (28." | 1.91 | The relationship between patients' kidney stone type and demographics in Israel: analysis of 10 K patients. ( Cohen, S; Dekel, Y; Friefeld, Y; Klein, I; Pilosov Solomon, I; Saliba, W; Tor, R; Zreik, R, 2023) |
| "Dyslipidemia is the most common risk factor for cardiovascular disease, causing more than 4 million deaths each year worldwide." | 1.91 | Dyslipidemia and its associated factors among adult cardiac patients at Ambo university referral hospital, Oromia region, west Ethiopia. ( Addisu, B; Bekele, S; Cheneke, W; Hirigo, AT; Wube, TB, 2023) |
| "Abdominal obesity is the strongest risk factor for type 2 diabetes in lean nonalcoholic fatty liver disease." | 1.91 | Association between the lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes in a healthy population of Northwest China: a retrospective cohort study with a 2-year follow-up period. ( Chang, M; Li, D; Li, N; Tan, H; Wu, S; Xang, W; Xie, C; Zhang, MY, 2023) |
| "Obesity was defined as a body mass index (BMI) of 23 (kg/m2) or more by Korean standards, and low skeletal muscle mass was defined as a skeletal muscle index (SMI) of <0." | 1.91 | Prevalence and clinical characteristics of low skeletal muscle index among adults visiting a health promotion center: Cross-sectional study. ( Kim, T; Kwon, RJ; Yun, J, 2023) |
| "Although obesity is associated with hyperuricemia, data on sex differences in this association are scarce." | 1.91 | Sex Difference in the Associations among Obesity-Related Indices with Hyperuricemia in a Large Taiwanese Population Study. ( Chen, SC; Huang, JC; Lin, TH; Liu, YH; Su, HM; Su, SY; Wu, PY, 2023) |
| "First-degree relatives (FDR) of type 2 diabetes mellitus have increased risk of developing insulin resistance-related disorders including hyperuricemia." | 1.91 | The role of high fat diet on serum uric acid level among healthy male first degree relatives of type 2 diabetes mellitus. ( Muhadi, M; Purnamasari, D; Tahapary, DL; Tarigan, TJE; Tricaesario, C; Umpuan, ARM; Wisnu, W, 2023) |
| "In this study, type 2 diabetes (T2D), sex, and menopausal status were combined to refine the stratification of obesity regarding the risk of advanced SLD and gain further insight into disease physiopathology." | 1.91 | Combining diabetes, sex, and menopause as meaningful clinical features associated with NASH and liver fibrosis in individuals with class II and III obesity: A retrospective cohort study. ( Baud, G; Bauvin, P; Caiazzo, R; Chatelain, E; Chetboun, M; Gnemmi, V; Lasailly, G; Lefebvre, P; Legendre, B; Leteurtre, E; Marciniak, C; Marot, G; Mathurin, P; Oukhouya-Daoud, N; Pattou, F; Raverdy, V; Staels, B; Vandel, J; Vantyghem, MC; Verkindt, H, 2023) |
| "Hyperuricemia was determined as serum uric acid ≥357μmol/L (6 mg/dl) for females and ≥417μmol/L (7 mg/dl) for males." | 1.72 | Mediation effect of obesity on the association between triglyceride-glucose index and hyperuricemia in Chinese hypertension adults. ( Bao, Q; Cai, S; Cheng, B; Li, M; Ma, S; Su, Y; Sun, J; Sun, M; Wang, S; Zhang, A; Zhang, Y; Zhu, P, 2022) |
| "The relationship between obesity and nephrolithiasis is a well-documented phenomenon." | 1.72 | Visceral adipose tissue loss and 24-hour urinary profile changes post-bariatric surgery. ( Al-Harbi, B; Hoogenes, J; Lena, RD; Matsumoto, ED; Shayegan, B; Uy, M; Woodward, A, 2022) |
| "This study focused on the visceral obesity defined by increased visceral fat area." | 1.72 | The abundance of bifidobacterium in relation to visceral obesity and serum uric acid. ( Gao, H; Gong, H; He, J; Ren, Q, 2022) |
| "Obesity is an important risk factor for hyperuricemia." | 1.72 | The perirenal fat thickness was independently associated with serum uric acid level in patients with type 2 diabetes mellitus. ( Cheng, Y; Fang, Y; Ke, J; Ma, Y; Xu, Y; Yang, Y; Zhao, D, 2022) |
| "Phthalimide derivatives have been extensively researched with various biological actions." | 1.72 | Antihyperlipidemic Activity of Glycoconjugated Phthalimides in Mice Submitted to a Model of Dyslipidemia and Insulin Resistance. ( da Rocha, IG; da Silva Júnior, JG; da Silva Neto, JC; de Araújo, HDA; de Menezes Lima, VL; de Oliveira Assis, SP; Oliveira, RN, 2022) |
| "Risk of hyperuricemia was high among those who remained metabolically unhealthy but of normal weight (OR, 3." | 1.72 | Association between metabolic obesity phenotype, transition of metabolic phenotypes and the risk of hyperuricemia in Chinese adults: A cohort study. ( Zhao, C; Zhao, W, 2022) |
| " Kaplan-Meier survival curves showed a clear dose-response relationship between C-index and all-cause mortality." | 1.72 | Conicity-index predicts all-cause mortality in Chinese older people: a 10-year community follow-up. ( Bao, Q; Cai, S; Cheng, B; Dong, J; Li, M; Li, Y; Ma, S; Su, Y; Sun, J; Wang, S; Zhang, A; Zhang, Y; Zhu, P, 2022) |
| "Gout was commonly observed in middle-aged men." | 1.62 | A Study of Metabolic Parameters in Patients with Gout: A Single Center Study from Nepal. ( Baral, R; Bhochhibhoya, M; Joshi, R; Lama, LD; Nakarmi, S; Vaidya, B, 2021) |
| "Uric acid response was not different between the two sugar types either baseline or 1 month, and there were no differences between baseline and 1 month." | 1.62 | Effect of a moderate dose of fructose in solid foods on TAG, glucose and uric acid before and after a 1-month moderate sugar-feeding period. ( Clifton, PM; Keogh, JB, 2021) |
| "Obesity has been demonstrated to show a consistent link with the increased possibility of nonalcoholic fatty liver disease (NAFLD)." | 1.62 | Serum Uric Acid Is a Mediator of the Association Between Obesity and Incident Nonalcoholic Fatty Liver Disease: A Prospective Cohort Study. ( Chen, S; Jiao, Y; Ma, X; Shi, H; Sun, X; Wu, S; Xing, J; Yang, R; Zhang, Q; Zhang, S, 2021) |
| "Obesity is a risk factor for periodontal disease (PD)." | 1.62 | Obesity-Related Gut Microbiota Aggravates Alveolar Bone Destruction in Experimental Periodontitis through Elevation of Uric Acid. ( Kato, T; Miura, N; Nakanishi, Y; Ohno, H; Okuda, S; Sato, K; Tsuzuno, T; Yamada-Hara, M; Yamazaki, K; Yokoji-Takeuchi, M, 2021) |
| "Nonalcoholic fatty liver disease (NAFLD) commonly occurs in patients with type 2 diabetes mellitus (T2DM)." | 1.56 | Increased plasma osteopontin levels are associated with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. ( Chen, W; He, M; Li, S; Liu, D; Long, M; Peng, J; Wang, C; Yang, G; Zhang, L, 2020) |
| "The prevalence of hyperuricemia has increased substantially in recent decades." | 1.56 | Association between dairy product consumption and hyperuricemia in an elderly population with metabolic syndrome. ( Abete, I; Alonso-Gómez, ÁM; Altozano Rodado, MC; Álvarez-Pérez, J; Arellano, AG; Babio, N; Barragán, R; Becerra-Tomás, N; Bernal, R; Cano-Ibáñez, N; Carmona-González, FJ; Caro, JLL; Casas, R; Corbella, E; Corella, D; Daimiel, L; de la Hera, MG; Díaz-López, A; Estruch, R; Fernández-Carrión, R; Fernández-García, JC; Fitó, M; Gaforio, JJ; Goday, A; Lapetra, J; Lopez-Miranda, J; Martín, M; Martínez, JA; Martínez-González, MÁ; Matía-Martín, P; Mena-Sánchez, G; Morey, M; Palau, A; Pérez-Vega, KA; Pintó, X; Romaguera, D; Ros, E; Ruiz-Canela, M; Salas-Salvadó, J; Santos-Lozano, JM; Serra-Majem, L; Sureda, A; Toledo, E; Tur, JA; Vaquero-Luna, J; Vázquez, C; Vidal, J; Vioque, J; Wärnberg, J; Zomeño, MD, 2020) |
| "Nonalcoholic fatty liver disease (NAFLD) is closely associated with obesity." | 1.56 | Associations between obesity and metabolic health with nonalcoholic fatty liver disease in elderly Chinese. ( Chen, G; Chen, XH; He, H; Kuang, Y; Lin, BY; Wu, LM; Zheng, SS, 2020) |
| "Gout is a multisystem disease that may present in different ways." | 1.56 | A leg ulcer with hard, yellow projections. ( Azevedo, F; Baudrier, T; Cerejeira, A; Gomes, N; Lopes, JM; Moura, CS, 2020) |
| "Elderly obese patients with NAFLD are at a higher risk of CKD." | 1.51 | Association of obesity with chronic kidney disease in elderly patients with nonalcoholic fatty liver disease. ( Bian, J; Chen, F; Jin, D; Li, H; Luo, K; Wang, J; Wang, Q, 2019) |
| "As uric acid levels increase there is a relevant clustering of metabolic risk factors, whereas elevated blood pressure is the risk factor less frequently present." | 1.48 | Uric acid is linked to cardiometabolic risk factors in overweight and obese youths. ( Alvarez-Pitti, J; Borghi, C; Lurbe, E; Redon, J; Redon, P; Torro, MI, 2018) |
| "Obesity is a risk factor for hypertension, diabetes mellitus (DM), dyslipidemia, and hyperuricemia." | 1.48 | Different Risk for Hypertension, Diabetes, Dyslipidemia, and Hyperuricemia According to Level of Body Mass Index in Japanese and American Subjects. ( Hisatome, I; Jalal, DI; Johnson, RJ; Kuwabara, M; Kuwabara, R; Lanaspa, MA; MacLean, PS; Niwa, K; Ohno, M; Roncal-Jimenez, CA; Smits, G; Yracheta, JM, 2018) |
| "Uric acid (UA) is a byproduct of the high-energy purine metabolism and is conventionally regarded as a marker of cardio-metabolic impairment." | 1.48 | Serum uric acid potentially links metabolic health to measures of fuel use in lean and obese individuals. ( Aimaretti, G; Mai, S; Marzullo, P; Mele, C; Saraceno, G; Scacchi, M; Tagliaferri, MA; Vietti, R; Zavattaro, M, 2018) |
| "Hyperuricemia is associated with metabolic syndrome (MetS), but the association is often confounded by the shared background of obesity." | 1.46 | Combined effect of obesity and uric acid on nonalcoholic fatty liver disease and hypertriglyceridemia. ( Du, T; Li, M; Lin, X; Lu, H; Yu, X; Zhang, S, 2017) |
| "Vitamin D deficiency is common in obesity; however, its contribution in the development of metabolic complications remains uncertain." | 1.46 | The potential impact of the hypovitaminosis D on metabolic complications in obese adolescents - Preliminary results. ( Janus, D; Kalicka-Kasperczyk, A; Starzyk, JB; Sztefko, K; Wojcik, M, 2017) |
| "Hyperuricemia is highly heritable and is associated with sex and body weight." | 1.46 | Association of ABCG2 rs2231142-A allele and serum uric acid levels in male and obese individuals in a Han Taiwanese population. ( Cheng, ST; Hsu, LA; Ko, YL; Su, CW; Teng, MS; Wu, S, 2017) |
| "Hyperuricemia was defined as serum uric acid ≥416 μmol/l in men and ≥357 μmol/l in women." | 1.43 | Prevalence of hyperuricemia and its correlates in rural Northeast Chinese population: from lifestyle risk factors to metabolic comorbidities. ( Guo, X; Ou, Q; Sun, Y; Yang, H; Yu, S; Zhang, X; Zheng, L; Zhou, Y, 2016) |
| "123 participants who had NAFLD at baseline lost NAFLD during the 8-year follow-up period." | 1.43 | Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study. ( Chen, XH; Li, YL; Lu, ZY; Shao, Z; Wulasihan, M, 2016) |
| "Hyperuricemia was defined as SUA ≥7mg/dl (420mmol/L) in men or ≥6mg/dl (360mmol/L) in women." | 1.43 | Metabolically healthy obesity also has risk for hyperuricemia among Chinese general population: A cross-sectional study. ( Chen, Y; Guo, X; Sun, G; Sun, Y; Yang, H; Yu, S; Zhang, N; Zheng, L, 2016) |
| " We aimed to explore the dose-response relation between FPG level and serum UA concentration by conducted this epidemiological research in a large health check-up population in China." | 1.43 | An Invert U-Shaped Curve: Relationship Between Fasting Plasma Glucose and Serum Uric Acid Concentration in a Large Health Check-Up Population in China. ( Guo, R; Li, H; Liu, M; Wen, Y; Zha, X; Zhu, Y, 2016) |
| "Nonalcoholic fatty liver disease (NAFLD) is highly prevalent and correlated with obesity." | 1.43 | Risk factor compositions of nonalcoholic fatty liver disease change with body mass index in males and females. ( Guo, J; Lu, J; Wang, L, 2016) |
| "Metabolic syndrome was found in 2502 of 18,222 healthy Chinese people (16." | 1.43 | Correlation of the leucocyte count with traditional and non-traditional components of metabolic syndrome. ( Gao, BL; Su, BY; Tian, CF; Tong, YH; Zhao, XH; Zheng, Y, 2016) |
| "The prevalence rates of NAFLD were 71." | 1.43 | Serum uric acid is independently and linearly associated with risk of nonalcoholic fatty liver disease in obese Chinese adults. ( Chen, N; He, CM; Li, X; Li, Z; Liu, CQ; Liu, S; Liu, Y; Shi, X; Wang, D; Yan, B; Yang, S; Zeng, X, 2016) |
| "Gouty arthritis is uncommon in childhood and adolescence." | 1.42 | Post-streptococcal acute glomerulonephritis complicated by gouty arthritis: a case report. ( Kamura, A; Kuniyoshi, Y; Tashiro, M; Yasuda, S, 2015) |
| "Whether nonalcoholic fatty liver disease (NAFLD) is related to vitamin D and bone health in obese children is unknown." | 1.42 | Vitamin D Status and Bone Mineral Density in Obese Children with Nonalcoholic Fatty Liver Disease. ( Chang, EJ; Yang, HR; Yi, DY, 2015) |
| "Overweight and obesity are becoming more and more relevant for armed forces in westernized countries, especially with respect to the impact on recruitment and soldiers' performance." | 1.42 | Results of a course based obesity intervention program during work. ( Sammito, S, 2015) |
| "Genotype TT is associated with type 2 diabetes (OR = 2." | 1.42 | [The study of the association of polymorphism rs5219 gene KCNJ11 with obesity and the risk of type 2 diabetes among residents of the Moscow Region]. ( Baturin, AK; Makurina, ON; Peskova, EV; Pogozheva, AV; Sorokina, EY; Tutelyan, VA, 2015) |
| "The pandemic of obesity is a global public health concern." | 1.40 | Overweight and obesity among low-income Muslim Uyghur women in far western China: correlations of body mass index with blood lipids and implications in preventive public health. ( Amanguli, A; Chen, C; Cong, L; Gu, Y; Hao, XL; Jing, MX; Li, F; Li, L; Li, SG; Ma, ZP; Mohemaiti, M; Saimaiti, A; Simayi, D; Tao, L; Wang, W; Wang, YH; Yang, L; Zhan, JQ; Zhang, HY; Zhang, W; Zhang, WJ; Zhao, J; Zou, XG, 2014) |
| "Uric acid was divided into quartiles in men (Q1: 59." | 1.40 | High uric acid level associated with increased arterial stiffness in apparently healthy women. ( Chang, CJ; Fang, JI; Lu, FH; Wang, RH; Wu, JS; Yang, YC, 2014) |
| " Dosing levels of SUA could be appropriate in the global management of patients with psoriasis, particularly in those who are obese and with serum triglycerides upper the normal range." | 1.40 | Hyperuricemia in patients with chronic plaque psoriasis. ( Gisondi, P, 2014) |
| "Hyperuricemia has been shown to be a strong correlate of hypertension in children." | 1.39 | Serum uric acid and blood pressure in children at cardiovascular risk. ( Antolini, L; Brambilla, P; Galbiati, S; Genovesi, S; Giussani, M; Mastriani, S; Pontremoli, R; Stella, A; Valsecchi, MG; Viazzi, F, 2013) |
| "Urolithiasis is a common urological disease predominantly affecting males." | 1.39 | Effect of BMI and urinary pH on urolithiasis and its composition. ( Bhaskar, N; Ishaq, S; Kaur, H; Mahajan, R; Masood, I; Najeeb, Q; Pandey, R; Prasad, S; Singh, J; Sodhi, KS, 2013) |
| "In conclusion, weight loss is effective in treating obese children with SDB." | 1.38 | Weight loss and sleep-disordered breathing in childhood obesity: effects on inflammation and uric acid. ( Aerts, P; De Backer, WA; Debode, P; Desager, KN; Franckx, H; Ramet, J; Van Gaal, LF; Van Hoorenbeeck, K; Verhulst, SL; Wouters, K, 2012) |
| "Hyperuricemia was defined as SUA ≥70 mg/L in men and ≥60 mg/L in women." | 1.38 | Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome. ( Gonçalves, JP; Lopes, C; Oliveira, A; Santos, AC; Severo, M, 2012) |
| "The development of obesity is determined by lifestyle and genetic mechanisms." | 1.38 | [The Trp64Arg polymorphism of beta3-adrenoreceptor gene study in persons with overweight and obesity]. ( Baturin, AK; Makurina, ON; Pogozheva, AV; Sorokina, EIu; Tutel'ian, VA, 2012) |
| "Gout is an ancient disease." | 1.38 | Management of gout: a 57-year-old man with a history of podagra, hyperuricemia, and mild renal insufficiency. ( Shmerling, RH, 2012) |
| "In all, 202 patients with type 2 diabetes (male/female: 91/111, aged: 58." | 1.37 | Which anthropometric parameter is best related with urinary albumin excretion and creatinine clearance in type 2 diabetes: body mass index, waist circumference, waist-to-hip ratio, or conicity index? ( Afsar, B; Elsurer, R; Güner, E; Kirkpantur, A, 2011) |
| "Hyperuricemia was defined as the values over the mean value plus 2 standard deviations for each age group." | 1.37 | Investigation on hyperuricemia in children with obesity or various pediatric disorders. ( Kubota, M; Nagai, A; Tang, L; Tokuda, M, 2011) |
| "The metabolic syndrome was defined based on the criteria of the Chinese Diabetes Society (CDS)." | 1.36 | The prevalence of microalbuminuria and its relationships with the components of metabolic syndrome in the general population of China. ( Chen, B; Chen, Y; Ni, Z; Xu, W; Yang, D; Ye, B, 2010) |
| "Responses to nocturnal hypoxemia accompanying sleep-disordered breathing (SDB) may vary in different populations." | 1.36 | Uric acid excretion in North American and Southeast European children with obstructive sleep apnea. ( Alexopoulos, E; Bhattacharjee, R; Capdevila, OS; Gourgoulianis, K; Gozal, D; Kaditis, A; Kheirandish-Gozal, L; Kim, J; Papathanasiou, AA; Snow, AB; Varlami, V; Zintzaras, E, 2010) |
| "Hyperuricemia is significantly predicted by anthropometric measure of SFT which is a simple clinical screening method along with creatinine levels." | 1.35 | Hyperuricemia and its related factors in an urban population, Izmir, Turkey. ( Akar, S; Akkoc, N; Birlik, M; Gurler, O; Onen, F; Pakoz, B; Sari, I; Sisman, AR, 2009) |
| "Uric acid urolithiasis was predominant in men in this study." | 1.35 | Local factors compared with systemic factors in the formation of bladder uric acid stones. ( Chou, YH; Huang, CH; Huang, SP; Li, CC; Li, WM; Liu, CC; Wu, WJ, 2009) |
| "Moreover, hyperuricemia is significantly correlated with hypertriglyceridemia, hypertension, and visceral obesity." | 1.35 | Serum uric acid levels and risk of metabolic syndrome in healthy adults. ( Bandarian, F; Ebrahimpour, P; Fakhrzadeh, H; Heshmat, R; Larijani, B, 2008) |
| "Insulin resistance was determined by using homeostasis model assessment (HOMA-IR)." | 1.34 | Ultrasonographic and biochemical evaluation of visceral obesity in obese women with non-alcoholic fatty liver disease. ( Akdag, B; Fenkci, S; Rota, S; Sabir, N, 2007) |
| "Hyperuricemia and gout have shown an increase worldwide." | 1.33 | The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China. ( Dong, Y; Gao, W; Nan, H; Qian, R; Qiao, Q; Tang, B; Tuomilehto, J, 2006) |
| "The pathogenesis of nephrolithiasis in Cushing's syndrome is still not completely clarified." | 1.32 | Nephrolithiasis in Cushing's disease: prevalence, etiopathogenesis, and modification after disease cure. ( Colao, A; Di Somma, C; Faggiano, A; Filippella, M; Lombardi, G; Melis, D; Petretta, M; Pivonello, R, 2003) |
| "Since hyperuricemia is associated with obesity, renal disease, hyperlipidemia, and atherosclerosis, whether or not serum urate is a cardiovascular risk factor per se has remained elusive." | 1.32 | Leptin might be a regulator of serum uric acid concentrations in humans. ( Alvur, M; Arik, N; Bedir, A; Tanyeri, F; Topbas, M, 2003) |
| "Obesity was significantly associated with a history of diabetes mellitus (18 vs." | 1.32 | Prevalence of obesity in an elderly Hungarian population. ( Antal, M; Donáth, J; Gergely, P; Kiss, C; Paksy, A; Poór, G; Zajkás, G, 2003) |
| "To investigate the impact of obstructive sleep apnea syndrome (OSAS) on testosterone levels and on the main parameters of the metabolic syndrome in abdominally obese men, 15 male subjects with abdominal obesity phenotype and polysomnographic diagnosis of OSAS (OB-OSAS) and 15 controls matched for age and anthropometric parameters (OB) were investigated." | 1.32 | Testosterone levels in obese male patients with obstructive sleep apnea syndrome: relation to oxygen desaturation, body weight, fat distribution and the metabolic parameters. ( Gambineri, A; Pasquali, R; Pelusi, C, 2003) |
| "Hyperuricemia is part of the "metabolic syndrome"." | 1.32 | Serum uric acid levels in obese children and adolescents: linkage to testosterone levels and pre-metabolic syndrome. ( Debatin, KM; Denzer, C; Heinze, E; Mayer, H; Muche, R; Wabitsch, M, 2003) |
| "Insulin resistance was estimated using the homeostasis model assessment (HOMA) method and the diagnosis of steatosis was determined by an ultrasound scan of the liver." | 1.32 | Insulin sensitivity and hepatic steatosis in obese subjects with normal glucose tolerance. ( Muggeo, M; Venturi, C; Zamboni, C; Zoppini, G, 2004) |
| "Insulin resistance was determined according to the Homeostasis Model Assessment (HOMA) formula." | 1.32 | Associations among sex hormone binding globulin concentrations and characteristics of the metabolic syndrome in obese women. ( Cikim, AS; Molvalilar, S; Orhan, Y; Ozbey, N; Sencer, E, 2004) |
| "Acyl-estrone levels were lower than expected in most obese women when compared to those of controls, suggesting an altered availability or function of this hormone." | 1.31 | Plasma acyl-estrone levels are altered in obese women. ( Alemany, M; Bullo, M; Cabot, C; Fernández-López, JA; García-Lorda, P; Masanés, R; Salas-Salvadó, J, 2000) |
| "In conclusion, hyperinsulinemia, as well as obesity, hyperuricemia, and hypertriglyceridemia were associated with hypertension in Japanese-Americans." | 1.31 | Hyperinsulinemia for the development of hypertension: data from the Hawaii-Los Angeles-Hiroshima Study. ( Egusa, G; Imazu, M; Kohno, N; Okubo, M; Sumii, K; Toyofuku, M; Yamakido, M; Yamamoto, H, 2001) |
| "While obesity was not associated with microalbuminuria once central adiposity was taken into account, elevated percent body fat remained associated with microalbuminuria." | 1.31 | Microalbuminuria, central adiposity and hypertension in the non-diabetic urban population of the MONICA Augsburg survey 1994/95. ( Döring, A; Hense, HW; Keil, U; Liese, AD; Stieber, J, 2001) |
| "The rates of progression to type 2 diabetes were lowest from the NGT subgroup, highest from the IGT group, with the PFH group in the middle, suggesting that PFH might be a transitional condition that precedes IGT and diabetes." | 1.30 | Progression to type 2 diabetes among high-risk groups in Kin-Chen, Kinmen. Exploring the natural history of type 2 diabetes. ( Chou, P; Li, CL; Tsai, ST; Wu, GS, 1998) |
| "13 patients had combination of hyperinsulinemia with obesity, dyslipidemia, arterial hypertension." | 1.30 | [Urate affection of kidneys and metabolic disturbances in hypertensive patients]. ( Anikina, SA; Balkarov, IM; Donskov, AS; Fadina, ZM; Feofanova, ID; Golub', GV; Goncharov, VS; Saltykova, NG, 1999) |
| "To determine if obstructive sleep apnea (OSA) is independently associated with cardiovascular risk factors and health status in subjects with severe obesity." | 1.29 | Impact of obstructive sleep apnea and sleepiness on metabolic and cardiovascular risk factors in the Swedish Obese Subjects (SOS) Study. ( Grunstein, RR; Hedner, J; Sjöström, L; Stenlöf, K, 1995) |
| "Epidemiologically, diabetes mellitus affects men by 64% and women by 36%." | 1.29 | [Diabetes mellitus at the National Hospital Center of Ouagadougou (Burkina Faso)]. ( Drabo, PY; Ilboudo, PD; Kabore, J; Lengani, A, 1996) |
| "Obesity is common amongst the Maoris and accentuates their natural tendency to hyperuricaemia." | 1.27 | Hyperuricaemia, gout and kidney function in New Zealand Maori men. ( Bremner, K; Gibson, T; Hatfield, P; Robinson, G; Waterworth, R, 1984) |
| " Results suggest that very-low-calorie diets can be an effective and safe means of substantial weight reduction." | 1.27 | Safety and effectiveness of weight reduction using a very-low-calorie formulated food. ( Budell, W; Clements, M; Kreitzman, SN; Krissman, P; Nichols, D; Pedersen, M, 1984) |
| "Obesity was associated with both bilateral and unilateral OA, but more strongly with bilateral OA." | 1.27 | The role of metabolic factors and blood pressure in the association of obesity with osteoarthritis of the knee. ( Davis, MA; Ettinger, WH; Neuhaus, JM, 1988) |
| "Uric acid metabolism was investigated in 27 overweight subjects, 11 men (176 +/- 30 percent of ideal body weight) and 16 women (169 +/- 20 percent of ideal body weight)." | 1.27 | Studies on the impaired metabolism of uric acid in obese subjects: marked reduction of renal urate excretion and its improvement by a low-calorie diet. ( Fujioka, S; Matsuzawa, Y; Tarui, S; Tokunaga, K; Yamashita, S, 1986) |
| "Cigarette smoking, hypertension, dyslipidemia, heredity, diabetes mellitus, obesity, beta blockades, and coronary artery bypass surgery are some of the topics discussed." | 1.27 | Preventive cardiology for coronary artery disease. ( Miller, WW, 1985) |
| "163 patients suffering from sudden hearing loss were examined with regard to their cardiovascular risk factors (hypertension, hyperlipaemia, cigarette smoking, hyperglycaemia, hyperuricaemia and obesity)." | 1.27 | [Etiology and pathogenesis of sudden deafness]. ( Friedrich, G, 1985) |
| "No single diet exists for the treatment of obesity." | 1.27 | Weight-reducing diets. ( Balabanski, L, 1985) |
| "Obesity has to be considered a connecting link between both of them, and it is accelerating their genesis." | 1.26 | [Hallux rigidus arthrosis and gout]. ( Mertz, DP, 1982) |
| "Obesity is very common in South Africal Black girls aged 18 - 20 years." | 1.26 | Serum high-density lipoprotein cholesterol, glucose tolerance and other variables in obese black adolescent girls. ( Bhamjee, D; Martin, AP; Walker, AR; Walker, BF, 1979) |
| "The uric acid clearance were 5." | 1.26 | Renal excretion of uric acid during prolonged fasting. ( Fox, IH; Goldstein, MB; Halperin, ML; Marliss, ER, 1976) |
| "Obesity was found in 19 per cent of all patients and serum uric acid levels over 0." | 1.25 | Myocardial infarction in young men. Study of risk factors in nine countries. ( Dolder, MA; Oliver, MF, 1975) |
| "Generalized osteoarthrosis was found to be significantly more common in older males with high than with low diastolic blood pressure." | 1.25 | Hypertension in relation to musculoskeletal disorders. ( Lawrence, JS, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 339 (39.65) | 18.7374 |
| 1990's | 60 (7.02) | 18.2507 |
| 2000's | 118 (13.80) | 29.6817 |
| 2010's | 213 (24.91) | 24.3611 |
| 2020's | 125 (14.62) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, CD | 1 |
| Boutwell, BB | 1 |
| Xiong, Y | 1 |
| Wangsheng, F | 1 |
| Wang, S | 5 |
| Zhou, W | 1 |
| Huang, X | 1 |
| Bao, H | 1 |
| Cheng, X | 4 |
| Tu, CM | 1 |
| Wei, TE | 1 |
| Tseng, GS | 1 |
| Chen, CC | 1 |
| Liu, CW | 1 |
| Andres-Hernando, A | 1 |
| Cicerchi, C | 1 |
| Kuwabara, M | 3 |
| Orlicky, DJ | 1 |
| Sanchez-Lozada, LG | 5 |
| Nakagawa, T | 4 |
| Johnson, RJ | 14 |
| Lanaspa, MA | 7 |
| Ran, Z | 1 |
| Xue, X | 1 |
| Han, L | 2 |
| Terkeltaub, R | 1 |
| Merriman, TR | 3 |
| Zhao, T | 1 |
| He, Y | 4 |
| Wang, C | 4 |
| Li, X | 7 |
| Liu, Z | 4 |
| Cui, L | 1 |
| Li, H | 4 |
| Ji, A | 1 |
| Hu, S | 1 |
| Lu, J | 4 |
| Li, C | 5 |
| Cota, BC | 1 |
| Priore, SE | 1 |
| Ribeiro, SAV | 1 |
| Juvanhol, LL | 1 |
| de Faria, ER | 1 |
| de Faria, FR | 1 |
| Pereira, PF | 1 |
| He, H | 6 |
| Pan, L | 4 |
| Ren, X | 2 |
| Wang, D | 3 |
| Du, J | 3 |
| Cui, Z | 2 |
| Zhao, J | 4 |
| Wang, H | 4 |
| Wang, X | 7 |
| Liu, F | 4 |
| Pa, L | 2 |
| Peng, X | 2 |
| Wang, Y | 4 |
| Yu, C | 1 |
| Shan, G | 4 |
| Obayemi, MJ | 1 |
| Akintayo, CO | 1 |
| Oniyide, AA | 1 |
| Aturamu, A | 1 |
| Badejogbin, OC | 1 |
| Atuma, CL | 1 |
| Saidi, AO | 1 |
| Mahmud, H | 1 |
| Olaniyi, KS | 1 |
| Sun, J | 3 |
| Sun, M | 1 |
| Su, Y | 3 |
| Li, M | 9 |
| Ma, S | 4 |
| Zhang, Y | 10 |
| Zhang, A | 3 |
| Cai, S | 3 |
| Cheng, B | 3 |
| Bao, Q | 3 |
| Zhu, P | 3 |
| Jin, Y | 2 |
| Jia, P | 1 |
| Cai, M | 2 |
| Dilimulati, D | 2 |
| Lin, Z | 2 |
| Sun, H | 3 |
| Cui, R | 1 |
| Fei, H | 1 |
| Gao, X | 3 |
| Zeng, Q | 1 |
| Shao, X | 2 |
| Zhang, M | 8 |
| Qu, S | 6 |
| Uy, M | 1 |
| Lena, RD | 1 |
| Hoogenes, J | 1 |
| Al-Harbi, B | 1 |
| Woodward, A | 1 |
| Shayegan, B | 1 |
| Matsumoto, ED | 1 |
| Kahaer, M | 1 |
| Zhang, B | 4 |
| Chen, W | 2 |
| Liang, M | 1 |
| Chen, M | 1 |
| Li, R | 1 |
| Tian, T | 1 |
| Hu, C | 2 |
| Sun, Y | 6 |
| Biswal, M | 1 |
| M, B | 1 |
| Corso, LML | 1 |
| Wing, RR | 1 |
| Tate, DF | 1 |
| Espeland, MA | 1 |
| Blanchard, BE | 1 |
| McCaffery, JM | 1 |
| Akbulut, T | 1 |
| Cinar, V | 1 |
| Ugur, K | 1 |
| Yardim, M | 1 |
| Karagoz, ZK | 1 |
| Aydin, S | 1 |
| Bragina, АЕ | 1 |
| Osadchiy, KK | 1 |
| Rodionova, JN | 1 |
| Bayutina, DА | 1 |
| Cherepanov, АG | 1 |
| Podzolkov, VI | 1 |
| Chen, HW | 1 |
| Chen, YC | 1 |
| Lee, JT | 1 |
| Yang, FM | 1 |
| Kao, CY | 1 |
| Chou, YH | 2 |
| Chu, TY | 1 |
| Juan, YS | 1 |
| Wu, WJ | 2 |
| Rajadhyaksha, A | 1 |
| Sarate, N | 1 |
| Raghorte, N | 1 |
| Ingawale, S | 1 |
| Al Aamri, KS | 1 |
| Alrawahi, AH | 1 |
| Al Busaidi, N | 1 |
| Al Githi, MS | 1 |
| Al Jabri, K | 1 |
| Al Balushi, F | 1 |
| Ronquillo-Talara, R | 1 |
| Al Balushi, S | 1 |
| Waly, M | 1 |
| Rao, J | 2 |
| Ye, P | 1 |
| Chen, B | 4 |
| Li, N | 3 |
| Zhang, H | 3 |
| Bo, H | 1 |
| Chen, X | 3 |
| Liu, H | 4 |
| Zhang, C | 1 |
| Wei, H | 2 |
| Wu, Q | 2 |
| Yan, Y | 1 |
| Mi, J | 1 |
| Yang, M | 4 |
| Bai, W | 1 |
| Jiang, B | 1 |
| Wang, Z | 1 |
| Cui, G | 1 |
| Song, X | 1 |
| Li, J | 7 |
| Wu, F | 1 |
| Chen, D | 1 |
| You, H | 2 |
| Gong, H | 1 |
| Gao, H | 1 |
| Ren, Q | 1 |
| He, J | 3 |
| Yao, J | 2 |
| Lin, YP | 1 |
| Lu, QY | 1 |
| Fan, GJ | 1 |
| Guo, P | 1 |
| Zhang, J | 7 |
| Niu, Y | 1 |
| Chen, S | 4 |
| Guo, F | 1 |
| Zhang, R | 2 |
| Li, Q | 1 |
| Yang, Y | 4 |
| Ma, Y | 2 |
| Cheng, Y | 1 |
| Xu, Y | 1 |
| Fang, Y | 1 |
| Ke, J | 1 |
| Zhao, D | 1 |
| Xian, W | 1 |
| Wu, D | 1 |
| Huo, Z | 1 |
| Hong, S | 1 |
| Li, Y | 12 |
| Xiao, H | 1 |
| Haueisen Sander Diniz, MF | 1 |
| M R Beleigoli, A | 1 |
| Isabel Rodrigues Galvão, A | 1 |
| Weiss Telles, R | 1 |
| Inês Schmidt, M | 1 |
| B Duncan, B | 1 |
| M Benseñor, I | 1 |
| Luiz P Ribeiro, A | 1 |
| Vidigal, PG | 1 |
| Maria Barreto, S | 1 |
| Jia, E | 1 |
| Zhu, H | 1 |
| Geng, H | 1 |
| Liu, R | 1 |
| Wo, X | 1 |
| Zeng, Y | 1 |
| Ma, W | 1 |
| Yao, X | 1 |
| Zhan, Z | 1 |
| Cheang, C | 1 |
| Law, S | 1 |
| Ren, J | 1 |
| Chan, W | 1 |
| Dong, Z | 1 |
| da Silva Júnior, JG | 1 |
| de Araújo, HDA | 1 |
| da Rocha, IG | 1 |
| da Silva Neto, JC | 1 |
| Oliveira, RN | 1 |
| de Oliveira Assis, SP | 1 |
| de Menezes Lima, VL | 1 |
| Maruszczak, K | 1 |
| Radzikowski, K | 1 |
| Schütz, S | 1 |
| Mangge, H | 4 |
| Bergsten, P | 1 |
| Forslund, A | 1 |
| Manell, H | 1 |
| Pixner, T | 1 |
| Ahlström, H | 1 |
| Kullberg, J | 1 |
| Mörwald, K | 1 |
| Weghuber, D | 3 |
| Rodriguez-Iturbe, B | 1 |
| Tolan, D | 1 |
| Gaucher, EA | 3 |
| Andrews, P | 2 |
| Ding, N | 1 |
| Hu, Z | 1 |
| Zhi, X | 1 |
| Li, B | 1 |
| Wang, J | 6 |
| Zhu, J | 3 |
| Zhang, Z | 5 |
| Hernandez-Hernandez, ME | 1 |
| Torres-Rasgado, E | 1 |
| Pulido-Perez, P | 1 |
| Nicolás-Toledo, L | 1 |
| Martínez-Gómez, M | 1 |
| Rodríguez-Antolín, J | 1 |
| Pérez-Fuentes, R | 1 |
| Romero, JR | 1 |
| Yazdi, F | 2 |
| Shakibi, MR | 1 |
| Baniasad, A | 1 |
| Najafzadeh, MJ | 1 |
| Najafipour, H | 1 |
| Sistani, S | 1 |
| Zhou, S | 1 |
| Yu, Y | 1 |
| Ma, L | 1 |
| Liu, T | 1 |
| Sun, R | 1 |
| Chen, Y | 7 |
| Seong, JM | 1 |
| Gi, MY | 1 |
| Cha, JA | 1 |
| Sung, HH | 1 |
| Park, SY | 1 |
| Park, CH | 1 |
| Yoon, H | 1 |
| He, HM | 3 |
| Zhang, L | 6 |
| Qiu, N | 3 |
| Zhou, ZT | 3 |
| Zhang, K | 4 |
| Chen, HB | 3 |
| Xu, JN | 3 |
| Zhao, W | 3 |
| Zhao, C | 3 |
| An, Y | 2 |
| Ouyang, F | 2 |
| Xiao, S | 2 |
| El-Eshmawy, MM | 3 |
| Ibrahim, A | 2 |
| Bahriz, R | 2 |
| Shams-Eldin, N | 2 |
| Mahsoub, N | 3 |
| Dong, J | 2 |
| Gor, Z | 1 |
| Bezen, D | 1 |
| Turkmenoglu, Y | 1 |
| Vurgun, E | 1 |
| Irdem, A | 1 |
| Dursun, H | 1 |
| Maloberti, A | 1 |
| Vanoli, J | 1 |
| Finotto, A | 1 |
| Bombelli, M | 1 |
| Facchetti, R | 1 |
| Redon, P | 2 |
| Mancia, G | 1 |
| Grassi, G | 1 |
| Choleva, M | 1 |
| Matalliotaki, E | 1 |
| Antoniou, S | 1 |
| Asimomyti, E | 1 |
| Drouka, A | 1 |
| Stefani, M | 1 |
| Yannakoulia, M | 1 |
| Fragopoulou, E | 1 |
| Zheng, J | 1 |
| Miao, Y | 1 |
| Zhang, Q | 3 |
| Wen, YF | 1 |
| Culhane-Pera, KA | 1 |
| Pergament, SL | 1 |
| Moua, Y | 1 |
| Vue, B | 1 |
| Yang, T | 2 |
| Lo, M | 1 |
| Sun, B | 1 |
| Knights, D | 1 |
| Straka, RJ | 1 |
| Zhang, W | 4 |
| Xiao, C | 1 |
| Wu, X | 1 |
| Cui, H | 1 |
| Yan, P | 1 |
| Yang, C | 2 |
| Tang, M | 2 |
| Chen, L | 4 |
| Liu, Y | 7 |
| Zou, Y | 1 |
| Alfredsson, L | 1 |
| Klareskog, L | 1 |
| Yao, Y | 2 |
| Jiang, X | 1 |
| Fiorentino, TV | 1 |
| De Vito, F | 1 |
| Suraci, E | 1 |
| Marasco, R | 1 |
| Hribal, ML | 1 |
| Luzza, F | 1 |
| Sesti, G | 1 |
| Lekpa, FK | 1 |
| Bebey, FS | 1 |
| Bouallo, I | 1 |
| Njonnou, SRS | 1 |
| Luma, HN | 1 |
| Singwe-Ngandeu, M | 1 |
| Choukem, SP | 1 |
| Primo, D | 1 |
| Izaola, O | 1 |
| de Luis, D | 1 |
| Kim, EY | 1 |
| Lee, HW | 1 |
| Lee, JW | 1 |
| Kwon, YJ | 1 |
| Son, NH | 1 |
| Tu, YC | 1 |
| Liu, YH | 2 |
| Chen, SC | 3 |
| Su, HM | 2 |
| Liu, J | 2 |
| Pan, H | 1 |
| Guan, M | 1 |
| Tong, X | 1 |
| Luo, Y | 1 |
| Yang, X | 2 |
| Guo, X | 7 |
| Tao, L | 2 |
| Koike, R | 1 |
| Kawakami, Y | 1 |
| Kondo, R | 1 |
| Onishi, M | 1 |
| Akiyama, M | 1 |
| Asai, T | 1 |
| Arai, H | 1 |
| Zreik, R | 1 |
| Pilosov Solomon, I | 1 |
| Saliba, W | 1 |
| Tor, R | 1 |
| Cohen, S | 1 |
| Friefeld, Y | 1 |
| Dekel, Y | 1 |
| Klein, I | 1 |
| Hwang, SM | 1 |
| Cho, KY | 1 |
| Lei, T | 1 |
| Zhu, Z | 1 |
| Yang, J | 2 |
| Hu, Y | 2 |
| Hua, L | 1 |
| Sun, L | 1 |
| Mu, Z | 1 |
| Novaes, JF | 1 |
| Filgueiras, MS | 1 |
| Suhett, LG | 1 |
| Silva, MA | 1 |
| Albuquerque, FM | 1 |
| Fonseca, RMS | 1 |
| Peluzio, MDCG | 1 |
| Addisu, B | 1 |
| Bekele, S | 1 |
| Wube, TB | 1 |
| Hirigo, AT | 1 |
| Cheneke, W | 1 |
| Xang, W | 1 |
| Wu, S | 4 |
| Li, D | 2 |
| Chang, M | 1 |
| Xie, C | 1 |
| Zhang, MY | 1 |
| Tan, H | 1 |
| Yun, J | 1 |
| Kwon, RJ | 1 |
| Kim, T | 1 |
| Wang, YY | 1 |
| Zhao, Q | 2 |
| Wang, N | 2 |
| Zhang, TJ | 1 |
| Jiang, YG | 1 |
| Wu, YL | 1 |
| He, N | 1 |
| Zhao, GM | 1 |
| Liu, X | 2 |
| Fernandez-Crespo, S | 1 |
| Vazquez-Agra, N | 1 |
| Marques-Afonso, AT | 1 |
| Cruces-Sande, A | 1 |
| Martinez-Olmos, MA | 1 |
| Araujo-Vilar, D | 1 |
| Hermida-Ameijeiras, A | 1 |
| Fang, G | 1 |
| Huang, C | 1 |
| An, W | 1 |
| Bai, X | 1 |
| Huang, Y | 2 |
| Su, SY | 1 |
| Lin, TH | 1 |
| Wu, PY | 1 |
| Huang, JC | 1 |
| González-Domínguez, Á | 1 |
| Belmonte, T | 1 |
| Domínguez-Riscart, J | 1 |
| Ruiz-Ocaña, P | 1 |
| Muela-Zarzuela, I | 1 |
| Saez-Benito, A | 1 |
| Montañez-Martínez, R | 1 |
| Mateos, RM | 1 |
| Lechuga-Sancho, AM | 1 |
| Shi, A | 1 |
| Deng, J | 2 |
| Ma, J | 1 |
| Yang, L | 3 |
| Tantai, X | 1 |
| Wang, Q | 2 |
| Chang, D | 2 |
| Lu, X | 2 |
| Shi, H | 3 |
| Ardekani, AM | 1 |
| Nava, ZH | 1 |
| Zaman, BA | 1 |
| Vahdat, S | 1 |
| Lame-Jouybari, AH | 1 |
| Mivefroshan, A | 1 |
| Di Sessa, A | 1 |
| Passaro, AP | 1 |
| Colasante, AM | 1 |
| Cioffi, S | 1 |
| Guarino, S | 1 |
| Umano, GR | 1 |
| Papparella, A | 1 |
| Miraglia Del Giudice, E | 1 |
| Marzuillo, P | 1 |
| Dong, M | 1 |
| An, K | 1 |
| Mao, L | 1 |
| Wakabayashi, D | 1 |
| Kato, S | 1 |
| Tanaka, M | 3 |
| Yamakage, H | 1 |
| Kato, H | 1 |
| Kusakabe, T | 1 |
| Ozu, N | 1 |
| Kasama, S | 1 |
| Kasahara, M | 1 |
| Satoh-Asahara, N | 1 |
| Purnamasari, D | 1 |
| Umpuan, ARM | 1 |
| Tricaesario, C | 1 |
| Wisnu, W | 1 |
| Tarigan, TJE | 1 |
| Tahapary, DL | 1 |
| Muhadi, M | 1 |
| Luan, H | 1 |
| Shi, C | 1 |
| Li, S | 3 |
| Yuan, S | 1 |
| Lin, G | 1 |
| Raverdy, V | 1 |
| Chatelain, E | 1 |
| Lasailly, G | 1 |
| Caiazzo, R | 1 |
| Vandel, J | 1 |
| Verkindt, H | 1 |
| Marciniak, C | 1 |
| Legendre, B | 1 |
| Bauvin, P | 1 |
| Oukhouya-Daoud, N | 1 |
| Baud, G | 1 |
| Chetboun, M | 1 |
| Vantyghem, MC | 1 |
| Gnemmi, V | 1 |
| Leteurtre, E | 1 |
| Staels, B | 1 |
| Lefebvre, P | 1 |
| Mathurin, P | 1 |
| Marot, G | 1 |
| Pattou, F | 1 |
| Sánchez-Bacaicoa, C | 1 |
| Santano-Mogena, E | 1 |
| Rico-Martín, S | 1 |
| Rey-Sánchez, P | 1 |
| Juárez-Vela, R | 1 |
| Sánchez Muñoz-Torrero, JF | 1 |
| López-Espuela, F | 1 |
| Calderón-García, JF | 1 |
| Jin, L | 1 |
| Zeng, N | 2 |
| Wang, L | 6 |
| Zhao, K | 1 |
| Lv, H | 2 |
| Xu, W | 4 |
| Zhang, P | 3 |
| Yeo, C | 1 |
| Kaushal, S | 1 |
| Lim, B | 1 |
| Syn, N | 1 |
| Oo, AM | 1 |
| Koura, A | 1 |
| Yeo, D | 1 |
| Al-Ozairi, E | 1 |
| Rivard, CJ | 2 |
| Sanchez Lozada, LG | 1 |
| Bjornstad, P | 1 |
| Al Salem, D | 1 |
| Alhubail, A | 1 |
| Megahed, A | 1 |
| Asad, RA | 1 |
| Stamp, LK | 2 |
| Chapman, P | 1 |
| Hudson, B | 1 |
| Frampton, C | 1 |
| Hamilton, G | 1 |
| Judd, A | 1 |
| Yang, SC | 1 |
| Huang, WC | 1 |
| Ng, XE | 1 |
| Lee, MC | 1 |
| Hsu, YJ | 1 |
| Huang, CC | 1 |
| Wu, HH | 1 |
| Yeh, CL | 1 |
| Shirakawa, H | 1 |
| Budijanto, S | 1 |
| Tung, TH | 2 |
| Tung, YT | 1 |
| He, M | 1 |
| Peng, J | 1 |
| Long, M | 1 |
| Liu, D | 1 |
| Yang, G | 1 |
| D'Elia, L | 1 |
| Giaquinto, A | 1 |
| Cappuccio, FP | 1 |
| Iacone, R | 1 |
| Russo, O | 1 |
| Strazzullo, P | 2 |
| Galletti, F | 1 |
| Mena-Sánchez, G | 1 |
| Babio, N | 1 |
| Becerra-Tomás, N | 1 |
| Martínez-González, MÁ | 1 |
| Díaz-López, A | 1 |
| Corella, D | 1 |
| Zomeño, MD | 1 |
| Romaguera, D | 1 |
| Vioque, J | 1 |
| Alonso-Gómez, ÁM | 1 |
| Wärnberg, J | 1 |
| Martínez, JA | 2 |
| Serra-Majem, L | 1 |
| Estruch, R | 1 |
| Bernal, R | 1 |
| Lapetra, J | 1 |
| Pintó, X | 1 |
| Tur, JA | 1 |
| Lopez-Miranda, J | 1 |
| Cano-Ibáñez, N | 1 |
| Gaforio, JJ | 1 |
| Matía-Martín, P | 1 |
| Daimiel, L | 1 |
| Caro, JLL | 1 |
| Vidal, J | 1 |
| Vázquez, C | 1 |
| Ros, E | 1 |
| Arellano, AG | 1 |
| Palau, A | 1 |
| Fernández-Carrión, R | 1 |
| Pérez-Vega, KA | 1 |
| Morey, M | 1 |
| de la Hera, MG | 1 |
| Vaquero-Luna, J | 1 |
| Carmona-González, FJ | 1 |
| Abete, I | 2 |
| Álvarez-Pérez, J | 1 |
| Casas, R | 1 |
| Fernández-García, JC | 1 |
| Santos-Lozano, JM | 1 |
| Corbella, E | 1 |
| Sureda, A | 1 |
| Ruiz-Canela, M | 1 |
| Barragán, R | 1 |
| Goday, A | 1 |
| Martín, M | 1 |
| Altozano Rodado, MC | 1 |
| Toledo, E | 1 |
| Fitó, M | 1 |
| Salas-Salvadó, J | 2 |
| Zupo, R | 1 |
| Castellana, F | 1 |
| Boninfante, B | 1 |
| Lampignano, L | 1 |
| Lattanzio, A | 1 |
| Sardone, R | 1 |
| Giannelli, G | 1 |
| De Pergola, G | 1 |
| Li, L | 3 |
| Song, Q | 1 |
| Huang, JY | 1 |
| Liu, L | 3 |
| Lo, K | 1 |
| Sun, S | 1 |
| Chen, CL | 3 |
| Feng, YQ | 1 |
| Huang, YQ | 1 |
| Araujo, DS | 1 |
| Scudine, KGO | 1 |
| Pedroni-Pereira, A | 1 |
| Gavião, MBD | 1 |
| Pereira, EC | 1 |
| Fonseca, FLA | 1 |
| Castelo, PM | 1 |
| Mazidi, M | 1 |
| Katsiki, N | 2 |
| Mikhailidis, DP | 4 |
| Banach, M | 1 |
| Rodríguez-San Nicolás, A | 1 |
| SÁnchez-RodrÍguez, MA | 1 |
| Zacarías-Flores, M | 1 |
| Correa-Muñoz, E | 1 |
| Mendoza-Núñez, VM | 1 |
| Zhou, H | 1 |
| Ma, ZF | 1 |
| Lu, Y | 1 |
| Du, Y | 2 |
| Shao, J | 1 |
| Pan, B | 1 |
| Zhu, W | 3 |
| Lin, WY | 1 |
| Chan, CC | 1 |
| Liu, YL | 1 |
| Yang, AC | 1 |
| Tsai, SJ | 1 |
| Kuo, PH | 1 |
| Wu, LM | 1 |
| Chen, G | 1 |
| Kuang, Y | 1 |
| Lin, BY | 1 |
| Chen, XH | 2 |
| Zheng, SS | 1 |
| Dore, R | 1 |
| Villasís-Keever, M | 1 |
| Zurita-Cruz, J | 1 |
| Dehlin, M | 2 |
| Jacobsson, L | 2 |
| Roddy, E | 1 |
| Russo, E | 1 |
| Leoncini, G | 1 |
| Esposito, P | 1 |
| Garibotto, G | 1 |
| Pontremoli, R | 2 |
| Viazzi, F | 2 |
| Gomes, N | 1 |
| Cerejeira, A | 1 |
| Moura, CS | 1 |
| Lopes, JM | 1 |
| Baudrier, T | 1 |
| Azevedo, F | 1 |
| Karava, V | 1 |
| Dotis, J | 1 |
| Kondou, A | 1 |
| Christoforidis, A | 1 |
| Liakopoulos, V | 1 |
| Tsioni, K | 1 |
| Kollios, K | 1 |
| Papachristou, F | 1 |
| Printza, N | 1 |
| Lai, CH | 1 |
| Huang, RJ | 1 |
| Wong, JK | 1 |
| Chang, SW | 1 |
| Chung, AH | 1 |
| Chi, YC | 1 |
| Yu, YC | 1 |
| Lee, SD | 1 |
| Ting, H | 1 |
| Vaidya, B | 1 |
| Baral, R | 1 |
| Lama, LD | 1 |
| Joshi, R | 1 |
| Bhochhibhoya, M | 1 |
| Nakarmi, S | 1 |
| Xu, R | 1 |
| Shen, P | 1 |
| Wu, C | 1 |
| Wan, Y | 1 |
| Fan, Z | 1 |
| Zhuang, J | 1 |
| Tang, P | 1 |
| Xiong, X | 1 |
| Deng, H | 1 |
| Matsushita, Y | 1 |
| Hasegawa, Y | 1 |
| Takebe, N | 1 |
| Onodera, K | 1 |
| Shozushima, M | 1 |
| Oda, T | 1 |
| Nagasawa, K | 1 |
| Honma, H | 1 |
| Nata, K | 1 |
| Sasaki, A | 1 |
| Ishigaki, Y | 1 |
| Fikri, AM | 1 |
| Smyth, R | 1 |
| Kumar, V | 1 |
| Al-Abadla, Z | 1 |
| Abusnana, S | 1 |
| Munday, MR | 1 |
| Clebak, KT | 1 |
| Morrison, A | 1 |
| Croad, JR | 1 |
| Bento, C | 1 |
| Matos, A | 1 |
| Cordeiro, A | 1 |
| Ramalho, A | 1 |
| Yang, S | 3 |
| Zhong, J | 1 |
| Ye, M | 1 |
| Miao, L | 1 |
| Lu, G | 1 |
| Xu, C | 1 |
| Xue, Z | 1 |
| Zhou, X | 2 |
| Clifton, PM | 1 |
| Keogh, JB | 1 |
| Bai, Z | 1 |
| Zhu, X | 1 |
| Dai, H | 1 |
| Bian, S | 1 |
| Tian, P | 1 |
| Huang, CP | 1 |
| Chen, WL | 1 |
| Son, YB | 1 |
| Yang, JH | 1 |
| Kim, MG | 1 |
| Jo, SK | 1 |
| Cho, WY | 1 |
| Oh, SW | 1 |
| Zhou, M | 1 |
| Yang, N | 1 |
| Xing, X | 2 |
| Zhao, Y | 3 |
| Asar, M | 1 |
| Elsehely, I | 1 |
| Lin, WT | 1 |
| Kao, YH | 1 |
| Lin, HY | 1 |
| Li, MS | 1 |
| Luo, T | 1 |
| Fritz, JM | 1 |
| Seal, DW | 1 |
| Lee, CH | 1 |
| Hu, CY | 1 |
| Tseng, TS | 1 |
| Zeng, J | 1 |
| Lawrence, WR | 1 |
| Tian, J | 1 |
| Lian, W | 1 |
| Qu, H | 1 |
| Li, G | 4 |
| Aztatzi-Aguilar, OG | 1 |
| Sierra-Vargas, MP | 1 |
| Ortega-Romero, M | 1 |
| Jiménez-Corona, AE | 1 |
| Nakamura, T | 2 |
| Nampei, M | 1 |
| Murase, T | 1 |
| Satoh, E | 1 |
| Akari, S | 1 |
| Katoh, N | 1 |
| Mizukami, H | 1 |
| Ma, X | 2 |
| Xing, J | 1 |
| Yang, R | 1 |
| Jiao, Y | 1 |
| Zhang, S | 5 |
| Sun, X | 2 |
| Sato, K | 1 |
| Yamazaki, K | 3 |
| Kato, T | 2 |
| Nakanishi, Y | 1 |
| Tsuzuno, T | 1 |
| Yokoji-Takeuchi, M | 1 |
| Yamada-Hara, M | 1 |
| Miura, N | 1 |
| Okuda, S | 1 |
| Ohno, H | 1 |
| Rasheed Kayani, R | 1 |
| Shamim, R | 1 |
| Sultana Munir, S | 1 |
| Sultana, M | 1 |
| Nazir, SUR | 1 |
| Riaz, H | 1 |
| Nazir, T | 1 |
| Maaz Ali, M | 1 |
| Islam, A | 1 |
| Feng, W | 1 |
| Ma, C | 1 |
| Arefan, D | 1 |
| Zhou, D | 2 |
| Yu, J | 1 |
| Gao, L | 1 |
| Du, L | 1 |
| Zhu, D | 1 |
| Du, T | 2 |
| Lu, H | 2 |
| Lin, X | 1 |
| Yu, X | 2 |
| Cabrera-Rode, E | 1 |
| Rodríguez, J | 1 |
| Álvarez, A | 1 |
| Echevarría, R | 1 |
| Reyes, AD | 1 |
| Cubas-Dueñas, I | 1 |
| Turcios-Tristá, SE | 1 |
| Díaz-Díaz, O | 1 |
| Wang, F | 1 |
| Zhao, M | 1 |
| Han, Z | 1 |
| Kong, X | 1 |
| Sun, N | 1 |
| Lei, P | 1 |
| Liang, LB | 1 |
| Li, SY | 1 |
| Li, SQ | 1 |
| An, ZM | 1 |
| Huang, HJ | 1 |
| Punzi, L | 1 |
| Landucci Bonifácio, K | 1 |
| Sabbatini Barbosa, D | 1 |
| Gastaldello Moreira, E | 1 |
| de Farias, CC | 1 |
| Higachi, L | 1 |
| Camargo, AEI | 1 |
| Favaro Soares, J | 1 |
| Odebrecht Vargas, H | 1 |
| Nunes, SOV | 1 |
| Berk, M | 1 |
| Dodd, S | 1 |
| Maes, M | 1 |
| Latourte, A | 1 |
| Bardin, T | 2 |
| Clerson, P | 1 |
| Ea, HK | 1 |
| Flipo, RM | 1 |
| Richette, P | 4 |
| Li, W | 2 |
| Zhang, T | 3 |
| Liu, G | 1 |
| Leng, J | 1 |
| Thottam, GE | 1 |
| Krasnokutsky, S | 1 |
| Pillinger, MH | 1 |
| Nielsen, SM | 1 |
| Bartels, EM | 1 |
| Henriksen, M | 1 |
| Wæhrens, EE | 1 |
| Gudbergsen, H | 1 |
| Bliddal, H | 1 |
| Astrup, A | 2 |
| Knop, FK | 1 |
| Carmona, L | 1 |
| Taylor, WJ | 1 |
| Singh, JA | 1 |
| Perez-Ruiz, F | 1 |
| Kristensen, LE | 1 |
| Christensen, R | 1 |
| Deng, T | 1 |
| Mai, Z | 1 |
| Cai, C | 1 |
| Duan, X | 1 |
| Wu, W | 1 |
| Zeng, G | 1 |
| Chu, FY | 1 |
| Chang, CC | 1 |
| Huang, PH | 1 |
| Lin, YN | 1 |
| Ku, PW | 1 |
| Sun, JT | 1 |
| Ho, JL | 1 |
| Yen, TH | 1 |
| Su, MJ | 1 |
| Zheng, R | 1 |
| Chen, C | 2 |
| Chen, Q | 2 |
| Lu, R | 1 |
| Mao, Y | 1 |
| Grygiel-Górniak, B | 1 |
| Mosor, M | 1 |
| Marcinkowska, J | 1 |
| Przysławski, J | 1 |
| Nowak, J | 1 |
| Wu, O | 1 |
| Leng, JH | 1 |
| Yang, FF | 1 |
| Yang, HM | 1 |
| Li, ZF | 1 |
| Zhang, XY | 1 |
| Yuan, CD | 1 |
| Li, JJ | 1 |
| Pan, Q | 1 |
| Liu, W | 1 |
| Ren, YJ | 1 |
| Liu, B | 2 |
| Liu, QM | 1 |
| Cao, CJ | 1 |
| Otto, BJ | 1 |
| Bozorgmehri, S | 1 |
| Kuo, J | 1 |
| Canales, M | 1 |
| Bird, VG | 1 |
| Canales, B | 1 |
| Kuraji, R | 1 |
| Fujita, M | 1 |
| Ito, H | 1 |
| Hashimoto, S | 2 |
| Numabe, Y | 1 |
| Wojcik, M | 2 |
| Janus, D | 2 |
| Kalicka-Kasperczyk, A | 1 |
| Sztefko, K | 2 |
| Starzyk, JB | 2 |
| Chekhonina, YG | 1 |
| Gapparova, KM | 1 |
| Sharafetdinov, KK | 1 |
| Grigoryan, ON | 1 |
| Alegría-Díaz, A | 1 |
| Valdez-Ortiz, R | 1 |
| Murguía-Romero, M | 1 |
| Jiménez-Flores, R | 1 |
| Villalobos-Molina, R | 1 |
| Mummidi, S | 1 |
| Duggirala, R | 1 |
| López-Alvarenga, JC | 1 |
| Pérez-Navarro, M | 1 |
| Malmström, H | 1 |
| Walldius, G | 1 |
| Carlsson, S | 1 |
| Grill, V | 1 |
| Jungner, I | 1 |
| Gudbjörnsdottir, S | 1 |
| Kosiborod, M | 1 |
| Hammar, N | 1 |
| Klisic, A | 1 |
| Kocic, G | 1 |
| Kavaric, N | 1 |
| Jovanovic, M | 1 |
| Stanisic, V | 1 |
| Ninic, A | 1 |
| Han, T | 1 |
| Meng, X | 1 |
| Shan, R | 1 |
| Zi, T | 1 |
| Ma, H | 1 |
| Shi, D | 1 |
| Qu, R | 1 |
| Na, L | 1 |
| Sun, C | 1 |
| Ruszała, A | 1 |
| Szczudlik, E | 1 |
| Drivelegka, P | 1 |
| Sigurdardottir, V | 1 |
| Svärd, A | 1 |
| Jacobsson, LTH | 1 |
| Abu-Ghanem, Y | 1 |
| Shvero, A | 1 |
| Kleinmann, N | 1 |
| Winkler, HZ | 1 |
| Zilberman, DE | 1 |
| Mancusi, C | 1 |
| Izzo, R | 1 |
| Ferrara, LA | 2 |
| Rozza, F | 1 |
| Losi, MA | 1 |
| Canciello, G | 1 |
| Pepe, M | 1 |
| de Luca, N | 1 |
| Trimarco, B | 1 |
| de Simone, G | 2 |
| Marco-Ramell, A | 1 |
| Tulipani, S | 1 |
| Palau-Rodriguez, M | 1 |
| Gonzalez-Dominguez, R | 1 |
| Miñarro, A | 1 |
| Jauregui, O | 1 |
| Sanchez-Pla, A | 1 |
| Macias-Gonzalez, M | 1 |
| Cardona, F | 1 |
| Tinahones, FJ | 1 |
| Andres-Lacueva, C | 1 |
| Lurbe, E | 1 |
| Torro, MI | 1 |
| Alvarez-Pitti, J | 1 |
| Redon, J | 1 |
| Borghi, C | 1 |
| Liu, M | 2 |
| Zhang, X | 4 |
| Li, YX | 1 |
| Fang, DH | 1 |
| Liu, TX | 1 |
| Kuwabara, R | 1 |
| Niwa, K | 1 |
| Hisatome, I | 1 |
| Smits, G | 1 |
| Roncal-Jimenez, CA | 1 |
| MacLean, PS | 1 |
| Yracheta, JM | 1 |
| Ohno, M | 1 |
| Jalal, DI | 1 |
| Larsson, SC | 1 |
| Burgess, S | 1 |
| Michaëlsson, K | 1 |
| Mele, C | 1 |
| Tagliaferri, MA | 1 |
| Saraceno, G | 1 |
| Mai, S | 1 |
| Vietti, R | 1 |
| Zavattaro, M | 1 |
| Aimaretti, G | 1 |
| Scacchi, M | 1 |
| Marzullo, P | 1 |
| Ali, N | 1 |
| Perveen, R | 1 |
| Rahman, S | 2 |
| Mahmood, S | 1 |
| Islam, S | 1 |
| Haque, T | 1 |
| Sumon, AH | 1 |
| Kathak, RR | 1 |
| Molla, NH | 1 |
| Islam, F | 1 |
| Mohanto, NC | 1 |
| Nurunnabi, SM | 1 |
| Ahmed, S | 1 |
| Rahman, M | 1 |
| Ferron, AJT | 1 |
| Francisqueti, FV | 1 |
| Minatel, IO | 1 |
| Silva, CCVA | 1 |
| Bazan, SGZ | 1 |
| Kitawara, KAH | 1 |
| Garcia, JL | 1 |
| Corrêa, CR | 1 |
| Moreto, F | 2 |
| Ferreira, ALA | 1 |
| Qiao, LS | 1 |
| Xu, XM | 1 |
| Yang, H | 4 |
| Fang, BM | 1 |
| Tan, Z | 1 |
| Zhu, C | 3 |
| Gao, J | 2 |
| Mei, F | 2 |
| Zhu, B | 1 |
| Lu, L | 1 |
| Yin, J | 1 |
| Bu, L | 1 |
| Sheng, C | 1 |
| Ruebel, ML | 1 |
| Piccolo, BD | 1 |
| Mercer, KE | 1 |
| Pack, L | 1 |
| Moutos, D | 1 |
| Shankar, K | 1 |
| Andres, A | 1 |
| Katayama, A | 1 |
| Yokokawa, H | 1 |
| Fukuda, H | 1 |
| Ono, Y | 1 |
| Isonuma, H | 1 |
| Hisaoka, T | 1 |
| Naito, T | 1 |
| Özalp Kızılay, D | 1 |
| Şen, S | 1 |
| Ersoy, B | 1 |
| Persil-Ozkan, O | 1 |
| Yigit, E | 1 |
| Yigit, Z | 1 |
| Min, HK | 1 |
| Cho, H | 1 |
| Park, SH | 1 |
| Pavlova, ZS | 1 |
| Golodnikov, II | 1 |
| Kamalov, AA | 1 |
| Nizov, AN | 1 |
| De Flines, J | 1 |
| Scheen, AJ | 1 |
| Paquot, N | 1 |
| Luo, K | 1 |
| Bian, J | 1 |
| Chen, F | 1 |
| Jin, D | 1 |
| Chatzipavlou, M | 1 |
| Magiorkinis, G | 1 |
| Koutsogeorgopoulou, L | 1 |
| Kassimos, D | 1 |
| Yee, J | 1 |
| Ishiro, M | 1 |
| Takaya, R | 1 |
| Mori, Y | 1 |
| Takitani, K | 1 |
| Kono, Y | 1 |
| Okasora, K | 1 |
| Kasahara, T | 1 |
| Tamai, H | 1 |
| Bray, GA | 1 |
| Zelzer, S | 2 |
| Stelzer, I | 1 |
| Paulmichl, K | 1 |
| Kammerhofer, D | 1 |
| Schnedl, W | 1 |
| Molnar, D | 1 |
| Skak-Nielsen, H | 1 |
| Torp-Pedersen, C | 1 |
| Finer, N | 1 |
| Caterson, ID | 1 |
| Van Gaal, L | 2 |
| James, WP | 1 |
| Maggioni, AP | 1 |
| Sharma, AM | 1 |
| Coutinho, W | 1 |
| Andersson, C | 1 |
| Rendina, D | 1 |
| De Filippo, G | 1 |
| De Pascale, F | 1 |
| Zampa, G | 1 |
| Muscariello, R | 1 |
| De Palma, D | 1 |
| Ippolito, R | 1 |
| Dalbeth, N | 3 |
| Pool, B | 1 |
| Yip, S | 1 |
| Cornish, J | 1 |
| Murphy, R | 2 |
| Blüher, S | 1 |
| Molz, E | 1 |
| Wiegand, S | 1 |
| Otto, KP | 1 |
| Sergeyev, E | 1 |
| Tuschy, S | 1 |
| L'Allemand-Jander, D | 1 |
| Kiess, W | 1 |
| Holl, RW | 1 |
| Antolini, L | 1 |
| Giussani, M | 1 |
| Brambilla, P | 1 |
| Galbiati, S | 1 |
| Mastriani, S | 1 |
| Stella, A | 1 |
| Valsecchi, MG | 1 |
| Genovesi, S | 1 |
| Kawamoto, R | 1 |
| Kusunoki, T | 1 |
| Abe, M | 2 |
| Kohara, K | 1 |
| Miki, T | 1 |
| Tsushima, Y | 1 |
| Nishizawa, H | 1 |
| Tochino, Y | 1 |
| Nakatsuji, H | 1 |
| Sekimoto, R | 1 |
| Nagao, H | 1 |
| Shirakura, T | 1 |
| Kato, K | 1 |
| Imaizumi, K | 1 |
| Takahashi, H | 1 |
| Tamura, M | 1 |
| Maeda, N | 1 |
| Funahashi, T | 3 |
| Shimomura, I | 1 |
| de la Iglesia, R | 1 |
| Lopez-Legarrea, P | 1 |
| Bondia-Pons, I | 1 |
| Navas-Carretero, S | 1 |
| Forga, L | 1 |
| Zulet, MA | 1 |
| Torricelli, FC | 1 |
| De, S | 1 |
| Li, I | 1 |
| Sarkissian, C | 1 |
| Monga, M | 1 |
| Shafiu, M | 2 |
| Sundaram, S | 1 |
| Le, M | 1 |
| Ishimoto, T | 1 |
| Sautin, YY | 2 |
| Uysal, Y | 1 |
| Wolters, B | 1 |
| Knop, C | 1 |
| Reinehr, T | 1 |
| Yu, Z | 1 |
| Lowndes, J | 1 |
| Rippe, J | 1 |
| Fabbrini, E | 2 |
| Serafini, M | 2 |
| Colic Baric, I | 1 |
| Hazen, SL | 1 |
| Klein, S | 2 |
| Morris, H | 1 |
| Grant, K | 1 |
| Khanna, G | 1 |
| White, AJ | 1 |
| Chang, HT | 1 |
| Shen, HC | 1 |
| Hu, YC | 1 |
| Chen, YF | 1 |
| Cong, L | 1 |
| Zhan, JQ | 1 |
| Li, SG | 1 |
| Zhang, HY | 1 |
| Ma, ZP | 1 |
| Hao, XL | 1 |
| Simayi, D | 1 |
| Amanguli, A | 1 |
| Mohemaiti, M | 1 |
| Jing, MX | 1 |
| Wang, W | 1 |
| Saimaiti, A | 1 |
| Zou, XG | 1 |
| Gu, Y | 1 |
| Wang, YH | 1 |
| Li, F | 1 |
| Zhang, WJ | 1 |
| Salem, S | 1 |
| Mehrsai, A | 1 |
| Heydari, R | 1 |
| Pourmand, G | 1 |
| Vallianou, NG | 1 |
| Evangelopoulos, AA | 1 |
| Bountziouka, V | 1 |
| Bonou, MS | 1 |
| Katsagoni, C | 1 |
| Vogiatzakis, ED | 1 |
| Avgerinos, PC | 1 |
| Barbetseas, J | 1 |
| Panagiotakos, DB | 1 |
| Gonzales, GF | 1 |
| Tapia, V | 1 |
| Deng, W | 1 |
| Ruiz-Hurtado, G | 1 |
| Ruilope, LM | 1 |
| Kacalak-Rzepka, A | 1 |
| Kiedrowicz, M | 1 |
| Maleszka, R | 1 |
| Umans, JG | 1 |
| Franceschini, N | 1 |
| Jolly, S | 1 |
| Lee, ET | 1 |
| Yeh, J | 1 |
| Devereux, RB | 1 |
| Howard, BV | 1 |
| Fang, JI | 1 |
| Wu, JS | 1 |
| Yang, YC | 1 |
| Wang, RH | 1 |
| Lu, FH | 1 |
| Chang, CJ | 1 |
| Kelley, EE | 1 |
| Vinha, AF | 1 |
| Barreira, SV | 1 |
| Costa, AS | 1 |
| Alves, RC | 1 |
| Oliveira, MB | 1 |
| Yuan, G | 1 |
| Pogodina, AV | 1 |
| Dolgikh, VV | 1 |
| Rychkova, LV | 1 |
| Gawron-Skarbek, A | 1 |
| Chrzczanowicz, J | 1 |
| Kostka, J | 1 |
| Nowak, D | 1 |
| Drygas, W | 1 |
| Jegier, A | 1 |
| Kostka, T | 1 |
| Zhang, MC | 1 |
| Mao, JF | 1 |
| Yi, LD | 1 |
| Dunn, JP | 1 |
| Moses, C | 2 |
| Kuroczycka-Saniutycz, E | 1 |
| Porowski, T | 2 |
| Protas, PT | 1 |
| Pszczółkowska, M | 1 |
| Porowska, H | 2 |
| Kirejczyk, JK | 2 |
| Wasilewska, A | 3 |
| Gisondi, P | 1 |
| Marotta, T | 1 |
| Liccardo, M | 1 |
| Schettini, F | 1 |
| Verde, F | 1 |
| Ferrara, AL | 1 |
| Battelli, MG | 1 |
| Polito, L | 1 |
| Bolognesi, A | 1 |
| Ogawa, S | 1 |
| Takiguchi, J | 1 |
| Nako, K | 1 |
| Okamura, M | 1 |
| Sakamoto, T | 1 |
| Kabayama, S | 1 |
| Mori, T | 1 |
| Kinouchi, Y | 1 |
| Ito, S | 1 |
| Viers, BR | 1 |
| Lieske, JC | 1 |
| Vrtiska, TJ | 1 |
| Herrera Hernandez, LP | 1 |
| Vaughan, LE | 1 |
| Mehta, RA | 1 |
| Bergstralh, EJ | 1 |
| Rule, AD | 1 |
| Holmes, DR | 1 |
| Krambeck, AE | 1 |
| Flipo, RN | 1 |
| Patrikos, DK | 1 |
| Wakasugi, M | 1 |
| Kazama, JJ | 1 |
| Narita, I | 1 |
| Konta, T | 1 |
| Fujimoto, S | 1 |
| Iseki, K | 1 |
| Moriyama, T | 1 |
| Yamagata, K | 1 |
| Tsuruya, K | 1 |
| Asahi, K | 1 |
| Kimura, K | 1 |
| Kondo, M | 1 |
| Kurahashi, I | 1 |
| Ohashi, Y | 1 |
| Watanabe, T | 1 |
| Huffman, JE | 1 |
| Albrecht, E | 1 |
| Teumer, A | 1 |
| Mangino, M | 1 |
| Kapur, K | 1 |
| Johnson, T | 1 |
| Kutalik, Z | 1 |
| Pirastu, N | 1 |
| Pistis, G | 1 |
| Lopez, LM | 1 |
| Haller, T | 1 |
| Salo, P | 1 |
| Goel, A | 1 |
| Tanaka, T | 2 |
| Dehghan, A | 1 |
| Ruggiero, D | 1 |
| Malerba, G | 1 |
| Smith, AV | 1 |
| Nolte, IM | 1 |
| Portas, L | 1 |
| Phipps-Green, A | 2 |
| Boteva, L | 1 |
| Navarro, P | 1 |
| Johansson, A | 1 |
| Hicks, AA | 1 |
| Polasek, O | 1 |
| Esko, T | 1 |
| Peden, JF | 1 |
| Harris, SE | 1 |
| Murgia, F | 1 |
| Wild, SH | 1 |
| Tenesa, A | 1 |
| Tin, A | 1 |
| Mihailov, E | 1 |
| Grotevendt, A | 1 |
| Gislason, GK | 1 |
| Coresh, J | 1 |
| D'Adamo, P | 1 |
| Ulivi, S | 1 |
| Vollenweider, P | 1 |
| Waeber, G | 1 |
| Campbell, S | 1 |
| Kolcic, I | 1 |
| Fisher, K | 1 |
| Viigimaa, M | 1 |
| Metter, JE | 1 |
| Masciullo, C | 1 |
| Trabetti, E | 1 |
| Bombieri, C | 1 |
| Sorice, R | 1 |
| Döring, A | 3 |
| Reischl, E | 1 |
| Strauch, K | 1 |
| Hofman, A | 1 |
| Uitterlinden, AG | 1 |
| Waldenberger, M | 1 |
| Wichmann, HE | 1 |
| Davies, G | 1 |
| Gow, AJ | 1 |
| Stamp, L | 1 |
| Smit, JH | 1 |
| Kirin, M | 1 |
| Nagaraja, R | 1 |
| Nauck, M | 1 |
| Schurmann, C | 1 |
| Budde, K | 1 |
| Farrington, SM | 1 |
| Theodoratou, E | 1 |
| Jula, A | 1 |
| Salomaa, V | 1 |
| Sala, C | 1 |
| Hengstenberg, C | 1 |
| Burnier, M | 1 |
| Mägi, R | 1 |
| Klopp, N | 1 |
| Kloiber, S | 1 |
| Schipf, S | 1 |
| Ripatti, S | 1 |
| Cabras, S | 1 |
| Soranzo, N | 1 |
| Homuth, G | 1 |
| Nutile, T | 1 |
| Munroe, PB | 1 |
| Hastie, N | 1 |
| Campbell, H | 1 |
| Rudan, I | 1 |
| Cabrera, C | 1 |
| Haley, C | 1 |
| Franco, OH | 1 |
| Gudnason, V | 1 |
| Pirastu, M | 1 |
| Penninx, BW | 1 |
| Snieder, H | 1 |
| Metspalu, A | 1 |
| Ciullo, M | 1 |
| Pramstaller, PP | 1 |
| van Duijn, CM | 1 |
| Ferrucci, L | 1 |
| Gambaro, G | 2 |
| Deary, IJ | 1 |
| Dunlop, MG | 1 |
| Wilson, JF | 1 |
| Gasparini, P | 1 |
| Gyllensten, U | 1 |
| Spector, TD | 1 |
| Wright, AF | 1 |
| Hayward, C | 1 |
| Watkins, H | 1 |
| Perola, M | 1 |
| Bochud, M | 1 |
| Kao, WH | 1 |
| Caulfield, M | 1 |
| Toniolo, D | 1 |
| Völzke, H | 1 |
| Gieger, C | 1 |
| Köttgen, A | 1 |
| Vitart, V | 1 |
| Voruganti, VS | 1 |
| Laston, S | 1 |
| Haack, K | 1 |
| Mehta, NR | 1 |
| Cole, SA | 1 |
| Butte, NF | 1 |
| Comuzzie, AG | 1 |
| Peluso, I | 1 |
| Teichner, A | 1 |
| Manafikhi, H | 1 |
| Palmery, M | 1 |
| Mai, L | 1 |
| Fang, L | 1 |
| Ying, K | 1 |
| Bjornstad, PS | 1 |
| Merriman, T | 1 |
| Sundborn, G | 1 |
| Donderski, R | 1 |
| Miśkowiec-Wiśniewska, I | 1 |
| Kretowicz, M | 1 |
| Grajewska, M | 1 |
| Manitius, J | 1 |
| Kamińska, A | 1 |
| Junik, R | 1 |
| Siódmiak, J | 1 |
| Stefańska, A | 1 |
| Odrowąż-Sypniewska, G | 1 |
| Pluta, A | 1 |
| Lanaspa, M | 1 |
| Ságodi, L | 1 |
| Fehér, V | 1 |
| Kiss-Tóth, E | 1 |
| Almási, A | 1 |
| Barkai, L | 1 |
| Duan, Y | 1 |
| Liang, W | 1 |
| Zhu, L | 1 |
| Nie, Z | 1 |
| He, L | 1 |
| Kuniyoshi, Y | 1 |
| Kamura, A | 1 |
| Yasuda, S | 1 |
| Tashiro, M | 1 |
| Bruun, JM | 1 |
| Maersk, M | 1 |
| Belza, A | 1 |
| Richelsen, B | 1 |
| Korzeniecka-Kozerska, A | 1 |
| Baran, M | 1 |
| Reschke, LD | 1 |
| Miller, ER | 2 |
| Fadrowski, JJ | 1 |
| Loeffler, LF | 1 |
| Holmes, KW | 1 |
| Appel, LJ | 2 |
| Brady, TM | 1 |
| Yu, S | 3 |
| Jiang, M | 1 |
| Sun, G | 2 |
| Ding, Y | 1 |
| Xu, P | 1 |
| Wang, T | 1 |
| An, N | 1 |
| Xie, J | 1 |
| Zhou, Y | 1 |
| Ou, Q | 1 |
| Zheng, L | 2 |
| Su, P | 1 |
| Hong, L | 1 |
| House, ME | 1 |
| Gamble, GD | 1 |
| Horne, A | 1 |
| Desideri, G | 1 |
| Puig, JG | 1 |
| Bassols, J | 1 |
| Martínez-Calcerrada, JM | 1 |
| Prats-Puig, A | 1 |
| Carreras-Badosa, G | 1 |
| Díaz-Roldán, F | 1 |
| Osiniri, I | 1 |
| Riera-Pérez, E | 1 |
| de Zegher, F | 1 |
| Ibáñez, L | 1 |
| López-Bermejo, A | 1 |
| Lee, SM | 1 |
| Cho, YH | 1 |
| Lee, SY | 1 |
| Jeong, DW | 1 |
| Cho, AR | 1 |
| Jeon, JS | 1 |
| Park, EJ | 1 |
| Kim, YJ | 1 |
| Lee, JG | 1 |
| Yi, YH | 1 |
| Tak, YJ | 1 |
| Hwang, HR | 1 |
| Lee, SH | 1 |
| Han, J | 1 |
| Dornas, WC | 1 |
| de Lima, WG | 1 |
| Pedrosa, ML | 1 |
| Silva, ME | 1 |
| Juraschek, SP | 1 |
| McAdams-Demarco, M | 1 |
| Gelber, AC | 1 |
| Sacks, FM | 1 |
| White, KJ | 1 |
| Chang, EJ | 2 |
| Yi, DY | 1 |
| Yang, HR | 2 |
| Cheng, ST | 1 |
| Su, CW | 1 |
| Teng, MS | 1 |
| Hsu, LA | 1 |
| Ko, YL | 1 |
| Sammito, S | 1 |
| Baturin, AK | 2 |
| Sorokina, EY | 1 |
| Pogozheva, AV | 2 |
| Peskova, EV | 1 |
| Makurina, ON | 2 |
| Tutelyan, VA | 1 |
| Poitou, C | 1 |
| Manivet, P | 1 |
| Denis, J | 1 |
| Bouillot, JL | 1 |
| Clément, K | 1 |
| Oppert, JM | 1 |
| Zhang, N | 2 |
| Chang, Y | 1 |
| Ye, N | 1 |
| Vassalle, C | 1 |
| Chatzianagnostou, K | 1 |
| Vannucci, A | 1 |
| Guiducci, L | 1 |
| Battaglia, D | 1 |
| Maffei, S | 1 |
| Arvia, C | 1 |
| Landi, P | 1 |
| Carpeggiani, C | 1 |
| Lu, ZY | 1 |
| Shao, Z | 1 |
| Li, YL | 1 |
| Wulasihan, M | 1 |
| Xiao, J | 1 |
| Zha, X | 1 |
| Zhu, Y | 3 |
| Guo, R | 1 |
| Wen, Y | 1 |
| Hulsegge, G | 1 |
| Herber-Gast, GC | 1 |
| Spijkerman, AM | 2 |
| Susan, H | 1 |
| Picavet, J | 1 |
| van der Schouw, YT | 2 |
| Bakker, SJ | 2 |
| Gansevoort, RT | 1 |
| Dollé, ME | 1 |
| Smit, HA | 1 |
| Monique Verschuren, WM | 1 |
| Norvik, JV | 1 |
| Storhaug, HM | 1 |
| Ytrehus, K | 1 |
| Jenssen, TG | 1 |
| Zykova, SN | 1 |
| Eriksen, BO | 1 |
| Solbu, MD | 1 |
| Castaldo, G | 1 |
| Monaco, L | 1 |
| Castaldo, L | 1 |
| Galdo, G | 1 |
| Cereda, E | 1 |
| Furuhashi, M | 1 |
| Omori, A | 1 |
| Matsumoto, M | 1 |
| Kataoka, Y | 1 |
| Moniwa, N | 1 |
| Ohnishi, H | 1 |
| Yoshida, H | 2 |
| Saitoh, S | 1 |
| Shimamoto, K | 1 |
| Miura, T | 1 |
| Guo, J | 1 |
| Liang, S | 1 |
| Liu, C | 1 |
| Qi, J | 1 |
| Jaramillo-Morales, OA | 1 |
| Espinosa-Juárez, JV | 1 |
| Corona-Ramos, JN | 1 |
| López-Muñoz, FJ | 1 |
| Krajcoviechova, A | 2 |
| Tremblay, J | 2 |
| Wohlfahrt, P | 2 |
| Bruthans, J | 2 |
| Tahir, MR | 2 |
| Hamet, P | 2 |
| Cifkova, R | 2 |
| Cambareri, GM | 1 |
| Giel, DW | 1 |
| Bayne, AP | 1 |
| Corbett, S | 1 |
| Schurtz, E | 1 |
| Kovacevic, L | 1 |
| Sukhu, T | 1 |
| Yap, M | 1 |
| Chiang, G | 1 |
| Moriya, C | 1 |
| Satoh, H | 1 |
| Su, BY | 1 |
| Tian, CF | 1 |
| Gao, BL | 1 |
| Tong, YH | 1 |
| Zhao, XH | 1 |
| Zheng, Y | 1 |
| Yu, GI | 1 |
| Jun, SE | 1 |
| Shin, DH | 1 |
| Spatola, L | 1 |
| Angelini, C | 1 |
| Badalamenti, S | 1 |
| Maringhini, S | 1 |
| Liu, CQ | 1 |
| He, CM | 1 |
| Chen, N | 1 |
| Shi, X | 1 |
| Zeng, X | 1 |
| Yan, B | 1 |
| Liu, S | 2 |
| Li, Z | 1 |
| Chen, MY | 1 |
| Zhao, CC | 1 |
| Li, TT | 1 |
| Yu, TP | 1 |
| Bao, YQ | 1 |
| Li, LX | 1 |
| Jia, WP | 1 |
| Maglio, C | 1 |
| Peltonen, M | 1 |
| Neovius, M | 1 |
| Jacobson, P | 2 |
| Rudin, A | 1 |
| Carlsson, LM | 2 |
| Chen, J | 1 |
| Gugliucci, A | 1 |
| Tsuda, K | 1 |
| Lambert, EA | 1 |
| Hachem, M | 1 |
| Hemmes, R | 1 |
| Straznicky, NE | 1 |
| Eikelis, N | 1 |
| Sari, CI | 1 |
| Schlaich, MP | 1 |
| Lambert, GW | 1 |
| Dixon, JB | 1 |
| Campos, V | 1 |
| Despland, C | 1 |
| Brandejsky, V | 1 |
| Kreis, R | 1 |
| Schneiter, P | 1 |
| Boesch, C | 1 |
| Tappy, L | 1 |
| Kawada, T | 2 |
| Amezawa, M | 1 |
| Nakou, ES | 1 |
| Filippatos, TD | 1 |
| Georgoula, M | 1 |
| Kiortsis, DN | 1 |
| Tselepis, AD | 1 |
| Elisaf, MS | 2 |
| Pacifico, L | 1 |
| Cantisani, V | 1 |
| Anania, C | 1 |
| Bonaiuto, E | 1 |
| Martino, F | 1 |
| Pascone, R | 1 |
| Chiesa, C | 1 |
| Negri, AL | 1 |
| Spivacow, FR | 1 |
| Del Valle, EE | 1 |
| Forrester, M | 1 |
| Rosende, G | 1 |
| Pinduli, I | 1 |
| Abdullah, AR | 1 |
| Hasan, HA | 1 |
| Raigangar, VL | 1 |
| Sari, I | 2 |
| Akar, S | 1 |
| Pakoz, B | 1 |
| Sisman, AR | 1 |
| Gurler, O | 1 |
| Birlik, M | 1 |
| Onen, F | 1 |
| Akkoc, N | 1 |
| Brown, CM | 1 |
| Dulloo, AG | 1 |
| Montani, JP | 1 |
| Shiraishi, H | 1 |
| Une, H | 1 |
| Li, WM | 1 |
| Li, CC | 1 |
| Liu, CC | 1 |
| Huang, SP | 1 |
| Huang, CH | 1 |
| Teff, KL | 1 |
| Grudziak, J | 1 |
| Townsend, RR | 1 |
| Dunn, TN | 1 |
| Grant, RW | 1 |
| Adams, SH | 1 |
| Keim, NL | 1 |
| Cummings, BP | 1 |
| Stanhope, KL | 1 |
| Havel, PJ | 1 |
| Kondo, T | 1 |
| Ueyama, J | 1 |
| Kimata, A | 1 |
| Yamamoto, K | 1 |
| Hori, Y | 1 |
| Miao, Z | 2 |
| Yan, S | 1 |
| Wang, B | 2 |
| Yuan, Y | 1 |
| Meng, D | 2 |
| Gu, J | 1 |
| Wang, CY | 1 |
| Alatalo, PI | 1 |
| Koivisto, HM | 1 |
| Hietala, JP | 1 |
| Bloigu, RS | 1 |
| Niemelä, OJ | 1 |
| Samara, A | 1 |
| Herbeth, B | 1 |
| Aubert, R | 1 |
| Berrahmoune, H | 1 |
| Fumeron, F | 1 |
| Siest, G | 2 |
| Visvikis-Siest, S | 1 |
| Cambuli, VM | 1 |
| Incani, M | 1 |
| Pilia, S | 1 |
| Congiu, T | 1 |
| Cavallo, MG | 1 |
| Cossu, E | 1 |
| Sentinelli, F | 1 |
| Mariotti, S | 1 |
| Loche, S | 1 |
| Baroni, MG | 1 |
| Korpachev, VV | 1 |
| Hurina, NM | 1 |
| Korpacheva, TI | 1 |
| Shuprovych, AA | 1 |
| Mosendz, IO | 1 |
| Strait, JB | 1 |
| Uda, M | 1 |
| Lakatta, EG | 1 |
| Najjar, SS | 1 |
| Sun, K | 1 |
| Hu, FB | 1 |
| Hui, R | 1 |
| Liu, CH | 1 |
| Su, HH | 1 |
| Yu, DT | 1 |
| Koga, M | 1 |
| Murai, J | 1 |
| Saito, H | 1 |
| Mukai, M | 1 |
| Kasayama, S | 1 |
| Indraratna, PL | 1 |
| Williams, KM | 1 |
| Graham, GG | 1 |
| Day, RO | 1 |
| Rathmann, W | 2 |
| Strassburger, K | 1 |
| Heier, M | 1 |
| Holle, R | 1 |
| Thorand, B | 1 |
| Giani, G | 1 |
| Meisinger, C | 2 |
| Simmons, D | 1 |
| Joshi, S | 1 |
| Shaw, J | 1 |
| Ishizaka, N | 1 |
| Ishizaka, Y | 1 |
| Toda, A | 1 |
| Tani, M | 1 |
| Koike, K | 2 |
| Yamakado, M | 1 |
| Nagai, R | 1 |
| Akin, F | 1 |
| Turgut, S | 1 |
| Bastemir, M | 1 |
| Turgut, G | 1 |
| Kursunluoglu, R | 1 |
| Karasu, U | 1 |
| Guclu, A | 1 |
| Ferguson, TF | 1 |
| Funkhouser, E | 2 |
| Roseman, J | 1 |
| Yang, D | 1 |
| Ye, B | 1 |
| Ni, Z | 1 |
| Kaditis, A | 1 |
| Gozal, D | 1 |
| Snow, AB | 1 |
| Kheirandish-Gozal, L | 1 |
| Alexopoulos, E | 1 |
| Varlami, V | 1 |
| Papathanasiou, AA | 1 |
| Capdevila, OS | 1 |
| Bhattacharjee, R | 1 |
| Kim, J | 1 |
| Gourgoulianis, K | 1 |
| Zintzaras, E | 1 |
| Galli-Tsinopoulou, A | 1 |
| Grammatikopoulou, MG | 1 |
| Stylianou, C | 1 |
| Emmanouilidou, E | 1 |
| Kokka, P | 1 |
| Becker, MA | 2 |
| Schumacher, HR | 1 |
| Espinoza, LR | 1 |
| Wells, AF | 1 |
| MacDonald, P | 1 |
| Lloyd, E | 1 |
| Lademacher, C | 1 |
| Shen, WW | 1 |
| Chen, HM | 1 |
| Chen, H | 1 |
| Xu, F | 1 |
| Li, LS | 1 |
| Liu, ZH | 1 |
| Hongo, M | 1 |
| Hidaka, H | 1 |
| Sakaguchi, S | 1 |
| Nakanishi, K | 1 |
| Ichikawa, M | 1 |
| Hirota, N | 1 |
| Tanaka, N | 1 |
| Tsuruta, G | 1 |
| Yazaki, Y | 1 |
| Kinoshita, O | 1 |
| Ikeda, U | 1 |
| Fu, J | 1 |
| Liu, P | 1 |
| Wu, B | 1 |
| Benner, SA | 2 |
| Oliver, W | 1 |
| Huang, RC | 1 |
| de Klerk, N | 1 |
| Mori, TA | 1 |
| Newnham, JP | 1 |
| Stanley, FJ | 1 |
| Landau, LI | 1 |
| Oddy, WH | 1 |
| Hands, B | 1 |
| Beilin, LJ | 1 |
| Khamsi, R | 1 |
| Krzystek-Korpacka, M | 2 |
| Patryn, E | 2 |
| Kustrzeba-Wojcicka, I | 2 |
| Chrzanowska, J | 2 |
| Gamian, A | 2 |
| Noczynska, A | 2 |
| Codoñer-Franch, P | 2 |
| Ballester-Asensio, E | 1 |
| Martínez-Pons, L | 1 |
| Vallecillo-Hernández, J | 1 |
| Navarro-Ruíz, A | 1 |
| del Valle-Pérez, R | 1 |
| Ichida, K | 1 |
| Teng, F | 1 |
| Zhu, R | 1 |
| Zou, C | 1 |
| Xue, Y | 1 |
| Song, H | 1 |
| Liang, J | 1 |
| Gilardini, L | 6 |
| Pasqualinotto, L | 1 |
| Di Matteo, S | 1 |
| Caffetto, K | 1 |
| Croci, M | 1 |
| Girola, A | 3 |
| Invitti, C | 6 |
| Tavárez-Alonso, S | 1 |
| Murria-Estal, R | 1 |
| Megías-Vericat, J | 1 |
| Tortajada-Girbés, M | 1 |
| Alonso-Iglesias, E | 1 |
| Nery, AB | 1 |
| Mesquita, ET | 1 |
| Lugon, JR | 1 |
| Kang, HC | 1 |
| de Miranda, VA | 1 |
| de Souza, BG | 1 |
| Andrade, JA | 1 |
| Rosa, ML | 1 |
| Afsar, B | 1 |
| Elsurer, R | 1 |
| Güner, E | 1 |
| Kirkpantur, A | 1 |
| Simão, AN | 2 |
| Lozovoy, MA | 2 |
| Simão, TN | 2 |
| Venturini, D | 1 |
| Barbosa, DS | 2 |
| Dichi, JB | 1 |
| Matsuo, T | 1 |
| Cecchini, R | 2 |
| Dichi, I | 2 |
| Chen, JH | 1 |
| Yeh, WT | 1 |
| Chuang, SY | 1 |
| Wu, YY | 1 |
| Pan, WH | 1 |
| Hohmann, MS | 1 |
| Morimoto, HK | 1 |
| Reiche, EM | 1 |
| Van Hoorenbeeck, K | 1 |
| Franckx, H | 1 |
| Debode, P | 1 |
| Aerts, P | 1 |
| Wouters, K | 1 |
| Ramet, J | 1 |
| Van Gaal, LF | 1 |
| Desager, KN | 2 |
| De Backer, WA | 2 |
| Verhulst, SL | 2 |
| Nishida, Y | 3 |
| Iyadomi, M | 1 |
| Higaki, Y | 1 |
| Tanaka, H | 1 |
| Hara, M | 1 |
| Tanaka, K | 1 |
| Bell, DS | 1 |
| Rho, YH | 1 |
| Choi, HK | 2 |
| Chohan, S | 1 |
| MacDonald, PA | 1 |
| Chefo, S | 1 |
| Jackson, RL | 1 |
| Kubota, M | 1 |
| Nagai, A | 1 |
| Tang, L | 1 |
| Tokuda, M | 1 |
| Tenderenda, E | 1 |
| Taranta-Janusz, K | 1 |
| Tobolczyk, J | 1 |
| Stypułkowska, J | 1 |
| Fukui, M | 1 |
| Kuroda, M | 1 |
| Yamazaki, M | 1 |
| Hasegawa, G | 1 |
| Oda, Y | 1 |
| Naito, Y | 1 |
| Toda, H | 1 |
| Yoshikawa, T | 1 |
| Nakamura, N | 1 |
| Gonçalves, JP | 1 |
| Oliveira, A | 1 |
| Severo, M | 1 |
| Santos, AC | 1 |
| Lopes, C | 1 |
| Chu, N | 1 |
| Yue, JR | 1 |
| Huang, CQ | 1 |
| Dong, BR | 1 |
| Lee, SG | 1 |
| Davis, CG | 1 |
| Kenny, A | 1 |
| Koo, SI | 1 |
| Chun, OK | 1 |
| Moreno-Navarrete, JM | 1 |
| Sabater, M | 1 |
| Ortega, F | 1 |
| Ricart, W | 1 |
| Fernández-Real, JM | 1 |
| Hussain, TA | 1 |
| Mathew, TC | 1 |
| Dashti, AA | 1 |
| Asfar, S | 1 |
| Al-Zaid, N | 1 |
| Dashti, HM | 1 |
| Turner, ST | 1 |
| Langaee, T | 1 |
| Gong, Y | 1 |
| Chapman, AB | 1 |
| Gums, JG | 1 |
| Johnson, JA | 1 |
| Sorokina, EIu | 1 |
| Tutel'ian, VA | 1 |
| Kadlec, AO | 1 |
| Greco, K | 1 |
| Fridirici, ZC | 1 |
| Hart, ST | 1 |
| Vellos, T | 1 |
| Turk, TM | 1 |
| de Oliveira, EP | 1 |
| Manda, RM | 1 |
| Torezan, GA | 1 |
| Teixeira, O | 1 |
| Michelin, E | 1 |
| Burini, RC | 1 |
| Keenan, T | 1 |
| Blaha, MJ | 1 |
| Nasir, K | 1 |
| Silverman, MG | 1 |
| Tota-Maharaj, R | 1 |
| Carvalho, JA | 1 |
| Conceição, RD | 1 |
| Blumenthal, RS | 1 |
| Santos, RD | 1 |
| Whelton, A | 1 |
| Soletsky, B | 1 |
| Feig, DI | 3 |
| Wystrychowski, G | 1 |
| Zukowska-Szczechowska, E | 1 |
| Obuchowicz, E | 1 |
| Grzeszczak, W | 1 |
| Wystrychowski, A | 1 |
| de Onis, M | 1 |
| Martínez-Costa, C | 1 |
| Núñez, F | 1 |
| Nguefack-Tsague, G | 1 |
| Montal, A | 1 |
| Brines, J | 1 |
| Huang, YF | 1 |
| Wang, JD | 1 |
| Sluijs, I | 1 |
| Beulens, JW | 1 |
| van der A, DL | 1 |
| Schulze, MB | 1 |
| Shmerling, RH | 1 |
| Kong, AP | 1 |
| Choi, KC | 1 |
| Ho, CS | 1 |
| Chan, MH | 1 |
| Ozaki, R | 1 |
| Chan, CW | 1 |
| Chan, JC | 1 |
| Sarzynski, MA | 1 |
| Rankinen, T | 1 |
| Carlsson, B | 1 |
| Sjöström, L | 3 |
| Bouchard, C | 1 |
| Papanas, N | 1 |
| Fonseca, VA | 1 |
| Maltezos, E | 1 |
| Xiong, Z | 1 |
| Qian, X | 1 |
| Wu, Z | 1 |
| Najeeb, Q | 1 |
| Masood, I | 1 |
| Bhaskar, N | 1 |
| Kaur, H | 1 |
| Singh, J | 1 |
| Pandey, R | 1 |
| Sodhi, KS | 1 |
| Prasad, S | 1 |
| Ishaq, S | 1 |
| Mahajan, R | 1 |
| Puerstner, P | 1 |
| Schnedl, WJ | 1 |
| Reeves, G | 1 |
| Postolache, TT | 1 |
| Tsunoda, S | 1 |
| Kamide, K | 1 |
| Minami, J | 1 |
| Kawano, Y | 1 |
| Moreno, LA | 1 |
| Pineda, I | 1 |
| Rodríguez, G | 1 |
| Fleta, J | 1 |
| Giner, A | 1 |
| Juste, MG | 1 |
| Sarría, A | 1 |
| Bueno, M | 1 |
| González-Ortiz, M | 2 |
| Robles-Cervantes, JA | 1 |
| Cárdenas-Camarena, L | 1 |
| Bustos-Saldaña, R | 1 |
| Martínez-Abundis, E | 2 |
| Tang, DH | 1 |
| Wu, HQ | 1 |
| Xia, B | 1 |
| Rheeder, P | 1 |
| Stolk, RP | 1 |
| Veenhouwer, JF | 1 |
| Grobbee, DE | 1 |
| Lin, JD | 3 |
| Chiou, WK | 2 |
| Weng, HF | 2 |
| Tsai, YH | 1 |
| Liu, TH | 2 |
| Yang, WS | 1 |
| Lee, WJ | 1 |
| Tanaka, S | 1 |
| Matsuzawa, Y | 4 |
| Chao, CL | 1 |
| Tai, TY | 1 |
| Chuang, LM | 1 |
| Guzzaloni, G | 1 |
| Morabito, F | 2 |
| Viberti, G | 2 |
| Iwatani, M | 3 |
| Faggiano, A | 1 |
| Pivonello, R | 1 |
| Melis, D | 1 |
| Filippella, M | 1 |
| Di Somma, C | 1 |
| Petretta, M | 1 |
| Lombardi, G | 1 |
| Colao, A | 1 |
| Robles, NR | 1 |
| Canelada, JA | 1 |
| Iglesias, M | 1 |
| Angulo, E | 1 |
| López Acedo, A | 1 |
| Díaz Olea, E | 1 |
| Cidoncha, F | 1 |
| Guerras, M | 1 |
| Fuentes, J | 1 |
| Garrido, J | 1 |
| Lapie, J | 1 |
| Peña, J | 1 |
| Aguilar, A | 1 |
| Hidalgo, P | 1 |
| Bedir, A | 1 |
| Topbas, M | 1 |
| Tanyeri, F | 1 |
| Alvur, M | 1 |
| Arik, N | 1 |
| Kiss, C | 1 |
| Poór, G | 1 |
| Donáth, J | 1 |
| Gergely, P | 1 |
| Paksy, A | 1 |
| Zajkás, G | 1 |
| Antal, M | 1 |
| Gambineri, A | 1 |
| Pelusi, C | 1 |
| Pasquali, R | 1 |
| Asayama, K | 1 |
| Hayashibe, H | 1 |
| Dobashi, K | 1 |
| Uchida, N | 1 |
| Nakane, T | 1 |
| Kodera, K | 1 |
| Shirahata, A | 1 |
| Taniyama, M | 1 |
| SHIPMAN, KH | 1 |
| BORRACHERO, J | 1 |
| MADRID, J | 1 |
| GIULIANI, A | 1 |
| SAMMARTINO, V | 1 |
| PRIOR, IA | 2 |
| ROSE, BS | 3 |
| DAVIDSON, F | 2 |
| CRISTOFORI, FC | 3 |
| DUNCAN, GG | 4 |
| MEES, EJ | 1 |
| GEYSKES, GG | 1 |
| DANOWSKI, TS | 2 |
| SARVER, ME | 1 |
| BONESSI, JV | 1 |
| RAPOPORT, A | 1 |
| FROM, GL | 1 |
| HUSDAN, H | 1 |
| ALDERMAN, MH | 1 |
| DAVIS, RP | 1 |
| DUNCAN, TG | 3 |
| SCHLESS, GL | 2 |
| BOURSIER, B | 1 |
| Takei, I | 1 |
| Watanabe, K | 1 |
| Denzer, C | 1 |
| Muche, R | 2 |
| Mayer, H | 2 |
| Heinze, E | 2 |
| Debatin, KM | 1 |
| Wabitsch, M | 2 |
| Siener, R | 1 |
| Glatz, S | 1 |
| Nicolay, C | 1 |
| Hesse, A | 1 |
| Nakanishi, N | 1 |
| Nishina, K | 1 |
| Okamoto, M | 1 |
| Matsuo, Y | 1 |
| Suzuki, K | 1 |
| Tatara, K | 1 |
| Filikowski, J | 1 |
| Rzepiak, M | 1 |
| Renke, W | 1 |
| Winnicka, A | 1 |
| Smolińska, D | 1 |
| Ogura, T | 3 |
| Matsuura, K | 3 |
| Matsumoto, Y | 1 |
| Mimura, Y | 2 |
| Kishida, M | 1 |
| Otsuka, F | 2 |
| Tobe, K | 3 |
| Wang, JG | 1 |
| He, X | 1 |
| Wang, GL | 1 |
| Zhou, HF | 1 |
| Zhang, WZ | 1 |
| Zhan, YM | 1 |
| Zhu, DL | 1 |
| Miyatake, N | 2 |
| Takanami, S | 1 |
| Kawasaki, Y | 1 |
| Fujii, M | 1 |
| Lin, KC | 1 |
| Tsao, HM | 1 |
| Chen, CH | 1 |
| Chou, P | 2 |
| Ekeruo, WO | 1 |
| Tan, YH | 1 |
| Young, MD | 1 |
| Dahm, P | 1 |
| Maloney, ME | 1 |
| Mathias, BJ | 1 |
| Albala, DM | 1 |
| Preminger, GM | 1 |
| Barskova, VG | 1 |
| Eliseev, MS | 1 |
| Nasonov, EL | 1 |
| Iakunina, IA | 1 |
| Zilov, AV | 1 |
| Il'inykh, EV | 1 |
| Arnold, TM | 1 |
| Reuter, JP | 1 |
| Delman, BS | 1 |
| Shanholtz, CB | 1 |
| Bieber, JD | 1 |
| Terkeltaub, RA | 2 |
| Venturi, C | 1 |
| Zoppini, G | 1 |
| Zamboni, C | 1 |
| Muggeo, M | 3 |
| Fang, JT | 1 |
| Palmer, BF | 1 |
| Rovda, IuI | 1 |
| Kazakova, LM | 1 |
| Rovda, TS | 1 |
| Rovda, EIu | 1 |
| Nakajima, H | 1 |
| Lyoussi, B | 1 |
| Ragala, MA | 1 |
| Mguil, M | 1 |
| Chraibi, A | 1 |
| Israili, ZH | 1 |
| Milionis, HJ | 1 |
| Rizos, E | 1 |
| Goudevenos, J | 1 |
| Seferiadis, K | 1 |
| Bo, S | 1 |
| Gambino, R | 1 |
| Pagani, A | 1 |
| Guidi, S | 1 |
| Gentile, L | 1 |
| Cassader, M | 1 |
| Pagano, GF | 1 |
| Kniazewska, MH | 1 |
| Zmudzińska-Kitczak, J | 1 |
| Urban, K | 1 |
| Obuchowicz, AK | 1 |
| Niwińska-Faryna, B | 1 |
| Pietrzak, JA | 1 |
| Swietochowska-Chechlińska, AA | 1 |
| Głowacki, JG | 1 |
| Kahn, HS | 1 |
| Mount, DB | 1 |
| Reginato, AM | 1 |
| Cikim, AS | 1 |
| Ozbey, N | 1 |
| Sencer, E | 1 |
| Molvalilar, S | 1 |
| Orhan, Y | 1 |
| McTernan, PG | 1 |
| da Silva, NF | 1 |
| Alberti, L | 1 |
| Kumar, S | 1 |
| Lee, SJ | 1 |
| Kavanaugh, A | 1 |
| Maffeis, C | 1 |
| Pontiggia, B | 2 |
| Mazzilli, G | 2 |
| Sartorio, A | 2 |
| Viberti, GC | 1 |
| Oyama, C | 1 |
| Takahashi, T | 1 |
| Oyamada, M | 1 |
| Oyamada, T | 1 |
| Ohno, T | 1 |
| Miyashita, M | 1 |
| Saito, S | 1 |
| Komatsu, K | 1 |
| Takashina, K | 1 |
| Takada, G | 1 |
| Nan, H | 1 |
| Qiao, Q | 1 |
| Dong, Y | 1 |
| Gao, W | 1 |
| Tang, B | 1 |
| Qian, R | 1 |
| Tuomilehto, J | 3 |
| Pływaczewski, R | 2 |
| Bednarek, M | 2 |
| Jonczak, L | 2 |
| Górecka, D | 2 |
| Sliwińiski, P | 1 |
| Chizyński, K | 1 |
| Rózycka, M | 1 |
| Onat, A | 1 |
| Uyarel, H | 1 |
| Hergenç, G | 1 |
| Karabulut, A | 1 |
| Albayrak, S | 1 |
| Yazici, M | 1 |
| Keleş, I | 1 |
| Gavrik, MV | 1 |
| Gapparov, MM | 1 |
| Heinig, M | 1 |
| Sliwiński, P | 1 |
| Fenkci, S | 1 |
| Rota, S | 1 |
| Sabir, N | 1 |
| Akdag, B | 1 |
| Van Hoeck, K | 1 |
| Schrauwen, N | 1 |
| Haentjens, D | 1 |
| Rooman, R | 1 |
| Agostinho Gimeno, SG | 1 |
| Rodrigues, D | 1 |
| Pagliaro, H | 1 |
| Cano, EN | 1 |
| de Souza Lima, EE | 1 |
| Baruzzi, RG | 1 |
| Otsuka, T | 1 |
| Katsumata, M | 1 |
| Suzuki, H | 1 |
| Parati, G | 1 |
| Tohen, M | 1 |
| Kryzhanovskaya, L | 1 |
| Carlson, G | 1 |
| Delbello, M | 1 |
| Wozniak, J | 1 |
| Kowatch, R | 1 |
| Wagner, K | 1 |
| Findling, R | 1 |
| Lin, D | 1 |
| Robertson-Plouch, C | 1 |
| Dittmann, RW | 1 |
| Biederman, J | 1 |
| Segal, MS | 1 |
| Sautin, Y | 1 |
| Kang, DH | 1 |
| Gersch, MS | 1 |
| Benner, S | 1 |
| Yen, SL | 1 |
| Chiu, TY | 1 |
| Lin, YC | 1 |
| Lee, YC | 1 |
| Lee, LT | 1 |
| Huang, KC | 1 |
| Palmer, IM | 1 |
| Schutte, AE | 1 |
| Huisman, HW | 1 |
| Van Rooyen, JM | 1 |
| Schutte, R | 1 |
| Malan, L | 1 |
| Malan, NT | 1 |
| Torun, D | 1 |
| Ozelsancak, R | 1 |
| Turan, I | 1 |
| Micozkadioglu, H | 1 |
| Sezer, S | 1 |
| Ozdemir, FN | 1 |
| Numata, T | 1 |
| Wada, J | 1 |
| Makino, H | 1 |
| Henderson, GN | 1 |
| Angerhofer, AJ | 1 |
| Koenig, W | 1 |
| Baumert, J | 1 |
| Luque-Ramírez, M | 1 |
| Alvarez-Blasco, F | 1 |
| Uriol Rivera, MG | 1 |
| Escobar-Morreale, HF | 1 |
| Pilz, S | 1 |
| Haj-Yahya, S | 1 |
| Almer, G | 1 |
| Yamamoto, T | 4 |
| Ebrahimpour, P | 1 |
| Fakhrzadeh, H | 1 |
| Heshmat, R | 1 |
| Bandarian, F | 1 |
| Larijani, B | 1 |
| Brandstätter, A | 1 |
| Kiechl, S | 1 |
| Kollerits, B | 1 |
| Hunt, SC | 1 |
| Heid, IM | 1 |
| Coassin, S | 1 |
| Willeit, J | 1 |
| Adams, TD | 1 |
| Illig, T | 1 |
| Hopkins, PN | 1 |
| Kronenberg, F | 1 |
| Montoye, HJ | 1 |
| Faulkner, JA | 1 |
| Dodge, HJ | 1 |
| Mikkelsen, WM | 2 |
| Willis, PW | 1 |
| Block, WD | 2 |
| Benedek, TG | 2 |
| Hollingsworth, DR | 2 |
| Bondy, PK | 1 |
| Hollister, LE | 1 |
| Overall, JE | 1 |
| Snow, HL | 1 |
| Krízek, V | 6 |
| Sadílek, L | 2 |
| Stépánek, P | 1 |
| Kannel, WB | 2 |
| Castelli, WP | 1 |
| McNamara, PM | 1 |
| Herman, JB | 3 |
| Goldbourt, U | 3 |
| Akaoka, I | 4 |
| Hayashi, E | 2 |
| Miyamoto, T | 1 |
| Matzkies, F | 2 |
| Budelski, I | 1 |
| Webs, B | 1 |
| Ambrosch, P | 1 |
| Neuberger, M | 1 |
| Reisin, E | 1 |
| Frohlich, ED | 1 |
| Messerli, FH | 1 |
| Dreslinski, GR | 1 |
| Dunn, FG | 1 |
| Jones, MM | 1 |
| Batson, HM | 1 |
| Klinger, M | 1 |
| Lattuada, E | 1 |
| Micheletto, G | 1 |
| Pravettoni, G | 1 |
| Stangoni, L | 1 |
| Vita, PM | 1 |
| Klinger, R | 1 |
| Kalkhoff, RK | 1 |
| Hartz, AH | 1 |
| Rupley, D | 1 |
| Kissebah, AH | 1 |
| Kelber, S | 1 |
| Taba, S | 1 |
| Hayashi, T | 1 |
| Scott, JC | 1 |
| Hochberg, MC | 1 |
| Mohan, V | 1 |
| Snehalatha, C | 1 |
| Jayashree, R | 1 |
| Ramachandran, A | 1 |
| Viswanathan, M | 1 |
| Kameswaran, L | 1 |
| Rocic, B | 1 |
| Breyer, D | 1 |
| Skrabalo, Z | 1 |
| Gatti, E | 1 |
| Noè, D | 1 |
| Gibson, T | 4 |
| Waterworth, R | 1 |
| Hatfield, P | 1 |
| Robinson, G | 1 |
| Bremner, K | 1 |
| Grajek, S | 1 |
| Jasiński, K | 1 |
| Paradowski, S | 1 |
| Jurczykowski, T | 1 |
| Szmydt, W | 1 |
| Adamski, M | 1 |
| Cieślicka, T | 1 |
| Ziemiański, A | 1 |
| Ochotny, R | 1 |
| Droszcz, C | 1 |
| Sundqvist, T | 1 |
| Magnusson, KE | 1 |
| Larsson, L | 2 |
| Tagesson, C | 1 |
| Backman, L | 2 |
| Nordenvall, B | 2 |
| Kolb, S | 1 |
| Sailer, D | 2 |
| Wilson, JH | 2 |
| Lamberts, SW | 2 |
| Swart, GR | 1 |
| Kupke, IR | 1 |
| Turpin, G | 1 |
| Pop, E | 1 |
| Popa, I | 1 |
| Bolcaş, D | 1 |
| Micle, T | 1 |
| Segal, N | 1 |
| Negrău, T | 1 |
| Serdült, I | 1 |
| Sirca, D | 1 |
| Pop, V | 1 |
| Curteanu, G | 1 |
| Deitel, M | 1 |
| Thompson, DA | 1 |
| Saldanha, CF | 1 |
| Ramshaw, PJ | 1 |
| Patterson, MC | 1 |
| Pritzker, KP | 1 |
| Kreitzman, SN | 1 |
| Pedersen, M | 1 |
| Budell, W | 1 |
| Nichols, D | 1 |
| Krissman, P | 1 |
| Clements, M | 1 |
| Beitins, IZ | 1 |
| Shah, A | 1 |
| O'Loughlin, K | 1 |
| Johnson, L | 1 |
| Ostrea, TR | 1 |
| Van Wart, J | 1 |
| McArthur, JW | 1 |
| Mertz, DP | 15 |
| Angster, H | 1 |
| Glonner, R | 1 |
| Halhuber, M | 1 |
| Tiselius, HG | 1 |
| Keller, U | 1 |
| Staub, JJ | 1 |
| Hauenstein, M | 1 |
| Müller, J | 1 |
| Iannotta, F | 1 |
| Zangrandi, A | 1 |
| Mamasaliev, NS | 1 |
| Tursunov, SIu | 1 |
| Nabieva, AF | 1 |
| Castle, WM | 1 |
| Schneider, H | 6 |
| Pastow, A | 1 |
| Rafnsson, V | 1 |
| Bengtsson, C | 2 |
| Nakazawa, K | 1 |
| Murata, K | 1 |
| Khaltaev, NG | 1 |
| Zakharbekov, RR | 1 |
| Khaltaeva, ED | 1 |
| Akhmeteli, MA | 1 |
| Sörbris, R | 1 |
| Aly, KO | 1 |
| Nilsson-Ehle, P | 1 |
| Petersson, BG | 1 |
| Ockerman, PA | 1 |
| Heidelmann, G | 5 |
| Thiele, P | 7 |
| Schröder, HE | 4 |
| Drobny, H | 1 |
| Schneyer, U | 1 |
| Coronas, R | 1 |
| Duran, S | 1 |
| Gomez, P | 1 |
| Romero, H | 1 |
| Sastre, A | 1 |
| Yost, RL | 1 |
| Stewart, RB | 1 |
| Hale, WE | 2 |
| Marks, RG | 1 |
| Kinner, B | 1 |
| Sauer, I | 4 |
| Botha, JL | 1 |
| Irwig, LM | 1 |
| Joffe, BI | 3 |
| Mendelsohn, D | 1 |
| Seftel, HC | 3 |
| Grabner, W | 2 |
| Worlicek, H | 1 |
| Yang, MU | 1 |
| Barbosa-Saldivar, JL | 1 |
| Pi-Sunyer, FX | 1 |
| Van Itallie, TB | 1 |
| Ziegelasch, HJ | 4 |
| Zschornak, M | 1 |
| Neumann, I | 1 |
| Haller, H | 2 |
| Lorant, P | 1 |
| Kremeier, E | 1 |
| Steinmetz, J | 1 |
| Panek, E | 1 |
| Fessel, WJ | 2 |
| Mingers, AM | 1 |
| Ströder, J | 1 |
| Pfüller, H | 1 |
| Lin'ova, V | 1 |
| Mantov, S | 1 |
| Shakhov, B | 1 |
| Kostadinov, D | 1 |
| Shubarov, K | 1 |
| Medalie, JH | 2 |
| Neufeld, HN | 2 |
| Scobie, IN | 1 |
| MacCuish, AC | 1 |
| Kesson, CM | 1 |
| McNeil, IR | 1 |
| Wolf, LM | 1 |
| Barthes, C | 1 |
| Houdent, C | 1 |
| Okada, M | 1 |
| Takeshita, M | 1 |
| Ueda, K | 1 |
| Omae, T | 1 |
| Hirota, Y | 1 |
| Adamska-Dyniewska, H | 1 |
| Bała, T | 1 |
| Florczak, H | 1 |
| Trojanowska, B | 1 |
| Trzcinka, M | 1 |
| Lockefeer, JH | 1 |
| De Bruin, RW | 1 |
| Asch, L | 2 |
| Schirardin, H | 1 |
| Weryha, A | 1 |
| Reuter, W | 3 |
| Dowse, GK | 2 |
| Gareeboo, H | 1 |
| Alberti, KG | 1 |
| Zimmet, P | 2 |
| Purran, A | 1 |
| Fareed, D | 1 |
| Chitson, P | 1 |
| Collins, VR | 1 |
| Grunstein, RR | 1 |
| Stenlöf, K | 1 |
| Hedner, J | 1 |
| Yamanouchi, T | 3 |
| Murata, M | 1 |
| Akaoka, Y | 1 |
| Vazquez, JA | 1 |
| Kazi, U | 1 |
| Madani, N | 1 |
| Lee, J | 1 |
| Sparrow, D | 1 |
| Vokonas, PS | 1 |
| Landsberg, L | 1 |
| Weiss, ST | 1 |
| Rett, K | 1 |
| Wicklmayr, M | 1 |
| Standl, E | 1 |
| Garbagnati, E | 2 |
| Boschetti, M | 1 |
| Eggenberger, M | 1 |
| Troillet, N | 1 |
| Gerster, JC | 1 |
| Zavaroni, I | 2 |
| Bonini, L | 1 |
| Fantuzzi, M | 1 |
| Dall'Aglio, E | 1 |
| Passeri, M | 1 |
| Reaven, GM | 1 |
| Hodge, AM | 1 |
| Zimmet, PZ | 1 |
| Schmidt, MI | 1 |
| Watson, RL | 1 |
| Duncan, BB | 1 |
| Metcalf, P | 1 |
| Brancati, FL | 1 |
| Sharrett, AR | 1 |
| Davis, CE | 1 |
| Heiss, G | 1 |
| Drabo, PY | 2 |
| Guira, O | 1 |
| Ouandaogo, BJ | 1 |
| Kabore, J | 2 |
| Quereda, C | 1 |
| Orte, L | 1 |
| Sabater, J | 1 |
| Navarro-Antolin, J | 1 |
| Villafruela, JJ | 1 |
| Ortuño, J | 1 |
| Crepaldi, G | 1 |
| Manzato, E | 1 |
| Valensi, P | 1 |
| Paries, J | 1 |
| Maheo, P | 1 |
| Gaudey, F | 1 |
| Attali, JR | 1 |
| al Ali, N | 1 |
| Malaviya, AN | 1 |
| Bonora, E | 2 |
| Targher, G | 2 |
| Zenere, MB | 2 |
| Saggiani, F | 2 |
| Cacciatori, V | 1 |
| Tosi, F | 1 |
| Travia, D | 1 |
| Zenti, MG | 1 |
| Branzi, P | 2 |
| Santi, L | 1 |
| Sinagra, D | 1 |
| Greco, D | 1 |
| Scarpitta, AM | 1 |
| Bonaventura, V | 1 |
| Blum, WF | 1 |
| Haug, C | 1 |
| Teller, W | 1 |
| Nakamura, H | 1 |
| Wasada, T | 2 |
| Katsumori, K | 1 |
| Saeki, A | 1 |
| Tsutsumi, Z | 3 |
| Takahashi, S | 3 |
| Moriwaki, Y | 3 |
| Higashino, K | 1 |
| Lengani, A | 1 |
| Ilboudo, PD | 1 |
| Marcisz, C | 1 |
| Jonderko, G | 1 |
| Olak, Z | 1 |
| Madianov, IV | 1 |
| Balabolkin, MI | 1 |
| Saperov, VN | 1 |
| Markov, DS | 1 |
| Oreshnikov, EV | 1 |
| Grigor'ev, AA | 1 |
| Markova, TN | 1 |
| Zhioua, R | 1 |
| Sebaï, L | 1 |
| Kriaa, L | 1 |
| el Euch, M | 1 |
| Mabrouk, S | 1 |
| Ouertani, A | 1 |
| Wingrove, CS | 1 |
| Walton, C | 1 |
| Stevenson, JC | 1 |
| Dyer, AR | 1 |
| Roseman, JM | 1 |
| Messaoudi, L | 1 |
| Donckier, J | 1 |
| Stoffel, M | 1 |
| Ketelslegers, JM | 1 |
| Kolanowski, J | 1 |
| Li, CL | 1 |
| Wu, GS | 1 |
| Tsai, ST | 1 |
| Matsuura, F | 1 |
| Yamashita, S | 2 |
| Nishida, M | 1 |
| Nozaki, S | 1 |
| Vague, J | 1 |
| Fruehwald-Schultes, B | 1 |
| Peters, A | 1 |
| Kern, W | 1 |
| Beyer, J | 1 |
| Pfützner, A | 1 |
| Donskov, AS | 2 |
| Balkarov, IM | 2 |
| Fadina, ZM | 1 |
| Golub', GV | 2 |
| Anikina, SA | 2 |
| Saltykova, NG | 2 |
| Goncharov, VS | 1 |
| Feofanova, ID | 1 |
| Alberiche, MP | 1 |
| Tsukamoto, C | 2 |
| Imai, A | 2 |
| Iwasaki, Y | 2 |
| Shimomura, H | 1 |
| Higashi, T | 1 |
| Tsuji, T | 1 |
| Pitkänen, OM | 1 |
| Vanhanen, H | 1 |
| Pitkänen, E | 1 |
| Iwamoto, Y | 1 |
| Kamatani, N | 2 |
| Wakabayashi, I | 1 |
| Dessein, PH | 1 |
| Shipton, EA | 1 |
| Stanwix, AE | 1 |
| Ramokgadi, J | 1 |
| Charles, MA | 1 |
| Hainer, V | 1 |
| Stunkard, AJ | 2 |
| Kunesová, M | 1 |
| Parízková, J | 1 |
| Stich, V | 1 |
| Allison, DB | 1 |
| Cabot, C | 1 |
| Masanés, R | 1 |
| Bullo, M | 1 |
| García-Lorda, P | 1 |
| Fernández-López, JA | 1 |
| Alemany, M | 1 |
| Gans, RO | 1 |
| ter Maaten, JC | 1 |
| Teerlink, T | 1 |
| Westerhoff, HV | 1 |
| Heine, RJ | 1 |
| Yamakita , J | 1 |
| Hada, T | 2 |
| Sun, JH | 1 |
| See, LC | 1 |
| Hsu, WC | 1 |
| Tsai, JS | 1 |
| Saiki, S | 1 |
| Sato, T | 1 |
| Kohzuki, M | 1 |
| Kamimoto, M | 1 |
| Yosida, T | 1 |
| Håglin, L | 1 |
| Lai, SW | 1 |
| Li, TC | 1 |
| Ng, KC | 1 |
| Chen, SY | 1 |
| Shen, ML | 1 |
| Imazu, M | 1 |
| Yamamoto, H | 1 |
| Toyofuku, M | 1 |
| Sumii, K | 1 |
| Okubo, M | 1 |
| Egusa, G | 1 |
| Yamakido, M | 1 |
| Kohno, N | 1 |
| Hosoya, T | 1 |
| Bener, A | 1 |
| Lestringant, GG | 1 |
| Townsend, A | 1 |
| Al-Mulla, HM | 1 |
| Liese, AD | 1 |
| Hense, HW | 1 |
| Stieber, J | 1 |
| Keil, U | 1 |
| De Lorenzo, A | 1 |
| Petroni, ML | 1 |
| De Luca, PP | 1 |
| Andreoli, A | 1 |
| Morini, P | 1 |
| Iacopino, L | 1 |
| Innocente, I | 1 |
| Perriello, G | 1 |
| Mora-Martínez, JM | 1 |
| Grover-Páez, F | 1 |
| Levchuk, SM | 1 |
| Gavrilova, ES | 1 |
| Valle, M | 1 |
| Gascón, F | 1 |
| Martos, R | 1 |
| Ruz, FJ | 1 |
| Bermudo, F | 1 |
| Morales, R | 1 |
| Cañete, R | 1 |
| Ko, YC | 1 |
| Wang, TN | 1 |
| Tsai, LY | 1 |
| Chang, FT | 1 |
| Chang, SJ | 1 |
| Fernández-Andrade, C | 1 |
| Church, TS | 1 |
| Finley, CE | 1 |
| Earnest, CP | 1 |
| Kampert, JB | 1 |
| Gibbons, LW | 1 |
| Blair, SN | 1 |
| Ota, T | 1 |
| Takamura, T | 1 |
| Hirai, N | 1 |
| Kobayashi, K | 1 |
| Harsch, IA | 1 |
| Schahin, SP | 1 |
| Fuchs, FS | 1 |
| Hahn, EG | 1 |
| Lohmann, T | 1 |
| Konturek, PC | 1 |
| Ficker, JH | 1 |
| Henninces, D | 1 |
| Anisimov, VE | 1 |
| Hohneck, A | 1 |
| Galyean, JR | 1 |
| Walker, AR | 1 |
| Bhamjee, D | 1 |
| Walker, BF | 1 |
| Martin, AP | 1 |
| Marinello, E | 1 |
| Pompucci, G | 1 |
| Riario-Sforza, G | 1 |
| Bassett, DR | 1 |
| Buckingham, RB | 1 |
| Sidiq, M | 1 |
| Shakibai, A | 1 |
| DiGaetano, R | 1 |
| Liou, LL | 1 |
| Halverson, JD | 1 |
| Wise, L | 1 |
| Wazna, MF | 1 |
| Ballinger, WF | 1 |
| Zazgornik, J | 1 |
| Balcke, P | 1 |
| Schmidt, P | 1 |
| Kopsa, H | 1 |
| Geisenhainer, G | 1 |
| Julich, H | 1 |
| Triebe, G | 1 |
| Rabast, U | 3 |
| Schönborn, J | 2 |
| Kasper, H | 3 |
| Godin, G | 1 |
| Krause, D | 1 |
| Stang, A | 1 |
| Zezschwitz, W | 1 |
| Buhr, J | 1 |
| Schütz, J | 1 |
| Kilbourn, K | 1 |
| Horner, I | 1 |
| Simmonds, HA | 2 |
| Balzola, F | 1 |
| Domeniconi, D | 1 |
| Fagiani, MB | 1 |
| Boggio-Bertinet, D | 1 |
| Palmo, A | 1 |
| Neuman, J | 1 |
| de Neumann, MP | 1 |
| Valero, E | 1 |
| Lindental, D | 1 |
| Gulbrandsen, CL | 1 |
| Morton, NE | 1 |
| Rao, DC | 1 |
| Rhoads, GG | 1 |
| Kagan, A | 2 |
| Ketker, S | 1 |
| Ketker, M | 1 |
| Bose, S | 1 |
| Sharma, KS | 1 |
| Schwenke, R | 1 |
| Altus, RE | 1 |
| Kirschner, I | 1 |
| Drozdov, DD | 1 |
| Kameneva, TS | 1 |
| Berchtold, P | 2 |
| Berger, M | 2 |
| Greiser, E | 1 |
| Dohse, M | 1 |
| Irmscher, K | 1 |
| Gries, FA | 2 |
| Zimmermann, H | 2 |
| Küstner, H | 1 |
| Zang, E | 1 |
| Ehl, M | 1 |
| Noppa, H | 1 |
| Björntorp, P | 2 |
| Smith, U | 1 |
| Tibblin, E | 1 |
| Heyden, S | 4 |
| Schräpler, P | 4 |
| Kleinschmidt, A | 1 |
| Haese, E | 1 |
| Brenner, W | 1 |
| Gschnait, F | 1 |
| Hunecke, I | 2 |
| Seifart, C | 1 |
| Jones, JJ | 1 |
| Watkins, PJ | 1 |
| Owyong, LY | 1 |
| Loh, PP | 1 |
| Kutty, MK | 1 |
| Jogie, B | 1 |
| Stein, MR | 1 |
| Julis, RE | 1 |
| Peck, CC | 1 |
| Hinshaw, W | 1 |
| Sawicki, JE | 1 |
| Deller, JJ | 1 |
| Chodorowski, Z | 1 |
| Blanc, JJ | 2 |
| Boschat, J | 2 |
| Morin, JF | 1 |
| Granatelli, D | 2 |
| Floch, H | 1 |
| Penther, P | 2 |
| Babucke, G | 3 |
| Sagebiel, L | 1 |
| Sapir, DG | 1 |
| Walser, M | 1 |
| Lewis, SB | 1 |
| Wallin, JD | 1 |
| Kane, JP | 1 |
| Gerich, JE | 1 |
| Schulz, E | 3 |
| András, B | 1 |
| Ferenc, F | 1 |
| Yano, K | 1 |
| Rhoads, G | 1 |
| Frank, O | 2 |
| Scott, JT | 6 |
| Sturge, RA | 1 |
| Kolenda, KD | 1 |
| Dwosh, IL | 1 |
| Roncari, DA | 1 |
| Marliss, E | 1 |
| Fox, IH | 3 |
| Uffelmann, K | 1 |
| Hirschel, B | 1 |
| Zürcher, HU | 1 |
| Meier, HR | 1 |
| Huber, M | 1 |
| Lämmli, J | 1 |
| Wick, A | 1 |
| Binswanger, U | 1 |
| Vetter, K | 1 |
| Muechler, EK | 1 |
| Wilke, H | 2 |
| Grossgerge, H | 1 |
| Haubold, E | 1 |
| Kahlke, W | 1 |
| Frahm, H | 2 |
| Regler, B | 1 |
| Hofmann, GG | 1 |
| Wolff, G | 1 |
| Glawtschew, P | 1 |
| Wassewa, W | 1 |
| Beaumont, V | 1 |
| Jacotot, B | 1 |
| Beaumont, JL | 1 |
| Samuelson, PN | 1 |
| Merin, RG | 1 |
| Taves, DR | 1 |
| Freeman, RB | 1 |
| Calimlim, JF | 1 |
| Kumazawa, T | 1 |
| Nishizawa, T | 1 |
| Kawaguchi, Y | 1 |
| Germa, D | 1 |
| Ewald, W | 1 |
| Burmeister, H | 1 |
| Schneider, J | 1 |
| Schmid, U | 1 |
| Ruiz-Torres, A | 1 |
| Botti, G | 1 |
| Coscelli, C | 1 |
| Tagliavini, S | 1 |
| Bonatti, V | 1 |
| Alpi, O | 1 |
| Bräuer, R | 1 |
| Clémençon, G | 1 |
| Otto, C | 1 |
| Emmerson, BT | 4 |
| Ravenscroft, PJ | 1 |
| Benson-Cooper, D | 1 |
| Bird, D | 1 |
| Laing, JK | 1 |
| Hannah, EE | 1 |
| Carrell, RW | 1 |
| Beaven, DW | 1 |
| Stanhope, JM | 1 |
| Malcolm, JB | 1 |
| Hiisi-Brummer, L | 1 |
| Gregory, JG | 1 |
| Starkloff, EB | 1 |
| Miyai, K | 1 |
| Schoenberg, HW | 1 |
| Young, SR | 1 |
| Stoelting, RK | 1 |
| Peterson, C | 1 |
| Madura, JA | 1 |
| Uccella, R | 1 |
| Muntoni, S | 1 |
| Pestel, M | 1 |
| Dolder, MA | 1 |
| Oliver, MF | 1 |
| Groothof, G | 1 |
| Du Plessis, JP | 1 |
| Versluis, EE | 1 |
| Louw, ME | 1 |
| Alberts, A | 1 |
| Visagie, ME | 1 |
| Laubscher, NF | 1 |
| Galpin, JS | 1 |
| Markham, R | 1 |
| Kempner, W | 1 |
| Newborg, BC | 1 |
| Peschel, RL | 1 |
| Skyler, JS | 1 |
| Gautier, JC | 1 |
| Morelot, D | 1 |
| Doury, P | 1 |
| Delahaye, RP | 1 |
| Leguay, G | 1 |
| Pattin, S | 1 |
| Metges, PJ | 1 |
| Montely, JM | 1 |
| Duret, JC | 1 |
| Salhi, A | 1 |
| Hartl, O | 1 |
| Clodi, PH | 1 |
| Lawrence, JS | 2 |
| Norikura, Y | 1 |
| Baba, Y | 1 |
| Chuman, Y | 1 |
| Marktl, W | 1 |
| Rudas, B | 1 |
| Horváth, I | 1 |
| Kodák, Z | 1 |
| Halperin, ML | 1 |
| Goldstein, MB | 1 |
| Marliss, ER | 1 |
| Siegenthaler-Zuber, G | 1 |
| Loewer, H | 1 |
| Millán Núñez-Cortés, J | 1 |
| Marchena, MJ | 1 |
| Lorenzo, A | 1 |
| Mangas, A | 1 |
| García Rojas, JF | 1 |
| García Calzado, MC | 1 |
| Gougeon, R | 1 |
| Hoffer, LJ | 1 |
| Pencharz, PB | 1 |
| Marliss, EB | 2 |
| Zwiauer, KF | 1 |
| Pakosta, R | 1 |
| Mueller, T | 1 |
| Widhalm, K | 1 |
| Takada, T | 1 |
| Kikuchi, K | 1 |
| Hasegawa, T | 1 |
| Komura, H | 1 |
| Suzuki, S | 1 |
| Satoh, N | 1 |
| Ohotomo, T | 1 |
| Nanba, M | 1 |
| Marusaki, S | 1 |
| Iimura, O | 1 |
| Gillum, RF | 1 |
| Anderson, JW | 1 |
| Hamilton, CC | 1 |
| Crown-Weber, E | 1 |
| Riddlemoser, M | 1 |
| Gustafson, NJ | 1 |
| Sewdarsen, M | 1 |
| Vythilingum, S | 1 |
| Jialal, I | 1 |
| Kamdar, MC | 1 |
| Matsushima, M | 1 |
| Ikeda, Y | 1 |
| Di Pietro, S | 1 |
| Suraci, C | 1 |
| Kanai, H | 1 |
| Tokunaga, K | 2 |
| Keno, Y | 1 |
| Kobatake, T | 1 |
| Fujioka, S | 2 |
| Nakajima, T | 1 |
| Tarui, S | 2 |
| Vaisman, N | 1 |
| Sklan, D | 1 |
| Dayan, Y | 1 |
| Loenen, HM | 1 |
| Eshuis, H | 1 |
| Löwik, MR | 1 |
| Schouten, EG | 1 |
| Hulshof, KF | 1 |
| Odink, J | 1 |
| Kok, FJ | 1 |
| Thouez, JP | 1 |
| Ekoé, JM | 1 |
| Foggin, PM | 1 |
| Verdy, M | 2 |
| Nadeau, M | 1 |
| Laroche, P | 1 |
| Rannou, A | 1 |
| Ghadirian, P | 1 |
| Laurenzi, M | 1 |
| Mancini, M | 1 |
| Menotti, A | 1 |
| Stamler, J | 3 |
| Stamler, R | 1 |
| Trevisan, M | 1 |
| Zanchetti, A | 1 |
| Collantes Estevez, E | 1 |
| Pineda Priego, M | 1 |
| Añon Barbudo, J | 1 |
| Sanchez Guijo, P | 1 |
| Maggi, S | 1 |
| Bush, TL | 1 |
| Hiyamuta, K | 1 |
| Toshima, H | 1 |
| Koga, Y | 1 |
| Nakayama, H | 1 |
| Yamaga, A | 1 |
| Shiraishi, A | 1 |
| Maruyama, H | 1 |
| Hidaka, Y | 1 |
| Ueno, T | 1 |
| Yoshiga, O | 1 |
| Andersen, T | 1 |
| McNair, P | 1 |
| Fogh-Andersen, N | 1 |
| Nielsen, TT | 1 |
| Hyldstrup, L | 1 |
| Transbøl, I | 1 |
| Davis, MA | 1 |
| Ettinger, WH | 1 |
| Neuhaus, JM | 1 |
| Fujimori, S | 1 |
| Saito, Y | 1 |
| Okamoto, K | 1 |
| Maeda, K | 1 |
| Ohtsuka, T | 1 |
| Takahashi, A | 1 |
| Okamoto, N | 1 |
| Yagyu, K | 1 |
| Modan, M | 3 |
| Halkin, H | 3 |
| Fuchs, Z | 1 |
| Lusky, A | 2 |
| Chetrit, A | 1 |
| Segal, P | 1 |
| Eshkol, A | 1 |
| Almog, S | 2 |
| Shefi, M | 2 |
| Karasik, A | 1 |
| Wolf, E | 1 |
| Taylor, R | 1 |
| Ram, P | 1 |
| King, H | 1 |
| Felson, DT | 1 |
| Anderson, JJ | 1 |
| Naimark, A | 1 |
| Walker, AM | 1 |
| Meenan, RF | 1 |
| Delli Gatti, I | 1 |
| La Corte, R | 1 |
| Bertelli, R | 1 |
| Gilli, G | 1 |
| Menozzi, L | 1 |
| Gelfand, RA | 1 |
| Sherwin, RS | 1 |
| Mesquita, MF | 1 |
| Seabra, MP | 1 |
| Halpern, MJ | 1 |
| Miller, WW | 1 |
| Segers, AM | 1 |
| de Forteza, IE | 1 |
| Conforti, FY | 1 |
| Abulafia, J | 1 |
| Darrelmann, O | 1 |
| Kreissig, I | 1 |
| Richard, G | 1 |
| Friedrich, G | 1 |
| Benfante, R | 1 |
| Reed, D | 1 |
| Brody, J | 1 |
| Hugk, D | 1 |
| Winkelvoss, E | 1 |
| John, D | 1 |
| DeBruyne, S | 1 |
| Dwosh, I | 1 |
| Palgi, A | 1 |
| Read, JL | 1 |
| Greenberg, I | 1 |
| Hoefer, MA | 1 |
| Bistrian, BR | 1 |
| Blackburn, GL | 1 |
| Balabanski, L | 1 |
| Burack, RC | 1 |
| Keller, JB | 1 |
| Higgins, MW | 1 |
| Nicholls, A | 2 |
| Peschel, G | 1 |
| Scheffler, W | 1 |
| Harvey, HP | 1 |
| Thomson, TJ | 2 |
| Runcie, J | 2 |
| Miller, V | 1 |
| Jelliffe, RW | 1 |
| Hill, D | 1 |
| Tatter, D | 1 |
| Lewis, E | 1 |
| Jouve, A | 1 |
| Sommer, A | 1 |
| Avierinos, C | 1 |
| Fondarai, J | 1 |
| Carmena, R | 1 |
| Yudkin, J | 2 |
| Zsernaviczky, J | 1 |
| von Torklus, D | 1 |
| Dreyfus, P | 1 |
| Six, B | 1 |
| Forette, B | 1 |
| Rose, HG | 1 |
| Kranz, P | 1 |
| Weinstock, M | 1 |
| Juliano, J | 1 |
| Haft, JI | 1 |
| Eisenberg, S | 1 |
| Bertrand, E | 1 |
| Baudin, L | 1 |
| Chauvet, J | 1 |
| Assamoi, MO | 1 |
| Beda, B | 1 |
| Renambot, J | 1 |
| Thomas, JY | 1 |
| Le Bras, M | 1 |
| Slany, J | 1 |
| Mösslacher, H | 1 |
| Bodner, P | 1 |
| Irsigler, K | 1 |
| Lageder, H | 1 |
| Schmid, P | 1 |
| Schlick, W | 1 |
| Schneider, HJ | 1 |
| Grahame, R | 5 |
| Mathew, G | 1 |
| Lifshitz, F | 1 |
| Koller, PU | 1 |
| Vollmar, J | 1 |
| Wiedemann, T | 1 |
| Diamond, HS | 1 |
| Carter, AC | 1 |
| Feldman, EB | 1 |
| Evans, E | 1 |
| Stock, AL | 1 |
| Seki, A | 1 |
| Fujii, J | 1 |
| Hagerup, LM | 1 |
| Munro, JF | 1 |
| Duncan, LJ | 1 |
| Barrow, MV | 1 |
| Ramsey, HW | 1 |
| Buchanan, KD | 2 |
| Lellouch, J | 3 |
| Tran, MH | 2 |
| Richard, JL | 2 |
| Rush, J | 1 |
| Mikus, F | 1 |
| Vojtisek, O | 1 |
| Kanková, D | 1 |
| de Seze, S | 1 |
| Klensch, H | 1 |
| Ranft, C | 1 |
| Harro, W | 1 |
| Berg, G | 1 |
| Bachmann, K | 1 |
| Bergner, D | 1 |
| Bornhofen, E | 1 |
| Stürzenhofecker, P | 1 |
| Klör, HU | 1 |
| Märtens, HR | 1 |
| van Eimeren, W | 1 |
| Härich, B | 1 |
| Ditschuneit, H | 1 |
| Schettler, G | 1 |
| Dickstein, SS | 1 |
| Frame, B | 1 |
| Goldstein, JL | 1 |
| Fialkow, PJ | 1 |
| Wollenweber, J | 2 |
| Christl, HL | 1 |
| Schlierf, C | 1 |
| Wohlenberg, H | 1 |
| Weismann, RE | 1 |
| Scott, HW | 1 |
| Dean, R | 1 |
| Shull, HJ | 1 |
| Abram, HS | 1 |
| Webb, W | 1 |
| Younger, RK | 1 |
| Brill, AB | 1 |
| Genuth, SM | 1 |
| Beighton, P | 1 |
| Solomon, L | 1 |
| Soskolne, CL | 1 |
| Sweet, B | 1 |
| Leonhardt, W | 1 |
| Moser, W | 1 |
| Hanefeld, M | 1 |
| Spitz, IM | 1 |
| Bersohn, I | 1 |
| Goldin, AR | 1 |
| Rubenstein, AH | 1 |
| Metzger, BE | 1 |
| Katz, JL | 1 |
| Weiner, H | 1 |
| Gutman, A | 1 |
| Yu, TF | 1 |
| Manes, JL | 1 |
| Taylor, HB | 1 |
| Starkloff, GB | 1 |
| de Jounge, K | 1 |
| Krotkiewski, M | 1 |
| Sullivan, L | 1 |
| Stenberg, J | 1 |
| van Stekelenburg, GJ | 1 |
| Stoop, JW | 1 |
| Krom, ML | 1 |
| Baddeley, M | 1 |
| Curri, SB | 1 |
| Gligore, V | 1 |
| Hincu, N | 1 |
| Tecuceanu, R | 1 |
| Sopon, E | 1 |
| Hoinărescu, E | 1 |
| Cristea, A | 1 |
| Tiso, B | 1 |
| Herrlein, A | 1 |
| Worthington, BS | 1 |
| Taylor, LE | 1 |
| Jourdan, M | 1 |
| Margen, S | 2 |
| Bradfield, RB | 1 |
| Zalokar, J | 1 |
| Claude, JR | 1 |
| Kuntz, D | 1 |
| Griebsch, A | 1 |
| Gibson, TJ | 1 |
| Borrie, P | 1 |
| Slack, J | 1 |
| Rapado, A | 1 |
| Cadenhead, A | 1 |
| Dean, BM | 1 |
| Papier, C | 1 |
| Tamir, S | 1 |
| Riss, E | 1 |
| Bäumer, A | 1 |
| Susić, D | 1 |
| Reese, GM | 1 |
| Bell, JD | 1 |
| Calloway, DH | 1 |
| Mertz, P | 1 |
| Goldbarg, AN | 1 |
| Moran, JF | 1 |
| Childers, RW | 1 |
| Ricketts, HT | 1 |
| Amatruda, TT | 1 |
| Scheig, R | 1 |
| Hartmann, G | 1 |
| Schmid, R | 1 |
| Sunder, JH | 1 |
| Epstein, FH | 1 |
| Kessler, E | 1 |
| Jung, Y | 1 |
| Khurana, RC | 1 |
| Corredor, DG | 1 |
| Pincherle, G | 1 |
| Vachtenheim, J | 1 |
| Srámek, F | 1 |
| Henninges, D | 3 |
| Darlington, LG | 1 |
| Shaw, S | 1 |
| Tellkamp, F | 2 |
| Feuerstein, C | 1 |
| Thorpe, JJ | 1 |
| Daley, JM | 1 |
| Edgren, B | 1 |
| Wester, PO | 1 |
| Tibblin, G | 1 |
| Schatanoff, J | 1 |
| Wallace, MR | 1 |
| James, KR | 1 |
| Liljefors, I | 1 |
| Klotz, H | 1 |
| Prohaska, E | 1 |
| Salmhofer, H | 1 |
| Schmid, L | 1 |
| Wildenhoff, KE | 1 |
| Dalsager, HH | 1 |
| Schwartz Sorensen, N | 1 |
| Rürup, B | 1 |
| Schulz, J | 1 |
| Boden, C | 1 |
| Boden, U | 1 |
| Schulz, HJ | 1 |
| Kaltreider, HB | 1 |
| Talal, N | 1 |
| Isomäki, H | 1 |
| Rubens-Duval, A | 1 |
| Villiaumey, J | 1 |
| Kaplan, G | 1 |
| Brondani, JC | 1 |
| Apfelbaum, M | 1 |
| Boudon, P | 1 |
| Lacatis, D | 1 |
| Nillus, P | 1 |
| Lloyd-Mostyn, RH | 1 |
| Lord, PS | 1 |
| Glover, R | 1 |
| West, C | 1 |
| Gilliland, IC | 1 |
| Wise, PH | 1 |
| Edwards, FM | 1 |
| Thomas, DW | 1 |
| Elliot, RB | 1 |
| Hatcher, L | 1 |
| Craig, R | 1 |
| Losse, H | 1 |
| Wessels, F | 1 |
| Gärtner, A | 1 |
| Schneider, V | 1 |
| Askanas, Z | 1 |
| Liszewska, D | 1 |
| Tylka, J | 1 |
| Travia, L | 1 |
| Doenecke, P | 1 |
| Greten, H | 1 |
| Hild, R | 1 |
| Nobbe, F | 1 |
| Schmidt, FH | 1 |
| Wagner, E | 1 |
| Zaar, I | 1 |
| Klöpfer-Zaar, M | 1 |
| Thieme, G | 1 |
| Scheier, CA | 1 |
| Jacobs, D | 1 |
| Gresham, GE | 1 |
| Keller, MD | 1 |
| Knappe, J | 1 |
| Knappe, G | 1 |
| Strube, G | 1 |
| Dück, KD | 1 |
| Relke, W | 1 |
| Eastwood, MR | 1 |
| Trevelyan, H | 1 |
| Van Peenen, HJ | 1 |
| Knowles, BR | 1 |
| Gatti, A | 1 |
| Scotti, G | 1 |
| Cucurachi, L | 1 |
| Zuliani, U | 1 |
| Dell'Anna, A | 1 |
| Cucurachi, P | 1 |
| Haslam, RM | 1 |
| Pokorný, M | 1 |
| Resl, V | 1 |
| Fossati, P | 1 |
| Lefebvre, J | 1 |
| Decoulx, M | 1 |
| Peltier, JM | 1 |
| Linquette, M | 1 |
| Welborn, TA | 1 |
| Cumpston, GN | 1 |
| Cullen, KJ | 1 |
| Curnow, DH | 1 |
| McCall, MG | 1 |
| Stenhouse, NS | 1 |
| Nielsen, SL | 1 |
| Juhl, E | 1 |
| Quaade, F | 1 |
| Leon, A | 1 |
| Chmidt, H | 1 |
| Janik, I | 1 |
| Voigt, KD | 1 |
| Boyle, JA | 1 |
| McKiddie, M | 1 |
| Jasani MK GRAY, HW | 1 |
| Jackson, IM | 1 |
| Buchanan, WW | 1 |
| Steiner, M | 1 |
| Farrish, GC | 1 |
| Gray, SJ | 1 |
| Lawlor, T | 1 |
| Wells, DG | 1 |
| Kawarabayashi, T | 1 |
| Kuroshima, A | 1 |
| Nakata, H | 1 |
| Ono, T | 1 |
| Hayami, O | 1 |
| Drenick, EJ | 1 |
| Bremner, JM | 1 |
| Healey, LA | 1 |
| Caner, JE | 1 |
| Basset, DR | 1 |
| Decker, JL | 1 |
| Whitehouse, FW | 1 |
| Cleary, WJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Dose-response Effect of Serum Uric Acid on the Prevalence and Electrocardiographic Left Ventricular Hypertrophy in the Apparently Healthy Individuals[NCT03473951] | 18,000 participants (Anticipated) | Observational | 2018-03-26 | Recruiting | |||
| Study of Novel Approaches for Prevention[NCT01183689] | 599 participants (Actual) | Interventional | 2010-08-31 | Completed | |||
| A Three Arms, Randomized, Double-blind Controlled Trial of the Efficacy of Amway Uric Acid Lowering Product on Hyperuricemia[NCT06084585] | 180 participants (Anticipated) | Interventional | 2023-10-23 | Recruiting | |||
| Data-driven Clustering for Metabolic Classification of Obesity Using Machine Learning[NCT04282837] | 2,495 participants (Actual) | Observational | 2020-03-01 | Completed | |||
| Registro Campania Salute Network for the Treatment of Hypertension and Correlated Diseases[NCT02211365] | 10,000 participants (Anticipated) | Observational [Patient Registry] | 2014-02-28 | Recruiting | |||
| Study for the Investigation of New Individual Risk Profiles and Therapeutic Strategies in Obesity Related Cardiovascular and Metabolic Disorders.[NCT00482924] | 1,500 participants (Anticipated) | Observational | 2003-01-31 | Recruiting | |||
| Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE): The Role of Angiotensin-(1-7) in Hypertension and Hypertension-Induced Heart and Kidney Damage[NCT04752293] | 125 participants (Anticipated) | Observational | 2021-05-19 | Recruiting | |||
| Non-alcoholic Fatty Liver Disease (NAFLD) in Overweight and Obese People Under Nutritional and Lifestyle Follow-up: a Randomized Controlled Trial[NCT03183193] | 120 participants (Anticipated) | Interventional | 2016-06-30 | Recruiting | |||
| Genetic-specific Effects of Fructose on Liver Lipogenesis[NCT03783195] | 15 participants (Actual) | Interventional | 2019-01-25 | Completed | |||
| "Evaluation of the Intervention Program Obeldicks for Obese Children and Adolescents"[NCT00435734] | 4,000 participants (Actual) | Observational | 1999-07-31 | Active, not recruiting | |||
| Pragmatic, Randomized, Multicenter, Double-blind, Controlled, Clinical Trial of Prednisolone Versus Colchicine for Acute Gout in Primary Care[NCT05698680] | Phase 4 | 314 participants (Anticipated) | Interventional | 2023-01-18 | Recruiting | ||
| The Oral Fructose Load Test and Inflammation, Lipid Metabolism, Blood Pressure and Organ Damage in Patients With Obesity, Chronic Kidney Disease With Comparison With Healthy Controls.[NCT01332526] | 70 participants (Anticipated) | Observational | 2011-05-31 | Not yet recruiting | |||
| Effect of Carbonated Soft Drinks on Body Weight, Fat Distribution and Metabolic Risk Factors[NCT00777647] | 60 participants (Actual) | Interventional | 2008-05-31 | Completed | |||
| Optimal Macronutrient Intake - Carbohydrate[NCT00608049] | 189 participants (Actual) | Interventional | 2008-02-29 | Completed | |||
| A Single-arm Trial to Evaluate the Efficacy of an Aggressive Weight Loss Program With a Ketogenic Induction Phase for the Treatment of Chronic Plaque Psoriasis[NCT03531528] | 37 participants (Actual) | Interventional | 2018-05-21 | Completed | |||
| Effects of Bariatric Surgery in Swedish Obese Subjects[NCT01479452] | 4,047 participants (Actual) | Interventional | 1987-01-31 | Completed | |||
| The Effect of Dietary Fructose on Gut Microbiota and Hepatosteatosis in Healthy Men[NCT04898621] | 58 participants (Actual) | Interventional | 2021-06-01 | Completed | |||
| Novel Methods for Ascertainment of Gout Flares -A Pilot Study[NCT02855437] | 44 participants (Actual) | Interventional | 2016-09-30 | Completed | |||
| A Phase 3, Randomized, Multicenter, Double-Blind, Allopurinol-Controlled Study Assessing the Efficacy and Safety of Oral Febuxostat in Subjects With Gout.[NCT00430248] | Phase 3 | 2,269 participants (Actual) | Interventional | 2007-02-28 | Completed | ||
| A Phase 3, Randomized, Multicenter, Allopurinol and Placebo-Controlled Study Assessing the Safety and Efficacy of Oral Febuxostat in Subjects With Gout.[NCT00174915] | Phase 3 | 1,072 participants (Actual) | Interventional | 2003-02-28 | Completed | ||
| A Phase 3, Randomized, Multicenter Study Comparing the Safety and Efficacy of Oral Febuxostat Versus Allopurinol in Subjects With Gout[NCT00102440] | Phase 3 | 760 participants (Actual) | Interventional | 2002-07-31 | Completed | ||
| Dietary Intervention in Type-2 Diabetics and Pre-Diabetics Emphasizing Personalized Carbohydrate Intake[NCT02519309] | 465 participants (Actual) | Interventional | 2015-08-31 | Completed | |||
| A Pilot Study Evaluating a Ketogenic Diet Concomitant to Nivolumab and Ipilimumab in Patients With Metastatic Renal Cell Carcinoma[NCT05119010] | 60 participants (Anticipated) | Interventional | 2023-03-24 | Recruiting | |||
| [NCT00288158] | Phase 2 | 60 participants (Actual) | Interventional | 2008-09-30 | Completed | ||
| Paediatric Obesity and Cardiovascular Dysfunction: Searching for Early Markers of Damage[NCT03169257] | 100 participants (Actual) | Interventional | 2015-01-15 | Completed | |||
| Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I Disorder[NCT00050206] | Phase 4 | 130 participants | Interventional | 2002-11-30 | Completed | ||
| Uric Acid and Hypertension in African Americans[NCT00241839] | Phase 3 | 150 participants (Actual) | Interventional | 2005-08-31 | Completed | ||
| Influence of Food Liking of Adding Spices to Replace Dietary Sugar Using Sequential Monadic CLT Methodology[NCT03139552] | 150 participants (Actual) | Interventional | 2016-10-17 | Completed | |||
| Influence on Food Liking of Adding Spices to Replace Dietary Sugar[NCT03134079] | 160 participants (Actual) | Interventional | 2015-09-10 | Completed | |||
| The Cardiovascular Risk Profile Associated With The Polycystic Ovary Syndrome And With Ovulatory Hyperandrogenism, And Its Changes During Treatment With Metformin Or Oral Contraceptives[NCT00428311] | Phase 4 | 50 participants | Interventional | 2004-04-30 | Completed | ||
| [NCT00005282] | 0 participants | Observational | 1981-12-31 | Completed | |||
| The Potential Role for Adenosine in the Haemodynamic Effects of Free Fatty Acids[NCT00184899] | 20 participants | Interventional | 2005-08-31 | Completed | |||
| Double-blind, Randomized Clinical Trial to Evaluate Effect of Combination Therapy of Metformin and Sibutramine Versus Metformin or Sibutramine Monotherapy Over Weight, Adiposity, Glucose Metabolism and Inflammatory State in Obese Patients[NCT00941382] | Phase 3 | 60 participants (Anticipated) | Interventional | 2008-11-30 | Active, not recruiting | ||
| [NCT00005123] | 0 participants | Observational | 1965-07-31 | Completed | |||
| [NCT00005232] | 0 participants | Observational | 1988-08-31 | Completed | |||
| [NCT00005186] | 0 participants | Observational | 1986-04-30 | Completed | |||
| Preoperative Resistance Training in Patients Scheduled for Total Hip Arthroplasty - a Prospective Randomized Study in Patients With Osteoarthritis[NCT01164111] | 80 participants (Actual) | Interventional | 2010-10-31 | Completed | |||
| [NCT00005122] | 0 participants | Observational | 1958-07-31 | Completed | |||
| Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study[NCT00637520] | 29 participants (Actual) | Observational | 2007-07-31 | Terminated | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Waist circumference will be measured using a Gulik tape measure and following a standardized protocol. Two measures of waist circumference will be taken; if the difference exceeds 1.0 cm, a third measure will be taken. Changes are measured from baseline to year 2. (NCT01183689)
Timeframe: Change from baseline to 2 years
| Intervention | centimeters (Mean) |
|---|---|
| Control Group | 0.21 |
| Small Behavior Changes | -1.06 |
| Large Behavior Changes | -2.21 |
Mean changes in the Center for Epidemiologic Studies Depression (CES-C) Scale. Reference: Turvey, C. L., Wallace, R. B., & Herzog, R. (1999). A revised CES-D measure of depressive symptoms and a DSM-based measure of major depressive episodes in the elderly. Int Psychogeriatr, 11(2), 139-148. 20 item questionnaire with a possible range of scores is zero to 60, and higher scores indicating the presence of more symptomatology. (NCT01183689)
Timeframe: 2 years
| Intervention | units on a scale (Mean) |
|---|---|
| Control Group | 1.68 |
| Small Behavior Changes | 0.60 |
| Large Behavior Changes | 1.73 |
"The Eating Inventory (Stunkard, 1988) is a 51-item self-report instrument, was used to assess the subscale of dietary restraint (e.g., degree of conscious control exerted over eating behaviors; range from 0-21 with higher scores reflecting greater levels of restraint).~Reference: Stunkard, A. J. M., S. (1988). Eating Inventory Manual. New York: Psychological Corporation." (NCT01183689)
Timeframe: 2 years
| Intervention | Units on a scale (Mean) |
|---|---|
| Control Group | 0.39 |
| Small Behavior Changes | 0.59 |
| Large Behavior Changes | 1.27 |
"The Eating Inventory (TFEQ(Stunkard, 1988), a 51-item self-report instrument, was used to assess the subscale of disinhibition (e.g., susceptibility to loss of control over eating; range 0-16, with higher scores reflecting greater levels of disinhibition).~REF: Stunkard, A. J. M., S. (1988). Eating Inventory Manual. New York: Psychological Corporation." (NCT01183689)
Timeframe: Changes at 2 years
| Intervention | Units on a scale (Mean) |
|---|---|
| Control Group | 0.07 |
| Small Behavior Changes | -0.78 |
| Large Behavior Changes | -0.03 |
"Flexible control is characterized by a balanced approach to eating (e.g., taking smaller portions to control weight, engaging in healthy compensation) and is associated with better weight management outcomes (Westenhoefer, Stunkard, & Pudel, 1999). Scores range from 0 to 12 with higher scores reflecting greater levels of flexible control.~REF: Westenhoefer, J., Stunkard, A. J., & Pudel, V. (1999). Validation of the flexible and rigid control dimensions of dietary restraint. Int J Eat Disord, 26(1), 53-64." (NCT01183689)
Timeframe: Changes from baseline to 2 years
| Intervention | units on a scale (Mean) |
|---|---|
| Control Group | 0.39 |
| Small Behavior Changes | 0.59 |
| Large Behavior Changes | 1.27 |
"The General Health Index, a one-item question from the CDC's Health-Related Quality of Life measure (Measuring Healthy Days, 2000) required participants to report whether in general their health is excellent (1), very good (2), good (3), fair (4), or poor (5). Lower scores denotes better outcomes.~Ref: Measuring Healthy Days. (2000). Atlanta, Georgia: Centers for Disease Control and Prevention" (NCT01183689)
Timeframe: Changes from baseline to 2 years
| Intervention | 2 year changes in units on a scale (Mean) |
|---|---|
| Control Group | 0.04 |
| Small Behavior Changes | -0.04 |
| Large Behavior Changes | -0.11 |
We calculated homeostatic model assessment insulin resistance (HOMA-IR): fasting glucose in (mg/dl) * fasting insulin in (uU/mL). (NCT01183689)
Timeframe: Change from baseline to 2 years
| Intervention | HOMA-IR (Mean) |
|---|---|
| Control Group | -0.03 |
| Small Behavior Changes | -0.15 |
| Large Behavior Changes | -0.33 |
Mean change in fasting glucose from baseline to 2 years in mg/dl for all participants with year 2 measures (NCT01183689)
Timeframe: 2 years
| Intervention | Mean change from baseline in mg/dl (Mean) |
|---|---|
| Control Group | 1.48 |
| Small Behavior Changes | 0.40 |
| Large Behavior Changes | -0.18 |
Mean change in fasting insulin (uU/ml) from baseline to 2 years (NCT01183689)
Timeframe: 2 years
| Intervention | Mean changes at 2 years in uU/ml (Mean) |
|---|---|
| Control Group | -0.27 |
| Small Behavior Changes | -0.73 |
| Large Behavior Changes | -1.48 |
Change from baseline to 2 years in diastolic blood pressure (NCT01183689)
Timeframe: 2 years
| Intervention | mmHg (Mean) |
|---|---|
| Control Group | -0.41 |
| Small Behavior Changes | -2.14 |
| Large Behavior Changes | -1.33 |
Mean changes from baseline to 2 years in total cholesterol among participants with Year 2 measurements (mg/dl) (NCT01183689)
Timeframe: 2 years
| Intervention | mg/dl (Mean) |
|---|---|
| Control Group | -0.56 |
| Small Behavior Changes | 0.74 |
| Large Behavior Changes | 1.33 |
Mean changes in HDL-C from baseline to year 2 in (mg/dl) for compared among the 3 arms using analysis of variance (NCT01183689)
Timeframe: 2 years
| Intervention | Mean Change from Baseline in mg/dl (Mean) |
|---|---|
| Control Group | -0.09 |
| Small Behavior Changes | 1.43 |
| Large Behavior Changes | 2.12 |
Mean changes between baseline and 2 years in low density lipoprotein cholesterol: LDL-c (mg/dl) (NCT01183689)
Timeframe: 2 years
| Intervention | Mean change in LDL-C in mg/dl (Mean) |
|---|---|
| Control Group | -0.01 |
| Small Behavior Changes | 0.16 |
| Large Behavior Changes | 1.43 |
Compare changes in systolic blood pressure across the three intervention groups (NCT01183689)
Timeframe: Measured at 2 Years
| Intervention | mmHg (Mean) |
|---|---|
| Control Group | 1.73 |
| Small Behavior Changes | -3.72 |
| Large Behavior Changes | -2.66 |
Mean differences in weight changes among intervention groups at 24 months post-randomization (NCT01183689)
Timeframe: 2 years
| Intervention | kilograms (Mean) |
|---|---|
| Control Group | 0.54 |
| Self-regulation With Small Behavior Changes | -0.77 |
| Self-regulation With Large Behavior Changes | -1.50 |
Percentage of those participants whose body mass index at baseline was less than 30 kg/m2 who subsequently transitioned to a body mass index of 30 kg/m2 or more (i.e. met criteria for obesity) sometime during 3 years of follow-up (i.e. at least one visit). Percentages will be compared among the three arms of the trial and summarized with odds ratios Participants were assigned values of 0 or 1 at each exam depending on their obesity level. Inference is based on generalized estimating equations. (NCT01183689)
Timeframe: 3 years
| Intervention | percentage of participants (Mean) |
|---|---|
| Control Group | 16.9 |
| Self-regulation With Small Behavior Changes | 7.9 |
| Self-regulation With Large Behavior Changes | 8.6 |
"Rigid control is characterized by an all-or-nothing inflexibility around dietary rules (e.g., strict calorie counting, with guilt following if calorie-dense foods are consumed) that is associated with poor weight outcomes and more binge eating (Westenhoefer, Stunkard, & Pudel, 1999). Scores range from 0 to 16 with higher scores reflecting greater rigid control.~REF: Stunkard, A. J. M., S. (1988). Eating Inventory Manual. New York: Psychological Corporation." (NCT01183689)
Timeframe: Changes from baseline to 2 years
| Intervention | 2 year changes in units on a scale (Mean) |
|---|---|
| Control Group | 0.35 |
| Small Behavior Changes | 0.22 |
| Large Behavior Changes | 1.75 |
Number of days per week the participant reports weighing themselves. This is divided into two groups: 1) more than once per week and 2) no more than once per week (NCT01183689)
Timeframe: 2 years
| Intervention | Participants (Count of Participants) |
|---|---|
| Control Group | 30 |
| Small Behavior Changes | 44 |
| Large Behavior Changes | 56 |
"Dietary intake was assessed using the 2005 Block Food Frequency Questionnaire (Block FFQ) at baseline and 2 years. This validated, quantitative 110-food item questionnaire is designed to assess relative intake of energy.~REF: Block G, Woods M, Potosky A, Clifford C. Validation of a self-administered diet history questionnaire using multiple diet records. J Clin Epidemiol 1990; 43:1327-1335." (NCT01183689)
Timeframe: Changes from baseline to 2 years in kilocalories
| Intervention | kilocalories (Mean) |
|---|---|
| Control Group | -134 |
| Small Behavior Changes | -186 |
| Large Behavior Changes | -185 |
Mean weight change from baseline across an average planned follow-up of three years. These mean changes will be compared among the three arms of the trial. (NCT01183689)
Timeframe: 3 years
| Intervention | kilograms (Mean) |
|---|---|
| Control Group | 0.26 |
| Self-regulation With Small Behavior Changes | -0.56 |
| Self-regulation With Large Behavior Changes | -2.37 |
Average over time (average follow-up of 3 years) of the percent of participants within each arm of the trial who gain 1 pound or more at each visit. These percentages will be compared among the three arms generalized estimating equations. Note that weight changes in units of pounds were used to define this outcome so that it may be more clear to participants. Elsewhere in the protocol, weight is reported in kilograms. Percentages at each visit are the percent who gained 1 pound or more from baseline among all who were weighed at that visit. Participants were assigned values of 0 or 1 at each visit depending on their weight gain status. (NCT01183689)
Timeframe: 3 years
| Intervention | percentage gaining 1 pound or more among (Mean) |
|---|---|
| Control Group | 40.8 |
| Self-regulation With Small Behavior Changes | 32.5 |
| Self-regulation With Large Behavior Changes | 23.6 |
Feasibility ----Assessed by the percentage of participants completing answer IRV/RheumPRO queries. (NCT02855437)
Timeframe: 6 months
| Intervention | percentage of weekly response (Mean) |
|---|---|
| Interactive Voice Response | 81 |
| RheumPro Smartphone Application | 80 |
Percentage of total study population preferring IVR vs. RheumPRO (NCT02855437)
Timeframe: 6 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Interactive Voice Response | 3 |
| RheumPro Smartphone Application | 28 |
The percent change in serum urate from baseline to the Final visit was summarized. The final visit was the last visit at which a serum urate value was collected. (NCT00430248)
Timeframe: Baseline and Last Visit on treatment (up to 6 months)
| Intervention | percent change from baseline (Mean) |
|---|---|
| Febuxostat 40 mg QD | -33.1 |
| Febuxostat 80 mg QD | -40.6 |
| Allopurinol 200 mg or 300 mg QD | -31.3 |
Serum urate values were obtained at the Month 2 visit. The percent change in serum urate from baseline to the Month 2 visit was summarized. (NCT00430248)
Timeframe: Baseline and Month 2
| Intervention | percent change from baseline (Mean) |
|---|---|
| Febuxostat 40 mg QD | -35.1 |
| Febuxostat 80 mg QD | -44.5 |
| Allopurinol 200 mg or 300 mg QD | -33.8 |
Serum urate values were obtained at the Month 4 visit. The percent change in serum urate from baseline to the Month 4 visit was summarized. (NCT00430248)
Timeframe: Baseline and Month 4
| Intervention | percent change from baseline (Mean) |
|---|---|
| Febuxostat 40 mg QD | -34.9 |
| Febuxostat 80 mg QD | -45.5 |
| Allopurinol 200 mg or 300 mg QD | -34.5 |
Serum urate values were obtained at the Month 6 visit. The percent change in serum urate from baseline to the Month 6 visit was summarized. (NCT00430248)
Timeframe: Baseline and Month 6
| Intervention | percent change from baseline (Mean) |
|---|---|
| Febuxostat 40 mg QD | -35.6 |
| Febuxostat 80 mg QD | -45.1 |
| Allopurinol 200 mg or 300 mg QD | -34.4 |
The percentage of subjects with mild-to-moderate renal impairment whose serum urate was <6.0 mg/dL at the final visit was summarized. The final visit was the last visit at which a serum urate value was collected. (NCT00430248)
Timeframe: Last Visit on treatment (up to 6 months)
| Intervention | percentage of subjects (Number) |
|---|---|
| Febuxostat 40 mg QD | 49.7 |
| Febuxostat 80 mg QD | 71.6 |
| Allopurinol 200 mg or 300 mg QD | 42.3 |
The percentage of subjects whose serum urate level was <6.0 mg/dL at the Final Visit was summarized. The Final Visit was the last visit at which a serum urate value was collected. (NCT00430248)
Timeframe: Last Visit on treatment (up to 6 months)
| Intervention | percentage of subjects (Number) |
|---|---|
| Febuxostat 40 mg QD | 45.2 |
| Febuxostat 80 mg QD | 67.1 |
| Allopurinol 200 mg or 300 mg QD | 42.1 |
The percentage of subjects whose serum urate level was <4.0 mg/dL at the Final Visit was summarized. The Final Visit was the last visit at which a serum urate values was collected. (NCT00430248)
Timeframe: Last Visit on treatment (up to 6 months)
| Intervention | percentage of subjects (Number) |
|---|---|
| Febuxostat 40 mg QD | 2.5 |
| Febuxostat 80 mg QD | 17.5 |
| Allopurinol 200 mg or 300 mg QD | 1.5 |
Serum urate values were obtained at the Month 2 visit. The percentage of subjects whose serum urate was <4.0 mg/dL at the Month 2 visit was summarized. (NCT00430248)
Timeframe: Month 2
| Intervention | percentage of subjects (Number) |
|---|---|
| Febuxostat 40 mg QD | 2.1 |
| Febuxostat 80 mg QD | 17.5 |
| Allopurinol 200 mg or 300 mg QD | 1.5 |
Serum urate values were obtained at the Month 4 visit. The percentage of subjects whose serum urate was <4.0 mg/dL at the Month 4 visit was summarized. (NCT00430248)
Timeframe: Month 4
| Intervention | percentage of subjects (Number) |
|---|---|
| Febuxostat 40 mg QD | 2.0 |
| Febuxostat 80 mg QD | 18.6 |
| Allopurinol 200 mg or 300 mg QD | 1.4 |
Serum urate values were obtained at the Month 6 visit. The percentage of subjects whose serum urate was <4.0 mg/dL at the Month 6 visit was summarized. (NCT00430248)
Timeframe: Month 6
| Intervention | percentage of subjects (Number) |
|---|---|
| Febuxostat 40 mg QD | 3.1 |
| Febuxostat 80 mg QD | 20.3 |
| Allopurinol 200 mg or 300 mg QD | 1.8 |
The percentage of subjects whose serum urate level was <5.0 mg/dL at the Final Visit was summarized. The Final Visit was the last visit at which a serum urate values was collected. (NCT00430248)
Timeframe: Last Visit on treatment (up to 6 months)
| Intervention | percentage of subjects (Number) |
|---|---|
| Febuxostat 40 mg QD | 16.5 |
| Febuxostat 80 mg QD | 44.0 |
| Allopurinol 200 mg or 300 mg QD | 13.2 |
Serum urate values were obtained at the Month 2 visit. The percentage of subjects whose serum urate was <5.0 mg/dL at the Month 2 visit was summarized. (NCT00430248)
Timeframe: Month 2
| Intervention | percentage of subjects (Number) |
|---|---|
| Febuxostat 40 mg QD | 15.4 |
| Febuxostat 80 mg QD | 45.9 |
| Allopurinol 200 mg or 300 mg QD | 11.7 |
Serum urate values were obtained at the Month 4 visit. The percentage of subjects whose serum urate was <5.0 mg/dL at the Month 4 visit was summarized. (NCT00430248)
Timeframe: Month 4
| Intervention | percentage of subjects (Number) |
|---|---|
| Febuxostat 40 mg QD | 15.0 |
| Febuxostat 80 mg QD | 51.6 |
| Allopurinol 200 mg or 300 mg QD | 13.5 |
Serum urate values were obtained at the Month 6 visit. The percentage of subjects whose serum urate was <5.0 mg/dL at the Month 6 visit was summarized. (NCT00430248)
Timeframe: Month 6
| Intervention | percentage of subjects (Number) |
|---|---|
| Febuxostat 40 mg QD | 19.3 |
| Febuxostat 80 mg QD | 49.7 |
| Allopurinol 200 mg or 300 mg QD | 14.8 |
Serum urate values were obtained at the Month 2 visit. The percentage of subjects whose serum urate was <6.0 mg/dL at the Month 2 visit was summarized. (NCT00430248)
Timeframe: Month 2
| Intervention | percentage of subjects (Number) |
|---|---|
| Febuxostat 40 mg QD | 49.1 |
| Febuxostat 80 mg QD | 74.1 |
| Allopurinol 200 mg or 300 mg QD | 43.2 |
Serum urate values were obtained at the Month 4 visit. The percentage of subjects whose serum urate was <6.0 mg/dL at the Month 4 visit was summarized. (NCT00430248)
Timeframe: Month 4
| Intervention | percentage of subjects (Number) |
|---|---|
| Febuxostat 40 mg QD | 47.1 |
| Febuxostat 80 mg QD | 75.2 |
| Allopurinol 200 mg or 300 mg QD | 45.5 |
Serum urate values were obtained at the Month 6 visit. The percentage of subjects whose serum urate was <6.0 mg/dL at the Month 6 visit was summarized. (NCT00430248)
Timeframe: Month 6
| Intervention | percentage of participants (Number) |
|---|---|
| Febuxostat 40 mg QD | 48.9 |
| Febuxostat 80 mg QD | 75.3 |
| Allopurinol 200 mg or 300 mg QD | 46.6 |
Change in number of tophi/subject was calculated for the subset of subjects with palpable tophi at the Screening. If the tophi were not palpable at the Final Visit, total count was assumed to be 0. The timing of the final visit may have differed for each subject. (NCT00174915)
Timeframe: Final Visit (up to 28 weeks)
| Intervention | number of tophi (Median) |
|---|---|
| Febuxostat 80 mg QD | 0.0 |
| Febuxostat 120 mg QD | 0.0 |
| Febuxostat 240 mg QD | 0.0 |
| Allopurinol QD | 0.0 |
| Placebo QD | 0.0 |
Change from baseline at Week 28 in the total number of tophi per subject was calculated for the subset of subjects with palpable tophi at the Screening Visit. If the tophi were not palpable at the Week 28 visit, the total count was assumed to be 0. (NCT00174915)
Timeframe: Baseline and Week 28
| Intervention | number of tophi (Median) |
|---|---|
| Febuxostat 80 mg QD | 0.0 |
| Febuxostat 120 mg QD | 0.0 |
| Febuxostat 240 mg QD | 0.0 |
| Allopurinol QD | 0.0 |
| Placebo QD | 0.0 |
The percent change in serum urate from baseline to the Final visit was summarized. The percent change in serum urate was calculated as [(Final visit - baseline levels)/baseline]*100. The final visit was the last visit at which a serum urate value was collected. The timing of the final visit may have differed for each subject. (NCT00174915)
Timeframe: Baseline and Final Visit (up to 28 weeks)
| Intervention | Percent change (Mean) |
|---|---|
| Febuxostat 80 mg QD | -45.2 |
| Febuxostat 120 mg QD | -51.9 |
| Febuxostat 240 mg QD | -66.3 |
| Allopurinol QD | -33.7 |
| Placebo QD | -3.0 |
Serum urate values were obtained at the Week 28 visit. The percent change in serum urate was calculated as [(Week 28 - baseline levels)/baseline]*100 and summarized. (NCT00174915)
Timeframe: Baseline and Week 28
| Intervention | Percent change (Mean) |
|---|---|
| Febuxostat 80 mg QD | -47.6 |
| Febuxostat 120 mg QD | -54.9 |
| Febuxostat 240 mg QD | -67.8 |
| Allopurinol QD | -34.4 |
| Placebo QD | -3.6 |
Percent change in primary tophus size was calculated as [(Final Visit - baseline sizes)/baseline]*100 for the subset of subjects with a primary palpable tophus at Screening. If tophus was not palpable at Final visit, the size was assumed to be 0. The timing of the final visit may have differed for each subject. (NCT00174915)
Timeframe: Baseline and Final Visit (up to 28 weeks)
| Intervention | percent change from baseline (Median) |
|---|---|
| Febuxostat 80 mg QD | -33.8 |
| Febuxostat 120 mg QD | -42.4 |
| Febuxostat 240 mg QD | -47.0 |
| Allopurinol QD | -22.6 |
| Placebo QD | -40.3 |
The percent change from baseline in primary tophus size as determined by physical measurement was calculated as [(Week 28 - baseline sizes)/baseline]*100 for the subset of subjects with a primary palpable tophus at the Screening Visit. If the primary tophus was no longer palpable at the Week 28 visit, the size was assumed to be zero. (NCT00174915)
Timeframe: Baseline and Week 28
| Intervention | percent change from baseline (Median) |
|---|---|
| Febuxostat 80 mg QD | -45.6 |
| Febuxostat 120 mg QD | -54.2 |
| Febuxostat 240 mg QD | -53.2 |
| Allopurinol QD | -31.5 |
| Placebo QD | -52.0 |
Percentage of subjects requiring treatment for a gout flare between Weeks 8 and 28 of the double-blind treatment period was summarized. A subject who reported more than 1 gout flare during this period was counted only once. (NCT00174915)
Timeframe: Weeks 8 through 28
| Intervention | percentage of subjects (Number) |
|---|---|
| Febuxostat 80 mg QD | 55 |
| Febuxostat 120 mg QD | 54 |
| Febuxostat 240 mg QD | 57 |
| Allopurinol QD | 46 |
| Placebo QD | 52 |
Each subject's serum urate at the last 3 visits determined the subject's response for the primary efficacy variable. A subject who prematurely discontinued without least 3 postbaseline serum urate levels was considered a nonresponder; if at least 3 serum urate were obtained postbaseline, those 3 visits were used. The last 3 visits used may have differed for each subject. (NCT00174915)
Timeframe: Last 3 visits (any last 3 visits up to week 28)
| Intervention | Percentage of subjects (Number) |
|---|---|
| Febuxostat 80 mg QD | 48 |
| Febuxostat 120 mg QD | 65 |
| Febuxostat 240 mg QD | 69 |
| Allopurinol QD | 22 |
| Placebo QD | 0 |
The percentage of subjects whose serum urate was <6.0 mg/dL at the final visit was summarized. The final visit was the last visit at which a serum urate value was collected and may have differed by subject. (NCT00174915)
Timeframe: Final Visit (up to 28 weeks).
| Intervention | Percentage of subjects (Number) |
|---|---|
| Febuxostat 80 mg QD | 72 |
| Febuxostat 120 mg QD | 79 |
| Febuxostat 240 mg QD | 92 |
| Allopurinol QD | 39 |
| Placebo QD | 1 |
Serum urate values were obtained at the Week 28 visit. The percentage of subjects whose serum urate was <6.0 mg/dL at the Week 28 visit was summarized. (NCT00174915)
Timeframe: Week 28
| Intervention | Percentage of subjects (Number) |
|---|---|
| Febuxostat 80 mg QD | 76 |
| Febuxostat 120 mg QD | 87 |
| Febuxostat 240 mg QD | 94 |
| Allopurinol QD | 41 |
| Placebo QD | 1 |
Change in number of tophi/subject calculated for the subset of subjects with palpable tophi at Screening. If the tophi were not palpable at the Final Visit, total count was assumed to be 0. The timing of the final visit may have differed for each subject. (NCT00102440)
Timeframe: Baseline and Final Visit (up to 52 weeks)
| Intervention | number of tophi (Median) |
|---|---|
| Febuxostat 80 mg QD | 0.0 |
| Febuxostat 120 mg QD | 0.0 |
| Allopurinol 300 mg QD | 0.0 |
The change from baseline at Week 28 in the total number of tophi per subject was calculated for the subset of subjects with palpable tophi at the Screening Visit. If the tophi were no longer palpable at the Week 28 visit, the total count was assumed to be zero. (NCT00102440)
Timeframe: Baseline and Week 28
| Intervention | number of tophi (Median) |
|---|---|
| Febuxostat 80 mg QD | 0.0 |
| Febuxostat 120 mg QD | 0.0 |
| Allopurinol 300 mg QD | 0.0 |
The change from baseline at Week 52 in the total number of tophi per subject was calculated for the subset of subjects with palpable tophi at the Screening Visit. If the tophi were no longer palpable at the Week 52 visit, the total count was assumed to be zero. (NCT00102440)
Timeframe: Baseline and Week 52
| Intervention | number of tophi (Median) |
|---|---|
| Febuxostat 80 mg QD | 0.0 |
| Febuxostat 120 mg QD | -1.0 |
| Allopurinol 300 mg QD | 0.0 |
The percent change in serum urate from baseline to the Final visit was calculated as [(Final Visit - baseline levels/baseline)]*100 and summarized. The Final visit was the last visit with a serum urate value. The timing of the final visit may have differed for each subject. (NCT00102440)
Timeframe: Baseline and Final Visit (up to 52 weeks)
| Intervention | percent change from baseline (Mean) |
|---|---|
| Febuxostat 80 mg QD | -44.7 |
| Febuxostat 120 mg QD | -51.5 |
| Allopurinol 300 mg QD | -33.0 |
Serum urate values were obtained at the Week 28 visit. The percent change in serum urate was calculated as [(week 28 - baseline levels/baseline)]*100 and summarized. (NCT00102440)
Timeframe: Baseline and Week 28
| Intervention | percent change from baseline (Mean) |
|---|---|
| Febuxostat 80 mg QD | -46.3 |
| Febuxostat 120 mg QD | -53.5 |
| Allopurinol 300 mg QD | -34.8 |
Serum urate values were obtained at the Week 52 visit. The percent change in serum urate was calculated as [(week 52 - baseline levels/baseline)]*100 and summarized. (NCT00102440)
Timeframe: Baseline and Week 52
| Intervention | percent change from baseline (Mean) |
|---|---|
| Febuxostat 80 mg QD | -47.7 |
| Febuxostat 120 mg QD | -53.0 |
| Allopurinol 300 mg QD | -34.8 |
Percent change in primary tophus size was calculated as [(Final Visit - baseline sizes)/baseline]*100 for the subset of subjects with a primary palpable tophus at Screening. If tophus was not palpable at Final visit, the size was assumed to be 0. The timing of the final visit may have differed for each subject. (NCT00102440)
Timeframe: Baseline and Final Visit (up to 52 weeks)
| Intervention | percent change from baseline (Median) |
|---|---|
| Febuxostat 80 mg QD | -51.7 |
| Febuxostat 120 mg QD | -43.8 |
| Allopurinol 300 mg QD | -39.6 |
The percent change from baseline in primary tophus size as determined by physical measurement was calculated as [(Week 28 - baseline sizes)/baseline]*100 for the subset of subjects with a primary palpable tophus at the Screening Visit. If the primary tophus was no longer palpable at the Week 28 visit, the size was assumed to be zero. (NCT00102440)
Timeframe: Baseline and Week 28
| Intervention | percent change from baseline (Median) |
|---|---|
| Febuxostat 80 mg QD | -29.5 |
| Febuxostat 120 mg QD | -49.5 |
| Allopurinol 300 mg QD | -28.6 |
The percent change from baseline in primary tophus size as determined by physical measurement was calculated as [(Week 52 - baseline sizes)/baseline]*100 for the subset of subjects with a primary palpable tophus at the Screening Visit. If the primary tophus was no longer palpable at the Week 52 visit, the size was assumed to be zero. (NCT00102440)
Timeframe: Baseline and Week 52
| Intervention | percent change from baseline (Median) |
|---|---|
| Febuxostat 80 mg QD | -83.4 |
| Febuxostat 120 mg QD | -65.5 |
| Allopurinol 300 mg QD | -49.7 |
The percentage of subjects requiring treatment for a gout flare between Weeks 8 and 52 of the double-blind treatment period was summarized. A subject who reported more than 1 gout flare during this period was counted only once. (NCT00102440)
Timeframe: Weeks 8 through 52
| Intervention | percentage of subjects (Number) |
|---|---|
| Febuxostat 80 mg QD | 64 |
| Febuxostat 120 mg QD | 70 |
| Allopurinol 300 mg QD | 64 |
The percentage of subjects whose serum urate was <6.0 mg/dL at the final visit was summarized. The final visit was the last visit at which a serum urate value was collected. The timing of the final visit may have differed for each subject. (NCT00102440)
Timeframe: Final Visit (up to 52 weeks)
| Intervention | Percentage of subjects (Number) |
|---|---|
| Febuxostat 80 mg QD | 74 |
| Febuxostat 120 mg QD | 80 |
| Allopurinol 300 mg QD | 36 |
Serum urate values were obtained at the Week 28 visit. The percentage of subjects whose serum urate was <6.0 mg/dL at the Week 28 visit was summarized. (NCT00102440)
Timeframe: Week 28
| Intervention | Percentage of subjects (Number) |
|---|---|
| Febuxostat 80 mg QD | 72 |
| Febuxostat 120 mg QD | 82 |
| Allopurinol 300 mg QD | 42 |
Serum urate values were obtained at the Week 52 visit. The percentage of subjects whose serum urate was <6.0 mg/dL at the Week 52 visit was summarized. (NCT00102440)
Timeframe: Week 52
| Intervention | Percentage of subjects (Number) |
|---|---|
| Febuxostat 80 mg QD | 81 |
| Febuxostat 120 mg QD | 82 |
| Allopurinol 300 mg QD | 39 |
Each subject's serum urate at the last 3 visits determined the subject's response for the primary efficacy variable. A subject who prematurely discontinued without least 3 postbaseline serum urate levels was considered a nonresponder; if at least 3 serum urate were obtained postbaseline, those 3 visits were used. The last 3 visits used may have differed for each subject. (NCT00102440)
Timeframe: Last 3 Visits (up to 52 weeks)
| Intervention | Percentage of subjects (Number) |
|---|---|
| Febuxostat 80 mg QD | 53 |
| Febuxostat 120 mg QD | 62 |
| Allopurinol 300 mg QD | 21 |
"The Diastolic BP was taken at Baseline and after 8-10 weeks of treatment or placebo while on chlorthalidone and potassium chloride. The blood pressure was measured according to Shared Care protocol: 15 minutes of quiet, undisturbed rest with three BP measurements obtained subsequently at 5 minute intervals.~The mean of the second and third reading was the value used for analysis for both the Baseline measurement and the measurement after 8 - 10 weeks of treatment. The dependent variable is baseline value minus ending value.~Measures are in millimeters of mercury (mm hg)" (NCT00241839)
Timeframe: Measured at 8-10 weeks on allopurinol / placebo
| Intervention | mm Hg (Mean) |
|---|---|
| A (Allopurinol) | 3.44 |
| B (Placebo) | -0.83 |
Subjects had 24 hr blood pressure monitoring (ABPM) at baseline and treatment end. The readings were averaged and the changes from baseline to treatment end were compared. (NCT00241839)
Timeframe: Baseline and end of treatment (8-10 weeks on allopurinol / placebo)
| Intervention | mm Hg (Mean) |
|---|---|
| A (Allopurinol) | -5.9 |
| B (Placebo) | 0.90 |
"The systolic BP was taken at Baseline and after 8-10 weeks of treatment on placebo, while on chlorthalidone and potassium chloride. The blood pressure was measured according to Shared Care protocol: 15 minutes of quiet, undisturbed rest with three BP measurements obtained subsequently at 5 minute intervals.~The mean of the second and third reading was the value used for analysis for both the Baseline measurement and the measurement after 8 - 10 weeks of treatment. The dependent variable is baseline value minus ending value.~Measures are in millimeters of mercury (mm hg)" (NCT00241839)
Timeframe: Measured at 8-10 weeks on allopurinol or placebo
| Intervention | mm Hg (Mean) |
|---|---|
| A (Allopurinol) | 0.21 |
| B (Placebo) | -0.95 |
Subjects on allopurinol are expected to lower their uric acid levels relative to placebo. (NCT00241839)
Timeframe: Baseline UA levels compared to end of treatment levels (8-10 weeks on allopurinol / placebo)
| Intervention | mg/dl (Mean) |
|---|---|
| A (Allopurinol) | 2.29 |
| B (Placebo) | 0.14 |
Overall liking of apple crisp with a 9-point hedonic rating scale instrument (whereby 0 = dislike extremely and 9 = like extremely ) (NCT03139552)
Timeframe: Day of taste testing
| Intervention | score on likert rating scale (Mean) |
|---|---|
| Full Sugar Recipe | 7.31 |
| Reduced Sugar Recipe | 6.83 |
| Reduced Sugar Plus Spice Recipe | 7.22 |
Overall liking of oatmeal with a 9-point hedonic rating scale instrument (whereby 0 = dislike extremely and 9 = like extremely ) (NCT03139552)
Timeframe: day of taste testing
| Intervention | score on a likert rating scale (Mean) |
|---|---|
| Full Sugar Recipe | 6.84 |
| Reduced Sugar Recipe | 5.70 |
| Reduced Sugar Plus Spice Recipe | 6.15 |
Overall liking of tea with a 9-point hedonic rating scale instrument (whereby 0 = dislike extremely and 9 = like extremely ) (NCT03139552)
Timeframe: day of taste testing
| Intervention | score on a likert rating scale (Mean) |
|---|---|
| Full Sugar Recipe | 6.00 |
| Reduced Sugar Recipe | 5.62 |
| Reduced Sugar Plus Spice Recipe | 5.85 |
Subjects ranked each recipe in order of likability as first, second or third. (NCT03139552)
Timeframe: day of taste testing
| Intervention | Participants (Count of Participants) |
|---|---|
| First Place Ranking | 54 |
| Second Place Ranking | 63 |
| Third Place Ranking | 33 |
Subjects ranked each recipe in order of likability as first, second or third. (NCT03139552)
Timeframe: day of taste testing
| Intervention | Participants (Count of Participants) |
|---|---|
| First Place Ranking | 88 |
| Second Place Ranking | 39 |
| Third Place Ranking | 21 |
Subjects ranked each recipe in order of likability as first, second or third. (NCT03139552)
Timeframe: day of taste testing
| Intervention | Participants (Count of Participants) |
|---|---|
| First Place Ranking | 66 |
| Second Place Ranking | 41 |
| Third Place Ranking | 42 |
Subjects ranked each recipe in order of likability as first, second or third. (NCT03139552)
Timeframe: day of taste testing
| Intervention | Participants (Count of Participants) |
|---|---|
| First Place Ranking | 48 |
| Second Place Ranking | 60 |
| Third Place Ranking | 40 |
Subjects ranked each recipe in order of likability as first, second or third. (NCT03139552)
Timeframe: day of taste testing
| Intervention | Participants (Count of Participants) |
|---|---|
| First Place Ranking | 63 |
| Second Place Ranking | 44 |
| Third Place Ranking | 43 |
Subjects ranked each recipe in order of likability as first, second or third. (NCT03139552)
Timeframe: day of taste testing
| Intervention | Participants (Count of Participants) |
|---|---|
| First Place Ranking | 49 |
| Second Place Ranking | 50 |
| Third Place Ranking | 50 |
Subjects ranked each recipe in order of likability as first, second or third. (NCT03139552)
Timeframe: day of taste testing
| Intervention | Participants (Count of Participants) |
|---|---|
| First Place Ranking | 33 |
| Second Place Ranking | 43 |
| Third Place Ranking | 74 |
Subjects ranked each recipe in order of likability as first, second or third. (NCT03139552)
Timeframe: day of taste testing
| Intervention | Participants (Count of Participants) |
|---|---|
| First Place Ranking | 12 |
| Second Place Ranking | 49 |
| Third Place Ranking | 87 |
Subjects ranked each recipe in order of likability as first, second or third. (NCT03139552)
Timeframe: Day of taste testings
| Intervention | Participants (Count of Participants) |
|---|---|
| First Place Ranking | 34 |
| Second Place Ranking | 58 |
| Third Place Ranking | 57 |
75 reviews available for uric acid and Obesity
| Article | Year |
|---|---|
Prevalence and related factors of hyperuricaemia in Chinese children and adolescents: a pooled analysis of 11 population-based studies.
Topics: Adolescent; Child; China; Cross-Sectional Studies; Female; Humans; Hyperuricemia; Male; Obesity; Pre | 2022 |
Do thrifty genes exist? Revisiting uricase.
Topics: Biological Evolution; Genotype; Humans; Obesity; Urate Oxidase; Uric Acid | 2022 |
Impact of bariatric surgery on serum uric acid levels and the incidence of gout-A meta-analysis.
Topics: Adolescent; Adult; Bariatric Surgery; Body Mass Index; Female; Gout; Humans; Male; MEDLINE; Middle A | 2019 |
Associations of serum uric acid with total and cause-specific mortality: Findings from individuals and pooling prospective studies.
Topics: Age Distribution; Alcohol Drinking; Cause of Death; Coronary Disease; Diet; Exercise; Female; Humans | 2020 |
Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors.
Topics: Adult; Aged; Case-Control Studies; Comorbidity; Ethnicity; Female; Gout; Gout Suppressants; Humans; | 2020 |
Fructose and Uric Acid: Major Mediators of Cardiovascular Disease Risk Starting at Pediatric Age.
Topics: Cardiovascular Diseases; Child; Diabetes Mellitus; Fructose; Humans; Hypertension; Insulin Resistanc | 2020 |
The Role of the Gut Microbiota in Coronary Heart Disease.
Topics: Animals; Cholesterol; Coronary Disease; Diabetes Complications; Dyslipidemias; Gastrointestinal Micr | 2020 |
Gout: Rapid Evidence Review.
Topics: Adrenal Cortex Hormones; Allopurinol; Colchicine; Febuxostat; Gout; Gout Suppressants; Humans; Obesi | 2020 |
Medicinal Plants and Nonsteroidal Anti-inflammatory Drugs (NSAIDs) in Treatment of Arthritis: A Literature Review.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Arthritis, Psoriatic; Arthritis, Rheumato | 2022 |
Change gout: the need for a new approach.
Topics: Biomarkers; Body Mass Index; Cardiovascular Diseases; Diet Therapy; Disease Progression; Evidence-Ba | 2017 |
Gout and Metabolic Syndrome: a Tangled Web.
Topics: Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Fructose; Gout; Humans; Hyperlipide | 2017 |
Weight loss for overweight and obese individuals with gout: a systematic review of longitudinal studies.
Topics: Bariatric Surgery; Diet Therapy; Diuretics; Exercise Therapy; Female; Gout; Humans; Hypoglycemic Age | 2017 |
[A role of fructose in urinary stone formation].
Topics: Animals; Fructose; Humans; Kidney Calculi; Metabolic Syndrome; Obesity; Uric Acid | 2019 |
Energy and fructose from beverages sweetened with sugar or high-fructose corn syrup pose a health risk for some people.
Topics: Beverages; Diabetes Mellitus; Diet; Dietary Sucrose; Fatty Liver; Fructose; Glucose; Gout; Humans; L | 2013 |
Sugar, uric acid, and the etiology of diabetes and obesity.
Topics: Animals; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dietary Sucrose; Disease Models, Animal | 2013 |
Xanthine oxidoreductase in atherosclerosis pathogenesis: not only oxidative stress.
Topics: Adipocytes; Animals; Atherosclerosis; Cardiovascular Diseases; Cell Differentiation; Cell Movement; | 2014 |
Modulation of genetic associations with serum urate levels by body-mass-index in humans.
Topics: Antigens, Nuclear; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Tra | 2015 |
Camellia sinensis in asymptomatic hyperuricemia: A meta-analysis of tea or tea extract effects on uric acid levels.
Topics: Antioxidants; Asymptomatic Diseases; Camellia sinensis; Cardiovascular Diseases; Dietary Supplements | 2017 |
Fat storage syndrome in Pacific peoples: a combination of environment and genetics?
Topics: Cultural Characteristics; Diabetes Mellitus, Type 2; Diet; Dietary Carbohydrates; Dietary Sucrose; E | 2014 |
The management of hyperuricemia with urate deposition.
Topics: Diet; Gout; Humans; Hyperuricemia; Obesity; Overweight; Uric Acid | 2015 |
Health implications of high-fructose intake and current research.
Topics: Animals; Diet; Dietary Sucrose; Fructose; Humans; Hypertension; Hypertriglyceridemia; Insulin; Insul | 2015 |
Kidney stones diseases and glycaemic statuses: focus on the latest clinical evidences.
Topics: Diabetes Mellitus; Humans; Hydrogen-Ion Concentration; Kidney Calculi; Metabolic Syndrome; Obesity; | 2017 |
Formation of Fructose-Mediated Advanced Glycation End Products and Their Roles in Metabolic and Inflammatory Diseases.
Topics: Adenosine Triphosphate; Animals; Diabetes Mellitus, Type 2; Disease Models, Animal; Fructose; Glycat | 2017 |
Sugary drinks in the pathogenesis of obesity and cardiovascular diseases.
Topics: Adiposity; Animals; Beverages; Caffeine; Cardiovascular Diseases; Dietary Sucrose; Dogs; Fructose; H | 2008 |
Using new tools to define the genetic underpinnings of risky traits associated with coronary artery disease: the SardiNIA study.
Topics: Blood Flow Velocity; Blood Glucose; Coronary Artery Disease; Genetic Carrier Screening; Genetic Mark | 2009 |
Plasma uric acid and hypertension in a Chinese community: prospective study and metaanalysis.
Topics: Adult; Blood Pressure; China; Female; Humans; Hypertension; Male; Middle Aged; Obesity; Prospective | 2009 |
[Hyperuricemia and metabolic syndrome].
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Fructose; Humans; Hyperuricemia; Insulin Resistance | 2010 |
Beware the low urine pH--the major cause of the increased prevalence of nephrolithiasis in the patient with type 2 diabetes.
Topics: Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Humans; Hydrogen-Ion Concentration; Insu | 2012 |
The epidemiology of uric acid and fructose.
Topics: Adult; Aged; Aged, 80 and over; Beverages; Diabetes Mellitus; Female; Fructose; Gout; Humans; Hyperu | 2011 |
[Carbohydrate sweeteners and obesity].
Topics: Animals; Causality; Feces; Fructose; Glucose; Humans; Intestines; Lipogenesis; Liver; Metagenome; Ob | 2012 |
Uric acid and diabetes: Is there a link?
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies | 2013 |
[Diet therapy for management of hyperuricemia and gout].
Topics: Adult; Alcoholic Beverages; Diet, Reducing; Gout; Humans; Hyperuricemia; Male; Obesity; Purines; Tem | 2003 |
[Diabetes mellitus and related nutritional examination].
Topics: Diabetes Mellitus; Dietary Fats; Fatty Acids; Glucose; Humans; Ketone Bodies; Lipid Metabolism; Nutr | 2003 |
Gout: on the brink of novel therapeutic options for an ancient disease.
Topics: Acute Disease; Benzothiadiazines; Diuretics; Female; Gout; Humans; Hypertension; Hyperuricemia; Kidn | 2004 |
[Hyperuricemia as a unique marker for metabolic syndrome].
Topics: Adipose Tissue; Arteriosclerosis; Biomarkers; Humans; Hyperuricemia; Insulin Resistance; Life Style; | 2005 |
Pathogenesis of gout.
Topics: Cardiovascular Diseases; Crystallization; Diet; Gout; Humans; Hyperuricemia; Inflammation; Insulin R | 2005 |
Recent developments in diet and gout.
Topics: Beer; Feeding Behavior; Female; Food, Formulated; Gout; Humans; Insulin Resistance; Male; Metabolic | 2006 |
[Is hyperuricemia a cardiovascular risk factor?].
Topics: Cardiovascular Diseases; Comorbidity; Female; Gout; Humans; Hyperuricemia; Obesity; Risk Factors; Se | 2006 |
Role of uric acid in hypertension, renal disease, and metabolic syndrome.
Topics: Biomarkers; Blood Pressure; Fructose; Humans; Hypertension; Hyperuricemia; Kidney Diseases; Metaboli | 2006 |
Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Fructose; Genetic Predispo | 2007 |
Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Fructose; Genetic Predispo | 2007 |
Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Fructose; Genetic Predispo | 2007 |
Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Fructose; Genetic Predispo | 2007 |
Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Fructose; Genetic Predispo | 2007 |
Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Fructose; Genetic Predispo | 2007 |
Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Fructose; Genetic Predispo | 2007 |
Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Fructose; Genetic Predispo | 2007 |
Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Fructose; Genetic Predispo | 2007 |
The planetary biology of ascorbate and uric acid and their relationship with the epidemic of obesity and cardiovascular disease.
Topics: Animals; Antioxidants; Ascorbic Acid; Biological Evolution; Blood Pressure; Cardiovascular Diseases; | 2008 |
[Definition and classification of hyperuricemia].
Topics: Alcohol Drinking; Diet, Reducing; Fructose; Glucose-6-Phosphatase; Glycogen Storage Disease Type I; | 2008 |
Osteoarthritis I: epidemiology.
Topics: Adolescent; Adult; Age Factors; Aged; Female; Humans; Male; Middle Aged; Obesity; Osteoarthritis; Se | 1984 |
[Current theories on the role of hyperuricemia as one of the risk factors in ischemic heart disease].
Topics: Carbohydrate Metabolism; Coronary Disease; Female; Gout; Humans; Hypercholesterolemia; Hypertension; | 1980 |
[Hyperuric acidemia and obesity].
Topics: Age Factors; Body Weight; Diet; Female; Humans; Male; Obesity; Uric Acid | 1995 |
[Complication of childhood obesity].
Topics: Body Mass Index; Cardiovascular Diseases; Child; Diabetes Mellitus, Type 2; Fatty Liver; Female; Hum | 1995 |
[Obesity and the related diseases: gout].
Topics: Alcohol Drinking; Animals; Female; Gout; Humans; Hyperlipidemias; Male; Obesity; Uric Acid | 1995 |
[The metabolic syndrome. Pathophysiologic causes, diagnosis, therapy].
Topics: Arteriosclerosis; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Humans; Hyperinsulini | 1994 |
[Hypertension, Type II diabetes mellitus and macroangiopathy: risk factors and their association].
Topics: Albuminuria; Alcohol Drinking; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Exercise; Female; H | 1994 |
[Polymetabolic syndrome].
Topics: Albuminuria; Cholesterol; Diabetes Mellitus, Type 2; Humans; Hyperlipidemias; Hypertension; Insulin; | 1995 |
[Association of hyperuricemia with hyperlipidemia and obesity].
Topics: Fatty Acids, Nonesterified; Female; Humans; Hypertriglyceridemia; Lipoprotein Lipase; Male; Obesity; | 1996 |
[Hyperuricemia and insulin resistance].
Topics: Cardiovascular Diseases; Cholesterol, HDL; Diabetes Mellitus, Type 2; Glucose Tolerance Test; Humans | 1996 |
[Gout and atherosclerosis].
Topics: Alcohol Drinking; Coronary Artery Disease; Gout; Humans; Hyperlipidemias; Hypertension; Obesity; Pla | 1996 |
[Insulin sensitizer and urate metabolism].
Topics: Chromans; Diabetes Mellitus, Type 2; Female; Glucose; Gout; Humans; Hyperlipidemias; Hypertension; H | 2000 |
[Update on the epidemiology of obesity and type 2 diabetes in France].
Topics: Adolescent; Adult; Body Mass Index; Child; Child, Preschool; Colonic Neoplasms; Coronary Disease; Di | 2000 |
[Multiple risk factor syndrome and hyperuricemia].
Topics: Female; Humans; Hyperlipidemias; Hypertension; Male; Myocardial Ischemia; Obesity; Risk Factors; Uri | 2001 |
[Renal markers and predictors, and renal and cardiovascular risk factors].
Topics: Age Factors; Alcohol Drinking; Biomarkers; Blood Pressure; Cardiovascular Diseases; Fatty Acids; Hum | 2002 |
[Hyperuricemia and arteriosclerosis].
Topics: Adult; Arteriosclerosis; Coronary Disease; Dehydroepiandrosterone; Female; Gout; Humans; Hyperlipide | 1978 |
Risk factors for coronary heart disease.
Topics: Animals; Beverages; Blood Vessels; Cholesterol; Contraceptives, Oral; Coronary Disease; Diabetes Com | 1978 |
[Therapy of gout].
Topics: Arteriosclerosis; Colchicine; Diabetes Mellitus; Diet; Gout; Humans; Hyperlipidemias; Kidney Calculi | 1977 |
Jejunoileal bypass for morbid obesity. A critical appraisal.
Topics: Adaptation, Physiological; Adult; Blood Glucose; Blood Pressure; Body Weight; Cholelithiasis; Humans | 1978 |
[Role of life style and nutrition in the etiology, prevention and therapy of coronary disease with special reference to lipid metabolism].
Topics: Cholesterol, Dietary; Coronary Disease; Diet, Sodium-Restricted; Dietary Fats; Female; Humans; Hyper | 1979 |
Dietetic treatment of obesity with low and high-carbohydrate diets: comparative studies and clinical results.
Topics: Adult; Blood Glucose; Body Weight; Cholesterol; Diet, Reducing; Dietary Carbohydrates; Dietary Fats; | 1979 |
[Epidemiology of coronary disease].
Topics: Adult; Age Factors; Aged; Alcoholism; Blood Pressure; Cholesterol; Coffee; Contraceptives, Oral; Cor | 1979 |
[Selected phsiopathological and clinical aspects of purine metabolism].
Topics: Alkalosis, Respiratory; Diabetes Mellitus; Diuresis; Female; Fructose Intolerance; Glomerular Filtra | 1976 |
Gout in Maoris.
Topics: Adult; Diabetes Complications; Europe; Female; Gout; Hemoglobins; History, 18th Century; History, 19 | 1975 |
[Clinical management of obesity and diabetes with hyperuricemia].
Topics: Diabetes Complications; Diabetes Mellitus; Gout; Humans; Obesity; Uric Acid | 1991 |
[Lipids and arteriosclerosis].
Topics: Adult; Age Factors; Aged; Animals; Arteriosclerosis; Cats; Cholesterol; Coronary Disease; Dogs; Gout | 1973 |
Fasting in the treatment of obesity.
Topics: Adolescent; Body Weight; Diet, Reducing; Fasting; Hospitalization; Humans; Hypokalemia; Middle Aged; | 1972 |
Precursors and prevention of coronary artery disease. An overview.
Topics: Aging; Coronary Disease; Diabetes Complications; Diet; Female; Humans; Hypercholesterolemia; Hyperli | 1972 |
Diabetes mellitus and gout.
Topics: Benzothiadiazines; Blood Glucose; Carbohydrate Metabolism; Diabetes Complications; Diabetes Mellitus | 1972 |
Epidemiology of coronary heart disease.
Topics: Adult; Aged; Arteriosclerosis; Cholesterol, Dietary; Coronary Disease; Diabetes Complications; Dieta | 1973 |
Dieting and depression reexamined. A critical review of reports of untoward responses during weight reduction for obesity.
Topics: Affective Symptoms; Age Factors; Ambulatory Care; Child; Depression; Diet, Reducing; Fasting; Female | 1974 |
[On the biochemistry and pathogenesis of gout].
Topics: Alcoholism; Glomerular Filtration Rate; Gout; Humans; Kidney Tubules; Obesity; Purines; Uric Acid | 1968 |
[The kidney in gout and gout of the kidney].
Topics: Arteriosclerosis Obliterans; Carbohydrate Metabolism; Cerebrovascular Disorders; Diabetes Complicati | 1968 |
47 trials available for uric acid and Obesity
| Article | Year |
|---|---|
Uric acid as a predictor of weight gain and cardiometabolic health in the Study of Novel Approaches to Weight Gain Prevention (SNAP) study.
Topics: Adult; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Obesity; Risk Factors; Uric Acid; | 2022 |
Effect of regular exercise on the levels of subfatin and asprosin: a trial with different types of exercise.
Topics: Exercise; Exercise Therapy; Glucose; Humans; Male; Obesity; Uric Acid | 2022 |
The effects of aerobic exercise on body composition in overweight and obese patients with gout: a randomized, open-labeled, controlled trial.
Topics: Adolescent; Adult; Body Composition; Cholesterol, HDL; Exercise; Exercise Therapy; Gout; Humans; Mid | 2022 |
Effects of long-term vitamin D supplementation on metabolic profile in middle-aged and elderly patients with type 2 diabetes.
Topics: Aged; Blood Glucose; C-Reactive Protein; Diabetes Mellitus, Type 2; Dietary Supplements; Double-Blin | 2023 |
Postprandial Metabolic and Oxidative Stress Responses to Grape Pomace Extract in Healthy Normal and Overweight/Obese Women: A Randomized, Double-Blind, Placebo-Controlled Crossover Study.
Topics: Antioxidants; Cross-Over Studies; Double-Blind Method; Female; Humans; Obesity; Overweight; Oxidativ | 2022 |
Hmong microbiome ANd Gout, Obesity, Vitamin C (HMANGO-C): A phase II clinical study protocol.
Topics: Adult; Ascorbic Acid; Clinical Trials, Phase II as Topic; COVID-19; Gout; Gout Suppressants; Humans; | 2023 |
High risk vs. "metabolically healthy" phenotype in juvenile obesity - neck subcutaneous adipose tissue and serum uric acid are clinically relevant.
Topics: Adiponectin; Adolescent; Carotid Artery Diseases; Child; Child, Preschool; Female; Humans; Insulin R | 2013 |
The changing profile of patients with calcium nephrolithiasis and the ascendancy of overweight and obesity: a comparison of two patient series observed 25 years apart.
Topics: Adult; Biomarkers; Body Mass Index; Calcium; Female; Humans; Male; Nephrolithiasis; Obesity; Overwei | 2013 |
A new dietary strategy for long-term treatment of the metabolic syndrome is compared with the American Heart Association (AHA) guidelines: the MEtabolic Syndrome REduction in NAvarra (RESMENA) project.
Topics: Adipose Tissue; American Heart Association; Biomarkers; Blood Glucose; Body Composition; Body Mass I | 2014 |
High-fructose corn syrup and sucrose have equivalent effects on energy-regulating hormones at normal human consumption levels.
Topics: Adult; Area Under Curve; Blood Glucose; Diet; Dietary Sucrose; Double-Blind Method; Energy Metabolis | 2013 |
[Analysis of the chosen parameters of metabolic status in patients with psoriasis].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; C-Reactive Protein; Cholesterol; Cholesterol, HDL; Chole | 2013 |
Pre-meal tomato (Lycopersicon esculentum) intake can have anti-obesity effects in young women?
Topics: Adipose Tissue; Adolescent; Adult; Antioxidants; Blood Glucose; Body Composition; Body Mass Index; C | 2014 |
Cardiovascular risk factors and total serum antioxidant capacity in healthy men and in men with coronary heart disease.
Topics: Adult; Aged; Antioxidants; Biomarkers; Comorbidity; Coronary Artery Disease; Humans; Incidence; Men; | 2014 |
The fructose tolerance test in patients with chronic kidney disease and metabolic syndrome in comparison to healthy controls.
Topics: Adult; Aged; Body Mass Index; Disease Progression; Female; Fructose; Glomerular Filtration Rate; Hum | 2015 |
Consumption of sucrose-sweetened soft drinks increases plasma levels of uric acid in overweight and obese subjects: a 6-month randomised controlled trial.
Topics: Adult; Animals; Carbonated Beverages; Dietary Sucrose; Drinking Water; Female; Humans; Insulin; Live | 2015 |
Effects of Lowering Glycemic Index of Dietary Carbohydrate on Plasma Uric Acid Levels: The OmniCarb Randomized Clinical Trial.
Topics: Adult; Black or African American; Blood Glucose; Cholesterol; Cholesterol, HDL; Cross-Over Studies; | 2016 |
The Clinical Characteristics of Obese Patients with Acanthosis Nigricans and Its Independent Risk Factors.
Topics: Acanthosis Nigricans; Adolescent; Adult; Body Mass Index; Female; Humans; Insulin; Male; Obesity; Ri | 2017 |
Metabolic Effects of Replacing Sugar-Sweetened Beverages with Artificially-Sweetened Beverages in Overweight Subjects with or without Hepatic Steatosis: A Randomized Control Clinical Trial.
Topics: Adult; Blood Glucose; Body Mass Index; Diet; Fatty Acids, Nonesterified; Fatty Liver; Female; Glucag | 2017 |
The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemia.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Aged; Anti-Obesity Agents; Anticholesteremic Agents; | 2008 |
Endocrine and metabolic effects of consuming fructose- and glucose-sweetened beverages with meals in obese men and women: influence of insulin resistance on plasma triglyceride responses.
Topics: Adolescent; Adult; Beverages; Blood Glucose; Body Mass Index; Cross-Over Studies; Diet; Eating; Fatt | 2009 |
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Comorbidity; Dose-Response Relationship, Dr | 2010 |
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Comorbidity; Dose-Response Relationship, Dr | 2010 |
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Comorbidity; Dose-Response Relationship, Dr | 2010 |
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Comorbidity; Dose-Response Relationship, Dr | 2010 |
Obesity-related glomerulopathy: body mass index and proteinuria.
Topics: Adult; Biomarkers; Biopsy; Blood Pressure; Body Mass Index; Caloric Restriction; China; Combined Mod | 2010 |
Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Cardiovascular Diseases; Comorbidity; Febux | 2012 |
Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Cardiovascular Diseases; Comorbidity; Febux | 2012 |
Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Cardiovascular Diseases; Comorbidity; Febux | 2012 |
Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Cardiovascular Diseases; Comorbidity; Febux | 2012 |
Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Cardiovascular Diseases; Comorbidity; Febux | 2012 |
Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Cardiovascular Diseases; Comorbidity; Febux | 2012 |
Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Cardiovascular Diseases; Comorbidity; Febux | 2012 |
Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Cardiovascular Diseases; Comorbidity; Febux | 2012 |
Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Cardiovascular Diseases; Comorbidity; Febux | 2012 |
Effect of low-calorie versus low-carbohydrate ketogenic diet in type 2 diabetes.
Topics: Adult; Blood Glucose; Body Mass Index; Caloric Restriction; Creatinine; Diabetes Mellitus, Type 2; D | 2012 |
Effect of low-calorie versus low-carbohydrate ketogenic diet in type 2 diabetes.
Topics: Adult; Blood Glucose; Body Mass Index; Caloric Restriction; Creatinine; Diabetes Mellitus, Type 2; D | 2012 |
Effect of low-calorie versus low-carbohydrate ketogenic diet in type 2 diabetes.
Topics: Adult; Blood Glucose; Body Mass Index; Caloric Restriction; Creatinine; Diabetes Mellitus, Type 2; D | 2012 |
Effect of low-calorie versus low-carbohydrate ketogenic diet in type 2 diabetes.
Topics: Adult; Blood Glucose; Body Mass Index; Caloric Restriction; Creatinine; Diabetes Mellitus, Type 2; D | 2012 |
Urate transporter gene SLC22A12 polymorphisms associated with obesity and metabolic syndrome in Caucasians with hypertension.
Topics: Adolescent; Adult; Aged; Female; Humans; Hypertension; Male; Metabolic Syndrome; Middle Aged; Obesit | 2012 |
Uric acid reduction rectifies prehypertension in obese adolescents.
Topics: Adolescent; Allopurinol; Blood Pressure; Child; Double-Blind Method; Drug Administration Schedule; F | 2012 |
The effects of surgically removing subcutaneous fat on the metabolic profile and insulin sensitivity in obese women after large-volume liposuction treatment.
Topics: Adipose Tissue; Adult; Blood Glucose; Body Height; Body Mass Index; Body Weight; Cholesterol, LDL; F | 2002 |
[Evaluation of lercanidipine in the general practice setting].
Topics: Aged; Antihypertensive Agents; Calcium Channel Blockers; Calcium Channels, L-Type; Cholesterol; Diab | 2003 |
Sleep-disordered breathing and uric acid in overweight and obese children and adolescents.
Topics: Adiposity; Adolescent; Biomarkers; Child; Female; Humans; Hypoxia; Linear Models; Male; Obesity; Ove | 2007 |
Olanzapine versus placebo in the treatment of adolescents with bipolar mania.
Topics: Adolescent; Age Factors; Alanine Transaminase; Antipsychotic Agents; Aspartate Aminotransferases; Be | 2007 |
Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin.
Topics: Adolescent; Adult; Body Mass Index; Cross-Sectional Studies; Cyproterone Acetate; Drug Combinations; | 2008 |
[Does short-term fasting lower the cardiovascular risk in obesity? Effects of the composition of the reducing diet].
Topics: Adult; Blood Glucose; Body Weight; Diet, Reducing; Dietary Fats; Female; Humans; Hypertension; Male; | 1983 |
Metabolic effects of substituting carbohydrate for protein in a low-calorie diet: a prolonged study in obese patients.
Topics: 3-Hydroxybutyric Acid; Adult; Body Weight; Diet, Reducing; Dietary Carbohydrates; Dietary Proteins; | 1981 |
Protein metabolism during weight reduction with very-low-energy diets: evaluation of the independent effects of protein and carbohydrate on protein sparing.
Topics: 3-Hydroxybutyric Acid; Adult; Amino Acids; Ammonia; Analysis of Variance; Blood Glucose; Body Compos | 1995 |
[Forestier disease and metabolism disorders. A prospective controlled study of 25 cases].
Topics: Adult; Aged; Body Mass Index; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Humans; Hyper | 1993 |
The effect of menopause on serum uric acid levels in non-obese healthy women.
Topics: Adult; Body Mass Index; Female; Humans; Insulin Resistance; Menopause; Middle Aged; Obesity; Referen | 1998 |
Changes in blood pressure and in vasoactive and volume regulatory hormones during semistarvation in obese subjects.
Topics: Adolescent; Adult; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Blood Urea Nitrogen; Body | 1998 |
Increased visceral fat accumulation further aggravates the risks of insulin resistance in gout.
Topics: Adult; Aged; Cluster Analysis; Creatinine; Eating; Gout; Humans; Insulin Resistance; Male; Middle Ag | 2001 |
Effects of halofenate and probenecid on serum lipids and uric acid in hyperlipidemic, hyperuricemic adults.
Topics: Adult; Aged; Body Weight; Cholesterol; Clinical Trials as Topic; Female; Glycolates; Halofenate; Hum | 1977 |
[The effect of benzbromarone on fasting-hyperuricemia as a model (author's transl)].
Topics: Adolescent; Adult; Benzbromarone; Benzofurans; Fasting; Female; Humans; Male; Middle Aged; Obesity; | 1978 |
Ineffectiveness of human chorionic gonadotropin in weight reduction: a double-blind study.
Topics: Adult; Anthropometry; Blood Glucose; Blood Pressure; Blood Proteins; Blood Urea Nitrogen; Body Heigh | 1976 |
Effect of diet composition on metabolic adaptations to hypocaloric nutrition: comparison of high carbohydrate and high fat isocaloric diets.
Topics: Adolescent; Adult; Blood Glucose; Body Weight; Diet, Reducing; Dietary Carbohydrates; Dietary Fats; | 1977 |
[Beta-thromboglobulin levels and atherosclerosis. Its relationship with the presence of risk factors].
Topics: Aged; Alcoholism; Apolipoproteins B; Arteriosclerosis; beta-Thromboglobulin; Diabetes Complications; | 1992 |
Ketosis, weight loss, uric acid, and nitrogen balance in obese women fed single nutrients at low caloric levels.
Topics: Acidosis; Adolescent; Adult; Blood Glucose; Blood Urea Nitrogen; Cholesterol; Clinical Trials as Top | 1969 |
Quantitative and qualitative effects of L-triiodothyronine in massive obesity.
Topics: Adipose Tissue; Adult; Aged; Buttocks; Chromatography, Gas; Clinical Trials as Topic; Diet, Reducing | 1970 |
Refractory obesity and diabetes.
Topics: Adult; Body Weight; Diabetes Mellitus; Diet, Diabetic; Fasting; Female; Glucose Tolerance Test; Huma | 1968 |
[Effect of ketogenic diet on body weight, intermediary and electrolyte metabolism of obese subjects].
Topics: Adult; Body Weight; Carbon Dioxide; Creatinine; Diet, Reducing; Diet, Sodium-Restricted; Female; Hum | 1969 |
733 other studies available for uric acid and Obesity
| Article | Year |
|---|---|
Using multiple Mendelian randomization approaches and genetic correlations to understand obesity, urate, and gout.
Topics: Causality; Genome-Wide Association Study; Gout; Humans; Linkage Disequilibrium; Lipoproteins, HDL; L | 2021 |
Positive association between body fat percentage and hyperuricemia in patients with hypertension: The China H-type hypertension registry study.
Topics: Adiposity; Biomarkers; Blood Pressure; China; Cross-Sectional Studies; Female; Humans; Hypertension; | 2021 |
Serum uric acid is associated with incident metabolic syndrome independent of body shape index and body roundness index in healthy individuals.
Topics: Adult; Biomarkers; Body Mass Index; Female; Humans; Hyperuricemia; Incidence; Male; Metabolic Syndro | 2021 |
Umami-induced obesity and metabolic syndrome is mediated by nucleotide degradation and uric acid generation.
Topics: Animals; Energy Intake; Metabolic Syndrome; Mice; Nucleotides; Obesity; Sodium Glutamate; Taste; Uri | 2021 |
Decrease in Serum Urate Level Is Associated With Loss of Visceral Fat in Male Gout Patients.
Topics: Adult; Body Composition; Body Mass Index; China; Gout; Humans; Intra-Abdominal Fat; Male; Middle Age | 2021 |
Cardiometabolic risk in adolescents with normal weight obesity.
Topics: Adolescent; Body Mass Index; Cardiovascular Diseases; Cross-Sectional Studies; Female; Humans; Male; | 2022 |
The Effect of Body Weight and Alcohol Consumption on Hyperuricemia and Their Population Attributable Fractions: A National Health Survey in China.
Topics: Alcohol Drinking; Body Weight; China; Cross-Sectional Studies; Female; Health Surveys; Humans; Hyper | 2022 |
Protective role of melatonin against adipose-hepatic metabolic comorbidities in experimentally induced obese rat model.
Topics: Adipose Tissue; Animals; Diet, High-Fat; Disease Models, Animal; Gene Expression Regulation; Ghrelin | 2021 |
Mediation effect of obesity on the association between triglyceride-glucose index and hyperuricemia in Chinese hypertension adults.
Topics: Adult; Aged; Biomarkers; Blood Glucose; China; Cross-Sectional Studies; Female; Glucose; Humans; Hyp | 2022 |
Body mass index was linked with multi-cardiometabolic abnormalities in Chinese children and adolescents: a community-based survey.
Topics: Adolescent; Adult; Body Mass Index; Cardiovascular Diseases; Child; Child, Preschool; Humans; Hypert | 2022 |
Correlation Between Serum Uric Acid and Body Fat Distribution in Patients With Polycystic Ovary Syndrome.
Topics: Absorptiometry, Photon; Adipose Tissue; Adult; Body Fat Distribution; Female; Humans; Hyperuricemia; | 2021 |
Visceral adipose tissue loss and 24-hour urinary profile changes post-bariatric surgery.
Topics: Bariatric Surgery; Humans; Intra-Abdominal Fat; Kidney Calculi; Obesity; Uric Acid | 2022 |
Triglyceride Glucose Index Is More Closely Related to Hyperuricemia Than Obesity Indices in the Medical Checkup Population in Xinjiang, China.
Topics: China; Female; Glucose; Humans; Hyperuricemia; Insulin Resistance; Male; Obesity; Obesity, Abdominal | 2022 |
Comparison of Serum Uric Acid Levels Among Men and Women with Metabolic Syndrome - A Study.
Topics: Adult; Cross-Sectional Studies; Female; Humans; Hyperuricemia; Male; Metabolic Syndrome; Obesity; Ri | 2022 |
Pararenal Fat and Renal Dysfunction in Patients without Significant Cardiovascular Disease.
Topics: Aged; Cardiovascular Diseases; Glomerular Filtration Rate; Humans; Middle Aged; Obesity; Overweight; | 2022 |
Prediction of the Uric Acid Component in Nephrolithiasis Using Simple Clinical Information about Metabolic Disorder and Obesity: A Machine Learning-Based Model.
Topics: Female; Gout; Humans; Kidney Calculi; Machine Learning; Male; Obesity; Uric Acid | 2022 |
A Clinical Profile of Patients with Hyperuricemia and the Relationship between Hyperuricemia and Metabolic Syndrome: A Cross-sectional Study at a Tertiary Hospital in the Indian Population.
Topics: Cardiovascular Diseases; Cross-Sectional Studies; Female; Humans; Hypertriglyceridemia; Hyperuricemi | 2022 |
The effect of low-carbohydrate ketogenic diet in the management of obesity compared with low caloric, low-fat diet.
Topics: Adult; Cholesterol; Diet, Fat-Restricted; Diet, Ketogenic; Glycated Hemoglobin; Humans; Lipids; Obes | 2022 |
Effects of a ketogenic diet in women with PCOS with different uric acid concentrations: a prospective cohort study.
Topics: Body Mass Index; Diet, Ketogenic; Female; Humans; Obesity; Overweight; Polycystic Ovary Syndrome; Pr | 2022 |
Serum fibrinogen-like protein 1 as a novel biomarker in polycystic ovary syndrome: a case-control study.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Biomarkers; Blood Glucose; Body Mass Index; Case- | 2022 |
The abundance of bifidobacterium in relation to visceral obesity and serum uric acid.
Topics: Bifidobacterium; Humans; Intra-Abdominal Fat; Obesity; Obesity, Abdominal; Subcutaneous Fat; Uric Ac | 2022 |
Correlation of obesity, dietary patterns, and blood pressure with uric acid: data from the NHANES 2017-2018.
Topics: Blood Pressure; Cross-Sectional Studies; Gout; Humans; Hyperuricemia; Nutrition Surveys; Obesity; Ri | 2022 |
Prevalence of hyperuricemia and the population attributable fraction of modifiable risk factors: Evidence from a general population cohort in China.
Topics: Adult; China; Female; Humans; Hyperuricemia; Male; Obesity; Overweight; Prevalence; Uric Acid | 2022 |
The perirenal fat thickness was independently associated with serum uric acid level in patients with type 2 diabetes mellitus.
Topics: Cholesterol; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Humans; Kidney; Male; Obesity; Risk | 2022 |
The role of obesity, type 2 diabetes, and metabolic factors in gout: A Mendelian randomization study.
Topics: Diabetes Mellitus, Type 2; Genome-Wide Association Study; Gout; Humans; Hypertension; Mendelian Rand | 2022 |
Serum uric acid is a predictive biomarker of incident metabolic syndrome at the Brazilian longitudinal study of adult Health (ELSA - Brasil).
Topics: Adult; Biomarkers; Brazil; Humans; Hyperuricemia; Longitudinal Studies; Metabolic Syndrome; Obesity; | 2022 |
Prevalence of hyperuricemia in patients with severe obesity and the relationship between serum uric acid and severe obesity: A decade retrospective cross-section study in Chinese adults.
Topics: Adult; China; Humans; Hyperuricemia; Obesity; Obesity, Morbid; Overweight; Prevalence; Retrospective | 2022 |
Antihyperlipidemic Activity of Glycoconjugated Phthalimides in Mice Submitted to a Model of Dyslipidemia and Insulin Resistance.
Topics: Animals; Carboxymethylcellulose Sodium; Cholesterol, LDL; Diabetes Mellitus, Type 2; Dyslipidemias; | 2022 |
Determinants of hyperglucagonemia in pediatric non-alcoholic fatty liver disease.
Topics: Adolescent; Child; Glucagon; Glucose; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Non- | 2022 |
Correlation of uric acid with body mass index based on NHANES 2013-2018 data: A cross-sectional study.
Topics: Body Mass Index; Cross-Sectional Studies; Female; Humans; Male; Nutrition Surveys; Obesity; Uric Aci | 2022 |
Disordered Glucose Levels Are Associated with Xanthine Oxidase Activity in Overweight Type 2 Diabetic Women.
Topics: Blood Glucose; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; M | 2022 |
Hyperuricaemia and its association with other risk factors for cardiovascular diseases: A population-based study.
Topics: Adolescent; Cardiovascular Diseases; Cross-Sectional Studies; Female; Humans; Hypertension; Hyperuri | 2022 |
Association of obesity, triglyceride-glucose and its derivatives index with risk of hyperuricemia among college students in Qingdao, China.
Topics: Adolescent; Adult; China; Cross-Sectional Studies; Female; Glucose; Humans; Hyperuricemia; Male; Obe | 2022 |
Gender Difference in the Association of Hyperuricemia with Insulin Resistance and beta-cell Function in Nondiabetic Korean Adults: The 2019 Korea National Health and Nutrition Examination Survey.
Topics: Adult; Female; Humans; Hyperuricemia; Insulin Resistance; Male; Nutrition Surveys; Obesity; Republic | 2023 |
Insulin resistance in school-aged girls with overweight and obesity is strongly associated with elevated white blood cell count and absolute neutrophil count.
Topics: Child; Cross-Sectional Studies; Female; Humans; Insulin Resistance; Leukocyte Count; Male; Neutrophi | 2022 |
Insulin resistance in school-aged girls with overweight and obesity is strongly associated with elevated white blood cell count and absolute neutrophil count.
Topics: Child; Cross-Sectional Studies; Female; Humans; Insulin Resistance; Leukocyte Count; Male; Neutrophi | 2022 |
Insulin resistance in school-aged girls with overweight and obesity is strongly associated with elevated white blood cell count and absolute neutrophil count.
Topics: Child; Cross-Sectional Studies; Female; Humans; Insulin Resistance; Leukocyte Count; Male; Neutrophi | 2022 |
Insulin resistance in school-aged girls with overweight and obesity is strongly associated with elevated white blood cell count and absolute neutrophil count.
Topics: Child; Cross-Sectional Studies; Female; Humans; Insulin Resistance; Leukocyte Count; Male; Neutrophi | 2022 |
Insulin resistance in school-aged girls with overweight and obesity is strongly associated with elevated white blood cell count and absolute neutrophil count.
Topics: Child; Cross-Sectional Studies; Female; Humans; Insulin Resistance; Leukocyte Count; Male; Neutrophi | 2022 |
Insulin resistance in school-aged girls with overweight and obesity is strongly associated with elevated white blood cell count and absolute neutrophil count.
Topics: Child; Cross-Sectional Studies; Female; Humans; Insulin Resistance; Leukocyte Count; Male; Neutrophi | 2022 |
Insulin resistance in school-aged girls with overweight and obesity is strongly associated with elevated white blood cell count and absolute neutrophil count.
Topics: Child; Cross-Sectional Studies; Female; Humans; Insulin Resistance; Leukocyte Count; Male; Neutrophi | 2022 |
Insulin resistance in school-aged girls with overweight and obesity is strongly associated with elevated white blood cell count and absolute neutrophil count.
Topics: Child; Cross-Sectional Studies; Female; Humans; Insulin Resistance; Leukocyte Count; Male; Neutrophi | 2022 |
Insulin resistance in school-aged girls with overweight and obesity is strongly associated with elevated white blood cell count and absolute neutrophil count.
Topics: Child; Cross-Sectional Studies; Female; Humans; Insulin Resistance; Leukocyte Count; Male; Neutrophi | 2022 |
Association between metabolic obesity phenotype, transition of metabolic phenotypes and the risk of hyperuricemia in Chinese adults: A cohort study.
Topics: Cohort Studies; Female; Humans; Hyperuricemia; Male; Obesity; Overweight; Phenotype; Prospective Stu | 2022 |
Association between metabolic obesity phenotype, transition of metabolic phenotypes and the risk of hyperuricemia in Chinese adults: A cohort study.
Topics: Cohort Studies; Female; Humans; Hyperuricemia; Male; Obesity; Overweight; Phenotype; Prospective Stu | 2022 |
Association between metabolic obesity phenotype, transition of metabolic phenotypes and the risk of hyperuricemia in Chinese adults: A cohort study.
Topics: Cohort Studies; Female; Humans; Hyperuricemia; Male; Obesity; Overweight; Phenotype; Prospective Stu | 2022 |
Association between metabolic obesity phenotype, transition of metabolic phenotypes and the risk of hyperuricemia in Chinese adults: A cohort study.
Topics: Cohort Studies; Female; Humans; Hyperuricemia; Male; Obesity; Overweight; Phenotype; Prospective Stu | 2022 |
Association between nocturnal sleep duration and the risk of hyperuricemia among Chinese government employees: A cross-sectional study.
Topics: Cohort Studies; Cross-Sectional Studies; East Asian People; Female; Humans; Hypertension; Male; Obes | 2022 |
Association between nocturnal sleep duration and the risk of hyperuricemia among Chinese government employees: A cross-sectional study.
Topics: Cohort Studies; Cross-Sectional Studies; East Asian People; Female; Humans; Hypertension; Male; Obes | 2022 |
Association between nocturnal sleep duration and the risk of hyperuricemia among Chinese government employees: A cross-sectional study.
Topics: Cohort Studies; Cross-Sectional Studies; East Asian People; Female; Humans; Hypertension; Male; Obes | 2022 |
Association between nocturnal sleep duration and the risk of hyperuricemia among Chinese government employees: A cross-sectional study.
Topics: Cohort Studies; Cross-Sectional Studies; East Asian People; Female; Humans; Hypertension; Male; Obes | 2022 |
Serum uric acid/creatinine ratio and free androgen index are synergistically associated with increased risk of polycystic ovary syndrome in obese women.
Topics: Androgens; Blood Glucose; Body Mass Index; Creatinine; Estradiol; Female; Follicle Stimulating Hormo | 2022 |
Serum uric acid/creatinine ratio and free androgen index are synergistically associated with increased risk of polycystic ovary syndrome in obese women.
Topics: Androgens; Blood Glucose; Body Mass Index; Creatinine; Estradiol; Female; Follicle Stimulating Hormo | 2022 |
Serum uric acid/creatinine ratio and free androgen index are synergistically associated with increased risk of polycystic ovary syndrome in obese women.
Topics: Androgens; Blood Glucose; Body Mass Index; Creatinine; Estradiol; Female; Follicle Stimulating Hormo | 2022 |
Serum uric acid/creatinine ratio and free androgen index are synergistically associated with increased risk of polycystic ovary syndrome in obese women.
Topics: Androgens; Blood Glucose; Body Mass Index; Creatinine; Estradiol; Female; Follicle Stimulating Hormo | 2022 |
Conicity-index predicts all-cause mortality in Chinese older people: a 10-year community follow-up.
Topics: Aged; Blood Glucose; Blood Pressure; Body Mass Index; East Asian People; Female; Follow-Up Studies; | 2022 |
Conicity-index predicts all-cause mortality in Chinese older people: a 10-year community follow-up.
Topics: Aged; Blood Glucose; Blood Pressure; Body Mass Index; East Asian People; Female; Follow-Up Studies; | 2022 |
Conicity-index predicts all-cause mortality in Chinese older people: a 10-year community follow-up.
Topics: Aged; Blood Glucose; Blood Pressure; Body Mass Index; East Asian People; Female; Follow-Up Studies; | 2022 |
Conicity-index predicts all-cause mortality in Chinese older people: a 10-year community follow-up.
Topics: Aged; Blood Glucose; Blood Pressure; Body Mass Index; East Asian People; Female; Follow-Up Studies; | 2022 |
Serum copeptin as a biomarker of hypertension in children with obesity.
Topics: Biomarkers; Child; Humans; Hypertension; Obesity; Potassium; Sodium; Uric Acid | 2022 |
Uric acid relationships with lipid profile and adiposity indices: Impact of different hyperuricemic thresholds.
Topics: Adiposity; Body Mass Index; Humans; Hypertension; Hyperuricemia; Obesity; Obesity, Abdominal; Trigly | 2023 |
Hyperuricemia as an effect modifier of the association between metabolic phenotypes and nonalcoholic fatty liver disease in Chinese population.
Topics: Body Mass Index; East Asian People; Humans; Hyperuricemia; Metabolic Syndrome; Non-alcoholic Fatty L | 2023 |
Using human genetics to understand the epidemiological association between obesity, serum urate, and gout.
Topics: Genome-Wide Association Study; Gout; Human Genetics; Humans; Obesity; Polymorphism, Single Nucleotid | 2023 |
Obesity and overweight are linked to increased sodium-glucose cotransporter 1 and glucose transporter 5 levels in duodenum.
Topics: Cross-Sectional Studies; Duodenum; Glucose; Glucose Transporter Type 5; Humans; Obesity; Overweight; | 2023 |
Gender difference in the association between gout at diagnosis and metabolic syndrome in African population: a retrospective cohort study.
Topics: Aged; Cameroon; Female; Gout; Humans; Hypertension; Male; Metabolic Syndrome; Middle Aged; Obesity; | 2022 |
Resistin/uric acid index as a marker of metabolic syndrome in females with obesity.
Topics: Adolescent; Body Mass Index; Cross-Sectional Studies; Female; Glucose; Humans; Insulin; Insulin Resi | 2023 |
Trends in serum uric acid levels among Korean children and adolescents between 2016 and 2020: a nationwide study.
Topics: Adolescent; Body Mass Index; Child; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Huma | 2023 |
Metabolic Syndrome and Its Components Are Associated with New-Onset Hyperuricemia in a Large Taiwanese Population Follow-Up Study.
Topics: Adult; Female; Follow-Up Studies; Humans; Hyperuricemia; Male; Metabolic Syndrome; Middle Aged; Obes | 2023 |
The association between muscle-to-fat ratio and cardiometabolic risks: The China National Health Survey.
Topics: Body Mass Index; Cardiovascular Diseases; Female; Health Surveys; Humans; Male; Muscles; Obesity; Ov | 2023 |
Distinct hyperuricemia trajectories are associated with different risks of incident diabetes: A prospective cohort study.
Topics: Adult; Diabetes Mellitus; Dyslipidemias; Humans; Hypertension; Hyperuricemia; Middle Aged; Obesity; | 2023 |
Effect of Dietary Counseling on Patients with Asymptomatic Hyperuricemia.
Topics: Female; Glomerular Filtration Rate; Gout; Humans; Hyperuricemia; Male; Obesity; Uric Acid | 2023 |
The relationship between patients' kidney stone type and demographics in Israel: analysis of 10 K patients.
Topics: Calcium Oxalate; Calcium Phosphates; Cystine; Diabetes Mellitus; Female; Humans; Hypertension; Israe | 2023 |
Noninvasive assessment of paediatric hepatic steatosis by using attenuation imaging.
Topics: Adolescent; Bayes Theorem; Child; Female; Humans; Liver; Male; Non-alcoholic Fatty Liver Disease; Ob | 2023 |
Comprehensive evaluation of serum cotinine on human health: Novel evidence for the systemic toxicity of tobacco smoke in the US general population.
Topics: Cotinine; Humans; Nicotiana; Nutrition Surveys; Obesity; Smoking; Tobacco Smoke Pollution; Uric Acid | 2023 |
The Significance and Correlation Analysis of Serum Uric Acid and High Sensitivity CRP in the Energy-Limiting Balance Intervention in Obese Patients.
Topics: Blood Glucose; C-Reactive Protein; Cholesterol; Correlation of Data; Glucose; Glycated Hemoglobin; H | 2023 |
Higher serum uric acid is associated with body fat, retinol-binding protein 4, and antioxidative status in Brazilian children.
Topics: Adipokines; Adipose Tissue; Antioxidants; Brazil; Child; Cross-Sectional Studies; Humans; Obesity; R | 2023 |
Dyslipidemia and its associated factors among adult cardiac patients at Ambo university referral hospital, Oromia region, west Ethiopia.
Topics: Adult; Cardiovascular Diseases; Cholesterol; Cross-Sectional Studies; Dyslipidemias; Ethiopia; Hospi | 2023 |
Association between the lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes in a healthy population of Northwest China: a retrospective cohort study with a 2-year follow-up period.
Topics: China; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Humans; Male; Middle Aged; Non-alcoholi | 2023 |
Prevalence and clinical characteristics of low skeletal muscle index among adults visiting a health promotion center: Cross-sectional study.
Topics: Adult; Body Mass Index; Cross-Sectional Studies; Female; Humans; Male; Muscle, Skeletal; Obesity; Pr | 2023 |
[Association between metabolism-related chronic disease combination and prevalence of non-alcoholic fatty liver disease in community residents in Shanghai].
Topics: Adult; Body Mass Index; China; Chronic Disease; Diabetes Mellitus; Female; Gout; Humans; Hyperlipide | 2023 |
The value of waist circumference as a preditor of cardiovascular risk in adult patients with classic phenylketonuria.
Topics: Adult; Body Mass Index; Cardiovascular Diseases; Case-Control Studies; Cholesterol, HDL; Female; Hea | 2023 |
Association between the Weight-Adjusted Waist Index and Serum Uric Acid: A Cross-Sectional Study.
Topics: Adult; Body Weight; Cross-Sectional Studies; Female; Humans; Male; Nutrition Surveys; Obesity; Uric | 2023 |
Sex Difference in the Associations among Obesity-Related Indices with Hyperuricemia in a Large Taiwanese Population Study.
Topics: Adiposity; Body Mass Index; Female; Humans; Hyperuricemia; Male; Obesity; Risk Factors; Sex Characte | 2023 |
Altered insulin secretion dynamics relate to oxidative stress and inflammasome activation in children with obesity and insulin resistance.
Topics: Case-Control Studies; Child; Diabetes Mellitus, Type 2; Humans; Inflammasomes; Inflammation; Insulin | 2023 |
Prevalence and Risk Factors of Metabolic Dysfunction-Associated Fatty Liver Disease with Renal Insufficiency in Overweight/Obese Adults.
Topics: Adult; Female; Humans; Liver Cirrhosis; Male; Non-alcoholic Fatty Liver Disease; Obesity; Overweight | 2023 |
The association between lipid profile, oxidized LDL and the components of metabolic syndrome with serum mineral status and kidney function in individuals with obesity.
Topics: Adult; Albumins; Cholesterol, LDL; Humans; Iron; Kidney; Magnesium; Metabolic Syndrome; Minerals; Ob | 2023 |
Kidney damage predictors in children with metabolically healthy and metabolically unhealthy obesity phenotype.
Topics: Adolescent; Adult; Body Mass Index; Child; Humans; Kidney; Kidney Diseases; Metabolic Syndrome; Obes | 2023 |
High levels of uric acid inhibit BAT thermogenic capacity through regulation of AMPK.
Topics: Adipocytes, Brown; Adipose Tissue, Brown; AMP-Activated Protein Kinases; Animals; Humans; Mice; Obes | 2023 |
Novel pathological implications of serum uric acid with cardiovascular disease risk in obesity.
Topics: Cardiovascular Diseases; Cohort Studies; Female; Humans; Hyperuricemia; Male; Obesity; Prospective S | 2023 |
The role of high fat diet on serum uric acid level among healthy male first degree relatives of type 2 diabetes mellitus.
Topics: Diabetes Mellitus, Type 2; Diet, High-Fat; Humans; Insulin; Insulin Resistance; Male; Obesity; Uric | 2023 |
Prevalence of hyperuricaemia among adults from Ningxia Hui Autonomous Region, China: a cross-sectional study.
Topics: China; Cross-Sectional Studies; Female; Humans; Hyperuricemia; Male; Obesity; Prevalence; Risk Facto | 2023 |
Effects of a two meals-a-day ketogenic diet on newly diagnosed obese patients with type 2 diabetes mellitus: A retrospective observational study.
Topics: Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Diet, Ketogenic; Humans; Meals; Obesity; | 2023 |
Combining diabetes, sex, and menopause as meaningful clinical features associated with NASH and liver fibrosis in individuals with class II and III obesity: A retrospective cohort study.
Topics: Diabetes Mellitus, Type 2; Female; Humans; Liver; Liver Cirrhosis; Male; Menopause; Middle Aged; Non | 2023 |
Association between Asymptomatic Hyperuricemia with Adiposity Indices: A Cross-Sectional Study in a Spanish Population.
Topics: Adiposity; Body Mass Index; Cross-Sectional Studies; Humans; Hyperuricemia; Obesity; Risk Factors; U | 2023 |
Metabolic Features of Individuals with Obesity Referred for Bariatric and Metabolic Surgery: a Cohort Study.
Topics: Adolescent; Adult; Aged; Bariatric Surgery; Biomarkers; C-Peptide; Cohort Studies; Cross-Sectional S | 2019 |
Fructose tolerance test in obese people with and without type 2 diabetes.
Topics: Adult; Aged; Blood Chemical Analysis; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Fem | 2020 |
The challenges of managing gout in primary care: Results of a best-practice audit.
Topics: Aged; Allopurinol; Clinical Audit; Clinical Chemistry Tests; Clinical Protocols; Colchicine; Comorbi | 2019 |
Rice Bran Reduces Weight Gain and Modulates Lipid Metabolism in Rats with High-Energy-Diet-Induced Obesity.
Topics: Adipose Tissue; Animals; Diet, High-Fat; Dietary Supplements; Lipid Metabolism; Lipids; Liver; Male; | 2019 |
Increased plasma osteopontin levels are associated with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
Topics: Adult; Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; Correlation of Data; Diabetes Mel | 2020 |
Circulating leptin is associated with serum uric acid level and its tubular reabsorption in a sample of adult middle-aged men.
Topics: Adult; Blood Pressure; Body Mass Index; C-Reactive Protein; Humans; Hypertension; Insulin Resistance | 2020 |
Association between dairy product consumption and hyperuricemia in an elderly population with metabolic syndrome.
Topics: Age Factors; Aged; Biomarkers; Cross-Sectional Studies; Dairy Products; Diet, Fat-Restricted; Diet, | 2020 |
Uric Acid and Potassium Serum Levels Are Independent Predictors of Blood Pressure Non-Dipping in Overweight or Obese Subjects.
Topics: Adult; Aged; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Carotid Intima-Media Thickness; | 2019 |
Lack of Associations between Elevated Serum Uric Acid and Components of Metabolic Syndrome Such as Hypertension, Dyslipidemia, and T2DM in Overweight and Obese Chinese Adults.
Topics: Adolescent; Adult; Aged; Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; China; Diabetes | 2019 |
Relationship between serum uric acid level and all-cause and cardiovascular mortality in population with obesity.
Topics: Body Mass Index; Cardiometabolic Risk Factors; Cardiovascular Diseases; Cause of Death; Confounding | 2020 |
Salivary uric acid is a predictive marker of body fat percentage in adolescents.
Topics: Adipose Tissue; Adiposity; Adolescent; Biomarkers; Body Composition; Brazil; Cross-Sectional Studies | 2020 |
[Relationship between central obesity and oxidative stress in premenopausal versus postmenopausal women].
Topics: Adult; Body Mass Index; Cross-Sectional Studies; Female; Humans; Malondialdehyde; Middle Aged; Obesi | 2020 |
Elevated serum uric acid, hyperuricaemia and dietary patterns among adolescents in mainland China.
Topics: Adolescent; Child; China; Cross-Sectional Studies; Diet; Female; Follow-Up Studies; Humans; Hyperuri | 2020 |
Sex-specific autosomal genetic effects across 26 human complex traits.
Topics: Adult; Aged; Anthropometry; Body Mass Index; Cholesterol, LDL; Diabetes Mellitus; Female; Glycated H | 2020 |
Associations between obesity and metabolic health with nonalcoholic fatty liver disease in elderly Chinese.
Topics: Aged; Blood Glucose; Blood Pressure; Body Mass Index; China; Cholesterol; Cross-Sectional Studies; F | 2020 |
Resistin/uric acid index for weight loss prediction?
Topics: Adolescent; Body Mass Index; Humans; Life Style; Obesity; Prognosis; Resistin; Uric Acid; Weight Los | 2020 |
Reply.
Topics: Adolescent; Humans; Life Style; Obesity; Prognosis; Resistin; Uric Acid | 2020 |
A leg ulcer with hard, yellow projections.
Topics: Aged, 80 and over; Gout; Humans; Leg Ulcer; Male; Obesity; Uric Acid | 2020 |
Association between relative fat mass, uric acid, and insulin resistance in children with chronic kidney disease.
Topics: Adolescent; Body Mass Index; Cross-Sectional Studies; Humans; Hyperuricemia; Insulin Resistance; Obe | 2021 |
Confounded by obesity and modulated by urinary uric acid excretion, sleep-disordered breathing indirectly relates to hyperuricaemia in males: A structural equation model.
Topics: Biomarkers; Body Mass Index; Humans; Hyperuricemia; Male; Middle Aged; Obesity; Polysomnography; Sle | 2021 |
A Study of Metabolic Parameters in Patients with Gout: A Single Center Study from Nepal.
Topics: Adult; Cross-Sectional Studies; Female; Gout; Humans; Male; Metabolic Syndrome; Middle Aged; Nepal; | 2021 |
BMI, high-sensitivity C-reactive protein and the conversion from metabolically healthy to unhealthy phenotype in Chinese adults: a cohort study.
Topics: Adult; Body Mass Index; C-Reactive Protein; China; Cohort Studies; Female; Humans; Male; Obesity; Ph | 2021 |
Serum C-X-C motif chemokine ligand 14 levels are associated with serum C-peptide and fatty liver index in type 2 diabetes mellitus patients.
Topics: Adiponectin; Age Factors; Aged; Alanine Transaminase; Biomarkers; Body Mass Index; C-Peptide; Chemok | 2021 |
Pre-diagnostic biomarkers of type 2 diabetes identified in the UAE's obese national population using targeted metabolomics.
Topics: 3-Hydroxybutyric Acid; Adult; Alanine; Amino Acids, Branched-Chain; Biomarkers; Chromatography, Liqu | 2020 |
Serum concentration of vitamin A and its relationship with body adiposity, oxidative stress, and cardiovascular risk in women with recommended dietary intake of vitamin A.
Topics: Adiposity; beta Carotene; Blood Glucose; Body Mass Index; Cardiometabolic Risk Factors; Cardiovascul | 2020 |
Association between the non-HDL-cholesterol to HDL-cholesterol ratio and non-alcoholic fatty liver disease in Chinese children and adolescents: a large single-center cross-sectional study.
Topics: Adolescent; Alanine Transaminase; Anthropometry; Blood Glucose; Body Mass Index; Child; China; Chole | 2020 |
Effect of a moderate dose of fructose in solid foods on TAG, glucose and uric acid before and after a 1-month moderate sugar-feeding period.
Topics: Adult; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Female; Fructose; Glucose Intolerance; Hum | 2021 |
Effects of bariatric surgery on serum uric acid in people with obesity with or without hyperuricaemia and gout: a retrospective analysis.
Topics: Adult; Bariatric Surgery; Female; Gout; Humans; Hyperuricemia; Male; Middle Aged; Obesity; Retrospec | 2021 |
Alterations in the Serum Urate Concentrations after Bariatric Surgery: a Short-Term Prospective Observational Study.
Topics: Bariatric Surgery; Body Mass Index; Humans; Obesity; Obesity, Morbid; Uric Acid | 2021 |
Relevance of Physical Fitness and Cardiovascular Disease Risk.
Topics: Cardiovascular Diseases; Coronary Artery Disease; Corticotropin-Releasing Hormone; Female; Humans; M | 2021 |
The effect of baseline serum uric acid on chronic kidney disease in normotensive, normoglycemic, and non-obese individuals: A health checkup cohort study.
Topics: Adult; Aged; Blood Pressure; Body Mass Index; Cohort Studies; Diabetes Mellitus; Female; Glomerular | 2021 |
Obesity interacts with hyperuricemia on the severity of non-alcoholic fatty liver disease.
Topics: Body Mass Index; Cross-Sectional Studies; Female; Humans; Hyperuricemia; Male; Non-alcoholic Fatty L | 2021 |
Association Between Total Bilirubin Levels and Cardio-Metabolic Risk Factors Related to Obesity.
Topics: Adult; Bilirubin; Body Mass Index; Cardiometabolic Risk Factors; Cardiovascular Diseases; Case-Contr | 2022 |
Age difference in the combined effect of soda drinks consumption and body adiposity on hyperuricaemia in US adults.
Topics: Adiposity; Adult; Carbonated Beverages; Female; Humans; Hyperuricemia; Male; Middle Aged; Nutrition | 2021 |
Association between serum uric acid and obesity in Chinese adults: a 9-year longitudinal data analysis.
Topics: Adult; Aged; China; Cross-Sectional Studies; Data Analysis; Female; Humans; Male; Obesity; Risk Fact | 2021 |
Osteopontin's relationship with malnutrition and oxidative stress in adolescents. A pilot study.
Topics: Adolescent; Aryldialkylphosphatase; Biomarkers; Blood Glucose; Body Mass Index; Catalase; Female; Hu | 2021 |
Influence of xanthine oxidoreductase inhibitor, topiroxostat, on body weight of diabetic obese mice.
Topics: Animals; Body Weight; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Fatty Acids, Nonesterified | 2021 |
Serum Uric Acid Is a Mediator of the Association Between Obesity and Incident Nonalcoholic Fatty Liver Disease: A Prospective Cohort Study.
Topics: Biomarkers; China; Female; Follow-Up Studies; Humans; Incidence; Longitudinal Studies; Male; Middle | 2021 |
Obesity-Related Gut Microbiota Aggravates Alveolar Bone Destruction in Experimental Periodontitis through Elevation of Uric Acid.
Topics: Alveolar Bone Loss; Animals; Diet, High-Fat; Dysbiosis; Fecal Microbiota Transplantation; Gastrointe | 2021 |
Machine Learning to Identify Metabolic Subtypes of Obesity: A Multi-Center Study.
Topics: Adult; Blood Glucose; Body Mass Index; China; Comorbidity; Female; Glucose Tolerance Test; Humans; H | 2021 |
Combined effect of obesity and uric acid on nonalcoholic fatty liver disease and hypertriglyceridemia.
Topics: Adult; Aged; China; Cohort Studies; Cross-Sectional Studies; Female; Humans; Hypertriglyceridemia; H | 2017 |
Effects of Obex in Overweight and Obese Subjects With or Without Impaired Fasting Glucose: A Pilot Study.
Topics: Adult; Anti-Obesity Agents; Blood Glucose; Blood Pressure; Body Mass Index; Cholesterol, HDL; Creati | 2017 |
Hyperuricemia as a Protective Factor for Mild Cognitive Impairment in Non-Obese Elderly.
Topics: Aged; C-Reactive Protein; Case-Control Studies; Cognitive Dysfunction; Female; Humans; Hyperuricemia | 2017 |
[The Preliminary Investigation of GLP-1 Receptor Agonist on Liver Steatosis in Obese Mice].
Topics: Animals; Diet, High-Fat; Exenatide; Fatty Liver; Glucagon-Like Peptide-1 Receptor; Insulin Resistanc | 2017 |
Indices of insulin resistance and glucotoxicity are not associated with bipolar disorder or major depressive disorder, but are differently associated with inflammatory, oxidative and nitrosative biomarkers.
Topics: Adult; Biomarkers; Bipolar Disorder; Blood Glucose; Body Mass Index; C-Reactive Protein; Cross-Secti | 2017 |
Dyslipidemia, Alcohol Consumption, and Obesity as Main Factors Associated With Poor Control of Urate Levels in Patients Receiving Urate-Lowering Therapy.
Topics: Aged; Alcohol Drinking; Comorbidity; Cross-Sectional Studies; Dyslipidemias; Female; France; Gout; G | 2018 |
Prevalence of hyperuricemia and its related risk factors among preschool children from China.
Topics: Child; Child, Preschool; China; Cross-Sectional Studies; Female; Humans; Hyperuricemia; Male; Obesit | 2017 |
Influence of weight status on 24-hour urine composition in adults without urolithiasis: A nationwide study based on a Chinese Han population.
Topics: Adult; Body Mass Index; Body Weight; Calcium; China; Citric Acid; Humans; Insulin Resistance; Logist | 2017 |
The Association of Uric Acid Calculi with Obesity, Prediabetes, Type 2 Diabetes Mellitus, and Hypertension.
Topics: Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Male; Middle Aged; Obesity; Prediabetic Sta | 2017 |
Serum Uric Acid Levels and the Risk of Obesity: a Longitudinal Population-Based Epidemiological Study.
Topics: Humans; Incidence; Longitudinal Studies; Obesity; Risk Factors; Uric Acid | 2017 |
Uric acid and obesity-related phenotypes in postmenopausal women.
Topics: Aged; Female; Humans; Middle Aged; Obesity; Phenotype; Polymorphism, Genetic; Postmenopause; PPAR ga | 2018 |
A comparative research on obesity hypertension by the comparisons and associations between waist circumference, body mass index with systolic and diastolic blood pressure, and the clinical laboratory data between four special Chinese adult groups.
Topics: Adult; Aged; Alanine Transaminase; Alkaline Phosphatase; Bilirubin; Blood Glucose; Blood Pressure; B | 2018 |
Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
Topics: Adolescent; Adult; Age Factors; Aged; Body Mass Index; Calcium; Calcium Oxalate; Calcium Phosphates; | 2017 |
Effects of experimental periodontitis on the metabolic system in rats with diet-induced obesity (DIO): an analysis of serum biochemical parameters.
Topics: Alanine Transaminase; Alveolar Bone Loss; Animals; Aspartate Aminotransferases; Biomarkers; Blood Gl | 2018 |
The potential impact of the hypovitaminosis D on metabolic complications in obese adolescents - Preliminary results.
Topics: Adolescent; Blood Pressure; Child; Female; Fibroblast Growth Factors; Humans; Male; Obesity; Poland; | 2017 |
[Comparative assessment of efficiency of the low-calorie diets modified by proteinaceous and vitamin cocktails].
Topics: Adult; Blood Glucose; Caloric Restriction; Cholesterol; Dietary Proteins; Female; Humans; Male; Midd | 2015 |
Clinical Significance of Serum Uric Acid Levels in Mexican Young Adults.
Topics: Adolescent; Adult; Cholesterol, LDL; Cross-Sectional Studies; Female; Glomerular Filtration Rate; Hu | 2018 |
Elevations of metabolic risk factors 20 years or more before diagnosis of type 2 diabetes: Experience from the AMORIS study.
Topics: Adult; Age Distribution; Biomarkers; Blood Glucose; Body Mass Index; Case-Control Studies; Diabetes | 2018 |
Body mass index is independently associated with xanthine oxidase activity in overweight/obese population.
Topics: Adult; Aged; Body Mass Index; C-Reactive Protein; Cross-Sectional Studies; Female; Humans; Inflammat | 2020 |
Temporal relationship between hyperuricemia and obesity, and its association with future risk of type 2 diabetes.
Topics: Adult; Aged; Body Mass Index; China; Diabetes Mellitus, Type 2; Female; Humans; Hyperuricemia; Longi | 2018 |
Shall we diagnose metabolic syndrome in adolescents?
Topics: Adolescent; Biomarkers; Blood Glucose; Body Mass Index; Cholesterol, HDL; Female; Humans; Insulin Re | 2018 |
Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Comorbidity; Dose-Response Relationship, Drug; Early | 2018 |
24-h urine metabolic profile: is it necessary in all kidney stone formers?
Topics: Adult; Aged; Body Mass Index; Calcium; Citric Acid; Comorbidity; Diabetes Mellitus; Female; Humans; | 2018 |
Is increased uric acid a risk factor or a defensive response? The Campania Salute Network.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Arterial Pressure; Biomarkers; | 2018 |
Untargeted Profiling of Concordant/Discordant Phenotypes of High Insulin Resistance and Obesity To Predict the Risk of Developing Diabetes.
Topics: Biomarkers; Diabetes Mellitus, Type 2; Diglycerides; Fatty Acids, Unsaturated; Humans; Insulin Resis | 2018 |
Uric acid is linked to cardiometabolic risk factors in overweight and obese youths.
Topics: Adolescent; Anthropometry; Blood Pressure; Blood Pressure Determination; Body Mass Index; Cardiovasc | 2018 |
Weight gain increases plasma levels of uric acid in adults in China.
Topics: Aged; Body Mass Index; China; Female; Humans; Male; Middle Aged; Obesity; Uric Acid; Weight Gain | 2019 |
Laparoscopic sleeve gastrectomy combined with single-anastomosis duodenal-jejunal bypass in the treatment of type 2 diabetes mellitus of patients with body mass index higher than 27.5 kg/m2 but lower than 32.5 kg/m2.
Topics: Adult; Bariatric Surgery; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Female; Humans; | 2018 |
Different Risk for Hypertension, Diabetes, Dyslipidemia, and Hyperuricemia According to Level of Body Mass Index in Japanese and American Subjects.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Blood Glucose; Blood Pressure; Body Mass Ind | 2018 |
Genetic association between adiposity and gout: a Mendelian randomization study.
Topics: Adiposity; Adult; Body Mass Index; Female; Gout; Humans; Male; Mendelian Randomization Analysis; Mid | 2018 |
Serum uric acid potentially links metabolic health to measures of fuel use in lean and obese individuals.
Topics: Adiposity; Adolescent; Adult; Biomarkers; Calorimetry, Indirect; Cross-Sectional Studies; Electric I | 2018 |
Prevalence of hyperuricemia and the relationship between serum uric acid and obesity: A study on Bangladeshi adults.
Topics: Adolescent; Adult; Bangladesh; Cross-Sectional Studies; Female; Humans; Hyperuricemia; Male; Middle | 2018 |
Association between Cardiac Remodeling and Metabolic Alteration in an Experimental Model of Obesity Induced by Western Diet.
Topics: Animals; Atrial Remodeling; Blood Glucose; Blood Pressure; Body Weight; Cardiovascular Diseases; Cho | 2018 |
[Clinical characteristics and prognosis of overweight and obese patients with pulmonary thromboembolism].
Topics: Aged; Aged, 80 and over; Body Mass Index; Humans; Male; Middle Aged; Obesity; Overweight; Prognosis; | 2018 |
Changes in Sex Hormones After Laparoscopic Sleeve Gastrectomy in Chinese Obese Men: a 12-Month Follow-Up.
Topics: Bariatric Surgery; China; Follow-Up Studies; Gastrectomy; Gonadal Steroid Hormones; Humans; Laparosc | 2019 |
Gender difference in the relationship between serum uric acid reduction and improvement in body fat distribution after laparoscopic sleeve gastrectomy in Chinese obese patients: a 6-month follow-up.
Topics: Adult; Asian People; Body Fat Distribution; Female; Gastrectomy; Humans; Laparoscopy; Male; Middle A | 2018 |
Obesity leads to distinct metabolomic signatures in follicular fluid of women undergoing in vitro fertilization.
Topics: Adolescent; Adult; Amino Acids; Antioxidants; Case-Control Studies; Female; Fertilization in Vitro; | 2019 |
Achievement of Target Serum Uric Acid Levels and Factors Associated with Therapeutic Failure among Japanese Men Treated for Hyperuricemia/Gout.
Topics: Adult; Aged; Anthropometry; Body Mass Index; Cross-Sectional Studies; Drug Monitoring; Dyslipidemias | 2019 |
Associations Between Serum Uric Acid Concentrations and Cardiometabolic Risk and Renal Injury in Obese and Overweight Children
Topics: Adolescent; Biomarkers; Body Mass Index; Cardiovascular Diseases; Child; Female; Follow-Up Studies; | 2019 |
Does weight loss affect the parameters that are metabolically related to cardiovascular diseases?
Topics: Adult; Aged; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Chi-Square Distribution; Ch | 2019 |
Pilot study: asymptomatic hyperuricemia patients with obesity and nonalcoholic fatty liver disease have increased risk of double contour sign.
Topics: Gout; Humans; Hyperuricemia; Non-alcoholic Fatty Liver Disease; Obesity; Pilot Projects; Ultrasonogr | 2020 |
[Metabolic complications and nutritional deficiencies related to excessive alcohol consumption].
Topics: Alcohol Drinking; Humans; Malnutrition; Nutritional Status; Obesity; Uric Acid | 2019 |
Association of obesity with chronic kidney disease in elderly patients with nonalcoholic fatty liver disease.
Topics: Age Factors; Aged; Biomarkers; Body Mass Index; Cross-Sectional Studies; Female; Humans; Kidney Func | 2019 |
Mediterranean diet intervention for patients with hyperuricemia: a pilot study.
Topics: Asymptomatic Diseases; Body Mass Index; Cholesterol, HDL; Cholesterol, LDL; Cohort Studies; Diet, Me | 2014 |
Nutrition in CKD: Songgaar | Burungaar.
Topics: Dietary Proteins; Humans; Interdisciplinary Communication; Obesity; Renal Insufficiency, Chronic; Ur | 2013 |
Association of uric acid with obesity and endothelial dysfunction in children and early adolescents.
Topics: Adolescent; Area Under Curve; Asian People; Biomarkers; Blood Pressure; Body Composition; Body Mass | 2013 |
Uric acid as a risk factor for cardiovascular disease and mortality in overweight/obese individuals.
Topics: Aged; Blood Glucose; Body Mass Index; Cardiovascular Diseases; Female; Humans; Male; Middle Aged; Ob | 2013 |
Effect of bariatric surgery on the inflammatory response to monosodium urate crystals: a prospective study.
Topics: Adult; Bariatric Surgery; Body Weight; Cells, Cultured; Cytokines; Female; Gout; Humans; Inflammatio | 2013 |
Body mass index, waist circumference, and waist-to-height ratio as predictors of cardiometabolic risk in childhood obesity depending on pubertal development.
Topics: Adolescent; Body Height; Body Mass Index; Cardiovascular Diseases; Child; Female; gamma-Glutamyltran | 2013 |
Serum uric acid and blood pressure in children at cardiovascular risk.
Topics: Adolescent; Age Factors; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Child; Cohort Stu | 2013 |
An association between body mass index and high-sensitivity C-reactive protein concentrations is influenced by age in community-dwelling persons.
Topics: Adiposity; Age Factors; Aged; Biomarkers; Blood Glucose; Body Mass Index; C-Reactive Protein; Choles | 2013 |
Uric acid secretion from adipose tissue and its increase in obesity.
Topics: 3T3-L1 Cells; Adipocytes; Adipose Tissue; Animals; Cell Hypoxia; Gene Knockdown Techniques; Male; Mi | 2013 |
Can obese stone formers follow dietary recommendations?
Topics: Adult; Body Mass Index; Citric Acid; Dietary Supplements; Female; Follow-Up Studies; Humans; Kidney | 2014 |
Components of the metabolic syndrome are negative predictors of weight loss in obese children with lifestyle intervention.
Topics: Adolescent; Blood Glucose; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Child; Female; | 2014 |
Effect of plasma uric acid on antioxidant capacity, oxidative stress, and insulin sensitivity in obese subjects.
Topics: Antioxidants; Female; Humans; Insulin Resistance; Male; Middle Aged; Obesity; Oxidative Stress; Uric | 2014 |
Gout in a 15-year-old boy with juvenile idiopathic arthritis: a case study.
Topics: Adolescent; Allopurinol; Ankle Joint; Arthritis, Gouty; Arthritis, Juvenile; Colchicine; Delayed Dia | 2014 |
Clinical investigation of metabolic syndrome in the female elderly occupational population.
Topics: Aged; Aged, 80 and over; Body Mass Index; Female; Humans; Metabolic Syndrome; Obesity; Prevalence; R | 2014 |
Overweight and obesity among low-income Muslim Uyghur women in far western China: correlations of body mass index with blood lipids and implications in preventive public health.
Topics: Adult; Aged; Apolipoproteins; Blood Glucose; Body Composition; Body Mass Index; Cardiovascular Disea | 2014 |
Serum uric acid as a risk predictor for erectile dysfunction.
Topics: Biomarkers; Cardiovascular Diseases; Case-Control Studies; Confidence Intervals; Erectile Dysfunctio | 2014 |
Association of butyrylcholinesterase with cardiometabolic risk factors among apparently healthy adults.
Topics: Adult; Biomarkers; Blood Glucose; Body Mass Index; Butyrylcholinesterase; Cross-Sectional Studies; D | 2014 |
Increased levels of serum γ-glutamyltransferase and uric acid on metabolic, hepatic and kidney parameters in subjects at high altitudes.
Topics: Adult; Aged; Altitude; Biomarkers; Dyslipidemias; Female; gamma-Glutamyltransferase; Hemoglobins; Hu | 2015 |
Elevated serum uric acid is associated with angiotensinogen in obese patients with untreated hypertension.
Topics: Adipose Tissue; Adult; Angiotensinogen; Body Mass Index; Case-Control Studies; China; Homeostasis; H | 2014 |
Hypertension and obesity: correlates with renin-angiotensin-aldosterone system and uric acid.
Topics: Angiotensinogen; Humans; Hypertension; Male; Obesity; Uric Acid | 2014 |
Serum uric acid does not predict incident metabolic syndrome in a population with high prevalence of obesity.
Topics: Aged; Body Composition; Body Mass Index; Cohort Studies; Female; Humans; Hypertension; Indians, Nort | 2014 |
High uric acid level associated with increased arterial stiffness in apparently healthy women.
Topics: Adult; Aged; Alcohol Drinking; Ankle Brachial Index; Anthropometry; Asymptomatic Diseases; Blood Glu | 2014 |
Comment on Fabbrini et al. Effect of plasma uric acid on antioxidant capacity, oxidative stress, and insulin sensitivity in obese subjects. Diabetes 2014;63:976-981.
Topics: Antioxidants; Female; Humans; Insulin Resistance; Male; Obesity; Oxidative Stress; Uric Acid | 2014 |
Response to Comment on Fabbrini et al. Effect of plasma uric acid on antioxidant capacity, oxidative stress, and insulin sensitivity in obese subjects. Diabetes 2014;63:976-981.
Topics: Antioxidants; Female; Humans; Insulin Resistance; Male; Obesity; Oxidative Stress; Uric Acid | 2014 |
Nontraditional risk factors for cardiovascular disease and visceral adiposity index among different body size phenotypes.
Topics: Adiposity; Adolescent; Adult; Aged; Apolipoprotein A-I; Apolipoproteins B; Body Mass Index; Cardiova | 2015 |
[Uric acid and factors of cardiometabolic risk in adolescents with arterial hypertension].
Topics: Adolescent; Blood Pressure Monitoring, Ambulatory; Body Mass Index; Glucose; Heart Diseases; Humans; | 2014 |
[Relationship between serum uric acid level and metabolic syndrome in Uygur children and adolescents with overweight or obesity].
Topics: Adolescent; Body Mass Index; Child; China; Female; Humans; Linear Models; Male; Metabolic Syndrome; | 2014 |
Correlation of serum lipids with uric acid and blood sugar in normal males.
Topics: Adult; Blood Glucose; Cholesterol; Coronary Artery Disease; Coronary Disease; Humans; Lipids; Longit | 1965 |
Does obesity or hyperuricemia influence lithogenic risk profile in children with urolithiasis?
Topics: Adolescent; Child; Electrolytes; Female; Humans; Hyperuricemia; Male; Obesity; Risk Factors; Uric Ac | 2015 |
Hyperuricemia in patients with chronic plaque psoriasis.
Topics: Adult; Body Mass Index; Female; Humans; Hypertension; Hyperuricemia; Italy; Male; Middle Aged; Obesi | 2014 |
Association of hyperuricemia with conventional cardiovascular risk factors in elderly patients.
Topics: Age Factors; Aged; Cardiovascular Diseases; Female; Humans; Hyperuricemia; Male; Metabolic Syndrome; | 2015 |
Elucidation of the etiology and characteristics of pink urine in young healthy subjects.
Topics: Adolescent; Angiotensinogen; Asian People; Blood Pressure; Body Mass Index; Color; Female; Humans; H | 2015 |
Endoscopic and histologic findings in a cohort of uric acid and calcium oxalate stone formers.
Topics: Aged; Biopsy; Calcium Oxalate; Case-Control Studies; Creatinine; Diabetes Mellitus; Endoscopy; Femal | 2015 |
Characteristics and management of gout patients in Europe: data from a large cohort of patients.
Topics: Adult; Allopurinol; Cohort Studies; Comorbidity; Cross-Sectional Studies; Europe; Febuxostat; Female | 2015 |
Association between hypouricemia and reduced kidney function: a cross-sectional population-based study in Japan.
Topics: Age Factors; Aged; Cross-Sectional Studies; Diabetes Mellitus; Female; Glomerular Filtration Rate; H | 2015 |
Serum uric acid concentrations and SLC2A9 genetic variation in Hispanic children: the Viva La Familia Study.
Topics: Adolescent; Biomarkers; Child; Cohort Studies; Genome-Wide Association Study; Glucose Transport Prot | 2015 |
The association of metabolic syndrome and its components with brachial-ankle pulse wave velocity in south China.
Topics: Adolescent; Adult; Aged; Ankle Brachial Index; Biomarkers; Blood Glucose; Blood Pressure; Cardiovasc | 2015 |
[Metabolic complications of obesity during adolescence, particularly regarding elevated uric acid levels].
Topics: Adolescent; Biomarkers; Blood Pressure; Body Mass Index; Case-Control Studies; Child; Cross-Sectiona | 2015 |
Association between serum uric acid levels and obesity among university students (China).
Topics: Adolescent; Body Mass Index; China; Cross-Sectional Studies; Female; Humans; Male; Obesity; Overweig | 2015 |
Post-streptococcal acute glomerulonephritis complicated by gouty arthritis: a case report.
Topics: Acute Disease; Arthritis, Gouty; Child; Complement C3; Glomerulonephritis; Humans; Male; Metatarsoph | 2015 |
Dyslipidaemia in overweight children and adolescents is associated with an increased risk of kidney stones.
Topics: Adolescent; Body Mass Index; Calcium; Case-Control Studies; Child; Child, Preschool; Citric Acid; Cr | 2015 |
Elevated uric acid and obesity-related cardiovascular disease risk factors among hypertensive youth.
Topics: Adolescent; Blood Pressure; Child; Child, Preschool; Cross-Sectional Studies; Echocardiography; Fema | 2015 |
Association between elevated serum alanine aminotransferase and cardiometabolic risk factors in rural Chinese population: a cross-sectional study.
Topics: Adult; Age Factors; Aged; Alanine Transaminase; Blood Pressure; Body Mass Index; Cardiovascular Dise | 2015 |
Adipose Tissues Characteristics of Normal, Obesity, and Type 2 Diabetes in Uygurs Population.
Topics: Adipose Tissue; Adult; Asian People; Blood Glucose; Blood Pressure; Body Composition; Body Mass Inde | 2015 |
Prevalence of hyperuricemia and its correlates in rural Northeast Chinese population: from lifestyle risk factors to metabolic comorbidities.
Topics: Adult; Aged; Aged, 80 and over; China; Comorbidity; Dyslipidemias; Female; Humans; Hypertension; Hyp | 2016 |
Relationship Between Hyperuricemia and Cardiovascular Disease Risk Factors in a Chinese Population: A Cross-Sectional Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alcohol Drinking; Blood Glucose; Blood Pressure; Body Ma | 2015 |
Body mass index modulates the relationship of sugar-sweetened beverage intake with serum urate concentrations and gout.
Topics: Adult; Aged; Analysis of Variance; Beverages; Body Mass Index; Cross-Sectional Studies; Female; Fruc | 2015 |
Uric acid, carotid intima-media thickness and body composition in prepubertal children.
Topics: Biomarkers; Blood Pressure; Body Composition; Body Mass Index; C-Reactive Protein; Cardiovascular Di | 2016 |
Urinary Malondialdehyde Is Associated with Visceral Abdominal Obesity in Middle-Aged Men.
Topics: Adult; Anthropometry; Biomarkers; Body Mass Index; C-Reactive Protein; Cross-Sectional Studies; gamm | 2015 |
Vitamin D Status and Bone Mineral Density in Obese Children with Nonalcoholic Fatty Liver Disease.
Topics: Adolescent; Adult; Body Composition; Bone Density; C-Reactive Protein; Child; Female; Humans; Insuli | 2015 |
Association of ABCG2 rs2231142-A allele and serum uric acid levels in male and obese individuals in a Han Taiwanese population.
Topics: Adult; Alleles; ATP Binding Cassette Transporter, Subfamily G, Member 2; Female; Genetic Predisposit | 2017 |
Results of a course based obesity intervention program during work.
Topics: Adult; Blood Pressure; Body Mass Index; Body Weight; Cholesterol; Exercise Tolerance; Female; German | 2015 |
[The study of the association of polymorphism rs5219 gene KCNJ11 with obesity and the risk of type 2 diabetes among residents of the Moscow Region].
Topics: Body Mass Index; Diabetes Mellitus, Type 2; DNA; Energy Metabolism; Female; Gene Frequency; Genotype | 2015 |
Weight Loss, Xanthine Oxidase, and Serum Urate Levels: A Prospective Longitudinal Study of Obese Patients.
Topics: Adult; Bariatric Surgery; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hyperuricemia; Longitud | 2016 |
A Body Shape Index and Body Roundness Index: Two new body indices for detecting association between obesity and hyperuricemia in rural area of China.
Topics: Adult; Aged; Body Mass Index; China; Cross-Sectional Studies; Female; Humans; Hyperuricemia; Logisti | 2016 |
Insulin resistance, body composition, and fat distribution in obese children with nonalcoholic fatty liver disease.
Topics: Abdominal Fat; Absorptiometry, Photon; Adolescent; Alanine Transaminase; Aspartate Aminotransferases | 2016 |
Gender differences for uric acid as predictor of hard events in patients referred for coronary angiography.
Topics: Age Factors; Aged; Aged, 80 and over; Coronary Angiography; Female; Glomerular Filtration Rate; Huma | 2016 |
Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Body Mass Index; China; Cholesterol, HDL; Cholesterol, LDL; | 2016 |
Metabolically healthy obesity also has risk for hyperuricemia among Chinese general population: A cross-sectional study.
Topics: Adult; Aged; Body Mass Index; China; Cross-Sectional Studies; Female; Health Status; Humans; Hyperur | 2016 |
[Association between serum direct bilirubin with metabolic syndrome and its components based on a longitudinal health check-up study].
Topics: Adult; Bilirubin; Biomarkers; Cohort Studies; Female; gamma-Glutamyltransferase; Humans; Longitudina | 2016 |
An Invert U-Shaped Curve: Relationship Between Fasting Plasma Glucose and Serum Uric Acid Concentration in a Large Health Check-Up Population in China.
Topics: Adolescent; Adult; Age Distribution; Age Factors; Aged; Aged, 80 and over; Alcohol Drinking; Biomark | 2016 |
Obesity and Age-Related Changes in Markers of Oxidative Stress and Inflammation Across Four Generations.
Topics: Adult; Aged; Aging; Biomarkers; Blood Pressure; Body Mass Index; C-Reactive Protein; Cholesterol, HD | 2016 |
Overweight modifies the longitudinal association between uric acid and some components of the metabolic syndrome: The Tromsø Study.
Topics: Aged; Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; Chi-Square Distribution; Female; H | 2016 |
An observational study of sequential protein-sparing, very low-calorie ketogenic diet (Oloproteic diet) and hypocaloric Mediterranean-like diet for the treatment of obesity.
Topics: Adult; Blood Glucose; Blood Urea Nitrogen; Caloric Restriction; Cardiovascular Diseases; Creatinine; | 2016 |
Independent Link Between Levels of Proprotein Convertase Subtilisin/Kexin Type 9 and FABP4 in a General Population Without Medication.
Topics: Age Factors; Aged; Alanine Transaminase; Aspartate Aminotransferases; Blood Urea Nitrogen; C-Reactiv | 2016 |
Risk factor compositions of nonalcoholic fatty liver disease change with body mass index in males and females.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Blood Glucose; Body Mass Index; Cholestero | 2016 |
Low insulin-like growth factor 1 is associated with low high-density lipoprotein cholesterol and metabolic syndrome in Chinese nondiabetic obese children and adolescents: a cross-sectional study.
Topics: Adolescent; Alanine Transaminase; Blood Glucose; Body Mass Index; Case-Control Studies; Child; Chole | 2016 |
Nociceptive Alteration by High Sucrose Diet in Hypoestrogenic Wistar Rats.
Topics: Animals; Blood Glucose; Body Weight; Dietary Sucrose; Estrogens; Female; Glucose Tolerance Test; Ins | 2016 |
The Impact of Blood Pressure and Visceral Adiposity on the Association of Serum Uric Acid With Albuminuria in Adults Without Full Metabolic Syndrome.
Topics: Adiposity; Adult; Albuminuria; Biomarkers; Blood Pressure; Chi-Square Distribution; Creatinine; Cros | 2016 |
Do Overweight and Obese Pediatric Stone Formers Have Differences in Metabolic Abnormalities Compared With Normal-weight Stone Formers?
Topics: Adolescent; Biomarkers; Body Mass Index; Child; Creatinine; Female; Follow-Up Studies; Humans; Kidne | 2017 |
Teneligliptin Decreases Uric Acid Levels by Reducing Xanthine Dehydrogenase Expression in White Adipose Tissue of Male Wistar Rats.
Topics: 3T3-L1 Cells; Adipocytes; Adipose Tissue, White; Animals; Diet, High-Fat; Dipeptidyl-Peptidase IV In | 2016 |
Correlation of the leucocyte count with traditional and non-traditional components of metabolic syndrome.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Blood Pressure; China; Female; Fibrinogen; Humans; Hy | 2016 |
Associations of VCAM-1 gene polymorphisms with obesity and inflammation markers.
Topics: Adult; Asian People; C-Reactive Protein; Female; Gene Frequency; Genetic Predisposition to Disease; | 2017 |
Serum uric acid is independently and linearly associated with risk of nonalcoholic fatty liver disease in obese Chinese adults.
Topics: Aged; Biomarkers; China; Disease Susceptibility; Female; Humans; Insulin Resistance; Life Style; Mal | 2016 |
Serum uric acid levels are associated with obesity but not cardio-cerebrovascular events in Chinese inpatients with type 2 diabetes.
Topics: Asian People; Cardiovascular Diseases; Cerebrovascular Disorders; China; Cross-Sectional Studies; Di | 2017 |
Effects of bariatric surgery on gout incidence in the Swedish Obese Subjects study: a non-randomised, prospective, controlled intervention trial.
Topics: Adult; Bariatric Surgery; Body Mass Index; Case-Control Studies; Controlled Clinical Trials as Topic | 2017 |
Oxidative Stress Participates in the Associations Between Serum Uric Acid and Albuminuria in the Obesity.
Topics: Adiposity; Adult; Albuminuria; Blood Pressure; Humans; Metabolic Syndrome; Obesity; Oxidative Stress | 2017 |
Response to Letter to the Editor entitled Oxidative Stress Participates in the Associations Between Serum Uric Acid and Albuminuria in Obesity.
Topics: Adiposity; Adult; Albuminuria; Blood Pressure; Humans; Metabolic Syndrome; Obesity; Oxidative Stress | 2017 |
Serum uric acid and the relationship with subclinical organ damage in adults.
Topics: Adult; Biomarkers; Cardiovascular Diseases; Cholesterol; Female; Humans; Male; Obesity; Triglyceride | 2017 |
Effects of exercise and serum uric acid on the metabolic syndrome for Japanese workers.
Topics: Adult; Blood Glucose; Blood Pressure; Cholesterol, HDL; Exercise; Humans; Japan; Male; Metabolic Syn | 2008 |
Serum uric acid and its association with metabolic syndrome and carotid atherosclerosis in obese children.
Topics: Alanine Transaminase; Blood Glucose; Blood Pressure; Carotid Artery Diseases; Child; Cholesterol; Co | 2009 |
Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers.
Topics: Adult; Calcium; Citric Acid; Creatinine; Female; Humans; Hydrogen-Ion Concentration; Magnesium; Male | 2008 |
Analysis of the relationship of leptin, high-sensitivity C-reactive protein, adiponectin, insulin, and uric acid to metabolic syndrome in lean, overweight, and obese young females.
Topics: Adiponectin; Adolescent; Adult; Biomarkers; Body Mass Index; C-Reactive Protein; Cross-Sectional Stu | 2009 |
Hyperuricemia and its related factors in an urban population, Izmir, Turkey.
Topics: Adult; Blood Glucose; Body Composition; Creatinine; Diabetes Mellitus; Female; Gout; Humans; Hyperte | 2009 |
The effect of the interaction between obesity and drinking on hyperuricemia in Japanese male office workers.
Topics: Adult; Aged; Alcohol Drinking; Biomarkers; Body Mass Index; Case-Control Studies; Cross-Sectional St | 2009 |
Local factors compared with systemic factors in the formation of bladder uric acid stones.
Topics: Adult; Aged; Aged, 80 and over; Creatinine; Diabetes Complications; Female; Humans; Hydrogen-Ion Con | 2009 |
Use of waist circumference and ultrasonographic assessment of abdominal fat distribution in predicting metabolic risk factors in healthy Japanese adults.
Topics: Abdominal Fat; Adult; Aged; Asian People; Blood Glucose; Female; Humans; Hypertension; Lipids; Male; | 2009 |
Insulin resistance acts as an independent risk factor exacerbating high-purine diet induced renal injury and knee joint gouty lesions.
Topics: Animals; Diabetes Mellitus, Type 2; Disease Models, Animal; Gout; Homeostasis; Hyperuricemia; Hypogl | 2009 |
Gender-dependent impacts of body mass index and moderate alcohol consumption on serum uric acid--an index of oxidant stress status?
Topics: Adult; Aged; Alcohol Drinking; Body Mass Index; Cell Survival; Female; Hepatocytes; Humans; Male; Mi | 2009 |
Sex-dependent associations of leptin with metabolic syndrome-related variables: the Stanislas study.
Topics: Adiposity; Adult; Analysis of Variance; Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; | 2010 |
Oral glucose tolerance test in Italian overweight/obese children and adolescents results in a very high prevalence of impaired fasting glycaemia, but not of diabetes.
Topics: Adolescent; Aging; Blood Glucose; Body Mass Index; Child; Cohort Studies; Diabetes Mellitus, Type 1; | 2009 |
[Peculiarities of uric acid balance disorders in patients with type 2 diabetes and metabolic syndrome].
Topics: Abdominal Fat; Aged; Diabetes Insipidus, Nephrogenic; Female; Humans; Hyperuricemia; Insulin Resista | 2009 |
Serum urate levels in different regions of the Chinese subcontinent and their possible relationship to gross domestic product per capita, predominance of sedentary occupations, and prevalence of obesity.
Topics: China; Gross Domestic Product; Humans; Obesity; Occupations; Prevalence; Sedentary Behavior; Taiwan; | 2010 |
Serum glycated albumin, but not glycated haemoglobin, is low in relation to glycemia in hyperuricemic men.
Topics: Blood Glucose; Blood Pressure; Body Mass Index; C-Reactive Protein; Glucose Tolerance Test; Glycated | 2010 |
Hyperuricemia, cardiovascular disease, and the metabolic syndrome.
Topics: Angiotensin II; Cardiovascular Diseases; Humans; Hypertension; Hyperuricemia; Metabolic Syndrome; Ob | 2009 |
Incidence of Type 2 diabetes in the elderly German population and the effect of clinical and lifestyle risk factors: KORA S4/F4 cohort study.
Topics: Aged; Blood Glucose; Blood Pressure; Cohort Studies; Diabetes Mellitus, Type 2; Female; Germany; Glu | 2009 |
Hypomagnesaemia is associated with diabetes: Not pre-diabetes, obesity or the metabolic syndrome.
Topics: Adult; Aged; Australia; Creatinine; Diabetes Mellitus; Female; Health Status; Humans; Magnesium; Mag | 2010 |
Changes in waist circumference and body mass index in relation to changes in serum uric acid in Japanese individuals.
Topics: Asian People; Body Mass Index; Female; Humans; Japan; Lipids; Male; Obesity; Odds Ratio; Patient Sel | 2010 |
Angiotensin-converting enzyme gene polymorphism in overweight and obese Turkish patients with insulin resistance.
Topics: Adipose Tissue; Adult; Blood Glucose; Blood Pressure; Body Mass Index; Diabetes Mellitus, Type 2; Fe | 2010 |
Factor analysis of metabolic syndrome components in the Coronary Artery Risk Development in Young Adults (CARDIA) study: examination of factors by race-sex groups and across time.
Topics: Adolescent; Adult; Black or African American; Blood Glucose; Body Mass Index; Cholesterol; Coronary | 2010 |
The prevalence of microalbuminuria and its relationships with the components of metabolic syndrome in the general population of China.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Albuminuria; Blood Glucose; Blood Pressure; | 2010 |
Uric acid excretion in North American and Southeast European children with obstructive sleep apnea.
Topics: Child; Child, Preschool; Environmental Exposure; Female; Greece; Humans; Hypoxia; Linear Models; Mal | 2010 |
Diabese youngsters have 3.7 more chances in developing metabolic syndrome compared with the obese.
Topics: Adolescent; Child; Child, Preschool; Diabetes Complications; Female; Humans; Hypertension; Male; Met | 2010 |
Association between serum uric acid levels and cardiometabolic risk factors among Japanese junior high school students.
Topics: Adolescent; Asian People; Dyslipidemias; Female; Heart Diseases; Humans; Hypertension; Male; Metabol | 2010 |
Substance P is associated with the development of obesity, chronic inflammation and type 2 diabetes mellitus.
Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; C-Reactive Protein; Cholesterol; Diabetes Mellitus, | 2011 |
Theodore E. Woodward award. The evolution of obesity: insights from the mid-Miocene.
Topics: Animals; Ascorbic Acid; Awards and Prizes; Biological Evolution; Birds; Diet; Fructose; History, Anc | 2010 |
Differential relationships between anthropometry measures and cardiovascular risk factors in boys and girls.
Topics: Adolescent; Age Factors; Analysis of Variance; Anthropometry; Biomarkers; Blood Pressure; Body Heigh | 2011 |
Theory is acid test for fructose's blood pressure role.
Topics: Adipose Tissue; Beverages; Blood Pressure; Carbonated Beverages; Fructose; Fruit; Glucose; Humans; I | 2010 |
Gender-specific association of serum uric acid with metabolic syndrome and its components in juvenile obesity.
Topics: Adolescent; Child; Child, Preschool; Female; Humans; Male; Metabolic Syndrome; Obesity; Poland; Risk | 2011 |
Cystatin C, cardiometabolic risk, and body composition in severely obese children.
Topics: Adolescent; Alanine Transaminase; Analysis of Variance; Blood Glucose; Blood Pressure; Body Composit | 2011 |
Interaction between serum uric acid and triglycerides in relation to blood pressure.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Biomarkers; Blood Glucose; Blood Pressure; Bod | 2011 |
Factors associated with early atherosclerosis and arterial calcifications in young subjects with a benign phenotype of obesity.
Topics: Adiponectin; Adolescent; Atherosclerosis; Biomarkers; Calcium; Carotid Arteries; Child; Cholesterol, | 2011 |
The effect of a one-year weight reduction program on serum uric acid in overweight/obese children and adolescents.
Topics: Adolescent; Age Factors; Child; Diet; Exercise; Female; Humans; Male; Metformin; Obesity; Sex Factor | 2011 |
Nitric oxide production is increased in severely obese children and related to markers of oxidative stress and inflammation.
Topics: Adolescent; Biomarkers; Child; Female; Humans; Inflammation; Insulin Resistance; Male; Nitrates; Nit | 2011 |
Prehypertension and cardiovascular risk factors in adults enrolled in a primary care programme.
Topics: Adult; Alcohol Drinking; Biomarkers; Body Mass Index; Brazil; Cardiovascular Diseases; Cross-Section | 2011 |
Which anthropometric parameter is best related with urinary albumin excretion and creatinine clearance in type 2 diabetes: body mass index, waist circumference, waist-to-hip ratio, or conicity index?
Topics: Aged; Albumins; Blood Pressure; Body Mass Index; Creatinine; Cross-Sectional Studies; Diabetes Melli | 2011 |
Immunological and biochemical parameters of patients with metabolic syndrome and the participation of oxidative and nitroactive stress.
Topics: Adiponectin; Adult; Antioxidants; Biomarkers; Body Mass Index; C-Reactive Protein; Case-Control Stud | 2011 |
Gender-specific risk factors for incident gout: a prospective cohort study.
Topics: Adult; Comorbidity; Female; Follow-Up Studies; Gout; Humans; Hyperlipidemias; Hypertension; Incidenc | 2012 |
Inflammatory biomarkers and oxidative stress measurements in patients with systemic lupus erythematosus with or without metabolic syndrome.
Topics: Acute-Phase Proteins; Adult; Biomarkers; C-Reactive Protein; Comorbidity; Female; Humans; Inflammati | 2011 |
Weight loss and sleep-disordered breathing in childhood obesity: effects on inflammation and uric acid.
Topics: Adenoidectomy; Adolescent; Belgium; Biomarkers; Child; Female; Follow-Up Studies; Humans; Inflammati | 2012 |
Influence of physical activity intensity and aerobic fitness on the anthropometric index and serum uric acid concentration in people with obesity.
Topics: Adult; Age Factors; Alcohol Drinking; Anthropometry; Body Mass Index; Exercise; Humans; Hyperuricemi | 2011 |
Uric acid: a danger signal from the RNA world that may have a role in the epidemic of obesity, metabolic syndrome, and cardiorenal disease: evolutionary considerations.
Topics: Animals; Biological Evolution; Cardio-Renal Syndrome; Humans; Metabolic Syndrome; Mutation; Obesity; | 2011 |
Investigation on hyperuricemia in children with obesity or various pediatric disorders.
Topics: Adolescent; Age Distribution; Child; Child, Preschool; Female; Humans; Hyperuricemia; Infant; Japan; | 2011 |
Markers of systemic inflammation in children with hyperuricemia.
Topics: Adolescent; Biomarkers; C-Reactive Protein; Chemokine CCL2; Child; Cross-Sectional Studies; Female; | 2012 |
Pepsinogen I/II ratio is related to glucose, triacylglycerol, and uric acid levels.
Topics: Adult; Age Factors; Aged; Alcohol Drinking; Biomarkers; Blood Glucose; Body Mass Index; Cholinestera | 2012 |
Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cohort Studies; Confounding Factors, Epidemiologic; Cros | 2012 |
Association between gout and polymorphisms in GCKR in male Han Chinese.
Topics: Adaptor Proteins, Signal Transducing; Asian People; Blood Glucose; Case-Control Studies; China; Chol | 2012 |
Association of serum uric acid with body mass index among long-lived Chinese.
Topics: Aged, 80 and over; Anthropometry; Blood Glucose; Blood Pressure; Body Mass Index; Female; Humans; Hy | 2012 |
Plasma total antioxidant capacity is associated with dietary intake and plasma level of antioxidants in postmenopausal women.
Topics: Adult; Aged; Anthocyanins; Antioxidants; beta Carotene; Blood Chemical Analysis; Cross-Sectional Stu | 2012 |
Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance.
Topics: Adult; Aged; Blood Glucose; Body Composition; Cholera Toxin; Glucose Tolerance Test; Haptoglobins; H | 2012 |
[The Trp64Arg polymorphism of beta3-adrenoreceptor gene study in persons with overweight and obesity].
Topics: Adult; Aged; Aged, 80 and over; Arginine; Blood Glucose; Body Mass Index; Body Weight; Female; Gene | 2012 |
Metabolic syndrome and urinary stone composition: what factors matter most?
Topics: Adult; Aged; Calcium Oxalate; Calcium Phosphates; Diabetes Complications; Dyslipidemias; Female; Hum | 2012 |
Pathological and behavioral risk factors for higher serum C-reactive protein concentrations in free-living adults--a Brazilian community-based study.
Topics: Abdominal Fat; Adult; Aged; Aged, 80 and over; Anthropometry; Blood Glucose; Body Mass Index; Brazil | 2013 |
Relation of uric acid to serum levels of high-sensitivity C-reactive protein, triglycerides, and high-density lipoprotein cholesterol and to hepatic steatosis.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Cholesterol, HDL; Fatty Liver; Femal | 2012 |
Hyperuricemia and hypertension: a confluence of concepts.
Topics: Blood Pressure; Female; Humans; Male; Obesity; Prehypertension; Uric Acid | 2012 |
Association between WHO cut-offs for childhood overweight and obesity and cardiometabolic risk.
Topics: Adolescent; Blood Glucose; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Child; Choleste | 2013 |
Hyperferritinemia and hyperuricemia may be associated with liver function abnormality in obese adolescents.
Topics: Adolescent; Alanine Transaminase; Body Mass Index; Ferritins; Humans; Hyperuricemia; Leukocyte Count | 2012 |
Plasma uric acid is associated with increased risk of type 2 diabetes independent of diet and metabolic risk factors.
Topics: Adiposity; Aged; Body Mass Index; Case-Control Studies; Cohort Studies; Diabetes Mellitus, Type 2; D | 2013 |
Management of gout: a 57-year-old man with a history of podagra, hyperuricemia, and mild renal insufficiency.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Colchicine; Gout | 2012 |
Associations of uric acid and gamma-glutamyltransferase (GGT) with obesity and components of metabolic syndrome in children and adolescents.
Topics: Adolescent; Biomarkers; Body Mass Index; Cardiovascular Diseases; Child; Cross-Sectional Studies; Fe | 2013 |
Changes in uric acid levels following bariatric surgery are not associated with SLC2A9 variants in the Swedish Obese Subjects Study.
Topics: Adult; Bariatric Surgery; Cross-Sectional Studies; Female; Follow-Up Studies; Genotype; Glucose Tran | 2012 |
Serum uric acid is associated with dietary and lifestyle factors in elderly women in suburban Guangzhou in Guangdong province of south China.
Topics: Aged; Aged, 80 and over; Alcohol Drinking; Animals; Anthropometry; China; Cholesterol, HDL; Choleste | 2013 |
Effect of BMI and urinary pH on urolithiasis and its composition.
Topics: Adult; Body Mass Index; Calcium Oxalate; Calcium Phosphates; Female; Humans; Hydrogen-Ion Concentrat | 2013 |
Uric acid best predicts metabolically unhealthy obesity with increased cardiovascular risk in youth and adults.
Topics: Adiponectin; Adiposity; Adolescent; Adult; Age Factors; Cardiovascular Diseases; Case-Control Studie | 2013 |
Uric acid best predicts metabolically unhealthy obesity with increased cardiovascular risk in youth and adults.
Topics: Adiponectin; Adiposity; Adolescent; Adult; Age Factors; Cardiovascular Diseases; Case-Control Studie | 2013 |
Uric acid best predicts metabolically unhealthy obesity with increased cardiovascular risk in youth and adults.
Topics: Adiponectin; Adiposity; Adolescent; Adult; Age Factors; Cardiovascular Diseases; Case-Control Studie | 2013 |
Uric acid best predicts metabolically unhealthy obesity with increased cardiovascular risk in youth and adults.
Topics: Adiponectin; Adiposity; Adolescent; Adult; Age Factors; Cardiovascular Diseases; Case-Control Studie | 2013 |
Decreases in serum uric acid by amelioration of insulin resistance in overweight hypertensive patients: effect of a low-energy diet and an insulin-sensitizing agent.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Blood Pressure; Body Weight; Caloric Restriction; Chroma | 2002 |
Leptin and metabolic syndrome in obese and non-obese children.
Topics: Blood Glucose; Blood Pressure; Body Height; Body Weight; Child; Cholesterol, HDL; Factor Analysis, S | 2002 |
[Influence of over-weight and obesity on blood pressure, blood sugar, lipid and uric acid in elderly people].
Topics: Aged; Aged, 80 and over; Blood Glucose; Blood Pressure; Body Weight; Cholesterol; Female; Humans; Li | 2000 |
The metabolic syndrome in black hypertensive women--waist circumference more strongly related than body mass index.
Topics: Black People; Blood Glucose; Body Constitution; Body Mass Index; Cholesterol, HDL; Cross-Sectional S | 2002 |
Comparison of three-dimensional anthropometric body surface scanning to waist-hip ratio and body mass index in correlation with metabolic risk factors.
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Blood Glucose; Blood Pressure; Body Composition; B | 2002 |
Plasma adiponectin levels in overweight and obese Asians.
Topics: Adiponectin; Blood Glucose; Blood Pressure; Body Constitution; Body Mass Index; Cholesterol, HDL; Fa | 2002 |
Prevalence and concomitants of glucose intolerance in European obese children and adolescents.
Topics: Adolescent; Birth Weight; Blood Glucose; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases | 2003 |
Nephrolithiasis in Cushing's disease: prevalence, etiopathogenesis, and modification after disease cure.
Topics: Adult; Analysis of Variance; Body Mass Index; Calcium; Citric Acid; Cushing Syndrome; Cystine; Cysti | 2003 |
Hyperuricemia in childhood primary hypertension.
Topics: Adolescent; Analysis of Variance; Blood Pressure; Body Mass Index; Child; Diastole; Female; Glomerul | 2003 |
Leptin might be a regulator of serum uric acid concentrations in humans.
Topics: Adult; Body Mass Index; Cholesterol; Cross-Sectional Studies; Female; Humans; Hypertension; Hyperuri | 2003 |
Prevalence of obesity in an elderly Hungarian population.
Topics: Age Distribution; Aged; Aged, 80 and over; Blood Glucose; Body Mass Index; Case-Control Studies; Com | 2003 |
Testosterone levels in obese male patients with obstructive sleep apnea syndrome: relation to oxygen desaturation, body weight, fat distribution and the metabolic parameters.
Topics: Adipose Tissue; Adult; Anthropometry; Arteries; Body Weight; Cholesterol, HDL; Gonadal Steroid Hormo | 2003 |
Decrease in serum adiponectin level due to obesity and visceral fat accumulation in children.
Topics: Adiponectin; Adipose Tissue; Adolescent; Alanine Transaminase; Anthropometry; Apolipoproteins; Body | 2003 |
HYPERURICEMIA DURING TOTAL FASTING: RENAL FACTORS.
Topics: Blood; Fasting; Humans; Hyperuricemia; Kidney; Kidney Function Tests; Metabolism; Obesity; Uric Acid | 1963 |
[THE LIPIDS AND RHEUMATIC DISEASES. PRELIMINARY NOTE].
Topics: Arthritis, Rheumatoid; Cholesterol; Gout; Humans; Lipid Metabolism; Lipids; Obesity; Phospholipids; | 1963 |
[CLINICAL CONTRIBUTION TO THE STUDY OF A NEW SYNTHETIC ANTICHOLESTEREMIC AGENT: BETA-BENZALBUTYRRAMIDE].
Topics: Amides; Anticholesteremic Agents; Arthritis; Arthritis, Rheumatoid; Asthma; Butyrates; Cholelithiasi | 1963 |
METABOLIC MALADIES IN NEW ZEALAND MAORIS.
Topics: Adolescent; Anthropometry; Blood Chemical Analysis; Cholesterol; Coronary Disease; Epidemiology; Eth | 1964 |
URIC ACID EXCRETION IN OBESE SUBJECTS DURING PERIODS OF TOTAL FASTING.
Topics: Acidosis; Basal Metabolism; Blood Glucose; Fasting; Glycine; Humans; Obesity; Pennsylvania; Probenec | 1964 |
A COMPARATIVE STUDY OF THE DIURETICS CHLORTHALIDONUM AND CYCLOPENTHIAZIDUM.
Topics: Benzothiadiazines; Bicarbonates; Biomedical Research; Blood; Chlorides; Chlorthalidone; Diet, Sodium | 1964 |
O-P'DDD THERAPY IN CUSHING'S SYNDROME AND IN OBESITY WITH CUSHINGOID CHANGES.
Topics: Adrenocorticotropic Hormone; Blood Chemical Analysis; Carbohydrate Metabolism; Child; Cushing Syndro | 1964 |
METABOLIC STUDIES IN PROLONGED FASTING. II. ORGANIC METABOLISM.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Alkaline Phosphatase; Aspartate Aminotransferases; Blood | 1965 |
HYPERURICEMIA IN STARVATION.
Topics: Biomedical Research; Blood; Creatine; Creatinine; Hyperuricemia; Kidney Function Tests; Kidney Tubul | 1965 |
SOME HAZARDS OF TOTAL FASTS IN THE CONTROL OF OBESITY AND DIABETES AND THEIR PREVENTION.
Topics: Anemia; Atrial Flutter; Blood; Diabetes Mellitus; Diet, Reducing; Fasting; Fatigue; Gout; Humans; Ne | 1964 |
[OVER-EXERTION AND METABOLIC DISORDERS].
Topics: Balneology; Blood; Catalase; Fatigue; Humans; Hyperlipidemias; Hypertension; Liver; Metabolic Diseas | 1965 |
Serum uric acid levels in obese children and adolescents: linkage to testosterone levels and pre-metabolic syndrome.
Topics: Adolescent; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Child; Cholesterol, HDL; Cohor | 2003 |
The role of overweight and obesity in calcium oxalate stone formation.
Topics: Adult; Body Mass Index; Calcium; Calcium Oxalate; Citric Acid; Creatinine; Diet; Female; Humans; Hyd | 2004 |
Clustering of components of the metabolic syndrome and risk for development of type 2 diabetes in Japanese male office workers.
Topics: Adult; Analysis of Variance; Blood Glucose; Body Mass Index; Cholesterol, LDL; Cluster Analysis; Dia | 2004 |
Selected risk factors of ischemic heart disease in Polish seafarers. Preliminary report.
Topics: Adult; Age Distribution; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Me | 2003 |
Recent trends of hyperuricemia and obesity in Japanese male adolescents, 1991 through 2002.
Topics: Adolescent; Adult; Alanine Transaminase; Body Mass Index; Cholesterol; Humans; Hypertension; Hyperur | 2004 |
Family-based associations between the angiotensin- converting enzyme insertion/deletion polymorphism and multiple cardiovascular risk factors in Chinese.
Topics: Adult; Aged; Asian People; Blood Glucose; Blood Pressure; Body Mass Index; Creatinine; Family Health | 2004 |
Relationship between visceral fat accumulation and physical fitness in Japanese women.
Topics: Abdomen; Adipose Tissue; Anaerobic Threshold; Asian People; Aspartate Aminotransferases; Body Compos | 2004 |
Hypertension was the major risk factor leading to development of cardiovascular diseases among men with hyperuricemia.
Topics: Adult; Arrhythmias, Cardiac; Arteriosclerosis; Female; Follow-Up Studies; Humans; Hypertension; Hype | 2004 |
Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Calcium; Comorbidity; Female; Humans; Kidney Calculi; Ma | 2004 |
[Insulin resistance syndrome in patients with gout and its influence on formation of clinical characteristics of the disease].
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Gout; Humans; | 2004 |
Use of single-dose rasburicase in an obese female.
Topics: Allopurinol; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Leukemia, Myelogen | 2004 |
Obesity and the metabolic syndrome in children and adolescents.
Topics: Adolescent; Biomarkers; C-Reactive Protein; Child; Humans; Metabolic Syndrome; Obesity; Uric Acid | 2004 |
Insulin sensitivity and hepatic steatosis in obese subjects with normal glucose tolerance.
Topics: Adult; Alanine Transaminase; Blood Glucose; Body Mass Index; Cholesterol; Cohort Studies; Fatty Live | 2004 |
Application of three-dimensional body scanner: observation of prevalence of metabolic syndrome.
Topics: Adult; Aged; Aged, 80 and over; Anthropometry; Blood Glucose; Body Composition; Body Constitution; B | 2004 |
Disturbances in renal autoregulation and the susceptibility to hypertension-induced chronic kidney disease.
Topics: Aging; Animals; Diabetes Mellitus; Disease Models, Animal; Endothelium, Vascular; Fetal Growth Retar | 2004 |
[Arterial hypertension in adolescents with different physical constitution including those with signs of metabolic syndrome].
Topics: Adolescent; Body Mass Index; Body Weights and Measures; Child; Cholesterol; Female; Glucose Toleranc | 2004 |
Gender-specific leptinemia and its relationship with some components of the metabolic syndrome in Moroccans.
Topics: Aged; Blood Glucose; Blood Pressure; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 2; Female; | 2005 |
Components of the metabolic syndrome and risk for first-ever acute ischemic nonembolic stroke in elderly subjects.
Topics: Aged; Apolipoprotein A-I; Brain Ischemia; Case-Control Studies; Cholesterol; Cholesterol, HDL; Diabe | 2005 |
Relationships between human serum resistin, inflammatory markers and insulin resistance.
Topics: Biomarkers; Blood Glucose; Body Composition; Body Mass Index; C-Reactive Protein; Case-Control Studi | 2005 |
[Characteristics of metabolic syndrome in children and adolescents with arterial hypertension].
Topics: Adolescent; Body Mass Index; Child; Cholesterol, HDL; Cholesterol, LDL; Female; Glucose Intolerance; | 2005 |
The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison.
Topics: Adolescent; Adult; Body Mass Index; Body Size; Cardiovascular Diseases; Female; Heart Rate; Humans; | 2005 |
Associations among sex hormone binding globulin concentrations and characteristics of the metabolic syndrome in obese women.
Topics: Adult; Age Factors; Androstenedione; Blood Glucose; Blood Pressure; Body Mass Index; Case-Control St | 2004 |
Adiponectin is a candidate marker of metabolic syndrome in obese children and adolescents.
Topics: Adiponectin; Adolescent; Biomarkers; C-Reactive Protein; Child; Female; Humans; Insulin; Interleukin | 2006 |
Metabolic syndrome in obese Caucasian children: prevalence using WHO-derived criteria and association with nontraditional cardiovascular risk factors.
Topics: Adolescent; Albuminuria; Blood Glucose; Cardiovascular Diseases; Child; Female; Glucose Tolerance Te | 2006 |
Serum uric acid as an obesity-related indicator in early adolescence.
Topics: Adolescent; Alanine Transaminase; Aspartate Aminotransferases; Body Height; Body Mass Index; Child; | 2006 |
The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China.
Topics: Adult; Aged; Alcohol Drinking; China; Cross-Sectional Studies; Female; Gout; Humans; Hypercholestero | 2006 |
[Hyperuricaemia in males with obstructive sleep apnoea (osa)].
Topics: Body Mass Index; Comorbidity; Humans; Hyperuricemia; Male; Metabolic Syndrome; Middle Aged; Obesity; | 2005 |
Serum uric acid is a determinant of metabolic syndrome in a population-based study.
Topics: Abdominal Fat; Adult; Aged; Biomarkers; Coronary Disease; Cross-Sectional Studies; Disease Susceptib | 2006 |
[The influence of ambulatory tested hypocaloric diet on biochemical indexes of patients of different ages suffering from obesity].
Topics: Adult; Ambulatory Care; Body Weight; Caloric Restriction; Creatinine; Diet, Reducing; Female; Humans | 2006 |
[Hyperuricaemia in females with obstructive sleep apnoea].
Topics: Aged; Body Mass Index; Comorbidity; Estrogens; Female; Humans; Hypertension, Pulmonary; Hyperuricemi | 2006 |
Ultrasonographic and biochemical evaluation of visceral obesity in obese women with non-alcoholic fatty liver disease.
Topics: Adult; Age Factors; Alanine Transaminase; Aspartate Aminotransferases; Blood Glucose; Blood Pressure | 2007 |
[Metabolic and anthropometric profile of Aruák Indians: Mehináku, Waurá and Yawalapití in the Upper Xingu, Central Brazil, 2000-2002].
Topics: Adult; Anthropometry; Body Constitution; Brazil; Chronic Disease; Dyslipidemias; Female; Humans; Hyp | 2007 |
Serum uric acid is significantly related to the components of the metabolic syndrome in Japanese workingmen.
Topics: Adult; Biomarkers; Blood Glucose; C-Reactive Protein; Cross-Sectional Studies; Dyslipidemias; Employ | 2007 |
Sympathoadrenergic and metabolic factors are involved in ambulatory blood pressure rise in childhood obesity.
Topics: Adolescent; Albuminuria; Aldosterone; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Body Ma | 2008 |
Obesity and hepatitis B infection are associated with increased risk of metabolic syndrome in university freshmen.
Topics: Adolescent; Adult; Alcohol Drinking; Body Mass Index; Epidemiologic Methods; Exercise; Female; Hepat | 2008 |
A comparison of uric acid levels in Black African vs Caucasian women from South Africa: the POWIRS study.
Topics: Adult; Black People; Blood Pressure; Blood Pressure Determination; Diet Surveys; Female; Humans; Met | 2007 |
For the patient. Obesity, uric acid, and high blood pressure.
Topics: Adult; Black People; Female; Humans; Hypertension; Obesity; South Africa; Uric Acid; White People | 2007 |
The relationship between obesity and transforming growth factor beta on renal damage in essential hypertension.
Topics: Adult; Albuminuria; Blood Glucose; Body Mass Index; Case-Control Studies; Creatinine; Female; Humans | 2007 |
Comparison of serum uric acid levels between Japanese with and without metabolic syndrome.
Topics: Abdominal Fat; Adult; Aged; Alcohol Drinking; Asian People; Dyslipidemias; Female; Humans; Male; Met | 2008 |
Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population: the MONICA/KORA cohort study.
Topics: Aged; C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Dyslipidemias; Follow-Up Studies; | 2008 |
Uric acid indicates a high cardiovascular risk profile but is not closely associated with insulin resistance in obese adolescents.
Topics: Adolescent; Cardiovascular Diseases; Humans; Insulin Resistance; Metabolic Syndrome; Obesity; Risk F | 2008 |
Serum uric acid levels and risk of metabolic syndrome in healthy adults.
Topics: Adult; Biomarkers; Cross-Sectional Studies; Female; Humans; Hypertension; Hypertriglyceridemia; Hype | 2008 |
Sex-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMI.
Topics: Adult; Aged; Austria; Body Mass Index; Diabetes Mellitus, Type 2; Female; Genetic Variation; Genotyp | 2008 |
Serum uric acid concentration among business executives. With observations on other coronary heart disease risk factors.
Topics: Adult; Aging; Alcoholic Beverages; Body Constitution; Cholesterol; Coronary Disease; Humans; Male; M | 1967 |
Correlations of serum uric acid and lipid concentrations in normal, gouty, and atherosclerotic men.
Topics: Adult; Arteriosclerosis; Black or African American; Blood Donors; Cholesterol; Ethnology; Female; Gl | 1967 |
Metabolic observations during starvation and refeeding in massively obese patients.
Topics: 17-Ketosteroids; Acidosis; Adolescent; Adrenal Cortex Hormones; Adult; Bicarbonates; Body Weight; Ch | 1967 |
Relationship of obesity to serum triglyceride, cholesterol, and uric acid, and to plasma-glucose levels.
Topics: Adult; Aged; Blood Glucose; Body Weight; Cholesterol; Glycerides; Humans; Male; Middle Aged; Obesity | 1967 |
[Ketosis during fasting].
Topics: Adult; Aged; Fasting; Female; Humans; Ketone Bodies; Male; Middle Aged; Obesity; Uric Acid | 1967 |
The coronary profile: 12-year follow-up in the Framingham study.
Topics: Age Factors; Angina Pectoris; Blood Pressure; Cholesterol; Coronary Disease; Death, Sudden; Diabetes | 1967 |
Uric acid and diabetes: observations in a population study.
Topics: Adult; Blood Glucose; Diabetes Mellitus; Humans; Hypercholesterolemia; Hyperglycemia; Male; Middle A | 1982 |
Elevated erythrocyte phosphoribosylpyrophosphate and ATP concentrations in Japanese sumo wrestlers.
Topics: Adenine Nucleotides; Adenosine Triphosphate; Body Weight; Dietary Proteins; Erythrocytes; Humans; Ja | 1983 |
[Effect of a fiber-containing dietary formula on metabolism].
Topics: Blood Pressure; Creatinine; Diet, Reducing; Dietary Fiber; Electrolytes; Food, Formulated; Humans; N | 1982 |
[A longitudinal study of secondary prevention of heart infarct].
Topics: Aftercare; Aged; Blood Glucose; Female; Humans; Hyperlipidemias; Hypertension; Longitudinal Studies; | 1983 |
Cardiovascular changes after weight reduction in obesity hypertension.
Topics: Blood Pressure; Body Weight; Diet, Reducing; Diet, Sodium-Restricted; Female; Hemodynamics; Humans; | 1983 |
[Fructose versus glucose. The effects on metabolic parameters in patients with "severe obesity"].
Topics: Acute Disease; Adolescent; Adult; Blood Glucose; Female; Fructose; Glucose Tolerance Test; Humans; I | 1983 |
Relationship of body fat distribution to blood pressure, carbohydrate tolerance, and plasma lipids in healthy obese women.
Topics: Adipose Tissue; Adolescent; Adult; Anthropometry; Blood Pressure; Body Height; Body Weight; Female; | 1983 |
Epidemiological studies on obesity in a Japanese rural district: the metabolic aspects of adult obesity comparing with child obesity.
Topics: Adult; Age Factors; Aged; Blood Glucose; Child; Female; Humans; Insulin; Japan; Lipids; Male; Middle | 1983 |
Serum uric acid concentrations in offspring of conjugal diabetic parents.
Topics: Adult; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Obesity; Uric Acid | 1984 |
[Ambulatory treatment of obesity with modified fasting (Modifast)].
Topics: Adolescent; Adult; Aged; Blood Glucose; Body Weight; Cholesterol; Diet, Reducing; Energy Intake; Hum | 1984 |
Hyperuricaemia, gout and kidney function in New Zealand Maori men.
Topics: Adult; Alcohol Drinking; Ethnicity; Gout; Humans; Kidney; Male; Middle Aged; New Zealand; Obesity; S | 1984 |
[Angina pectoris in patients with arterial hypertension aged 40-59 years. I. Incidence and risk factors].
Topics: Adult; Angina Pectoris; Humans; Hypercholesterolemia; Hyperglycemia; Hypertension; Male; Middle Aged | 1984 |
Reduced intestinal permeability to low-molecular-weight polyethyleneglycols (PEG 400) in patients with jejunoileal bypass.
Topics: Adult; Creatinine; Female; Glomerular Filtration Rate; Humans; Ileum; Intestinal Mucosa; Jejunum; Ma | 1984 |
A metabolic ward study of a high protein, very-low-energy diet.
Topics: 3-Hydroxybutyric Acid; Adult; Body Weight; Diet, Reducing; Dietary Proteins; Electrocardiography; Fe | 1983 |
[Risk indicators of atherogenesis in early childhood. Studies on children in Düsseldorf kindergartens].
Topics: Age Factors; Arteriosclerosis; Blood Glucose; Blood Pressure; Body Height; Body Weight; Child; Child | 1983 |
[Metabolic disorders in hyperuricemia].
Topics: Diabetes Mellitus; Glycerides; Gout; Humans; Metabolic Diseases; Obesity; Uric Acid | 1983 |
Study on the detection and epidemiology of risk factors in ischemic cardiopathy in some localities of Bihor county.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Coronary Disease; Diabetes Complications; Female; | 1983 |
"Pink urine" in morbidly obese patients following gastric partitioning.
Topics: Adult; Color; Crystallography; Female; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Obesit | 1984 |
Safety and effectiveness of weight reduction using a very-low-calorie formulated food.
Topics: Blood Proteins; Body Weight; Cholesterol; Diet, Reducing; Electrolytes; Food, Formulated; Humans; Hy | 1984 |
The effects of fasting on serum and urinary gonadotropins in obese postmenopausal women.
Topics: Acetoacetates; Adult; Fasting; Female; Follicle Stimulating Hormone; Humans; Kinetics; Luteinizing H | 1980 |
[The hypothyroid rheumatic syndrome in the strict sense (author's transl)].
Topics: Adult; Aged; Diabetes Complications; Female; Humans; Hypertension; Hypothyroidism; Male; Middle Aged | 1980 |
Risk factor modification in the framework of rehabilitation. Results of a long-term rehabilitation program in Bavaria.
Topics: Cholesterol; Exercise Therapy; Germany, West; Humans; Hypertension; Long-Term Care; Myocardial Infar | 1982 |
Urine composition following jejunoileal bypass.
Topics: Adult; Calcium; Citrates; Creatinine; Female; Humans; Ileum; Jejunum; Magnesium; Male; Middle Aged; | 1983 |
[Thyroid and adrenal diagnosis in obesity are not worth while].
Topics: Adult; Aged; Body Weight; Cushing Syndrome; Diabetes Complications; Female; Humans; Hyperlipidemias; | 1983 |
[Comparison of 2 isocaloric diets with different carbohydrate content in the treatment of essential obesity].
Topics: Adolescent; Adult; Blood Glucose; Diabetes Mellitus; Diet, Reducing; Dietary Carbohydrates; Female; | 1980 |
Fructose for weight reduction.
Topics: Fructose; Humans; Insulin; Obesity; Sweetening Agents; Uric Acid | 1980 |
[100 years of gout: from quackery and hypothesis to directed therapy].
Topics: Europe; Gout; Gout Suppressants; History, 19th Century; History, 20th Century; Humans; Life Style; M | 1982 |
Coronary heart disease risk factors in black and white man in zimbabwe and the effect of living standards.
Topics: Adult; Age Factors; Black or African American; Black People; Blood Glucose; Blood Pressure; Choleste | 1982 |
[Hallux rigidus arthrosis and gout].
Topics: Calcium; Gout; Hallux; Humans; Obesity; Osteoarthritis; Uric Acid | 1982 |
[The cardiovascular risk profile of the long-term diabetic].
Topics: Cardiovascular Diseases; Diabetes Complications; Humans; Hypercholesterolemia; Hypertension; Middle | 1982 |
Erythrocyte sedimentation rate and cardiovascular disease. Results from a population study of women in Göteborg, Sweden.
Topics: Adult; Angina Pectoris; Blood Sedimentation; Cardiovascular Diseases; Cerebrovascular Disorders; Cho | 1982 |
Serum high density lipoprotein cholesterol: as a cholesterol risk factor index for atherosclerotic diseases.
Topics: Aging; Arteriosclerosis; Blood Glucose; Blood Pressure; Cholesterol; Cholesterol, HDL; Coronary Dise | 1982 |
[Hyperuricemia, risk factors of ischemic heart disease and the character of nutrition].
Topics: Adult; Alcohol Drinking; Coronary Disease; Dietary Carbohydrates; Disease Susceptibility; Energy Int | 1982 |
Vegetarian fasting of obese patients: a clinical and biochemical evaluation.
Topics: Adult; Blood Proteins; Diet, Vegetarian; Electrolytes; Fasting; Female; Humans; Lipids; Liver Functi | 1982 |
[Extraarticular diseases and findings in gout].
Topics: Arteriosclerosis; Diabetes Complications; Female; Gout; Humans; Hyperlipoproteinemias; Hypertension; | 1982 |
[Prognosis for disorders of purine metabolism].
Topics: Age Factors; Arterial Occlusive Diseases; Diabetes Mellitus; Germany, East; Gout; Humans; Hyperlipop | 1982 |
[Studies on the incidence of diabetes mellitus in obese patients].
Topics: Adult; Cholesterol; Diabetes Mellitus; Female; Germany, East; Glucose Tolerance Test; Humans; Male; | 1982 |
Modified total fasting and obesity: results of a multicentric study.
Topics: Body Weight; Diet, Reducing; Energy Intake; Fasting; Female; Food, Formulated; Humans; Male; Obesity | 1982 |
Selected physiologic and drug effects on serum uric acid levels in an elderly population.
Topics: Aged; Allopurinol; Diuretics; Female; Humans; Hypertension; Male; Obesity; Probenecid; Thyroid Disea | 1981 |
[Metabolic risk factors in the very old].
Topics: Aged; Aging; Cardiovascular Diseases; Coronary Disease; Diabetes Complications; Female; Humans; Hype | 1981 |
Serum lipid, uric acid and glucose levels in urban black males doing manual or clerical work.
Topics: Adult; Black or African American; Black People; Blood Glucose; Cholesterol; Humans; Lipids; Lipoprot | 1981 |
[The relation between gout and diabetes mellitus].
Topics: Blood Glucose; Diabetes Complications; Diabetes Mellitus; Gout; Humans; Hyperlipoproteinemias; Metab | 1981 |
[The cardiovascular risk profile in patients with disorders of glucose tolerance (borderline diabetes) dependent on the heredity of the diabetes].
Topics: Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Glucose Tolerance Test; Humans; | 1981 |
[Long-term effects of weight reduction on body weight and metabolic parameters in adipose non-diabetics and adipose maturity-onset diabetics].
Topics: Adult; Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus; Fasting; Female; Humans; Male; Mi | 1981 |
[The cardiovascular risk profile in persons with normal glucose tolerance with reference to the familial occurrence of diabetes mellitus].
Topics: Adolescent; Adult; Aged; Cardiovascular Diseases; Diabetes Mellitus; Female; Glucose Tolerance Test; | 1981 |
[Cardiovascular diseases in Vienna. Epidemiological results of the "Vienna Health Study 1979"].
Topics: Adult; Austria; Cardiovascular Diseases; Cerebrovascular Disorders; Cholesterol; Coronary Disease; F | 1981 |
Personal and familial factors in cholesterolemia: criteria for selection of a reference population.
Topics: Adult; Age Factors; Alcohol Drinking; Blood Glucose; Blood Pressure; Body Weight; Cholesterol; Contr | 1980 |
High uric acid as an indicator of cardiovascular disease. Independence from obesity.
Topics: Aged; Body Weight; Cardiovascular Diseases; Coronary Disease; Female; Follow-Up Studies; Gout; Human | 1980 |
[Studies of metabolism of overweight children before and during weight reducing diet applied some weeks (author's transl)].
Topics: Acid-Base Equilibrium; Adolescent; Bilirubin; Blood Glucose; Blood Proteins; Blood Urea Nitrogen; Bo | 1980 |
[Clinical biochemical changes in ischemic heart disease: hyperuricemia as a risk factor].
Topics: Blood Glucose; Blood Proteins; Blood Urea Nitrogen; Cholesterol; Chronic Disease; Coronary Disease; | 1980 |
Serum uric acid: correlation with biochemical, anthropometric, clinical and behavioral parameters in 10,000 Israeli men.
Topics: Adult; Aging; Anthropometry; Coronary Disease; Diabetes Mellitus; Epidemiologic Methods; Ethnicity; | 1980 |
Neutropenia during allopurinol treatment in total therapeutic starvation.
Topics: Adult; Agranulocytosis; Allopurinol; Female; Humans; Male; Neutropenia; Obesity; Starvation; Uric Ac | 1980 |
[Metabolic prognosis of obesity].
Topics: Adolescent; Adult; Aged; Blood Glucose; Body Weight; Cholesterol; Female; Humans; Male; Middle Aged; | 1980 |
Factors influencing the serum uric acid level. A study based on a population survey in Hisayama town, Kyushu, Japan.
Topics: Adult; Age Factors; Aged; Analysis of Variance; Cholesterol; Creatinine; Female; Health Surveys; Hum | 1980 |
[Blood cadmium level in coronary disease depending on the risk factors].
Topics: Adult; Aged; Cadmium; Coronary Disease; Diabetes Mellitus; Humans; Hyperlipidemias; Hypertension; Mi | 1980 |
[Epidemiology and clinical aspects of hyperuricemia and gout].
Topics: Aged; Alcohol Drinking; Blood Pressure; Body Weight; Diagnosis, Differential; Feeding Behavior; Gout | 1980 |
[Treatment of obese patients with a low calorie standardized liquid diet].
Topics: Adolescent; Adult; Blood Chemical Analysis; Body Weight; Diet; Electrolytes; Energy Intake; Female; | 1980 |
[Gout as a joint disease and as a generalized disease. Incidence, diagnosis and therapy].
Topics: Allopurinol; Colchicine; Diabetes Complications; Gout; Humans; Hypertension; Indomethacin; Kidney Di | 1980 |
[Erythrocyte uric acid in the non-gouty subject].
Topics: Benzbromarone; Erythrocytes; Humans; Obesity; Renal Dialysis; Uric Acid | 1980 |
[Associated cardiovascular factors of risk in borderline-diabetes (author's transl)].
Topics: Adult; Aged; Cholesterol; Diabetes Complications; Female; Glucose Tolerance Test; Humans; Hyperlipop | 1980 |
[Longitudinal study of uric acid changes in a constant group from 1968-78].
Topics: Adult; Cholesterol; Female; Humans; Longitudinal Studies; Male; Middle Aged; Obesity; Sex Factors; U | 1980 |
Changes in population cholesterol concentrations and other cardiovascular risk factor levels after five years of the non-communicable disease intervention programme in Mauritius. Mauritius Non-communicable Disease Study Group.
Topics: Adult; Aged; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholesterol; Cross-Sectional | 1995 |
Impact of obstructive sleep apnea and sleepiness on metabolic and cardiovascular risk factors in the Swedish Obese Subjects (SOS) Study.
Topics: Adult; Anthropometry; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Cohort Studies; Female | 1995 |
Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome. The Normative Aging Study.
Topics: Adult; Aged; Aged, 80 and over; Aging; Alcohol Drinking; Anthropometry; Body Constitution; Cohort St | 1995 |
Uric acid homeostasis in lean and obese girls during pubertal development.
Topics: Adolescent; Child; Female; Homeostasis; Humans; Obesity; Osmolar Concentration; Puberty; Reference V | 1994 |
Hyperinsulinaemia, obesity, and syndrome X.
Topics: Adult; Blood Glucose; Blood Pressure; Body Mass Index; Case-Control Studies; Female; Humans; Hyperin | 1994 |
Association of body mass index and waist-hip circumference ratio with cardiovascular disease risk factors in Micronesian Nauruans.
Topics: Abdomen; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anthropometry; Blood Glucose; Blood P | 1993 |
Urate changes in lean and obese boys during pubertal development.
Topics: Adolescent; Case-Control Studies; Child; Cross-Sectional Studies; Homeostasis; Humans; Kidney; Male; | 1996 |
Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators.
Topics: Cluster Analysis; Diabetes Complications; Diabetes Mellitus; Humans; Hyperlipidemias; Hypertension; | 1996 |
[Arterial hypertension and diabetes in Ouagadougou (Burkina Faso)].
Topics: Adult; Aged; Burkina Faso; Diabetes Complications; Diabetic Angiopathies; Female; Humans; Hyperchole | 1996 |
Urinary calcium excretion in treated and untreated essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aldosterone; Antihypertensive Agents; Benzothiadiazines; Blood G | 1996 |
Erythrocyte rheological changes in obese patients: influence of hyperinsulinism.
Topics: Adult; Blood Glucose; Body Mass Index; C-Peptide; Creatinine; Erythrocyte Deformability; Female; Hem | 1996 |
Hyperuricemia among Kuwaitis.
Topics: Adult; Female; Gout; Hospitals, General; Humans; Kuwait; Life Style; Male; Middle Aged; Obesity; Pre | 1996 |
Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study.
Topics: Adipose Tissue; Adolescent; Alcohol Drinking; Arteriosclerosis; Blood Pressure; Body Composition; Bo | 1996 |
Serum uric acid, insulin secretion and resistance in nonhyperuricemic and hyperuricemic obese female subjects.
Topics: Adult; C-Peptide; Female; Glucose Clamp Technique; Humans; Insulin; Insulin Resistance; Insulin Secr | 1996 |
Insulin-like growth factors and their binding proteins before and after weight loss and their associations with hormonal and metabolic parameters in obese adolescent girls.
Topics: Adolescent; Age Factors; Blood Pressure; Body Constitution; Body Mass Index; Cholesterol; Dehydroepi | 1996 |
[Diabetes mellitus at the National Hospital Center of Ouagadougou (Burkina Faso)].
Topics: Adult; Burkina Faso; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Diabetes Me | 1996 |
[Influence of energy expenditure and other factors on the incidence of arterial hypertension in employees with some types of employment in Tychy].
Topics: Adolescent; Adult; Age Distribution; Aged; Air Pollution; Alcohol Drinking; Cholesterol; Energy Meta | 1996 |
[Hyperuricemia as a risk factor for noninfectious diseases in the inhabitants of Chuvashia].
Topics: Adolescent; Adult; Aged; Diabetes Mellitus, Type 2; Female; Humans; Hyperlipidemias; Hypertension; M | 1997 |
[Risk factors and etiology of retinal vein occlusion].
Topics: Adult; Age Factors; Aged; Arteriosclerosis; Behcet Syndrome; Coronary Disease; Diabetes Complication | 1995 |
Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA study. Coronary Artery Risk Development in Young Adults.
Topics: Adult; Black People; Body Mass Index; Cardiovascular Diseases; Cholesterol, HDL; Cross-Sectional Stu | 1998 |
Progression to type 2 diabetes among high-risk groups in Kin-Chen, Kinmen. Exploring the natural history of type 2 diabetes.
Topics: Adult; Age Factors; Blood Glucose; Body Constitution; Body Mass Index; Cholesterol, HDL; Diabetes Me | 1998 |
Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity.
Topics: Adipose Tissue; Adolescent; Adult; Aged; Body Constitution; Body Mass Index; Humans; Male; Middle Ag | 1998 |
The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. 1956.
Topics: Adrenal Cortex Hormones; Androgens; Arteriosclerosis; Body Constitution; Cholelithiasis; Diabetes Me | 1999 |
Serum leptin is associated with serum uric acid concentrations in humans.
Topics: Adipose Tissue; Analysis of Variance; Body Constitution; Body Mass Index; Case-Control Studies; Cros | 1999 |
[Urate affection of kidneys and metabolic disturbances in hypertensive patients].
Topics: Biomarkers; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Female; Humans; | 1999 |
Obesity worsens cardiovascular risk profiles independently of hyperinsulinaemia.
Topics: Adult; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Female; Glucose Tolerance Test; Human | 1997 |
Relationship between serum leptin and fatty liver in Japanese male adolescent university students.
Topics: Adipose Tissue; Adolescent; Adult; Alanine Transaminase; Analysis of Variance; Aspartate Aminotransf | 1999 |
Metabolic syndrome is associated with changes in D-mannose metabolism.
Topics: Aged; Blood Glucose; Body Mass Index; Cholesterol; Diabetes Mellitus, Type 2; Female; Glucose Intole | 1999 |
Age-related change in relationship between body-mass index, serum sialic acid, and atherogenic risk factors.
Topics: Adult; Aging; Arteriosclerosis; Biomarkers; Blood Pressure; Body Mass Index; Cholesterol; Cholestero | 1998 |
Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study.
Topics: Adult; Body Mass Index; Diet, Reducing; Dietary Fats, Unsaturated; Dietary Proteins; Follow-Up Studi | 2000 |
Intrapair resemblance in very low calorie diet-induced weight loss in female obese identical twins.
Topics: Adipose Tissue; Adult; Body Composition; Body Weight; Cardiovascular Diseases; Cholesterol; Choleste | 2000 |
Plasma acyl-estrone levels are altered in obese women.
Topics: Acylation; Adipose Tissue; Adult; Aspartate Aminotransferases; Blood Glucose; Body Composition; Body | 2000 |
The potential role of adenosine in the pathophysiology of the insulin resistance syndrome.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Adipose Tissue; Animals; Coronary Disease; | 2001 |
Hyperinsulinemia and insulin resistance related metabolic syndrome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cross-Sectional Studies; Female; Humans; Hyperglycemia; | 2001 |
Serum leptin correlates with serum uric acid but not serum testosterone in non-obese male adolescents.
Topics: Adolescent; Alanine Transaminase; Body Composition; Body Mass Index; Cholesterol; Estradiol; Humans; | 2000 |
Changes in serum hypoxanthine levels by exercise in obese subjects.
Topics: Adult; Anaerobic Threshold; Body Mass Index; Body Weight; Exercise Test; Humans; Hypoxanthine; Obesi | 2001 |
Hypophosphataemia: cause of the disturbed metabolism in the metabolic syndrome.
Topics: Blood Glucose; Body Mass Index; Cardiovascular Diseases; Cross-Sectional Studies; Diabetes Mellitus, | 2001 |
Body mass index and its related factors in the elderly.
Topics: Aged; Aged, 80 and over; Body Mass Index; Comorbidity; Cross-Sectional Studies; Female; Humans; Hype | 2001 |
Clinical features of familial gout and effects of probable genetic association between gout and its related disorders.
Topics: Age of Onset; Alcohol Drinking; Body Mass Index; Comorbidity; Creatinine; Cross-Sectional Studies; D | 2001 |
Hyperinsulinemia for the development of hypertension: data from the Hawaii-Los Angeles-Hiroshima Study.
Topics: Blood Glucose; Blood Pressure; Body Mass Index; Cholesterol; Female; Hawaii; Humans; Hyperinsulinism | 2001 |
Association of acanthosis nigricans with risk of diabetes mellitus, and hormonal disturbances in arabian females: case-control study.
Topics: Acanthosis Nigricans; Adolescent; Adult; Aged; Aldosterone; Blood Glucose; Blood Pressure; Body Mass | 2001 |
Microalbuminuria, central adiposity and hypertension in the non-diabetic urban population of the MONICA Augsburg survey 1994/95.
Topics: Adult; Age Factors; Aged; Albuminuria; Body Constitution; Cholesterol; Cholesterol, HDL; Diabetes Co | 2001 |
Use of quality control indices in moderately hypocaloric Mediterranean diet for treatment of obesity.
Topics: Absorptiometry, Photon; Adipose Tissue; Adult; Basal Metabolism; Blood Glucose; Body Composition; Bo | 2001 |
Renal handling of uric acid assessed by means of pharmacological tests in obese women.
Topics: Absorption; Adult; Body Mass Index; Cross-Sectional Studies; Female; Homeostasis; Humans; Kidney; Ki | 2001 |
Increased visceral fat accumulation in patients with primary gout.
Topics: Fats; Gout; Humans; Incidence; Japan; Male; Obesity; Uric Acid | 2000 |
[Clinical implication of the body mass and waist/thigh indices in hypertensive patients: correlations with blood uric acid levels].
Topics: Anthropometry; Body Mass Index; Cholesterol; Female; Humans; Hypertension; Male; Middle Aged; Obesit | 2002 |
Metabolic cardiovascular syndrome in obese prepubertal children: the role of high fasting insulin levels.
Topics: Alanine Transaminase; Apolipoproteins; Aspartate Aminotransferases; Blood Pressure; Cardiovascular D | 2002 |
High prevalence of hyperuricemia in adolescent Taiwan aborigines.
Topics: Adolescent; Asian People; Cholesterol; Creatinine; Female; Gout; Humans; Male; Native Hawaiian or Ot | 2002 |
Relative associations of fitness and fatness to fibrinogen, white blood cell count, uric acid and metabolic syndrome.
Topics: Adipose Tissue; Adult; Body Composition; Body Constitution; Body Mass Index; Cross-Sectional Studies | 2002 |
Preobesity in World Health Organization classification involves the metabolic syndrome in Japanese.
Topics: Adult; Asian People; Biomarkers; Blood Glucose; Body Mass Index; Cholesterol, HDL; Cross-Sectional S | 2002 |
Insulin resistance, hyperleptinemia, and obstructive sleep apnea in Launois-Bensaude syndrome.
Topics: Adult; Aged; Body Mass Index; Glucose Clamp Technique; Humans; Hyperinsulinism; Insulin Resistance; | 2002 |
[Gout in young subjects].
Topics: Adolescent; Adult; Age Factors; Angina Pectoris; Back Pain; Diabetes Complications; Fatty Liver; Fem | 1977 |
[Frequency and distribution of types of hyperlipoproteinemia with life-shortening risk factors among ambulant patients (author's transl)].
Topics: Cholesterol; Diabetes Complications; Female; Germany, West; Gout; Humans; Hyperlipidemias; Hypertens | 1975 |
Serum high-density lipoprotein cholesterol, glucose tolerance and other variables in obese black adolescent girls.
Topics: Adolescent; Adult; Black or African American; Black People; Blood Glucose; Blood Pressure; Body Heig | 1979 |
[Interrelationship between purine, carbohydrate, lipid and aminoacid metabolism, in hyperuricaemia and gout (author's transl)].
Topics: Alcoholic Intoxication; Alcoholism; Amino Acids; Carbohydrate Metabolism; Diabetes Mellitus; Fructos | 1978 |
[Frequency of cardiovascular risk factors in renal transplant patients (author's transl)].
Topics: Adolescent; Adult; Cardiovascular Diseases; Cholesterol; Diabetes Complications; Female; Humans; Hyp | 1978 |
[Important prognostic factors for the results of physiotherapeutic exercises in intermittent claudication (author's transl)].
Topics: Aged; Coronary Disease; Diabetes Complications; Exercise Therapy; Female; Humans; Hypercholesterolem | 1977 |
[Diabetes mellitus and coronary disease--common problems in long-term care].
Topics: Adult; Coronary Disease; Diabetes Complications; Female; Humans; Hyperlipidemias; Hypertension; Male | 1979 |
Mechanism and treatment of hypertriglyceridaemia in gout.
Topics: Alcohol Drinking; Allopurinol; Cholesterol; Gout; Humans; Hyperlipidemias; Male; Middle Aged; Obesit | 1979 |
["Resistent" obesity. Clinical and metabolic aspects, cellularity of the adipose tissue and personality factors].
Topics: Adipose Tissue; Adult; Blood Glucose; Female; Humans; Insulin; Lipid Metabolism; Male; Middle Aged; | 1979 |
Epidemiology of coronary heart disease risk factors in a free-living population.
Topics: Adolescent; Adult; Aged; Argentina; Coronary Disease; Diabetes Mellitus; Electrocardiography; Female | 1979 |
[The cardiovascular risk profile of the borderline diabetic].
Topics: Adult; Aged; Cardiovascular Diseases; Coronary Disease; Diabetes Complications; Humans; Hypercholest | 1979 |
Determinants of plasma uric acid.
Topics: Adult; Alcohol Drinking; Female; Genetic Variation; Hematocrit; Humans; Male; Middle Aged; Obesity; | 1979 |
"Ponderal index and serum uric acid levels in healthy medical students".
Topics: Adolescent; Adult; Body Weight; Female; Humans; In Vitro Techniques; Male; Obesity; Students, Medica | 1979 |
[Outpatient care in uric acid disorders].
Topics: Adult; Aged; Alcohol Drinking; Allopurinol; Ambulatory Care; Female; Humans; Male; Metabolic Disease | 1979 |
[Non-drug therapy. Diet therapy. Family physician and family medicine].
Topics: Diabetes Mellitus; Diet, Reducing; Humans; Hyperlipidemias; Obesity; Physical Exertion; Physician-Pa | 1979 |
[Modern differential-therapeutic aspects of the drug therapy of chronic gout].
Topics: Allopurinol; Arteriosclerosis; Citrates; Gout; Humans; Hypertension; Kidney Diseases; Obesity; Pheny | 1979 |
[Uric acid content in hypertension complicated by obesity].
Topics: Adult; Female; Humans; Hypertension; Male; Middle Aged; Obesity; Uric Acid | 1977 |
Cardiovascular risk factors in gross obesity.
Topics: Adult; Age Factors; Blood Glucose; Cardiovascular Diseases; Cholesterol; Female; Follow-Up Studies; | 1977 |
[Outpatient treatment of obesity using a low-carbohydrate diet (author's transl)].
Topics: Adolescent; Adult; Aged; Ambulatory Care; Blood Glucose; Blood Pressure; Body Weight; Cholesterol; D | 1978 |
Overweight in women--metabolic aspects. The population study of women in Göteborg 1968--1969.
Topics: Adult; Alcohol Drinking; Blood Glucose; Blood Pressure; Body Composition; Body Height; Body Weight; | 1978 |
The workinghman's diet. II. Effect of weight reduction in obese patients with hypertension, diabetes, hyperuricemia and hyperlipidemia.
Topics: Body Weight; Diet, Diabetic; Diet, Reducing; Evaluation Studies as Topic; Female; Follow-Up Studies; | 1978 |
[Obesity and cardiovascular risk].
Topics: Adult; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus; Female; Humans; Hyperlipidemias; Hyp | 1978 |
Serum uric acid levels in untreated and PUVA-treated patients with psoriasis.
Topics: Cholesterol; DNA; Epidermis; Humans; Methoxsalen; Obesity; Photochemotherapy; Psoriasis; Purines; Tr | 1978 |
The rarity of coronary heart disease in South African blacks.
Topics: Adolescent; Adult; Age Factors; Black or African American; Black People; Blood Pressure; Child; Chol | 1978 |
[Metabolic studies in the longitudinal study of the Gerontological Research Project].
Topics: Adult; Aged; Aging; Cholesterol; Fatty Acids; Female; Germany, East; Humans; Longitudinal Studies; M | 1978 |
Diabetes and its vascular complications in Malaysia.
Topics: Adult; Aged; Blood Glucose; Cerebrovascular Disorders; Cholesterol; Coronary Disease; Diabetes Melli | 1978 |
[Proceedings: Therapy of obesity using carbohydrate-reduced and carbohydrate-rich isocaloric formula-diets (comparative studies)].
Topics: Cholesterol; Diet, Reducing; Dietary Carbohydrates; Humans; Obesity; Triglycerides; Uric Acid | 1975 |
[Myocardial infarction: comparative study of principal risk factors in the two sexes].
Topics: Adult; Age Factors; Aged; Blood Glucose; Female; France; Humans; Hyperlipidemias; Hypertension; Lipi | 1976 |
[Hyperuricemia in Parkinson's syndrome--by chance or probable?].
Topics: Adult; Aged; Female; Gout; Humans; Hypertension; Levodopa; Male; Middle Aged; Obesity; Parkinson Dis | 1976 |
[Definition and treatment requirements of uricemia].
Topics: Adult; Aged; Chronic Disease; Diabetes Mellitus; Female; Gout; Humans; Hypertension, Renal; Liver Di | 1977 |
Nitrogen sparing induced early in starvation by infusion of branched-chain ketoacids.
Topics: Adult; Amino Acids; Creatinine; Fasting; Female; Humans; Keto Acids; Nitrogen; Obesity; Quaternary A | 1977 |
[Changes of kidney function in obese subjects during absolute fasting (author's transl)].
Topics: Adult; Creatinine; Fasting; Female; Humans; Kidney; Kidney Function Tests; Male; Obesity; p-Aminohip | 1977 |
[Caused of variations in uric acid level in diabetes].
Topics: Diabetes Mellitus; Humans; Obesity; Uric Acid | 1977 |
Epidemiology of serum uric acid among 8000 Japanese-American men in Hawaii.
Topics: Aged; Alcohol Drinking; Coronary Disease; Diabetes Mellitus; Hawaii; Humans; Hypertension; Japan; Ma | 1977 |
Nutritional state and purine metabolism.
Topics: Adult; Age Factors; Aged; Alcohol Drinking; Body Weight; Coronary Disease; Diabetes Complications; D | 1977 |
The effect of weight loss on plasma and urinary uric acid and lipid levels.
Topics: Body Weight; Cholesterol; Female; Gout; Humans; Male; Obesity; Triglycerides; Uric Acid | 1977 |
[The "alcohol-syndrome" from internal medical view (author's transl)].
Topics: Adult; Age Factors; Alcoholism; Anxiety; Fatty Liver; Humans; Hyperlipidemias; Hypertension; Obesity | 1977 |
Hypouricemia in disease: a study of different mechanisms.
Topics: Adenocarcinoma; Adult; Aged; Fanconi Syndrome; Fasting; Female; Humans; Hypoparathyroidism; Kidney; | 1977 |
[Risk factors in the patient of the general practitioner].
Topics: Adult; Age Factors; Aged; Diabetes Mellitus; Family Practice; Female; Heart Diseases; Humans; Male; | 1977 |
[Dr. Atkins' dietetic revolution: a critique].
Topics: Acidosis; Adult; Cholesterol; Diet, Reducing; Dietary Carbohydrates; Dietary Fats; Energy Intake; Hu | 1977 |
[Acute kidney failure as a complication of fasting therapy].
Topics: Acidosis; Acute Kidney Injury; Adult; Diuresis; Fasting; Female; Furosemide; Humans; Ketosis; Middle | 1977 |
[Therapy of obesity--indication and effectiveness of calorically-reduced mixed diets].
Topics: Body Weight; Diet, Reducing; Dietary Carbohydrates; Dietary Fats; Dietary Proteins; Energy Intake; F | 1977 |
Testosterone-producing ovarian tumor associated with erythrocytosis, hyperuricemia, and recurrent deep vein thrombosis.
Topics: Diabetes Mellitus; Female; Humans; Middle Aged; Obesity; Ovarian Neoplasms; Polycythemia; Recurrence | 1977 |
[Frequency and distribution of risk factors in hearing loss].
Topics: Adolescent; Adult; Aged; Deafness; Female; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; | 1977 |
[Therapy of obesity].
Topics: Adolescent; Adult; Alanine Transaminase; Appetite Depressants; Aspartate Aminotransferases; Body Wei | 1976 |
[Health maintenance despite health risks. III. 3 civilization diseases: hypertension, diabetes, and gout].
Topics: Adolescent; Adult; Aged; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus; Female; Gout | 1976 |
[Diabetes mellitus, hyperuricemia and pyelonephritis].
Topics: Adult; Diabetes Complications; Diabetes Mellitus; Humans; Hypoglycemic Agents; Obesity; Purines; Pye | 1976 |
Ischaemic disease in men and women with familial hypercholesterolaemia and xanthomatosis. A comparative study of genetic and environmental factors in 274 heterozygous cases.
Topics: Adult; Cholesterol; Coronary Disease; Female; Heterozygote; Humans; Hypercholesterolemia; Hypertensi | 1976 |
Toxicity following methoxyflurane anaesthesia. IV. The role of obesity and the effect of low dose anaesthesia on fluoride metabolism and renal function.
Topics: Anesthesia; Female; Fluorides; Humans; Kidney; Male; Meperidine; Methoxyflurane; Obesity; Tubocurari | 1976 |
Some factors related to obesity in the Japanese sumo wrestler.
Topics: Adolescent; Adult; Blood Glucose; Blood Pressure; Blood Proteins; Body Composition; Body Constitutio | 1976 |
[Hyperuricaemia and stenotic coronary atherosclerosis. A description of 214 recent cases of myocardial infarction (author's transl)].
Topics: Adult; Aged; Carbohydrate Metabolism; Coronary Disease; Female; Humans; Hyperlipidemias; Male; Metab | 1976 |
[Effect and severity of obesity on serum lipids and serum uric acid].
Topics: Female; Humans; Hyperlipidemias; Lipids; Male; Obesity; Uric Acid | 1976 |
[Pathogenesis of hyperuricemia and its treatment by means of rigorous fasting (so-called null-diet)].
Topics: Allopurinol; Fasting; Humans; Obesity; Probenecid; Uric Acid | 1976 |
[Pathogenesis of hyperuricemia due to reducing].
Topics: Acidosis; Bicarbonates; Diet, Reducing; Exercise Therapy; Female; Humans; Ketones; Male; Obesity; So | 1976 |
[Transposition of the kidney function in persons with obesity under strict fasting].
Topics: Creatinine; Fasting; Humans; Kidney; Obesity; Urea; Uric Acid | 1976 |
[Coronary disease during primary hyperuricemia].
Topics: Adult; Coronary Disease; Female; Humans; Male; Middle Aged; Obesity; Triglycerides; Uric Acid | 1976 |
[Serum levels of uric acid in patients from general practices (author's transl)].
Topics: Age Factors; Cholesterol; Family Practice; Female; Humans; Hypertension; Male; Obesity; Rheumatoid F | 1976 |
Abnormal renal urate homeostasis in systemic disorders.
Topics: Alcoholism; Diabetes Mellitus; Female; Fructose Intolerance; Glomerular Filtration Rate; Glycogen St | 1975 |
Obesity in a New Zealand community.
Topics: Adult; Age Factors; Aged; Blood Glucose; Blood Proteins; Body Height; Body Weight; Family Characteri | 1975 |
Coronary risk factors in New Zealand Maori and European adolescents: The Rotoua Lakes Study 2.
Topics: Adolescent; Body Height; Body Weight; Coronary Disease; Ethnicity; Female; Humans; Hypercholesterole | 1975 |
Etiopathogenesis of the gouty arthritis.
Topics: Arthritis; Gout; Humans; Obesity; Uric Acid | 1975 |
Urologic complications of ileal bypass operation for morbid obesity.
Topics: Body Weight; Calcium; Follow-Up Studies; Humans; Ileum; Intestine, Small; Jejunum; Obesity; Oxalates | 1975 |
Anesthetic biotransformation and renal function in obese patients during and after methoxyflurane or halothane anesthesia.
Topics: Adjuvants, Anesthesia; Adult; Anesthesia, Inhalation; Biopsy, Needle; Biotransformation; Fatty Liver | 1975 |
Hyperuricaemia--to treat or not?
Topics: Alcohol Drinking; Diet; Endocrine System Diseases; Gout; Hematologic Diseases; Humans; Hyperlipidemi | 1975 |
[The interrelation between obesity, hyperinsulinism and hyperuricemia].
Topics: Adolescent; Adult; Aged; Blood Glucose; Cholesterol; Diabetes Complications; Diabetes Mellitus; Fatt | 1975 |
[Metabolic aspects of obesity].
Topics: Carbohydrate Metabolism; Fatty Acids; Humans; Insulin; Insulin Resistance; Obesity; Triglycerides; U | 1975 |
[Factors of coronary risk in men and women].
Topics: Adult; Age Factors; Blood Glucose; Coronary Disease; Female; Follow-Up Studies; Humans; Hypertension | 1975 |
Myocardial infarction in young men. Study of risk factors in nine countries.
Topics: Adult; Australia; Body Weight; Cholesterol; Coronary Disease; Diabetes Complications; Germany, West; | 1975 |
Biochemical aspects of a study of 100 obese white subjects.
Topics: Blood Glucose; Body Weight; Diet, Reducing; Dietary Carbohydrates; Female; Glucose Tolerance Test; H | 1975 |
Treatment of massive obesity with rice/reduction diet program. An analysis of 106 patients with at least a 45-kg weight loss.
Topics: Adolescent; Adult; Aged; Blood Glucose; Blood Pressure; Body Weight; Cholesterol; Diet, Reducing; Fe | 1975 |
[Cerebral infarctions. Study of their prevention].
Topics: Adult; Aged; Atrial Fibrillation; Contraceptive Agents; Diabetes Complications; Female; Heart Diseas | 1975 |
[Diffuse articular chondrocalcinosis and Paget's disease].
Topics: Adult; Aged; Alkaline Phosphatase; Chondrocalcinosis; Diabetes Complications; Female; Humans; Hydrox | 1975 |
[Latent diabetes mellitus as a risk factor in myocardial infarct].
Topics: Adult; Aged; Diabetes Complications; Humans; Hypercholesterolemia; Hypertension; Middle Aged; Myocar | 1975 |
Hypertension in relation to musculoskeletal disorders.
Topics: Blood Pressure; Cholesterol; Female; Humans; Hypertension; Intervertebral Disc; Knee Joint; Male; Ne | 1975 |
[Hyperuricemia and diabetes mellitus].
Topics: Adult; Diabetes Mellitus; Humans; Male; Middle Aged; Obesity; Uric Acid | 1975 |
Screening for risks of cardiovascular disease in children. A preliminary report.
Topics: Austria; Cardiovascular Diseases; Child; Cholesterol; Humans; Mass Screening; Obesity; Risk; Triglyc | 1976 |
[Experience with various fasting-reducing diets with reference to the prevention of hyperuricacidemia].
Topics: Allopurinol; Diet, Reducing; Dietary Carbohydrates; Fasting; Humans; Obesity; Uric Acid | 1976 |
Renal excretion of uric acid during prolonged fasting.
Topics: Adolescent; Adult; Aspirin; Bicarbonates; Fasting; Female; Humans; Hydroxybutyrates; Kidney; Lactate | 1976 |
[Which uric acid value is in need of treatment?].
Topics: Allopurinol; Benzbromarone; Citrates; Coronary Disease; Gout; Humans; Hyperlipidemias; Hypertension; | 1976 |
[First indications of decrease in the incidence of hyperuricemia in North Germany].
Topics: Adult; Aged; Aged, 80 and over; Cross-Sectional Studies; Feeding Behavior; Female; Germany; Gout; Hu | 1992 |
Protein metabolism in obese subjects during a very-low-energy diet.
Topics: Acid-Base Equilibrium; Adult; Blood Glucose; Diet, Reducing; Dietary Proteins; Electrolytes; Energy | 1992 |
Cardiovascular risk factors in obese children in relation to weight and body fat distribution.
Topics: Adipose Tissue; Adolescent; Analysis of Variance; Anthropometry; Apolipoproteins; Blood Glucose; Blo | 1992 |
[The role of hyperinsulinemia on the renal mechanism of hyperuricemia in overweight patients with essential hypertension].
Topics: Female; Humans; Hypertension; Insulin; Kidney; Male; Middle Aged; Natriuresis; Obesity; Uric Acid | 1991 |
Blood groups, serum cholesterol, serum uric acid, blood pressure, and obesity in adolescents.
Topics: ABO Blood-Group System; Adolescent; Analysis of Variance; Blood Pressure; Child; Cholesterol; Female | 1991 |
Safety and effectiveness of a multidisciplinary very-low-calorie diet program for selected obese individuals.
Topics: Adolescent; Adult; Aged; Blood Glucose; Blood Pressure; Body Weight; Cholesterol; Cholesterol, HDL; | 1991 |
Coronary risk factors in newly diagnosed and previously diagnosed type 2 diabetic men with myocardial infarction.
Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Diabetes Complications; Di | 1991 |
Metabolic abnormalities in first-degree relatives of type 2 diabetics.
Topics: Adult; Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Glucose; Glucose Tolerance | 1990 |
Hypertension in obese children: fasting serum insulin levels are closely correlated with blood pressure.
Topics: Anthropometry; Blood Pressure; Child; Female; Humans; Hypertension; Insulin; Male; Obesity; Probabil | 1990 |
Effect of moderate semi-starvation on plasma lipids.
Topics: Adult; Blood Glucose; Cholesterol; Cholesterol, HDL; Diet, Reducing; Energy Intake; Fatty Acids, Non | 1990 |
Serum uric acid correlates in elderly men and women with special reference to body composition and dietary intake (Dutch Nutrition Surveillance System).
Topics: Aged; Alcohol Drinking; Anthropometry; Antihypertensive Agents; Body Mass Index; Body Weight; Diet; | 1990 |
Obesity, hypertension, hyperuricemia and diabetes mellitus among the Cree and Inuit of northern Québec.
Topics: Adolescent; Adult; Aged; Diabetes Mellitus; Female; Humans; Hypertension; Indians, North American; I | 1990 |
Multiple risk factors in hypertension: results from the Gubbio study.
Topics: Adult; Age Factors; Aged; Antiporters; Carrier Proteins; Erythrocytes; Female; Humans; Hypercholeste | 1990 |
Hyperuricemia-hyperlipemia association in the absence of obesity and alcohol abuse.
Topics: Adult; Alcohol Drinking; Cholesterol; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertension; H | 1990 |
Diabetes mellitus and other cardiovascular risk factors in an elderly population.
Topics: Aged; Aged, 80 and over; Cholesterol; Coronary Disease; Diabetes Mellitus; Female; Humans; Hypertens | 1990 |
Relationship between coronary risk factor and arteriographic feature of coronary atherosclerosis.
Topics: Adult; Aged; Cholesterol; Coronary Angiography; Coronary Artery Disease; Diabetes Complications; Fem | 1990 |
Increased parathyroid hormone as a consequence of changed complex binding of plasma calcium in morbid obesity.
Topics: Adult; Arachidonic Acid; Arachidonic Acids; Calcium; Citrates; Citric Acid; Fatty Acids, Nonesterifi | 1986 |
The role of metabolic factors and blood pressure in the association of obesity with osteoarthritis of the knee.
Topics: Adipose Tissue; Aged; Blood Pressure; Cholesterol; Diabetes Mellitus; Female; Humans; Knee Joint; Ma | 1988 |
[Obesity as a risk factor in gout].
Topics: Diet; Female; Gout; Humans; Male; Middle Aged; Obesity; Risk Factors; Uric Acid | 1988 |
[Effect of obesity on blood pressure, serum lipid, liver function, blood sugar and uric acid].
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Female; Humans; Lipids; Liver; Male; Middle Aged; Obesit | 1988 |
Hyperinsulinemia--a link between glucose intolerance, obesity, hypertension, dyslipoproteinemia, elevated serum uric acid and internal cation imbalance.
Topics: Adult; Aged; Arteriosclerosis; Blood Glucose; Female; Glucose Tolerance Test; Humans; Hypertension; | 1987 |
Elevated serum uric acid--a facet of hyperinsulinaemia.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Glucose Tolerance Test; Hu | 1987 |
Plasma uric acid level and its association with diabetes mellitus and some biologic parameters in a biracial population of Fiji.
Topics: Adult; Aged; Black People; Body Constitution; Cholesterol; Diabetes Mellitus; Feeding Behavior; Fema | 1988 |
Altered erythrocyte and plasma sodium and potassium in hypertension, a facet of hyperinsulinemia.
Topics: Erythrocytes; Female; Humans; Hyperinsulinism; Hypertension; Insulin Resistance; Longitudinal Studie | 1988 |
Obesity and knee osteoarthritis. The Framingham Study.
Topics: Activities of Daily Living; Adult; Age Factors; Epidemiologic Methods; Female; Humans; Knee Joint; M | 1988 |
[Diffuse idiopathic dysmetabolic hyperostosis and metabolic diseases].
Topics: Aged; Blood Glucose; Diabetes Complications; Female; Glucose Tolerance Test; Humans; Hyperlipidemias | 1987 |
Nitrogen conservation in starvation revisited: protein sparing with intravenous fructose.
Topics: Acid-Base Equilibrium; Adult; Amino Acids; Blood Glucose; Fasting; Female; Fructose; Glucagon; Human | 1986 |
Simple carbohydrates in the diet.
Topics: Animals; Coronary Artery Disease; Diabetes Mellitus; Dietary Carbohydrates; Dietary Fats; Dietary Pr | 1987 |
Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study.
Topics: Age Factors; Cholesterol; Coronary Disease; Diabetes Complications; Female; Fibrinogen; Humans; Lipi | 1987 |
[Relation between obesity and atherogenic risk factors in a longitudinal study].
Topics: Adult; Arteriosclerosis; Blood Glucose; Blood Pressure; Body Weight; Cholesterol; Female; Humans; Lo | 1986 |
[Hyperuricuria after fasting as a risk factor for the development of uric acid urolithiasis].
Topics: Diuresis; Fasting; Female; Humans; Male; Obesity; Risk; Uric Acid; Urinary Calculi | 1986 |
Studies on the impaired metabolism of uric acid in obese subjects: marked reduction of renal urate excretion and its improvement by a low-calorie diet.
Topics: Adolescent; Adult; Diet, Reducing; Energy Intake; Female; Humans; Kidney; Male; Middle Aged; Obesity | 1986 |
Preventive cardiology for coronary artery disease.
Topics: Cholestyramine Resin; Combined Modality Therapy; Coronary Disease; Humans; Hyperlipidemias; Hyperten | 1985 |
[Cellulite].
Topics: Adipose Tissue; Carbohydrate Metabolism; Cellulitis; Cholesterol; Female; Galactorrhea; Humans; Hype | 1985 |
[Bilateral retinal vein occlusions and general risk factors].
Topics: Aged; Constriction, Pathologic; Diabetic Retinopathy; Female; Heart Failure; Humans; Hypercholestero | 1985 |
[Etiology and pathogenesis of sudden deafness].
Topics: Adult; Cardiovascular Diseases; Female; Hearing Loss, Sudden; Humans; Hyperglycemia; Hyperlipidemias | 1985 |
Biological and social predictors of health in an aging cohort.
Topics: Aged; Aging; Alcohol Drinking; Anthropometry; Blood Glucose; Blood Pressure; Chronic Disease; Epidem | 1985 |
[Ambulatory weight reduction program and possible effects on lipid and purine metabolism].
Topics: Adult; Aged; Body Weight; Cholesterol; Diet, Reducing; Female; Health Education; Humans; Lipids; Mal | 1985 |
Hyperuricemia and hypertriglyceridemia: metabolic basis for the association.
Topics: Adult; Aged; Creatinine; Dietary Carbohydrates; Fat Emulsions, Intravenous; Female; Glucose; Gout; H | 1985 |
Multidisciplinary treatment of obesity with a protein-sparing modified fast: results in 668 outpatients.
Topics: Adult; Behavior Therapy; Blood Glucose; Blood Pressure; Body Weight; Cholesterol; Diet, Reducing; Di | 1985 |
Weight-reducing diets.
Topics: Dairy Products; Diet, Reducing; Dietary Fats; Dietary Proteins; Energy Intake; Energy Metabolism; Fa | 1985 |
Cardiovascular risk factors and obesity: are baseline levels of blood pressure, glucose, cholesterol and uric acid elevated prior to weight gain?
Topics: Adolescent; Adult; Age Factors; Aged; Blood Glucose; Blood Pressure; Body Weight; Cardiovascular Dis | 1985 |
Effect of weight-loss on plasma and urinary levels of uric acid.
Topics: Adult; Aged; Body Weight; Diet Therapy; Dietary Carbohydrates; Female; Gout; Humans; Male; Middle Ag | 1972 |
[8 years of SGPT screening at the District Institute for Blood Donation and Transfusion Services in Karl-Marx-Stadt].
Topics: Adult; Alanine Transaminase; Biopsy; Blood Donors; Clinical Enzyme Tests; Diabetes Mellitus; Fatty L | 1973 |
Hyperuricaemia, gout, and diabetic abnormality in Polynesian people.
Topics: Adult; Aged; Blood; Blood Pressure; Diabetes Mellitus; Ethnology; Female; Glucose Tolerance Test; Gl | 1966 |
Treatment of obesity by total fasting for up to 249 days.
Topics: Adult; Aged; Body Weight; Fasting; Female; Humans; Intestinal Mucosa; Ketones; Male; Middle Aged; Ob | 1966 |
Death from weight-control pills. A case report with objective postmortem confirmation.
Topics: Adult; Amphetamine; Appetite Depressants; Arrhythmias, Cardiac; Death, Sudden; Digitalis Glycosides; | 1969 |
[Ist results of a prospective survey on cardiovascular diseases in a large enterprise].
Topics: Adult; Age Factors; Angina Pectoris; Arteriosclerosis; Cardiovascular Diseases; Cholesterol; France; | 1973 |
[Incidence of primary hyperuricemia in ambulant patients (author's transl)].
Topics: Adult; Age Factors; Aged; Ambulatory Care; Blood Protein Disorders; Diabetes Mellitus; Female; Germa | 1974 |
Sugar and disease.
Topics: Animals; Blood Glucose; Cholesterol; Coronary Disease; Dental Caries; Dermatitis, Seborrheic; Diabet | 1972 |
[Multiple osteonecrosis with type IV hyperlipoproteinemia (author's transl)].
Topics: Adult; Blood Protein Disorders; Bone Diseases; Glucose Tolerance Test; Gout; Hip Joint; Humans; Hype | 1974 |
[Diet therapy in gout].
Topics: Diet Therapy; Diuresis; Gout; Humans; Hypersensitivity; Kidney Diseases; Obesity; Purines; Uric Acid | 1969 |
Inheritance of combined hyperlipoproteinemia: evidence for a new lipoprotein phenotype.
Topics: Adolescent; Adult; Aged; Blood Protein Electrophoresis; Child; Coronary Disease; Diseases in Twins; | 1973 |
Type 3 hyperlipoproteinaemia.
Topics: Adult; Apoproteins; Autopsy; Blood Glucose; Cholesterol; Chylomicrons; Dietary Carbohydrates; Electr | 1973 |
[Coronaropathies in the black African. Clinical, etiological and current epidemiological aspects (apropos of 45 cases)].
Topics: Adult; Age Factors; Aged; Angina Pectoris; Black People; Coronary Disease; Cote d'Ivoire; Diabetes C | 1974 |
[Cardiovascular changes during therapeutic starvation in obese subjects (author's transl)].
Topics: Adult; Blood Glucose; Blood Pressure; Blood Volume; Body Composition; Body Weight; Cardiac Output; C | 1974 |
[Is there an effective prevention of urolithiasis? (author's transl)].
Topics: Activities of Daily Living; Bacteriuria; Calcium; Cystinuria; Humans; Hydrogen-Ion Concentration; Hy | 1974 |
Gout and hyperlipidaemia.
Topics: Adult; Aged; Alcohol Drinking; Allopurinol; Aspartate Aminotransferases; Body Height; Body Weight; C | 1974 |
Hyperuricemia in a child: a complication of treatment of obesity.
Topics: Acetone; Blood Chemical Analysis; Body Height; Body Weight; Child; Dextroamphetamine; Diabetes Melli | 1974 |
[Effect of anthropometric factors on serum concentration of uric acid. Studies on 300 unselected ambulant outpatients (author's transl)].
Topics: Adolescent; Adult; Age Factors; Aged; Anthropometry; Blood Donors; Body Weight; Colorimetry; Female; | 1974 |
Abnormal regulation of carbohydrate metabolism in primary gout.
Topics: Adult; Aged; Blood Glucose; Body Weight; Carbohydrate Metabolism; Cholesterol; Fatty Acids, Nonester | 1974 |
The absence of undesirable changes during consumption of the low carbohydrate diet.
Topics: Adult; Cholesterol; Creatinine; Diet, Reducing; Dietary Carbohydrates; Dietary Fats; Dietary Protein | 1974 |
[Hyperuricemia in hypertension (author's transl)].
Topics: Adult; Age Factors; Aged; Female; Humans; Hypertension; Male; Middle Aged; Obesity; Uric Acid | 1974 |
Alteration of urate metabolism by weight reduction.
Topics: Gout; Humans; Hypertension; Male; Metabolic Clearance Rate; Middle Aged; Obesity; Uric Acid | 1973 |
Coronary heart disease risk factors in men and women. From the population study in Glostrup, Denmark.
Topics: Angina Pectoris; Arteriosclerosis; Blood Glucose; Blood Pressure; Body Constitution; Cardiac Volume; | 1974 |
[The body fat of an active French group of 4000 46-52-year-old men. II. Relations to various biological variables (especially serum lipids) and arterial pressure].
Topics: Blood Glucose; Blood Pressure; Body Weight; Cholesterol; Humans; Lipids; Male; Middle Aged; Obesity; | 1973 |
[Hyperuricemia and myocardial infarct].
Topics: Arteriosclerosis; Coronary Disease; Diabetes Complications; Female; Gout; Humans; Hypercholesterolem | 1972 |
[Uric acid level and body weight].
Topics: Acidosis; Body Weight; Fasting; Female; Gout; Humans; Male; Obesity; Time Factors; Uric Acid | 1972 |
[Gout in women].
Topics: Adult; Age Factors; Female; Gout; Humans; Kidney Diseases; Male; Menopause; Middle Aged; Obesity; Se | 1972 |
[Aseptic, primary osteonecrosis of the femur head].
Topics: Alcoholism; Femur Head; Femur Head Necrosis; Gout; Humans; Hyperlipidemias; Ischemia; Obesity; Osteo | 1972 |
[Diagnostic valence of various risk factor tests for early recognition of coronary diseases].
Topics: Adult; Ballistocardiography; Blood Pressure; Cholesterol; Coronary Disease; Electrocardiography; Hea | 1972 |
[Epidemiology of cerebral vascular occlusions].
Topics: Adult; Age Factors; Cerebrovascular Disorders; Cholesterol; Diabetic Angiopathies; Encephalomalacia; | 1972 |
[Relationship between metabolic diseases and the severity of coronary disease].
Topics: Angina Pectoris; Angiocardiography; Cholesterol; Diabetes Complications; Diabetic Angiopathies; Fema | 1972 |
[Hyperlipidemia and other risk factors in coronary sclerosis].
Topics: Adult; Aged; Cholesterol; Coronary Disease; Diabetes Complications; Glucose Tolerance Test; Humans; | 1972 |
Risk factors in coronary heart disease: possibilities of prevention in the Federal Republic of West Germany.
Topics: Age Factors; Body Weight; Cholesterol; Diabetes Complications; Europe; Female; Germany, West; Hepari | 1972 |
[Changes between 1948 and 1970 in the epidemiology and clinical features of primary gout].
Topics: Adult; Age Factors; Aged; Alcohol Drinking; Blood Protein Disorders; Diabetes Complications; Fatty L | 1973 |
Urinary tract calculi after intestinal shunt operations for the treatment of obesity.
Topics: Adolescent; Adult; Calcium; Defecation; Female; Humans; Ileum; Jejunum; Kidney Calculi; Male; Michig | 1973 |
The Alström syndrome. Report of three cases with further delineation of the clinical, pathophysiological, and genetic aspects of the disorder.
Topics: Adolescent; Adult; Albuminuria; Blood Cell Count; Blood Urea Nitrogen; Child; Complement System Prot | 1973 |
[Hyperlipoproteinemia in out-patients. Occurrence, type distribution and correlation to clinical findings].
Topics: Adult; Age Factors; Aged; Alcohol Drinking; Blood Glucose; Blood Protein Disorders; Body Weight; Dia | 1973 |
Surgical palliation of massive and severe obesity.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Blood Glucose; Body Weight; Calcium; Carotenoids; Cho | 1973 |
[Gout and hyperuricemia during fasting. Action of associated thyroid hormone therapy].
Topics: Adolescent; Adult; Fasting; Female; Gout; Humans; Male; Middle Aged; Obesity; Triiodothyronine; Uric | 1973 |
Considerations in use of jejunoileal bypass in patients with morbid obesity.
Topics: Adolescent; Adult; Alkaline Phosphatase; Ascorbic Acid; Aspartate Aminotransferases; Bilirubin; Caro | 1973 |
Effects of oral alanine administration in fasting obese subjects.
Topics: Administration, Oral; Adult; Alanine; Blood Glucose; Female; Gluconeogenesis; Humans; Hydroxybutyrat | 1973 |
Serum uric acid concentrations in a rural Tswana community in Southern Africa.
Topics: Adolescent; Adult; Age Factors; Aged; Female; Gout; Humans; Male; Middle Aged; Obesity; Sex Factors; | 1973 |
[Relation of blood pressure to the body weight index and to metabolic parameters].
Topics: Adolescent; Adult; Age Factors; Aged; Blood Glucose; Blood Pressure; Body Weight; Cholesterol; Diet, | 1973 |
Metabolic features of Johannesburg Bantu with myocardial infarction.
Topics: Adult; Aged; Arteriosclerosis; Black or African American; Black People; Blood Glucose; Fasting; Fema | 1973 |
Hyperuricemia, gout, and the executive suite.
Topics: Achievement; Adolescent; Adult; Body Height; Body Weight; Drive; Feeding Behavior; Gout; Humans; Mal | 1973 |
Relationship between hepatic morphology and clinical and biochemical findings in morbidly obese patients.
Topics: Adipose Tissue; Adolescent; Adult; Age Factors; Carbohydrate Metabolism; Cell Nucleus; Fatty Liver; | 1973 |
Physical training in human obesity. 3. Effects of long-term physical training on body composition.
Topics: Adipose Tissue; Adolescent; Adult; Blood Glucose; Body Composition; Child; Cholesterol; Female; Gluc | 1973 |
Age dependency of mean values in blood and blood serum of healthy Dutch school children between 4 and 13 years of age.
Topics: Adolescent; Aging; Blood; Blood Proteins; Body Height; Body Surface Area; Body Weight; Calcium; Chil | 1973 |
Surgical treatment of obesity.
Topics: Blood Sedimentation; Calcium; Cholesterol; Diarrhea; Fatty Liver; Folic Acid; Humans; Ileostomy; Iro | 1973 |
Fat body mass. II. Its relationships with some biological parameters, blood pressure and physical training in a population of 8660 men aged 20 to 55.
Topics: Adipose Tissue; Adult; Age Factors; Blood Glucose; Blood Pressure; Body Weight; Cholesterol; Humans; | 1973 |
The diagnostic significance of the finger-tip biopsy in microangiopathies. Pathology of the arteriovenous anastomoses and preterminal circulation.
Topics: Adult; Arteriovenous Anastomosis; Biopsy; Cells, Cultured; Connective Tissue; Diabetic Angiopathies; | 1973 |
[Significance of hyperlipoproteinemia in diabetes mellitus].
Topics: Adult; Cholesterol; Cholinesterases; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathie | 1973 |
[The aetiology of myocardial infarction in young people (author's transl)].
Topics: Adult; Age Factors; Contraceptives, Oral; Female; Humans; Infections; Male; Metabolic Diseases; Myoc | 1973 |
Balanced low-calorie vs. low-protein-low-carbohydrate reducing diets. II. Biochemical changes.
Topics: Acidosis; Adult; Appetite; Blood Glucose; Blood Urea Nitrogen; Diet, Reducing; Dietary Carbohydrates | 1974 |
Protein-sparing effect in obese women fed low calorie diets.
Topics: Adult; Basal Metabolism; Body Weight; Creatinine; Diet, Reducing; Dietary Carbohydrates; Dietary Fat | 1974 |
Epidemiology of serum uric acid and gout in Frenchmen.
Topics: Adult; Age Factors; Body Constitution; Epidemiologic Methods; France; Gout; Humans; Male; Middle Age | 1974 |
[Diet in gout and hyperuricemia].
Topics: Diet Therapy; Gout; Humans; Obesity; Purines; Uric Acid | 1974 |
Plasma uric acids and body weight.
Topics: Body Weight; Obesity; Uric Acid | 1974 |
Proceedings: Gout, hypertriglyceridaemia, and alcohol consumption.
Topics: Alcohol Drinking; Fasting; Gout; Humans; Hyperlipidemias; Male; Obesity; Sulfobromophthalein; Trigly | 1974 |
A clinical syndrome characteristic of primary Type IV-V hyperlipoproteinaemia.
Topics: Abdomen; Adult; Cholesterol; Chylomicrons; Clofibrate; Diabetes Complications; Diet, Reducing; Elect | 1974 |
Relationship between gout and arterial hypertension.
Topics: Acute Disease; Adult; Aged; Blood Pressure; Chronic Disease; Diabetes Complications; Female; Gout; H | 1974 |
Gout and hyperlipidaemia.
Topics: Adult; Aged; Alcohol Drinking; Alkaline Phosphatase; Aspartate Aminotransferases; Beer; Bilirubin; B | 1974 |
Metabolic studies of thiopurinol in man and the pig.
Topics: Adult; Alcohol Drinking; Allopurinol; Animals; Carbon Radioisotopes; Duodenum; Gout; Humans; Hypoxan | 1974 |
Diabetes mellitus among 10,000 adult men. I. Five-year incidence and associated variables.
Topics: ABO Blood-Group System; Adult; Africa, Northern; Age Factors; Aged; Asia; Blood Glucose; Blood Press | 1974 |
Results and correlations of multistage exercise tests in a group of clinically normal business executives.
Topics: Adult; Age Factors; Blood Glucose; Body Weight; Cholesterol; Coronary Disease; Diagnosis, Computer-A | 1970 |
[Prolonged fasting as a method of treating obesity].
Topics: Acid-Base Equilibrium; Aged; Coronary Disease; Diabetes Mellitus; Diabetic Ketoacidosis; Fasting; Fa | 1967 |
Comparisons of serum lipid and uric acid content in white and Negro men.
Topics: ABO Blood-Group System; Adult; Black or African American; Cholesterol; Culture; Diet; Gout; Humans; | 1970 |
[Gout, diabetes mellitus and fatty liver].
Topics: Adult; Arteriosclerosis; Body Weight; Diabetes Complications; Fatty Liver; Female; Gout; Humans; Hyp | 1972 |
Coronary heart disease: risk factors as guides to preventive action.
Topics: Adult; Coronary Disease; Dietary Fats; Female; Humans; Hypercholesterolemia; Hyperglycemia; Hyperten | 1972 |
[Serum uric acid level in the rural population of Austria].
Topics: Adult; Aged; Alcohol Drinking; Austria; Diet; Environmental Health; Female; Humans; Joint Diseases; | 1972 |
Hyperuricemia in health and disease.
Topics: Arteriosclerosis; Arthritis; Blood Group Antigens; Carbohydrate Metabolism; Diabetes Complications; | 1972 |
Proteinuria and mild glucose intolerance.
Topics: Adult; Age Factors; Aged; Blood Glucose; Blood Urea Nitrogen; Body Weight; Creatinine; Fasting; Fema | 1971 |
Factors affecting the mean serum cholesterol.
Topics: Adult; Age Factors; Aged; Blood Pressure; Body Height; Calcinosis; Cholesterol; Coronary Disease; Fe | 1971 |
[Clinical symptoms and progress of gout complicated by urolithiasis].
Topics: Adult; Aged; Diabetes Complications; Female; Gout; Humans; Hypertension; Male; Middle Aged; Obesity; | 1971 |
[Uric acid abnormalities in juveniles. Peculiarities of the clinical picture].
Topics: Adolescent; Adult; Diabetes Complications; Diagnosis, Differential; Fatty Liver; Gout; Humans; Hyper | 1971 |
Plasma lipid levels and platelet adhesiveness in gout.
Topics: Blood Group Antigens; Cholesterol; Fatty Acids, Nonesterified; Glycerides; Gout; Hemoglobinometry; H | 1971 |
[Serum uric acid levels and the occurrence of hyperuricemia].
Topics: Adolescent; Adult; Age Factors; Aged; Blood Pressure Determination; Body Weight; Cerebrovascular Dis | 1971 |
Hyperuricemia and gout in an employee population.
Topics: Adult; Age Factors; Alcoholism; Coronary Disease; Diabetes Complications; Diuretics; Gout; Humans; H | 1971 |
Impairment of glomerular filtration in fasting for obesity.
Topics: Adult; Aged; Aminohippuric Acids; Bicarbonates; Blood Urea Nitrogen; Creatinine; Diet, Reducing; Fas | 1971 |
Contraindications and therapeutic results of fasting in obese patients.
Topics: Anemia; Anuria; Atrial Flutter; Blood; Diabetes Mellitus; Diet, Sodium-Restricted; Fasting; Female; | 1965 |
High blood pressure in men aged 50--a population study of men born in 1913.
Topics: Blood Glucose; Blood Pressure Determination; Blood Sedimentation; Blood Volume; Communicable Disease | 1967 |
Renal function in obese hyperuricaemic Maoris.
Topics: Adult; Chronic Disease; Creatinine; Female; Humans; Kidney; Kidney Diseases; Male; Middle Aged; New | 1969 |
Coronary heart disease in male twins. Hereditary and environmental factors in concordant and discordant pairs.
Topics: Adult; Aged; Angina Pectoris; Autopsy; Blood Pressure; Body Height; Body Weight; Cholesterol; Confli | 1970 |
[Gout from the view of a special hospital for rheumatic patients].
Topics: Acute Disease; Adolescent; Adult; Aged; Austria; Child; Cholesterol; Colchicine; Colic; Diabetes Com | 1971 |
[Ketone bodies in the blood and urine of overweight patients treated by absolute fasting].
Topics: 17-Ketosteroids; Acetoacetates; Adolescent; Adult; Blood Glucose; Blood Pressure; Creatinine; Electr | 1969 |
[Risk factors for heart and circulatory diseases in an aged population. Pilot study in a home for the aged].
Topics: Adult; Aged; Cardiovascular Diseases; Cholesterol; Diet; Electrocardiography; Female; Geriatrics; He | 1969 |
Bilateral parotid gland enlargement and hyperlipoproteinemia.
Topics: Adult; Alcohol Drinking; Blood Glucose; Cholesterol; Diagnosis, Differential; Diet; Female; Glucose | 1969 |
Hyperuricaemia in northern Finland. An epidemiological study of serum uric acid in rural, urban and hospital populations.
Topics: Adolescent; Adult; Age Factors; Aged; Anemia; Body Weight; Cerebrovascular Disorders; Cholesterol; C | 1969 |
[Clinical aspects of arthrosis].
Topics: Adult; Age Factors; Aged; Ankle Joint; Brachial Plexus Neuritis; Cervical Vertebrae; Female; Hand; H | 1970 |
[Metabolic effects of protein diet in 41 obese persons].
Topics: Adolescent; Adult; Body Weight; Calcium; Cholesterol; Diet Therapy; Dietary Proteins; Female; Humans | 1970 |
Uric acid metabolism in starvation.
Topics: Allopurinol; Female; Gout; Humans; Male; Obesity; Starvation; Uric Acid | 1970 |
Hyperglycaemia in the urbanized Aboriginal. The Davenport survey.
Topics: Activities of Daily Living; Adolescent; Adult; Australia; Blood Glucose; Child; Cholesterol; Civiliz | 1970 |
[Dietary management of hazard factors in cardiovascular diseases].
Topics: Aged; Cardiovascular Diseases; Diabetes Complications; Diet Therapy; Humans; Hypercholesterolemia; H | 1970 |
[Physiopathology of essential hypertension].
Topics: Adrenal Glands; Body Constitution; Diabetes Complications; Hemodynamics; Humans; Hypertension; Kidne | 1970 |
[Current problems of gout].
Topics: Blood Glucose; Cholesterol; Coronary Disease; Diabetes Complications; Female; Gout; Humans; Hypercho | 1970 |
Interaction between psychic and somatic risk factors of myocardial infarction.
Topics: Adult; Cholesterol; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Obesity; Persona | 1970 |
[Current status of the therapy of diabetes, with special reference to the diuretic aspects].
Topics: Diabetes Mellitus; Diet, Diabetic; Diuretics; Glucose Tolerance Test; Humans; Hypoglycemic Agents; I | 1970 |
[Incidence of hyperlipemia, hyperuricemia, diabetes mellitus, hypertension and overweight in arterial obliterating disease].
Topics: Adult; Aged; Arteriosclerosis Obliterans; Blood Glucose; Body Weight; Cholesterol; Diabetic Angiopat | 1971 |
[Alterations of lipid metabolism in primary gout and hyperuircemia].
Topics: Adult; Aged; Blood Glucose; Cholesterol; Diabetes Mellitus; Fatty Acids; Fatty Acids, Nonesterified; | 1971 |
The aetiology and possible prevention of myocardial infarction.
Topics: Adult; Age Factors; Aged; Calcium; Diabetes Complications; Female; Humans; Hyperlipidemias; Hyperten | 1971 |
Hyperuricemia and chronic renal disease.
Topics: Adult; Aged; Alcohol Drinking; Chronic Disease; Creatinine; Diabetes Mellitus; Diuretics; Female; Go | 1971 |
[Ischemic heart disease and so-called risk factors--results of an epidemiological study in Erfurt].
Topics: Angina Pectoris; Blood Glucose; Cardiovascular Diseases; Computers; Coronary Disease; Fatty Acids, E | 1971 |
[Gout in young patients].
Topics: Adolescent; Adult; Age Factors; Diabetes Complications; Fatty Liver; Gout; Humans; Hyperlipidemias; | 1971 |
Stress and coronary heart disease.
Topics: Adult; Blood Pressure; Cholesterol; Coronary Disease; Employment; Female; Humans; Male; Mass Screeni | 1971 |
The causes of nonazotemic hyperuricemia.
Topics: Adult; Age Factors; Animals; Arteriosclerosis; Blood Urea Nitrogen; Computers; Coronary Disease; Dia | 1971 |
Triglyceride concentrations in primary gout and gout of chronic lead nephropathy.
Topics: Adult; Aged; Alcoholic Beverages; Cholesterol; Gout; Humans; Kidney Failure, Chronic; Lead Poisoning | 1971 |
[Comparison between blood uric acid values in normal aged patients and in hypertensive, obese or diabetic subjects].
Topics: Aged; Aging; Diabetes Mellitus; Female; Humans; Hypertension; Male; Obesity; Uric Acid | 1967 |
[Fasting in the therapy of obesity].
Topics: Adult; Carbohydrate Metabolism; Diet, Reducing; Enzymes; Fasting; Female; Humans; Ketone Bodies; Lip | 1967 |
Sulphobromophthalein retention in gout and asymptomatic hyperuricaemia.
Topics: Adolescent; Adult; Age Factors; Aged; Alcoholic Beverages; Female; Gout; Humans; Liver; Liver Diseas | 1968 |
Fasting in obese females. I. A study of thyroid function tests, serum proteins and electrolytes.
Topics: Adolescent; Adult; Blood Protein Electrophoresis; Blood Proteins; Calcium; Fasting; Female; Humans; | 1968 |
[Body weight and overweight in urolithiasis with different composition of the concrements].
Topics: Adult; Age Factors; Aged; Body Height; Body Weight; Czechoslovakia; Factor Analysis, Statistical; Fe | 1968 |
Psoriasis and factors affecting the level of uricaemia.
Topics: Female; Follow-Up Studies; Gout; Humans; Male; Obesity; Psoriasis; Respiratory Tract Infections; Sex | 1968 |
[Variations of uricemia during fasting by the obese].
Topics: Fasting; Gout; Humans; Male; Middle Aged; Obesity; Uric Acid | 1968 |
The prevalence of coronary heart disease and associated factors in an Australian rural community.
Topics: Adult; Age Factors; Aged; Australia; Blood Glucose; Blood Pressure; Cholesterol; Coronary Disease; E | 1969 |
[Metabolic changes under total fasting].
Topics: Adult; Blood Glucose; Body Weight; Creatinine; Electrolytes; Fasting; Female; Follow-Up Studies; Hum | 1969 |
[Factors of coronary risk].
Topics: Castration; Coronary Disease; Dietary Fats; Heart Diseases; Humans; Hyperglycemia; Hypertension; Neu | 1969 |
Dietes mellitus and gout. Blood sugar and plasma insulin responses to oral glucose in normal weight, overweight, and gouty patients.
Topics: Adult; Aged; Blood Glucose; Body Weight; Diabetes Complications; Diabetes Mellitus; Dietary Carbohyd | 1969 |
Intestinal uptake of valine in calorie and protein deprivation.
Topics: Adult; Biopsy; Blood Glucose; Blood Urea Nitrogen; Body Weight; Carbon Isotopes; Cholesterol; Creati | 1969 |
Metabolic hazards of fasting.
Topics: Adult; Anemia; Autoanalysis; Blood Cell Count; Blood Proteins; Blood Urea Nitrogen; Body Weight; Chl | 1969 |
Plasma lipids concentrations in obese children living in a cold area.
Topics: Adolescent; Child; Cold Climate; Fatty Acids, Nonesterified; Humans; Japan; Male; Obesity; Skin; Tri | 1969 |
Total fasting, hyperuricaemia and gout.
Topics: Fasting; Female; Gout; Humans; Male; Middle Aged; Obesity; Uric Acid | 1969 |
Hyperuricemia, acute gout, renal insufficiency and urate nephrolithiasis due to starvation.
Topics: Blood; Colchicine; Diet, Reducing; Fasting; Gout; Humans; Kidney Calculi; Kidney Diseases; Obesity; | 1965 |
Serum uric acid in relation to body weight.
Topics: Adolescent; Adult; Aged; Body Weight; Female; Gout; Humans; Male; Middle Aged; Obesity; Uric Acid | 1966 |
Population studies of serum uric acid.
Topics: Black or African American; Blood; Ethnology; Gout; Humans; Obesity; Statistics as Topic; Uric Acid; | 1966 |
Serum uric acid and obesity in Hawaiians.
Topics: Adult; Blood; Ethnology; Hawaii; Humans; Male; Obesity; Uric Acid | 1966 |
Diabetes mellitus in patients with gout.
Topics: Adult; Aged; Animals; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Experimental; Female; Glu | 1966 |